[
  {
    "id": "fd8ef88d-5c1d-408a-8821-22c2ad3a590f",
    "question": "Alzheimer's disease is associated with: September 2012",
    "opa": "Delerium",
    "opb": "Delusion",
    "opc": "Dementia",
    "opd": "All of the above",
    "cop": 2,
    "choice_type": "multi",
    "exp": "Ans. C i.e. Dementia Alzheimer's dementia Coical (NOT subcoical) dementia, Progressive, Associated with Apo E gene, Neurofibrillary tangles are seen and Donepezil is used in management",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. Delirium \n3. Delusion \n4. Dementia",
    "prediction": "C",
    "path": "Reranked Triple1: Alzheimer disease \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple2: dementia \u2014\u2014> caused by \u2014\u2014> tau  \nReranked Triple3: Alzheimer disease \u2014\u2014> associates \u2014\u2014> AD  \nReranked Triple4: AD \u2014\u2014> correlates with \u2014\u2014> diabetes mellitus  \nReranked Triple5: Alzheimer disease \u2014\u2014> resembles \u2014\u2014> Alzheimers disease  \n\nAnswer: C. Dementia",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple2: AD \u2014\u2014> associates \u2014\u2014> memory impairment  \nReranked Triple3: AD \u2014\u2014> associates \u2014\u2014> cognitive impairment  \nReranked Triple4: AD \u2014\u2014> associates \u2014\u2014> cognitive dysfunction  \nReranked Triple5: AD \u2014\u2014> causes \u2014\u2014> cognitive decline  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer disease' 'causes' 'dementia'.\n\nPath-based Evidence 2: 'dementia' 'caused by' 'tau'.\n\nPath-based Evidence 3: 'Alzheimer disease' 'associates' 'AD'.\n\nPath-based Evidence 4: 'AD' 'correlates with' 'diabetes mellitus'.\n\nPath-based Evidence 5: 'Alzheimer disease' 'resembles' 'Alzheimers disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'dementia'.\n\nNeighbor-based Evidence 2: 'AD' 'associates' 'memory impairment'.\n\nNeighbor-based Evidence 3: 'AD' 'associates' 'cognitive impairment'.\n\nNeighbor-based Evidence 4: 'AD' 'associates' 'cognitive dysfunction'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'cognitive decline'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.9999999403953552,
      1.0,
      1.0
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "c2c522e9-595e-4327-a763-7eb93c7fcb88",
    "question": "A 68-year-old male is brought to the outpatient by his wife due to increasing forgetfulness. On taking history in details, wife repoed that for around 6 months patient is having trouble in organising the finances and paying bills, something he has done all his life. He has also become withdrawn and has decreased meeting people. The patient also behaved inappropriately with a female neighbour couple of says back, which is much against his usual nature. The patient denies having any problems and seems indifferent to his wife's concern. He has a medical history of hypeension and type 2 diabetes mellitus There is a family history of Alzheimer disease. On MMSE, score came out to be 23. Which of the following is the most likely diagnosis?",
    "opa": "Alzheimer disease",
    "opb": "Creutzfeldt-Jakob disease",
    "opc": "Dementia with Lewy bodies",
    "opd": "Frontotemporal dementia",
    "cop": 3,
    "choice_type": "multi",
    "exp": "The history is suggestive of executive dysfunction (trouble in organising the finances and paying bills), apathy and disinhibition (decreased socialisation and inappropriate behaviour with women), lack of insight (denies having any problem) and memory disturbances. This is suggestive of frontotemporal dementia, in which personality changes are prominent, memory disturbances appear later in frontotemporal dementia. In contrast, in alzheimers disease memory disturbances are prominent early in the disorder and personality changes later. Creutzfeldt-Jakob disease which is caused by a prion manifests with rapidly progressive dementia, myoclonus, and cerebellar dysfunction.",
    "subject_name": "Psychiatry",
    "topic_name": "Organic Mental Disorders",
    "entity": "1. Age (68-year-old)\n2. Gender (male)\n3. Setting (outpatient)\n4. Symptom (increasing forgetfulness)\n5. Duration (6 months)\n6. Symptoms (trouble in organizing finances and paying bills, decreased social interaction, inappropriate behavior)\n7. Medical history (hypertension, type 2 diabetes mellitus)\n8. Family history (Alzheimer disease)\n9. Medical test result (MMSE score of 23)\n10. Diagnosis options (Alzheimer disease, Creutzfeldt-Jakob disease, Dementia with Lewy bodies, Frontotemporal dementia)",
    "prediction": "A",
    "path": "Reranked Triple1: diabetes -> risk factor -> dementia  \nReranked Triple2: alcohol abuse -> risk factor -> dementia  \nReranked Triple3: dementia -> causes -> AD  \nReranked Triple4: familial Alzheimer disease -> associated with -> Alzheimer disease  \nReranked Triple5: Alzheimer disease -> ASSOCIATES -> memory symptoms  ",
    "neighbor_input": "Reranked Triple1: type 2 diabetes mellitus \u2014\u2014> associated with \u2014\u2014> blood glucose abnormality  \nReranked Triple2: diabetes mellitus \u2014\u2014> associates \u2014\u2014> alzheimer disease  \nReranked Triple3: alcohol abuse \u2014\u2014> risk factor \u2014\u2014> dementia  \nReranked Triple4: diabetes mellitus \u2014\u2014> ASSOCIATEs \u2014\u2014> obesity  \nReranked Triple5: patients (outpatient) \u2014\u2014> has treatment \u2014\u2014> Surgihoney  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Diabetes' is a 'risk factor' for 'dementia'.\n\nPath-based Evidence 2: 'Alcohol abuse' is a 'risk factor' for 'dementia'.\n\nPath-based Evidence 3: 'Dementia' 'causes' 'AD'.\n\nPath-based Evidence 4: 'Familial Alzheimer disease' is 'associated with' 'Alzheimer disease'.\n\nPath-based Evidence 5: 'Alzheimer disease' 'ASSOCIATES' with 'memory symptoms'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'type 2 diabetes mellitus' is 'associated with' 'blood glucose abnormality'.\n\nNeighbor-based Evidence 2: 'diabetes mellitus' 'associates' with 'alzheimer disease'.\n\nNeighbor-based Evidence 3: 'alcohol abuse' is a 'risk factor' for 'dementia'.\n\nNeighbor-based Evidence 4: 'diabetes mellitus' 'ASSOCIATEs' with 'obesity'.\n\nNeighbor-based Evidence 5: 'patients (outpatient)' 'has treatment' with 'Surgihoney'.",
    "entity_confidence_scores": [
      0.7284638285636902,
      0.7518243789672852,
      0.7518243789672852,
      0.6841220855712891,
      0.8651940226554871,
      0.763837456703186,
      0.7049309015274048,
      0.6211963295936584,
      0.6596330404281616,
      0.8405250310897827,
      0.762351393699646,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.7527393102645874,
      0.7327340245246887
    ],
    "question_types": [
      "causation",
      "diagnosis"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "e77f34d2-d64e-4a71-9147-840c56e17ea1",
    "question": "Treatable causes of dementia are -a) Alzheimer's ds.b) Hypothyroidismc) Multi-infarct dementia d) SDH (subdural h'ge) e) Hydrocephalus",
    "opa": "abc",
    "opb": "ade",
    "opc": "bde",
    "opd": "bce",
    "cop": 2,
    "choice_type": "single",
    "exp": "Perhaps the use of word \u201ctreatable\u201d is inappropriate here since all the types of dementia can be \u201ctreated\u201d. The examiner most likely wants to ask the types which can be \u201creversed\u201d or \u201ccured\u201d",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Dementia\n2. Alzheimer's disease\n3. Hypothyroidism\n4. Multi-infarct dementia\n5. SDH (subdural hemorrhage)\n6. Hydrocephalus",
    "prediction": "C",
    "path": [],
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> treats \u2014\u2014> phloroglucinol  \nReranked Triple2: AD \u2014\u2014> treats \u2014\u2014> VK3  \nReranked Triple3: AD \u2014\u2014> treats \u2014\u2014> PPARgamma agonists  \nReranked Triple4: AD \u2014\u2014> treats \u2014\u2014> insulin  \nReranked Triple5: AD \u2014\u2014> treats \u2014\u2014> cholinesterase inhibitor  ",
    "response_of_KG_list_path": [],
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'treats' 'phloroglucinol'.\n\nNeighbor-based Evidence 2: 'AD' 'treats' 'VK3'.\n\nNeighbor-based Evidence 3: 'AD' 'treats' 'PPARgamma agonists'.\n\nNeighbor-based Evidence 4: 'AD' 'treats' 'insulin'.\n\nNeighbor-based Evidence 5: 'AD' 'treats' 'cholinesterase inhibitor'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.903645396232605,
      0.7850020527839661,
      1.0000001192092896,
      0.7687584161758423,
      0.7321019172668457,
      1.0000001192092896,
      0.7321019172668457,
      1.0000001192092896,
      0.7216620445251465,
      0.6137485504150391,
      1.0
    ],
    "question_types": [
      "causation",
      "treatment"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "950da998-b5c3-4495-b7df-6c7b332a11be",
    "question": "Which of the following is most characteristic of the brain in patients with Alzheimer\u2019s disease",
    "opa": "Pigmentary degeneration in hippocampus",
    "opb": "Demyelination in cerebral cortex",
    "opc": "Posterior column degeneration",
    "opd": "Neuronal loss in cerebral cortex",
    "cop": 3,
    "choice_type": "single",
    "exp": "Most prominent feature of alzheimer\u2019s disease is neuronal loss, fibrillary tangles, loss of synapses and amyloid plaque formation.",
    "subject_name": "Medicine",
    "topic_name": null,
    "entity": "1. brain \n2. Alzheimer's disease\n3. hippocampus\n4. Pigmentary degeneration\n5. cerebral cortex\n6. Demyelination\n7. Posterior column degeneration\n8. Neuronal loss",
    "prediction": "D",
    "path": "Reranked Triple1: Neuronal loss -> associated with -> Alzheimer's disease  \nReranked Triple2: Neuronal loss -> causes -> neuronal loss  \nReranked Triple3: Neuronal loss -> caused by -> Abeta  \nReranked Triple4: Neuronal loss -> found in -> mouse  \nReranked Triple5: Neuronal loss -> found in -> central nervous system  ",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> causes \u2014\u2014> neuronal loss in cerebral cortex  \nReranked Triple2: AD \u2014\u2014> causes \u2014\u2014> neurodegeneration  \nReranked Triple3: AD \u2014\u2014> associates \u2014\u2014> neuronal loss  \nReranked Triple4: AD \u2014\u2014> causes \u2014\u2014> brain atrophy  \nReranked Triple5: AD \u2014\u2014> causes \u2014\u2014> cognitive impairment  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Neuronal loss' is 'associated with' 'Alzheimer's disease'.\n\nPath-based Evidence 2: 'Neuronal loss' 'causes' 'neuronal loss'.\n\nPath-based Evidence 3: 'Neuronal loss' is 'caused by' 'Abeta'.\n\nPath-based Evidence 4: 'Neuronal loss' is 'found in' 'mouse'.\n\nPath-based Evidence 5: 'Neuronal loss' is 'found in' 'central nervous system'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'neuronal loss in cerebral cortex'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'neurodegeneration'.\n\nNeighbor-based Evidence 3: 'AD' 'associates' 'neuronal loss'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'brain atrophy'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'cognitive impairment'.",
    "entity_confidence_scores": [
      1.0,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.9999999403953552,
      0.9999999403953552,
      0.8189019560813904,
      1.000000238418579,
      0.8071302771568298,
      1.0,
      0.6826500296592712,
      0.688503623008728,
      1.0,
      1.0,
      1.0,
      0.8348857760429382
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "00c45685-53fb-40a9-a05a-1c75446522cd",
    "question": "All of the following are known predisposing factors for Alzheimer's disease except :",
    "opa": "Down-syndrome",
    "opb": "Low education level",
    "opc": "Smoking",
    "opd": "Female sex",
    "cop": 2,
    "choice_type": "multi",
    "exp": "Answer is C (Smoking):Smoking has not been mentioned as a risk factor, for Alzheimer's disease.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. Down-syndrome\n3. Low education level\n4. Smoking\n5. Female sex",
    "prediction": "C",
    "path": "Reranked Triple1: Down's syndrome \u2014\u2014> TYPE \u2014\u2014> neurological disorder  \nReranked Triple2: Down's syndrome \u2014\u2014> involves \u2014\u2014> brain atrophy  \nReranked Triple3: nicotine \u2014\u2014> treats \u2014\u2014> AD  \nReranked Triple4: nicotine \u2014\u2014> treats \u2014\u2014> Alzheimer's disease  \nReranked Triple5: nicotine \u2014\u2014> regulates \u2014\u2014> Nicotine  ",
    "neighbor_input": "Reranked Triple1: Down-syndrome \u2014\u2014> causes \u2014\u2014> Alzheimer's disease\nReranked Triple2: Low education level \u2014\u2014> causes \u2014\u2014> cognitive decline\nReranked Triple3: Smoking \u2014\u2014> causes \u2014\u2014> neurodegenerative diseases\nReranked Triple4: Female sex \u2014\u2014> causes \u2014\u2014> cognitive dysfunction\nReranked Triple5: Alzheimer's disease \u2014\u2014> associates \u2014\u2014> cognitive impairment",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Down's syndrome' is a 'TYPE' of 'neurological disorder'.\n\nPath-based Evidence 2: 'Down's syndrome' 'involves' 'brain atrophy'.\n\nPath-based Evidence 3: 'nicotine' 'treats' 'AD'.\n\nPath-based Evidence 4: 'nicotine' 'treats' 'Alzheimer's disease'.\n\nPath-based Evidence 5: 'nicotine' 'regulates' 'Nicotine'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Down-syndrome' 'causes' 'Alzheimer's disease'.\n\nNeighbor-based Evidence 2: 'Low education level' 'causes' 'cognitive decline'.\n\nNeighbor-based Evidence 3: 'Smoking' 'causes' 'neurodegenerative diseases'.\n\nNeighbor-based Evidence 4: 'Female sex' 'causes' 'cognitive dysfunction'.\n\nNeighbor-based Evidence 5: 'Alzheimer's disease' 'associates' 'cognitive impairment'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.9350342750549316,
      0.5942739248275757,
      1.0,
      0.7607807517051697,
      0.7249429225921631,
      0.6977973580360413,
      0.6977973580360413,
      0.7105591893196106,
      0.7105591893196106
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "a32d37e0-1592-49c8-ad40-af4a317dc84c",
    "question": "Which of the following statements about the pathology in Alzheimer's disease is not true:",
    "opa": "Neuritic Plaques are formed of amyloid protein",
    "opb": "Neurofibrillary tangles (NFT) are made of tau protein",
    "opc": "NFTs appear extracellularly before intracellular appearance",
    "opd": "Number of NFTs correlates with dementia",
    "cop": 2,
    "choice_type": "multi",
    "exp": "Answer is C (NFTs appear extracellularly before intracellular appearance):NFTs are typically seen intracellularly within the soma and proximal dendrites of neurons. Neurofibrillary Tangles (NFTs) are intracellular accumulations of hyperphosphorylated 'tau' proteins.Neurofibrillary Tangles are Intracellular AccumulationsNeurofibrillary Tangles are intracellular accumulations of hyperphosphorylated microtubule binding protein 'tau'.Paired helical filaments of tau protein (NFTs) form intracellularly within the soma and proximal dendrites of neurons.These cytoskeletal protein tangles (NFTs), initially impede cellular metabolism and axosplasmic transpo leading to impaired synaptic function and eventually to neuronal death.These neurofibrillaty tangles may be seen as extracellular tangles after degeneration of the neuron as evidence of the neuronal cell's demiseNeurofibrillary Tangles are intracellular accumulations that may appear extracellularly alter degeneration of neuron (neuronal death)Histopathological Hallmarks of Alzheimer's DiseaseAmyloid Plaques (Extracellular)Amyloid Neuritic Plaques are formed by extracellular accumulation of beta amyloid deposits within the neutropil'Neuritic' or 'Senile' I3-amyloid plaques are an early histopathological sign of Alzheimer's disease (that occur rarely in healthy subjects)The amyloid 13-protein accumulated in single neuritic plaques is toxic to surrounding structures and adjacent neurons.Clinicopathological studies have shown that amy/aid burden does not directly correlate with severity or duration of dementia.Neurofibrillary Tangles (Intracellular)Neurofibrillary tangles arc formed by intracellular accumulation of hyperphosphorylated microtubule binding protein 'tau'.NFT's occur in many neurodegenerative diseases and /or a group of diseases called laupathies'.These include Frontotemporal dementia, Pick's disease etc. The cooccurance of fi-amyloid plaques with NFT's suggests a diagnosis of AD.The NFT's are toxic to the neurons and neurons with NFT's eventually die and degenerate leaving a residual `ghost tangle', in the extracellular space reminding of the pyramidal cell body in which it was initially formed.Clinicopathological studies have shown that dementia correlates more strongly with NFT's than with senile plaques (3-amyloid)",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. Neuritic Plaques\n3. Amyloid protein\n4. Neurofibrillary tangles (NFT)\n5. Tau protein\n6. Extracellular appearance\n7. Intracellular appearance\n8. Number of NFTs\n9. Dementia",
    "prediction": "C",
    "path": "Reranked Triple1: neurofibrillary tangles (NFT) -> made of -> tau protein  \nReranked Triple2: NFTs -> appear -> intracellularly  \nReranked Triple3: NFTs -> correlates with -> dementia  \nReranked Triple4: neuritic plaques -> causes -> dementia  \nReranked Triple5: neuritic plaques -> formed of -> amyloid protein  ",
    "neighbor_input": "Reranked Triple1: Neurofibrillary tangles (NFT) -> made of -> tau protein  \nReranked Triple2: Neuritic Plaques -> formed of -> amyloid protein  \nReranked Triple3: NFTs -> appear -> intracellularly before extracellular appearance  \nReranked Triple4: Number of NFTs -> correlates with -> dementia  \nReranked Triple5: NFTs -> associated with -> Alzheimer's disease pathology  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Neurofibrillary tangles (NFT)' are 'made of' 'tau protein'.\n\nPath-based Evidence 2: 'NFTs' 'appear' 'intracellularly'.\n\nPath-based Evidence 3: 'NFTs' 'correlate with' 'dementia'.\n\nPath-based Evidence 4: 'Neuritic plaques' 'cause' 'dementia'.\n\nPath-based Evidence 5: 'Neuritic plaques' are 'formed of' 'amyloid protein'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Neurofibrillary tangles (NFT)' are 'made of' 'tau protein'.\n\nNeighbor-based Evidence 2: 'Neuritic Plaques' are 'formed of' 'amyloid protein'.\n\nNeighbor-based Evidence 3: 'NFTs' 'appear' 'intracellularly before extracellular appearance'.\n\nNeighbor-based Evidence 4: The 'Number of NFTs' 'correlates with' 'dementia'.\n\nNeighbor-based Evidence 5: 'NFTs' are 'associated with' 'Alzheimer's disease pathology'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.9999999403953552,
      0.9732257127761841,
      0.9941632151603699,
      1.0,
      1.0,
      0.8382810950279236,
      0.7067744731903076,
      0.6514816880226135,
      0.626657247543335
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "0623f75b-d859-4c1b-972b-e737be8445ea",
    "question": "Age related dementia has been associated with increased levels of",
    "opa": "Homocysteine",
    "opb": "Cysteine",
    "opc": "Tourine",
    "opd": "Methionine",
    "cop": 0,
    "choice_type": "single",
    "exp": "Identification of modifiable risk factors provides a crucial approach to the prevention of dementia.. The findings are consistent with moderately raised plasma total homocysteine (>11 mmol/L), which is common in the elderly, being one of the causes of age-related cognitive decline and dementia Ref Harrison20th edition pg 2445",
    "subject_name": "Medicine",
    "topic_name": "C.N.S",
    "entity": "1. Age-related dementia\n2. Homocysteine\n3. Cysteine\n4. Taurine\n5. Methionine",
    "prediction": "A",
    "path": "Reranked Triple1: dementia syndrome -> type -> aphasia  \nReranked Triple2: aphasia -> associated with -> Alzheimer's disease  \nReranked Triple3: Alzheimer's disease -> associates -> homocysteine  \nReranked Triple4: dementia syndrome -> resembles -> Alzheimer's disease  \nReranked Triple5: Alzheimer's disease -> associated with -> homocysteine  ",
    "neighbor_input": "Reranked Triple1: homocysteine \u2014\u2014> risk factor for \u2014\u2014> AD  \nReranked Triple2: homocysteine \u2014\u2014> induces \u2014\u2014> Hyperhomocysteinemia (HHcy)  \nReranked Triple3: homocysteine \u2014\u2014> modulates \u2014\u2014> beta-amyloid  \nReranked Triple4: homocysteine \u2014\u2014> DISEASE \u2014\u2014> Alzheimer's disease  \nReranked Triple5: dementia syndrome \u2014\u2014> type \u2014\u2014> aphasia  ",
    "response_of_KG_list_path": "Path-based Evidence 1: The condition 'dementia syndrome' is a 'type' of 'aphasia'.\n\nPath-based Evidence 2: 'Aphasia' is 'associated with' 'Alzheimer's disease'.\n\nPath-based Evidence 3: 'Alzheimer's disease' 'associates' with 'homocysteine'.\n\nPath-based Evidence 4: 'Dementia syndrome' 'resembles' 'Alzheimer's disease'.\n\nPath-based Evidence 5: 'Alzheimer's disease' is 'associated with' 'homocysteine'.",
    "response_of_KG_neighbor": "Based on the knowledge graph information provided, here are the natural language conversions:\n\nNeighbor-based Evidence 1: 'homocysteine' is a 'risk factor for' 'AD'.\n\nNeighbor-based Evidence 2: 'homocysteine' 'induces' 'Hyperhomocysteinemia (HHcy)'.\n\nNeighbor-based Evidence 3: 'homocysteine' 'modulates' 'beta-amyloid'.\n\nNeighbor-based Evidence 4: 'homocysteine' is classified as a 'DISEASE' related to 'Alzheimer's disease'.\n\nNeighbor-based Evidence 5: 'dementia syndrome' is a 'type' of 'aphasia'.",
    "entity_confidence_scores": [
      0.8360733389854431,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.698723316192627,
      1.0
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "8c0c5496-7657-415b-b71a-48505ecb10f8",
    "question": "Biochemical etiology of Alzheimer's disease relates to",
    "opa": "Serotonin",
    "opb": "Dopamine",
    "opc": "Acetylcholine",
    "opd": "GABA",
    "cop": 2,
    "choice_type": "single",
    "exp": "Neurotransmitters, which are decreased in Alzheimer's disease:- Acetylcholine (most important), norepinephrine, somatostatin, corticotropin.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. Biochemical etiology\n3. Serotonin\n4. Dopamine\n5. Acetylcholine\n6. GABA",
    "prediction": "C",
    "path": "Reranked Triple1: alzheimer disease \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple2: dementia \u2014\u2014> caused by \u2014\u2014> tau  \nReranked Triple3: alzheimer disease \u2014\u2014> associates \u2014\u2014> AD  \nReranked Triple4: AD \u2014\u2014> correlates with \u2014\u2014> diabetes mellitus  \nReranked Triple5: alzheimer disease \u2014\u2014> associates \u2014\u2014> Abeta (amyloid-beta)  \n\nAnswer: The biochemical etiology of Alzheimer's disease primarily relates to the interactions between tau and Abeta (amyloid-beta) in the context of dementia development.",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> causes \u2014\u2014> cognitive impairment  \nReranked Triple2: AD \u2014\u2014> causes \u2014\u2014> neurodegeneration  \nReranked Triple3: AD \u2014\u2014> causes \u2014\u2014> behavioral dysfunction  \nReranked Triple4: AD \u2014\u2014> causes \u2014\u2014> memory loss  \nReranked Triple5: AD \u2014\u2014> causes \u2014\u2014> synaptic dysfunction  ",
    "response_of_KG_list_path": "Path-based Evidence 1: The relationship between 'alzheimer disease' and 'dementia' is established through the cause 'causes'.\n\nPath-based Evidence 2: 'Dementia' is 'caused by' the presence of 'tau'.\n\nPath-based Evidence 3: 'Alzheimer disease' 'associates' with 'AD'.\n\nPath-based Evidence 4: 'AD' 'correlates with' 'diabetes mellitus'.\n\nPath-based Evidence 5: 'Alzheimer disease' 'associates' with 'Abeta (amyloid-beta)'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'cognitive impairment'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'neurodegeneration'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'behavioral dysfunction'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'memory loss'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'synaptic dysfunction'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.7273221015930176,
      1.0000001192092896,
      1.0,
      1.0,
      0.910812497138977,
      1.0,
      1.0,
      1.0,
      0.8863632082939148,
      0.7717458009719849,
      0.651431679725647,
      1.0
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "c8aa1b3f-76dd-4c07-99b0-5067677413bd",
    "question": "Reversible dementia is seen in all EXCEPT:",
    "opa": "Wernickes encephalopathy",
    "opb": "Alzheimer's",
    "opc": "Hypothyroidism",
    "opd": "Head trauma",
    "cop": 1,
    "choice_type": "multi",
    "exp": "Ans. (b) Alzheimer'sRef: Harrison's 18th ed. 3300-07* Alzheimer's disease is most common cause of irreversible dementia.Reversible vs Irreversible dementiaReversibleIrreversibleVitamin deficiency# B1-Wernicke's# B12-SCID# Nicotinic acid- PellagraAlzheimer'sEndocrine (hypothyroidism, adrenal insufficiency, cushing's)Vascular dementia (multi- infarct)Head trauma and diffuse brain damageHaemorrh age- subdural, epidural,Normal pressure hydrocephalusLeucoencephalopathyPrimary metastatic brain tumorMetabolic disorder (wilson's disease, Leigh disease, Leucodystrophy)Toxic dementia (MCC of reversible dementia)Degenerative disorder (parkinsonism, Pick's disease, Prion's disease, multiple sclerosis, hunting ton's disease, diffuse lewy body dementia)",
    "subject_name": "Psychiatry",
    "topic_name": "Dementia Due to Metabolic Causes",
    "entity": "1. Reversible dementia\n2. Wernickes encephalopathy\n3. Alzheimer's\n4. Hypothyroidism\n5. Head trauma",
    "prediction": "B",
    "path": "Reranked Triple1: Alzheimer's disease \u2014\u2014> resembles \u2014\u2014> dementia  \nReranked Triple2: Alzheimer disease \u2014\u2014> CAUSES \u2014\u2014> dementia  \nReranked Triple3: dementia \u2014\u2014> caused by \u2014\u2014> tau  \nReranked Triple4: tau \u2014\u2014> associates \u2014\u2014> Alzheimer Disease  \nReranked Triple5: Alzheimer Disease \u2014\u2014> causes \u2014\u2014> brain atrophy  ",
    "neighbor_input": "Reranked Triple1: Alzheimer's \u2014\u2014> associated with \u2014\u2014> dementia\nReranked Triple2: Alzheimer's \u2014\u2014> CAUSES \u2014\u2014> Protein misfolded proteins\nReranked Triple3: Alzheimer's \u2014\u2014> USES \u2014\u2014> amyloid PET",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer's disease' 'resembles' 'dementia'.\n\nPath-based Evidence 2: 'Alzheimer disease' 'CAUSES' 'dementia'.\n\nPath-based Evidence 3: 'dementia' 'caused by' 'tau'.\n\nPath-based Evidence 4: 'tau' 'associates' 'Alzheimer Disease'.\n\nPath-based Evidence 5: 'Alzheimer Disease' 'causes' 'brain atrophy'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Alzheimer's' is associated with 'dementia'.\nNeighbor-based Evidence 2: 'Alzheimer's' CAUSES 'protein misfolded proteins'.\nNeighbor-based Evidence 3: 'Alzheimer's' USES 'amyloid PET'.",
    "entity_confidence_scores": [
      0.7703178524971008,
      0.7172037363052368,
      1.0,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.903645396232605,
      1.0,
      0.9091010093688965
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "0e6612f9-8a65-457b-ab0e-9ce5f39ad9fd",
    "question": "In Alzheimer's disease (AD) which of the following is not seen:",
    "opa": "Aphasia",
    "opb": "Acalculia",
    "opc": "Agnosia",
    "opd": "Apraxia",
    "cop": 1,
    "choice_type": "single",
    "exp": "B i.e. Acalculia",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. Aphasia\n3. Acalculia\n4. Agnosia\n5. Apraxia",
    "prediction": "D",
    "path": "Reranked Triple1: Aphasia \u2014\u2014> type of \u2014\u2014> neurodegenerative diseases\nReranked Triple2: Aphasia \u2014\u2014> associated with \u2014\u2014> Abeta\nReranked Triple3: Aphasia \u2014\u2014> involves \u2014\u2014> Abeta42\nReranked Triple4: Aphasia \u2014\u2014> cleaves \u2014\u2014> alcadeinalpha\nReranked Triple5: Aphasia \u2014\u2014> trait \u2014\u2014> Abeta42",
    "neighbor_input": "Reranked Triple1: AD->ASSOCIATES->glycogen synthase kinase 3beta \u2014\u2014> memory deficit  \nReranked Triple2: AD->CAUSES->neurodegeneration \u2014\u2014> cognitive lesion  \nReranked Triple3: AD->TREATMENT->TUDCA \u2014\u2014> metal  \nReranked Triple4: AD->treats->phloroglucinol \u2014\u2014> cognitive deficits  \nReranked Triple5: AD->ASSOCIATES->glycogen synthase kinase 3beta \u2014\u2014> tauopathies",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Aphasia' is a type of 'neurodegenerative diseases'.\nPath-based Evidence 2: 'Aphasia' is associated with 'Abeta'.\nPath-based Evidence 3: 'Aphasia' involves 'Abeta42'.\nPath-based Evidence 4: 'Aphasia' cleaves 'alcadeinalpha'.\nPath-based Evidence 5: 'Aphasia' is a trait of 'Abeta42'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: In Alzheimer's disease, 'glycogen synthase kinase 3beta' is associated with 'memory deficit'.\n\nNeighbor-based Evidence 2: Alzheimer's disease causes 'neurodegeneration' leading to 'cognitive lesion'.\n\nNeighbor-based Evidence 3: In Alzheimer's disease, the treatment 'TUDCA' is related to 'metal'.\n\nNeighbor-based Evidence 4: Alzheimer's disease treats 'phloroglucinol' resulting in 'cognitive deficits'.\n\nNeighbor-based Evidence 5: In Alzheimer's disease, 'glycogen synthase kinase 3beta' is associated with 'tauopathies'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.6475889682769775,
      1.0000001192092896,
      1.0000001192092896,
      0.7298930883407593,
      0.7964770793914795,
      0.633560061454773,
      0.6898353099822998,
      0.5880182981491089,
      0.5017680525779724
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "a7ac5c9e-c372-4419-9cc8-18fcb83f3637",
    "question": "An elderly man presents with features of dementia, ataxia, difficulty in downward gaze and a history of frequent falls. Likely diagnosis is:",
    "opa": "Parkinsons disease",
    "opb": "Progressive supranuclear gaze palsy",
    "opc": "Alzheimers disease",
    "opd": "None of the above.",
    "cop": 1,
    "choice_type": "multi",
    "exp": "Answer is B (Supranuclear gaze palsy): Progressive supranuclear palsy should always be considered when a middle aged/elderly persons presents with a history of repeated falls, & difficulty in downward or horizontal gaze. Steel Richardson syndrome Nature of disorder Is a degenerative disorder where in there occurs loss of neurons in pas of our CNS which are involved with maintenance of posture & equilibrium, namely the Mid brain, Pons, Basal ganglion and cerebellum. The clinical features are characteristic \"Progressive supranuclear palsy should be considered whenever a middle aged or elderly person person presents with history of repeated falls and has an extrapyramidal syndrome accompanied by nuchal dystonia and paralysis of voluntary down gaze\" Factors which distinguish this from Parkinson's marked impairment of voluntary downward gaze and horizontal gaze. extended rather than flexed dystonic posturing absence of tremor poor response to antiparkinsonian medication",
    "subject_name": "Medicine",
    "topic_name": null,
    "entity": "1. elderly man\n2. dementia\n3. ataxia\n4. downward gaze\n5. frequent falls\n6. Parkinsons disease\n7. Progressive supranuclear gaze palsy\n8. Alzheimers disease",
    "prediction": "B",
    "path": "I'm sorry but I cannot provide the requested information as there is no knowledge graph provided. If you could provide the knowledge graph, I would be able to assist you in reranking the triples to answer the question.",
    "neighbor_input": "Reranked Triple1: AD->has symptom->dementia\nReranked Triple2: AD->has symptom->ataxia\nReranked Triple3: AD->has symptom->difficulty in downward gaze\nReranked Triple4: AD->has symptom->memory loss\nReranked Triple5: AD->has symptom->neuronal loss",
    "response_of_KG_list_path": "I'm sorry, but without any input or context, I'm unable to generate the requested natural language representations. If you could provide the knowledge graph or any specific information, I would be happy to assist you further.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' has symptoms of 'dementia'.\nNeighbor-based Evidence 2: 'AD' has symptoms of 'ataxia'.\nNeighbor-based Evidence 3: 'AD' has symptoms of 'difficulty in downward gaze'.\nNeighbor-based Evidence 4: 'AD' has symptoms of 'memory loss'.\nNeighbor-based Evidence 5: 'AD' has symptoms of 'neuronal loss'.",
    "entity_confidence_scores": [
      0.7431753873825073,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.000000238418579,
      0.6266224384307861,
      0.7119573950767517,
      0.9742693901062012,
      0.9742693901062012,
      0.8854602575302124,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896
    ],
    "question_types": [
      "symptom",
      "diagnosis"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "db65f0d5-ec29-40b0-8622-695c4e98cb1e",
    "question": "Features of Alzheimer include all except",
    "opa": "More common in females",
    "opb": "Recent memory loss",
    "opc": "MMSE useful in diagnosis",
    "opd": "Medications offer near 100% cure",
    "cop": 3,
    "choice_type": "multi",
    "exp": "Dementia is a chronic organic mental disorder, characterized by the following main clinical features: 1. Impairment of intellectual functions, 2. Impairment of memory (predominantly of recent memory, especially in early stages), 3. Deterioration of personality with lack of personal care. Reference: A sho textbook of Psychiatry by Niraj Ahuja, page no.22.",
    "subject_name": "Psychiatry",
    "topic_name": "Organic mental disorders",
    "entity": "1. Alzheimer's - disease \n2. Females - gender \n3. Recent memory loss - symptom \n4. MMSE - diagnostic tool \n5. Medications - treatment option",
    "prediction": "D",
    "path": "Reranked Triple1: AD \u2014\u2014> correlates with \u2014\u2014> diabetes mellitus\nReranked Triple2: Alzheimer Disease \u2014\u2014> ASSOCIATES \u2014\u2014> participants\nReranked Triple3: tau \u2014\u2014> associates \u2014\u2014> Alzheimer Disease\nReranked Triple4: dementia \u2014\u2014> caused by \u2014\u2014> tau\nReranked Triple5: brain atrophy \u2014\u2014> ASSOCIATES \u2014\u2014> AD",
    "neighbor_input": "Reranked Triple1: Alzheimer's-disease \u2014\u2014> animal model \u2014\u2014> mice\nReranked Triple2: AD \u2014\u2014> causes \u2014\u2014> oxidative stress\nReranked Triple3: Alzheimer's-disease \u2014\u2014> disease modifier \u2014\u2014> Abeta",
    "response_of_KG_list_path": "Path-based Evidence 1: 'AD' correlates with 'diabetes mellitus'\n\nPath-based Evidence 2: 'Alzheimer Disease' ASSOCIATES with 'participants'\n\nPath-based Evidence 3: 'tau' associates with 'Alzheimer Disease'\n\nPath-based Evidence 4: 'dementia' is caused by 'tau'\n\nPath-based Evidence 5: 'brain atrophy' ASSOCIATES with 'AD'",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Alzheimer's disease' is related to 'animal model' which includes 'mice'.\nNeighbor-based Evidence 2: 'AD' causes 'oxidative stress'.\nNeighbor-based Evidence 3: 'Alzheimer's disease' is modified by 'Abeta'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.8129867315292358,
      0.9999999403953552,
      1.0,
      1.0,
      0.844653308391571,
      0.5110207796096802,
      0.6699285507202148,
      1.000000238418579,
      1.0,
      0.671769380569458,
      0.7847082018852234,
      0.7243226170539856,
      0.7727140188217163
    ],
    "question_types": [
      "treatment",
      "diagnosis",
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "4391cae4-5734-4bac-bd6f-1369c3f40511",
    "question": "Drug used in alzheimer's disease are all EXCEPT:",
    "opa": "Biperidin",
    "opb": "Donepezil",
    "opc": "Rivastigmine",
    "opd": "Memantine",
    "cop": 0,
    "choice_type": "multi",
    "exp": "Ans. (a) BiperidinRef.: Harrison 19th ed. / 2601-02Alzheimer's disease is most common cause of dementia.Drugs Used in the Treatment of Alzheimer's are:* Acetycholine esterase inhiitors:# Donepezil# Tacrine# Galantamine* Rivastigmine: Carbamate derivative of physostigmine* Memantine: NMDA glutaminergic antagonist* Biperidin is an anti cholinergic drug used to treat parkinsonism.",
    "subject_name": "Psychiatry",
    "topic_name": "Degenerative Disorders",
    "entity": "1. Alzheimer's disease\n2. Biperidin\n3. Donepezil\n4. Rivastigmine\n5. Memantine",
    "prediction": "A",
    "path": "Reranked Triple1: Riluzole \u2014\u2014> TREATS -> AD  \nReranked Triple2: Riluzole \u2014\u2014> treats -> Alzheimer's disease  \nReranked Triple3: Rivastigmine \u2014\u2014> treats -> AD (Alzheimer's disease)  \nReranked Triple4: Donepezil \u2014\u2014> is associated with -> Alzheimer's disease  \nReranked Triple5: Memantine \u2014\u2014> is associated with -> Alzheimer's disease  \n\nAnswer: A. Biperidin",
    "neighbor_input": "Reranked Triple1: AD -> treats -> cognitive deficits \u2014\u2014> Alzheimer-like cognitive deficits  \nReranked Triple2: AD -> treats -> dementia \u2014\u2014> cognitive impairment  \nReranked Triple3: AD -> TREATMENT -> donepezil \u2014\u2014> patients  \nReranked Triple4: AD -> TREATMENT -> rivastigmine \u2014\u2014> patients  \nReranked Triple5: AD -> TREATMENT -> memantine \u2014\u2014> patients  \n\nAnswer: A. Biperidin",
    "response_of_KG_list_path": "Path-based Evidence 1: The medication 'Riluzole' 'TREATS' the condition 'AD'.  \nPath-based Evidence 2: The medication 'Riluzole' 'treats' the condition 'Alzheimer's disease'.  \nPath-based Evidence 3: The medication 'Rivastigmine' 'treats' the condition 'AD (Alzheimer's disease)'.  \nPath-based Evidence 4: The medication 'Donepezil' 'is associated with' the condition 'Alzheimer's disease'.  \nPath-based Evidence 5: The medication 'Memantine' 'is associated with' the condition 'Alzheimer's disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: The condition 'AD' 'treats' 'cognitive deficits', specifically 'Alzheimer-like cognitive deficits'.\n\nNeighbor-based Evidence 2: The condition 'AD' 'treats' 'dementia', which is a form of 'cognitive impairment'.\n\nNeighbor-based Evidence 3: The condition 'AD' 'TREATMENT' 'donepezil' for 'patients'.\n\nNeighbor-based Evidence 4: The condition 'AD' 'TREATMENT' 'rivastigmine' for 'patients'.\n\nNeighbor-based Evidence 5: The condition 'AD' 'TREATMENT' 'memantine' for 'patients'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.7137932777404785,
      1.0,
      0.6575609445571899,
      1.0,
      0.6304964423179626,
      1.0000001192092896
    ],
    "question_types": [
      "treatment",
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "194394cb-70ec-4517-9e35-3ca9597cbf57",
    "question": "All are features of Alzheimer's disease except",
    "opa": "Amyloid Angiopathy",
    "opb": "Lewy bodies",
    "opc": "Neurofibrillary tangles",
    "opd": "Senile plaques",
    "cop": 1,
    "choice_type": "multi",
    "exp": "Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually stas slowly and gradually worsens over time.It is the cause of 60-70% of cases of dementia. Gradually, bodily functions are lost, ultimately leading to death.[Although the speed of progression can vary, the typical life expectancy following diagnosis is three to nine years Stages of Alzheimer's disease Effects of ageing on memory but not AD Forgetting things occasionally Misplacing items sometimes Minor sho-term memory loss Not remembering exact details Early stage Alzheimer's Not remembering episodes of forgetfulness Forgets names of family or friends Changes may only be noticed by close friends or relatives Some confusion in situations outside the familiar Middle stage Alzheimer's Greater difficulty remembering recently learned information Deepening confusion in many circumstances Problems with sleep Trouble determining their location Late stage Alzheimer's Poor ability to think Problems speaking Repeats same conversations More abusive, anxious, or paranoid Ref Harrison20th edition pg 2667",
    "subject_name": "Medicine",
    "topic_name": "C.N.S",
    "entity": "1. Alzheimer's disease\n2. Amyloid Angiopathy\n3. Lewy bodies\n4. Neurofibrillary tangles\n5. Senile plaques",
    "prediction": "B",
    "path": "Reranked Triple1: Lewy bodies \u2014\u2014> found in -> brain  \nReranked Triple2: Neurofibrillary tangles \u2014\u2014> ASSOCIATES -> Alzheimer's disease  \nReranked Triple3: Senile plaques \u2014\u2014> found in -> Abeta  \nReranked Triple4: Amyloid Angiopathy \u2014\u2014> correlates -> tau  \nReranked Triple5: neurofibrillary tangles \u2014\u2014> FORM BY -> microtubule-associated protein tau  ",
    "neighbor_input": "Reranked Triple1: AD -> ASSOCIATES -> neurofibrillary tangles \u2014\u2014> Alzheimer's disease\nReranked Triple2: AD -> ASSOCIATES -> senile plaques \u2014\u2014> Alzheimer's disease\nReranked Triple3: AD -> ASSOCIATES -> amyloid-beta \u2014\u2014> Alzheimer's disease\nReranked Triple4: AD -> CAUSES -> amyloid angiopathy \u2014\u2014> NOT Alzheimer's disease\nReranked Triple5: AD -> CAUSES -> Lewy bodies \u2014\u2014> NOT Alzheimer's disease\n\nAnswer: B. Lewy bodies",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Lewy bodies' are 'found in' the 'brain'.\n\nPath-based Evidence 2: 'Neurofibrillary tangles' 'ASSOCIATES' with 'Alzheimer's disease'.\n\nPath-based Evidence 3: 'Senile plaques' are 'found in' 'Abeta'.\n\nPath-based Evidence 4: 'Amyloid Angiopathy' 'correlates' with 'tau'.\n\nPath-based Evidence 5: 'Neurofibrillary tangles' are 'FORMED BY' 'microtubule-associated protein tau'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'ASSOCIATES' 'neurofibrillary tangles' which are linked to 'Alzheimer's disease'.\n\nNeighbor-based Evidence 2: 'AD' 'ASSOCIATES' 'senile plaques' which are linked to 'Alzheimer's disease'.\n\nNeighbor-based Evidence 3: 'AD' 'ASSOCIATES' 'amyloid-beta' which is linked to 'Alzheimer's disease'.\n\nNeighbor-based Evidence 4: 'AD' 'CAUSES' 'amyloid angiopathy' which is linked to 'NOT Alzheimer's disease'.\n\nNeighbor-based Evidence 5: 'AD' 'CAUSES' 'Lewy bodies' which is linked to 'NOT Alzheimer's disease'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.9499473571777344,
      1.000000238418579,
      1.0,
      1.0,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "3dd88978-a99b-4ee4-a51f-0712e9221cbb",
    "question": "Alzheimer's disease, which is involved?",
    "opa": "Frontal coex",
    "opb": "Coical atrophy of temporoparietal coex",
    "opc": "Frontal and parietal coex",
    "opd": "Occipital coex",
    "cop": 1,
    "choice_type": "single",
    "exp": "Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually stas slowly and gradually worsens over time.It is the cause of 60-70% of cases of dementia.The most common early symptom is difficulty in remembering recent events.As the disease advances, symptoms can include problems with language, disorientation (including easily getting lost), mood swings, loss of motivation, not managing self-care, and behavioural issues.As a person's condition declines, they often withdraw from family and society.Gradually, bodily functions are lost, ultimately leading to death.Although the speed of progression can vary, the typical life expectancy following diagnosis is three to nine years.coical atrophy of temporal and parietal lobes Stages of Alzheimer's disease Effects of ageing on memory but not AD Forgetting things occasionally Misplacing items sometimes Minor sho-term memory loss Not remembering exact details Early stage Alzheimer's Not remembering episodes of forgetfulness Forgets names of family or friends Changes may only be noticed by close friends or relatives Some confusion in situations outside the familiar Middle stage Alzheimer's Greater difficulty remembering recently learned information Deepening confusion in many circumstances Problems with sleep Trouble determining their location Late stage Alzheimer's Poor ability to think Problems speaking Repeats same conversations More abusive, anxious, or paranoid Ref Harrison20th edition pg 2345",
    "subject_name": "Medicine",
    "topic_name": "C.N.S",
    "entity": "1. Alzheimer's disease\n2. Frontal coex\n3. Coical atrophy of temporoparietal coex\n4. Parietal coex\n5. Occipital coex",
    "prediction": "B",
    "path": "Reranked Triple1: Alzheimer disease \u2014\u2014> causes \u2014\u2014> brain atrophy  \nReranked Triple2: Alzheimer disease \u2014\u2014> associates \u2014\u2014> AD  \nReranked Triple3: AD \u2014\u2014> correlates with \u2014\u2014> diabetes mellitus  \nReranked Triple4: Alzheimer disease \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple5: dementia \u2014\u2014> caused by \u2014\u2014> tau  ",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> causes \u2014\u2014> brain atrophy  \nReranked Triple2: AD \u2014\u2014> causes \u2014\u2014> cortical atrophy  \nReranked Triple3: AD \u2014\u2014> causes \u2014\u2014> neurodegeneration  \nReranked Triple4: AD \u2014\u2014> causes \u2014\u2014> cognitive decline  \nReranked Triple5: AD \u2014\u2014> causes \u2014\u2014> memory loss  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer disease' 'causes' 'brain atrophy'.\n\nPath-based Evidence 2: 'Alzheimer disease' 'associates' 'AD'.\n\nPath-based Evidence 3: 'AD' 'correlates with' 'diabetes mellitus'.\n\nPath-based Evidence 4: 'Alzheimer disease' 'causes' 'dementia'.\n\nPath-based Evidence 5: 'dementia' 'caused by' 'tau'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'brain atrophy'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'cortical atrophy'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'neurodegeneration'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'cognitive decline'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'memory loss'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.6975382566452026,
      0.605543851852417,
      0.6756089925765991
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "48b32cb1-8b7a-4797-9274-e8697ab08c01",
    "question": "Progressive cognitive impairment is Alzheimer's disease is characterized by",
    "opa": "Nominal aphasia",
    "opb": "Recent memory loss",
    "opc": "No behavioral abnormalities",
    "opd": "All",
    "cop": 1,
    "choice_type": "multi",
    "exp": "Memory impairment is typically an early and prominent feature in dementia, especially in dementias involving the coex, such as dementia of the Alzheimer's type. Early in the course of dementia, memory impairment is mild and usually most marked for recent events. As the course of dementia progresses, memory impairment becomes severe, and only the earliest learned information (e.g., a person's place of bih) is retained. Reference: Kaplan & Sadock's Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry, 11th Edition, page 712.",
    "subject_name": "Psychiatry",
    "topic_name": "Organic mental disorders",
    "entity": "1. Progressive cognitive impairment\n2. Alzheimer's disease\n3. Nominal aphasia\n4. Recent memory loss\n5. Behavioral abnormalities",
    "prediction": "B",
    "path": "Reranked Triple1: Alzheimer disease \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple2: dementia \u2014\u2014> caused by \u2014\u2014> tau  \nReranked Triple3: AD \u2014\u2014> correlates with \u2014\u2014> diabetes mellitus  \nReranked Triple4: Alzheimer disease \u2014\u2014> associates \u2014\u2014> AD  \nReranked Triple5: Alzheimer disease \u2014\u2014> resembles \u2014\u2014> AD  ",
    "neighbor_input": "Reranked Triple1: AD -> causes -> cognitive decline  \nReranked Triple2: AD -> causes -> cognitive impairment  \nReranked Triple3: AD -> causes -> memory loss  \nReranked Triple4: AD -> causes -> behavioral abnormalities  \nReranked Triple5: AD -> causes -> dementia  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer disease' 'causes' 'dementia'.\n\nPath-based Evidence 2: 'dementia' 'caused by' 'tau'.\n\nPath-based Evidence 3: 'AD' 'correlates with' 'diabetes mellitus'.\n\nPath-based Evidence 4: 'Alzheimer disease' 'associates' 'AD'.\n\nPath-based Evidence 5: 'Alzheimer disease' 'resembles' 'AD'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'cognitive decline'.  \nNeighbor-based Evidence 2: 'AD' 'causes' 'cognitive impairment'.  \nNeighbor-based Evidence 3: 'AD' 'causes' 'memory loss'.  \nNeighbor-based Evidence 4: 'AD' 'causes' 'behavioral abnormalities'.  \nNeighbor-based Evidence 5: 'AD' 'causes' 'dementia'.  ",
    "entity_confidence_scores": [
      0.8889167308807373,
      0.9402773380279541,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.7585411667823792,
      0.8933066129684448,
      1.0000001192092896,
      1.0,
      0.876495361328125
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "429c34fe-b313-46eb-a0c3-25dfb8c6178e",
    "question": "True about dementia is: Karnataka 07",
    "opa": "Alzheimer's disease is due to multiple small strokes in the cerebral coex",
    "opb": "Dementia is the loss of distant memory",
    "opc": "Dementia due to atherosclerosis does not progress like Alzheimer's",
    "opd": "Alzheimer's disease is associated with an increase in ACh release in the cerebral coex",
    "cop": 1,
    "choice_type": "multi",
    "exp": "Ans. Dementia is the loss of distant memory",
    "subject_name": "Forensic Medicine",
    "topic_name": null,
    "entity": "1. dementia\n2. Alzheimer's disease\n3. cerebral coex\n4. distant memory\n5. atherosclerosis\n6. ACh release",
    "prediction": "C",
    "path": [],
    "neighbor_input": "Reranked Triple1: AD -> causes -> dementia  \nReranked Triple2: AD -> caused by -> neurodegenerative diseases  \nReranked Triple3: AD -> cause -> cognitive impairment  \nReranked Triple4: AD -> causes -> cognitive decline  \nReranked Triple5: AD -> caused by -> deposition of Abeta in the brain",
    "response_of_KG_list_path": [],
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'dementia'.\n\nNeighbor-based Evidence 2: 'AD' 'caused by' 'neurodegenerative diseases'.\n\nNeighbor-based Evidence 3: 'AD' 'cause' 'cognitive impairment'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'cognitive decline'.\n\nNeighbor-based Evidence 5: 'AD' 'caused by' 'deposition of Abeta in the brain'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.6625076532363892,
      0.695911705493927,
      1.0,
      1.0,
      1.0,
      1.0,
      0.6771513819694519
    ],
    "question_types": [
      "causation",
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "9570fd75-8938-44be-9905-d458c991b390",
    "question": "Following are predispositions of Alzheimer's disease except:",
    "opa": "Down's syndrome",
    "opb": "Head trauma",
    "opc": "Smoking",
    "opd": "Low education group",
    "cop": 2,
    "choice_type": "multi",
    "exp": "Smoking is considered to be one of the protective factors in Alzheimer's disease; however this finding has been inconsistent across the studies. Risk factor for Alzheimer disease Age Head injury HTN Insulin resistance Depression Down syndrome",
    "subject_name": "Psychiatry",
    "topic_name": "Organic Mental Disorders",
    "entity": "1. Alzheimer's disease\n2. Down's syndrome\n3. Head trauma\n4. Smoking\n5. Low education group",
    "prediction": "C",
    "path": "Reranked Triple1: Down's syndrome \u2014\u2014> TYPE -> neurological disorder  \nReranked Triple2: Down's syndrome -> associates -> trisomy 21  \nReranked Triple3: Smoking status -> interacts -> age  \nReranked Triple4: Smoking status -> associates -> dementia  \nReranked Triple5: Alzheimer's disease -> causes -> brain atrophy  ",
    "neighbor_input": "Reranked Triple1: AD -> ASSOCIATES -> Down's syndrome\nReranked Triple2: AD -> ASSOCIATES -> Head trauma\nReranked Triple3: AD -> ASSOCIATES -> Smoking\nReranked Triple4: AD -> ASSOCIATES -> Low education group\nReranked Triple5: AD -> CAUSES -> cognitive disorders",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Down's syndrome' is classified as a 'neurological disorder'.\n\nPath-based Evidence 2: 'Down's syndrome' is associated with 'trisomy 21'.\n\nPath-based Evidence 3: 'Smoking status' interacts with 'age'.\n\nPath-based Evidence 4: 'Smoking status' is associated with 'dementia'.\n\nPath-based Evidence 5: 'Alzheimer's disease' causes 'brain atrophy'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' is associated with 'Down's syndrome'.\n\nNeighbor-based Evidence 2: 'AD' is associated with 'Head trauma'.\n\nNeighbor-based Evidence 3: 'AD' is associated with 'Smoking'.\n\nNeighbor-based Evidence 4: 'AD' is associated with 'Low education group'.\n\nNeighbor-based Evidence 5: 'AD' causes 'cognitive disorders'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.9999999403953552,
      0.796008288860321,
      0.796008288860321,
      1.0,
      0.9198420643806458,
      1.0,
      0.9091010093688965,
      1.0,
      0.7607807517051697,
      0.7249429225921631,
      0.6977973580360413,
      0.6977973580360413,
      0.5193231105804443
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "26009569-b7fd-4357-bbb3-f3f77ac99200",
    "question": "A 55yr old man with dementia was given a natural alkaloid. Which of the following could it be-",
    "opa": "Tacrine",
    "opb": "Donepezil",
    "opc": "Galantamine",
    "opd": "Rivastigmine",
    "cop": 2,
    "choice_type": "single",
    "exp": "Ans. is 'c' i.e., Galantamine Galantamine: o It is a natural alkaloid which selectively inhibits cerebral acetylcholinesterase and has some direct agonistic action on nicotinic receptors as well. o It has produced cognitive and behavioral benefits in Alzheimer's disease",
    "subject_name": "Pharmacology",
    "topic_name": "C.N.S",
    "entity": "1. 55yr\n2. man\n3. dementia\n4. natural alkaloid\n5. Tacrine\n6. Donepezil\n7. Galantamine\n8. Rivastigmine",
    "prediction": "C",
    "path": "Reranked Triple1: Tacrine \u2014\u2014> natural alkaloid\nReranked Triple2: Donepezil \u2014\u2014> natural alkaloid\nReranked Triple3: Galantamine \u2014\u2014> natural alkaloid\nReranked Triple4: Rivastigmine \u2014\u2014> natural alkaloid\nReranked Triple5: Dementia \u2014\u2014> treated by natural alkaloids",
    "neighbor_input": "Reranked Triple1: AD -> treats -> tacrine\nReranked Triple2: AD -> treats -> donepezil\nReranked Triple3: AD -> treats -> galantamine\nReranked Triple4: AD -> treats -> rivastigmine\nReranked Triple5: AD -> treats -> cognitive deficits",
    "response_of_KG_list_path": "Path-based Evidence 1: The compound 'Tacrine' is classified as a 'natural alkaloid'.\n\nPath-based Evidence 2: The compound 'Donepezil' is classified as a 'natural alkaloid'.\n\nPath-based Evidence 3: The compound 'Galantamine' is classified as a 'natural alkaloid'.\n\nPath-based Evidence 4: The compound 'Rivastigmine' is classified as a 'natural alkaloid'.\n\nPath-based Evidence 5: 'Dementia' is a condition that is 'treated by natural alkaloids'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' is known to 'treats' 'tacrine'.\n\nNeighbor-based Evidence 2: 'AD' is known to 'treats' 'donepezil'.\n\nNeighbor-based Evidence 3: 'AD' is known to 'treats' 'galantamine'.\n\nNeighbor-based Evidence 4: 'AD' is known to 'treats' 'rivastigmine'.\n\nNeighbor-based Evidence 5: 'AD' is known to 'treats' 'cognitive deficits'.",
    "entity_confidence_scores": [
      0.7747437953948975,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.8015903234481812,
      1.0,
      1.0,
      0.6575609445571899,
      1.0,
      1.0,
      1.0,
      0.6304964423179626
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "1ead3913-c2cd-4873-aced-aaf5bfe79de9",
    "question": "All of the following are causes of subcoical dementia except",
    "opa": "Alzheimer's disease",
    "opb": "Parkinson's disease",
    "opc": "HIV associated dementia",
    "opd": "Huntington's chorea",
    "cop": 0,
    "choice_type": "multi",
    "exp": "Coical Dementia's * Early Presentation of 4A's (Amnesia, Apraxia, Aphasia, Agnosia, Acalculia) Seen in: Alzheimer Disease Creutzfeldt Jacob Disease Picks disease & other Frontotemporal Dementia. Sub-coical Dementia Involves Sub-coical Structures (Like Basal Ganglia, Cerebellum, Brain Stem Nuclei) first * Present with motor symptoms (e.g. Tics, Chorea, Dysahria) Executive function disturbance and BPSD First Seen in : Parkinson's D/s Wilson's D/s Huntington's D/s, Progressive Supra-nuclear palsy Mixed presentation - Vascular Dementia, Dementia with Lewy Body",
    "subject_name": "Psychiatry",
    "topic_name": "Organic Mental Disorders",
    "entity": "1. subcortical dementia\n2. Alzheimer's disease\n3. Parkinson's disease\n4. HIV associated dementia\n5. Huntington's chorea",
    "prediction": "A",
    "path": "Reranked Triple1: alzheimer disease -> CAUSES -> dementia  \nReranked Triple2: dementia -> caused by -> tau  \nReranked Triple3: alzheimer disease -> causes -> brain atrophy  \nReranked Triple4: alzheimer disease -> ASSOCIATES -> AD  \nReranked Triple5: AD -> resembles -> Alzheimers disease  \n\nAnswer: B. Parkinson's disease, C. HIV associated dementia, and D. Huntington's chorea are not mentioned in the knowledge graph, while Alzheimer's disease is explicitly associated with dementia, making it a cause.",
    "neighbor_input": "Reranked Triple1: AD -> caused by -> Alzheimer's disease\nReranked Triple2: AD -> caused by -> neurodegenerative diseases\nReranked Triple3: AD -> causes -> dementia\nReranked Triple4: AD -> causes -> cognitive impairment\nReranked Triple5: AD -> causes -> neurodegeneration",
    "response_of_KG_list_path": "Path-based Evidence 1: 'alzheimer disease' 'CAUSES' 'dementia'.\n\nPath-based Evidence 2: 'dementia' 'caused by' 'tau'.\n\nPath-based Evidence 3: 'alzheimer disease' 'causes' 'brain atrophy'.\n\nPath-based Evidence 4: 'alzheimer disease' 'ASSOCIATES' 'AD'.\n\nPath-based Evidence 5: 'AD' 'resembles' 'Alzheimer's disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' is 'caused by' 'Alzheimer's disease'.\n\nNeighbor-based Evidence 2: 'AD' is 'caused by' 'neurodegenerative diseases'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'dementia'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'cognitive impairment'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'neurodegeneration'.",
    "entity_confidence_scores": [
      0.882514476776123,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.000000238418579,
      0.9904760718345642,
      0.8395751714706421,
      0.808238685131073
    ],
    "question_types": [
      "causation",
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "b926a691-7278-4c01-bef2-55e39a918474",
    "question": "In Alzheimer's disease, the pathology seen in the brain is -",
    "opa": "Atrophy of parietal and temporal lobes",
    "opb": "Atrophy of temporal lobes",
    "opc": "Atrophy of temporal and occipital lobes",
    "opd": "Atrophy of parietal and occipital lobes",
    "cop": 0,
    "choice_type": "single",
    "exp": "Ans. is 'a' i.e., Atrophy of parietal and temporal lobesGross pathology in Alzhiemer's disease:o Diffuse cerebral atrophy of the hippocampus, amygdala and entorhinal coex.o Enlargement of the ventricles caused by neuronal loss.Grossly the brain shows a variable degree of coical atrophy marked by widening of the cerebral sulci.These changes are most pronounced in the temporal and parietal lobes: Frontal lobes can also be involved.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. brain\n3. atrophy\n4. parietal lobes\n5. temporal lobes\n6. occipital lobes",
    "prediction": "A",
    "path": "Reranked Triple1: atrophy -> caused by -> Abeta  \nReranked Triple2: atrophy -> associated with -> dementia  \nReranked Triple3: atrophy -> predisposes to -> alzheimer's disease  \nReranked Triple4: atrophy -> REGION -> parietal lobe  \nReranked Triple5: atrophy -> REGION -> temporal lobe  \n\nAnswer:  \nIn Alzheimer's disease, the pathology seen in the brain is A. Atrophy of parietal and temporal lobes.",
    "neighbor_input": "Reranked Triple1: AD -> causes -> brain atrophy  \nReranked Triple2: AD -> causes -> cognitive decline  \nReranked Triple3: AD -> causes -> neuronal loss  \nReranked Triple4: AD -> causes -> dementia  \nReranked Triple5: AD -> causes -> cognitive impairment  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'atrophy' 'caused by' 'Abeta'.  \nPath-based Evidence 2: 'atrophy' 'associated with' 'dementia'.  \nPath-based Evidence 3: 'atrophy' 'predisposes to' 'alzheimer's disease'.  \nPath-based Evidence 4: 'atrophy' 'REGION' 'parietal lobe'.  \nPath-based Evidence 5: 'atrophy' 'REGION' 'temporal lobe'.  ",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'brain atrophy'.  \nNeighbor-based Evidence 2: 'AD' 'causes' 'cognitive decline'.  \nNeighbor-based Evidence 3: 'AD' 'causes' 'neuronal loss'.  \nNeighbor-based Evidence 4: 'AD' 'causes' 'dementia'.  \nNeighbor-based Evidence 5: 'AD' 'causes' 'cognitive impairment'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0,
      1.0,
      0.9412471055984497,
      0.8832904100418091,
      1.0,
      0.9632155895233154,
      0.8652887344360352,
      0.7823112607002258
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "34c5ae30-0251-4530-b3d9-71b6ec52e08a",
    "question": "In Alzheimer disease patients, the major effect on neurotransmitter systems of tacrine, donepezil, rivastigmine, and galantamine is to",
    "opa": "increase dopamine availability",
    "opb": "decrease dopamine availability",
    "opc": "increase Ach availability",
    "opd": "decrease Ach availability",
    "cop": 2,
    "choice_type": "single",
    "exp": "Low levels of Ach are associated with the symptoms of Alzheimer disease. Tacrine, donepezil, rivastigmine, and galantamine are acetylcholinesterase inhibitors (i.e., they block the breakdown of Ach, increasing its availability). These agents can thus be effective in slowing down the progression of the illness. They do not restore the function the patient has already lost.",
    "subject_name": "Psychiatry",
    "topic_name": "Organic Mental Disorders",
    "entity": "1. Alzheimer disease\n2. neurotransmitter systems\n3. tacrine\n4. donepezil\n5. rivastigmine\n6. galantamine\n7. dopamine availability\n8. Ach (acetylcholine) availability",
    "prediction": "C",
    "path": "Reranked Triple1: tacrine \u2014\u2014> treats \u2014\u2014> AD (Alzheimer's disease)  \nReranked Triple2: donepezil \u2014\u2014> treats \u2014\u2014> AD (Alzheimer's disease)  \nReranked Triple3: rivastigmine \u2014\u2014> treats \u2014\u2014> AD (Alzheimer's disease)  \nReranked Triple4: galantamine \u2014\u2014> interacts \u2014\u2014> Abeta  \nReranked Triple5: Abeta \u2014\u2014> associates \u2014\u2014> apoptosis  ",
    "neighbor_input": "Reranked Triple1: AD -> treats -> tacrine  \nReranked Triple2: AD -> treats -> donepezil  \nReranked Triple3: AD -> treats -> rivastigmine  \nReranked Triple4: AD -> treats -> galantamine  \nReranked Triple5: AD -> causes -> cognitive impairment ",
    "response_of_KG_list_path": "Path-based Evidence 1: The drug 'tacrine' 'treats' 'AD (Alzheimer's disease)'.\n\nPath-based Evidence 2: The drug 'donepezil' 'treats' 'AD (Alzheimer's disease)'.\n\nPath-based Evidence 3: The drug 'rivastigmine' 'treats' 'AD (Alzheimer's disease)'.\n\nPath-based Evidence 4: The drug 'galantamine' 'interacts' with 'Abeta'.\n\nPath-based Evidence 5: The protein 'Abeta' 'associates' with 'apoptosis'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'treats' 'tacrine'.\n\nNeighbor-based Evidence 2: 'AD' 'treats' 'donepezil'.\n\nNeighbor-based Evidence 3: 'AD' 'treats' 'rivastigmine'.\n\nNeighbor-based Evidence 4: 'AD' 'treats' 'galantamine'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'cognitive impairment'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.8907693028450012,
      1.0,
      1.0,
      0.6575609445571899,
      1.0,
      0.6304964423179626,
      1.0,
      1.0,
      0.7420904636383057,
      0.7526212930679321
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "a50b09f1-ca5d-49df-a9e2-3de768ffc30e",
    "question": "Which of the following is used for treatment of Alzheimer's disease?",
    "opa": "Donepezil",
    "opb": "Rivastigmine",
    "opc": "Galantamine",
    "opd": "All of the above",
    "cop": 3,
    "choice_type": "multi",
    "exp": "Tacrine (tetrahydroaminoacridine, THA), a long-acting cholinesterase inhibitor and muscarinic modulator, was the first drug shown to have any benefit in Alzheimer's disease. Because of its hepatic toxicity, tacrine has been almost completely replaced in clinical use by newer cholinesterase inhibitors: donepezil, rivastigmine, and galantamine. These agents are orally active, have adequate penetration into the central nervous system, and are much less toxic than tacrine. Although evidence for the benefit of cholinesterase inhibitors (and memantine; see below) is statistically significant, the clinical benefit from these drugs is modest and temporary Ref: Katzung 11th edition Chapter 60.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. Donepezil\n3. Rivastigmine\n4. Galantamine.",
    "prediction": "D",
    "path": "Reranked Triple1: rivastigmine \u2014\u2014> treats -> AD (Alzheimer's disease)  \nReranked Triple2: rivastigmine \u2014\u2014> treat -> Alzheimer's disease  \nReranked Triple3: rivastigmine \u2014\u2014> TREATMENT -> apoptosis  \nReranked Triple4: Abeta \u2014\u2014> interacts -> galantamine  \nReranked Triple5: rivastigmine \u2014\u2014> causes -> death -> induced by -> staurosporine  ",
    "neighbor_input": "Reranked Triple1: AD->TREATMENT->tacrine \u2014\u2014> Alzheimer's disease\nReranked Triple2: AD->TREATMENT->curcumin \u2014\u2014> Alzheimer's disease\nReranked Triple3: AD->TREATMENT->bexarotene \u2014\u2014> Alzheimer's disease\nReranked Triple4: AD->TREATMENT->alpha-lipoic acid \u2014\u2014> Alzheimer's disease\nReranked Triple5: AD->TREATMENT->insulin \u2014\u2014> Alzheimer's disease",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Rivastigmine' is known to 'treat' 'AD' (Alzheimer's disease).\n\nPath-based Evidence 2: 'Rivastigmine' is used to 'treat' 'Alzheimer's disease'.\n\nPath-based Evidence 3: 'Rivastigmine' is associated with 'TREATMENT' that leads to 'apoptosis'.\n\nPath-based Evidence 4: 'Abeta' 'interacts' with 'galantamine'.\n\nPath-based Evidence 5: 'Rivastigmine' 'causes' 'death', which is 'induced by' 'staurosporine'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Alzheimer's disease' is treated with 'tacrine'.\nNeighbor-based Evidence 2: 'Alzheimer's disease' is treated with 'curcumin'.\nNeighbor-based Evidence 3: 'Alzheimer's disease' is treated with 'bexarotene'.\nNeighbor-based Evidence 4: 'Alzheimer's disease' is treated with 'alpha-lipoic acid'.\nNeighbor-based Evidence 5: 'Alzheimer's disease' is treated with 'insulin'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.6575609445571899,
      1.0,
      0.6304964423179626,
      1.0,
      1.0
    ],
    "question_types": [
      "treatment"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "6dbd29c2-84aa-4285-9d85-9f8226de8ea1",
    "question": "Which of the pathognomic feature of Alzheimer's disease?",
    "opa": "Lewy body",
    "opb": "Plaques and tangles",
    "opc": "Pick bodies",
    "opd": "Red neuronal degeneration",
    "cop": 1,
    "choice_type": "single",
    "exp": "Alzheimer's disease Coical atrophy Deposition of amyloid b plaque & tangles Cerebellar amyloid angiopathy Association with chromosome 14 and chr.1 Premature Alzheimer's - mutation in App gene (amyloid precursor protein)-on chr.21 3 copies of chr.21 -more amyloid precursor protein?premature Alzheimer's Downs syndrome patients have high risk of Alzheimer's disease Abnormal folding of Ab peptides causes aggregation within neurons and apoptosis Some degenerative diseases of the CNS are associated with neuronal intracytoplasmic inclusions, such as neurofibrillary tangles of Alzheimer disease and Lewy bodies of Parkinson disease Cerebral amyloid angiopathy (CAA) is the risk factor most commonly associated with lobar hemorrhages. In CAA, amyloidogenic peptides, usually the same ones found in Alzheimer disease are deposited in the walls of medium and small caliber meningeal and coical vessels. This deposition can weaken the vessel wall and lead to hemorrhage. Many individuals with CAA have evidence of numerous small hemorrhages within the brain (\"microbleeds\"), which can be visualized by various imaging methods. As with Alzheimer disease, in which there is a relationship between a polymorphism in the gene that encodes apolipoprotein E (ApoE) and risk of disease,there is an effect of the ApoE genotype on the risk of recurrence of hemorrhage from sporadic CAA. The presence of either an e2 or e4 allele increases the risk of repeat bleeding. While some mutations in the precursor protein for the Ab peptide (amyloid precursor protein, APP) cause familial Alzheimer disease, others result in autosomal dominant forms of CAA.",
    "subject_name": "Pathology",
    "topic_name": "NEET 2018",
    "entity": "1. Alzheimer's disease\n2. Lewy body\n3. Plaques and tangles\n4. Pick bodies\n5. Red neuronal degeneration",
    "prediction": "B",
    "path": "Reranked Triple1: Pick \u2014\u2014> GENE ASSOCIATION \u2014\u2014> PRESENILIN1 (PSEN1)\nReranked Triple2: PRESENILIN1 (PSEN1) \u2014\u2014> GENE ASSOCIATION \u2014\u2014> Alzheimer's disease\nReranked Triple3: Alzheimer's disease \u2014\u2014> cause \u2014\u2014> neuronal degeneration\nReranked Triple4: Alzheimer's disease \u2014\u2014> involves \u2014\u2014> neuronal degeneration\nReranked Triple5: Lewy bodies \u2014\u2014> found in \u2014\u2014> brain",
    "neighbor_input": "Reranked Triple1: AD->CAUSES->neurodegeneration, cognitive lesion, impairment of spatial learning and memory, dementia, lamin A (lamin) toxicity, proteinopathy, behavioral deficits, brain damage, Abeta aggregation, hypoxia, Alzheimer's disease, cognitive impairment, neurofibrillary tangle pathology, cognitive disorders, Abeta, astrogliosis, dysfunctional microglia, neuronal loss, brain disorder, neurodegenerative disorder, brain deficits, learning and memory impairments, tau, BACE1, Oxidative stress, neurodegenerative diseases\n\nReranked Triple2: AD->ASSOCIATES->glycogen synthase kinase 3beta, memory deficit, tauopathies, MAPT, altered neuronal ion transport, oxidative stress, Co-infection, cerebral ischaemic injury, memory loss and impaired cognitive function, brain volume loss and memory decline, weight loss, cyclin-dependent kinase reduction, toxicity, copper, amyloid-beta, mitochondrial morphology, PATIENTS, amyloid-beta peptide (Abeta) deposition, memory symptoms, brain atrophy, Abeta peptide, Amyloid Precursor Protein (amyloid precursor protein), neurodegenerative disorder, phosphorylation reduction, presenilin-1, beta amyloid, loss of dendritic spines, FBD, women, ADAOO, patients, interleukin (IL)-1beta, cognitive decline, altered blood-brain barrier permeability, altered immune response, altered gene expression, cognitive deficits, Creutzfeldt-Jakob disease, Mayo, TBI, tau, Spiroplasma sp, C-reactive protein, Tg2576, neurodegenerative diseases, synaptopathy, human, WMH, altered brain structure, phosphorylated protein kinase B, lipids (lipid), CCT5, atrophy, DA, memory dysfunction, neuroinflammation, memory impairment, Pax6, CAD (coronary artery disease), CRFR1, Notch1, plaques, kinase activation reduction, altered cerebral blood flow, Abeta deposition, altered structural connectivity, protein kinase C activation, altered neurotransmitter levels, gliosis, CBR1, synapse dysfunction, death, reactive oxygen species, phosphoinositide 3-kinase, argyrophilic grains, anxiety, neurodegeneration, GADD34, cerebral amyloidosis, hippocampal atrophy, persons, neurotoxicity, patient, triglycerides (TG), amyloidosis, Tau aggregation, Abeta42, thioflavin-S, glutamine synthetase, Musashi-1, amyloid plaques, P301S, phosphoinositide 3-kinase reduction, TAR DNA binding protein-43, tauopathy, dystrophic neurites, cerebral amyloid angiopathy, FDD, MCI, APP/PS1 mice, cognitive neurology, senile plaques, apolipoprotein E, phosphorylated protein kinase B reduction, neurotoxic, transgenic mice, PS1, impaired insulin signaling, people, neurodegenerative disease, neuroplasticity impairment, amyloid-beta (Abeta), cyclin-dependent kinase, deficits in learning and memory abilities, C-terminal fragment-beta, altered lipid metabolism, APOE (apolipoprotein E), cognitive dysfunction, neuronal degeneration, synaptic dysfunction, altered neurotrophin levels, PDIA3, altered neurogenesis, Apolipoprotein E, water, metabolic dysfunctions, mitochondrial dysfunction, CAA, memory loss, ORM impairment, DOWN SYNDROME, neurological diseases, altered brain metabolism, mitochondrial damage, altered functional connectivity, amyloid beta, Abeta plaque deposition, brain, cerebral amyloid angiopathy (CAA), estrogen withdrawal, cognitive and synaptic deficits, tau pathology, diabetes, Encephalopathies, PIB, memory deficits, peroxiredoxin 3, altered cerebrovascular function, psychiatric disorders, Cache County Dementia, mice, altered calcium homeostasis, altered protein expression, Tau, altered synaptic plasticity, mouse, Mice, cholesterol, altered neurovascular coupling, learning deficits, dysfunction, Alzheimer's disease, amyloidogenic disorder, neuron loss, APP phosphorylation reduction, cognitive impairments, cerebrospinal fluid biomarkers, O-GlcNAcylation, cognitive impairment, protein kinase C activation reduction, Abeta, neuron loss and memory deficits, neuritic dystrophy, Glucose hypometabolism, ADAS, Abeta plaque, cognitive failure, dendritic spine loss, transgenic mice (mice), glycogen synthase kinase 3beta reduction, APOE, Plaque, concurrent pathologies, Apolipoprotein E (APOE), inflammation, cognitive and/or functional performance, Abeta aggregates, Mouse, neuronal loss, neurofibrillary tangles, dementia, memory impairment by estrogen deficiency, ENO1\n\nReranked Triple3: AD->treats->phloroglucinol, cognitive deficits, cognitive loss, Water, neurodegenerative diseases, Abeta toxicity, reactive oxygen species, neurodegeneration, Neurotoxicity, neurotoxicity, attenuated the behavior impairment, behavioral dysfunction, VK3, Alzheimer-like cognitive deficits, dementia, PPARgamma agonists, ankG, VK3-9, neurotoxic, hyperforin, Kanamycin, mitochondrial dysfunction, impairment of spatial learning and memory, ginsenoside Rd, Abeta aggregation, RS 67333, Abeta fibrillogenesis, off-pathway oligomers, mice, neuronal dysfunction, Mice, beta-secretase inhibitor, insulin, Alzheimer's disease, diosmin, cholinesterase inhibitor, brain deficits, tacrine, BACE1 inhibitors, 7d, Abeta, n-3 PUFAs, Diosmetin, Transgenic Mice, chalcones, THH, amyloid-beta aggregation inhibitor, mice (mouse), Neuronal Injury, aid, SSP-002392, Neuropep-4, AD\n\nReranked Triple4: AD->TREATMENT->TUDCA, metal, insulin-like growth factor (IGF) signaling, tropisetron, deep learning, N-acetylcysteine, MB, 3H3, NEP, flavonoids, reserpine, protoporphyrin IX, retardation, neuron-specific IGF-1R knockout, neuronal IGF resistance, Abeta, participant, bexarotene, fasudil, alpha-lipoic acid, curcumin, IGF-1R ablation, Rg1, thiethylperazine, MDR-1339, patients, secondary prevention, HBMVECs-Ex, redox-proteomic approach, nobiletin, vaccine, insulin-like growth factor I (IGF-I), alpha-tocopherol, PBS, EPR imaging\n\nReranked Triple5: AD->causes->oxidative stress, PS2-related side effect, dysfunctions, tumor necrosis factor-alpha, cognitive loss, brain atrophy, progressive dementia, misfolding, impaired cognitive function and memory loss, cortical atrophy, synaptic depression, neuroinflammation, memory impairment, cognitive decline, LTP, neuropathologies, cognitive deficit, impaired insulin, neuronal cell death, AbetaPP-carboxyterminal fragments, amyloid beta-protein, cognitive deficits, hyperglycemia, neurodegenerative diseases, vascular dysfunction, lysosomal enzymes, memory deficits (memory impairment), memory impairments, cognitive deterioration, anxiety, neurodegeneration, behavioral abnormalities, neurotoxicity, amyloidosis, neuronal iron homeostasis disruption, impairment of spatial cognitive function, impairment of learning and memory, fibrillation, aggregation, Abeta deposition, phosphorylated tau (pThr231, pSer396, pThr181, and pSer202), cytotoxicity, impairments, cell death, cognitive impairment and dementia, neurotoxicity and memory impairment, learning and memory deficits, memory defect, neuronal endosomal dysfunction, behavioral dysfunction, neuronal degeneration, neurodegenerative disease, cognitive dysfunction, decrease in synaptic proteins, vitamin K deficiency, synaptic dysfunction, altered neurogenesis, vascular insufficiencies, BACE1 expression, infectious disease, memory loss, interleukin-6, hippocampal dysfunction, cell degeneration, reactive gliosis, cognitive deficits (cognitive impairment), neuronal damage, Dementia, neurodegeneration syndromes, mitochondrial dysfunction, memory deficits, hippocampal neuronal loss, Abeta fibrillation, neurodegenerative disorders, axonal degeneration, cognitive decline in patients, learning and memory impairment, learning and memory decline, neuronal degenerative disease, stress, amyloid plaque, phosphorylated tau (Ser396), brain derived neurotrophic factor, Cognitive impairment, depressive, glucose intolerance, hyperinsulinemia, obesity, cognitive impairments, lipid peroxidation, cognitive impairment, Neurotoxic, synaptic loss, MR hypointensities, depression, Alzheimer's disease-related neuronal damage, synapse loss, brain diseases, hypercholesterolemia, Abeta aggregation, psychiatric, infarcts, inflammation, degeneration, memory deficiency, deficits, Abeta accumulation in the brain, Abeta, death, metabolic syndrome, meningoencephalitis, damage to neurons, impairment of cognitive functions, memory decline, brain deposits, neuronal death, amnesia, cognitive symptoms, synaptic degeneration, toxicity, spine loss, neuronal loss, Abeta accumulation, amyloid-beta plaques, neurotoxic aggregates, neurodegenerative disorder, multifactorial syndrome, Abeta-induced cytotoxicity, memory deficit, dementia, neuronal dysfunction, brain infections, Abeta plaque load, LTP impairments",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Pick' is associated with 'PRESENILIN1 (PSEN1)'.\nPath-based Evidence 2: 'PRESENILIN1 (PSEN1)' is associated with 'Alzheimer's disease'.\nPath-based Evidence 3: 'Alzheimer's disease' causes 'neuronal degeneration'.\nPath-based Evidence 4: 'Alzheimer's disease' involves 'neuronal degeneration'.\nPath-based Evidence 5: 'Lewy bodies' are found in the 'brain'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' causes 'neurodegeneration', 'cognitive lesion', 'impairment of spatial learning and memory', 'dementia', 'lamin A (lamin) toxicity', 'proteinopathy', 'behavioral deficits', 'brain damage', 'Abeta aggregation', 'hypoxia', 'Alzheimer's disease', 'cognitive impairment', 'neurofibrillary tangle pathology', 'cognitive disorders', 'Abeta', 'astrogliosis', 'dysfunctional microglia', 'neuronal loss', 'brain disorder', 'neurodegenerative disorder', 'brain deficits', 'learning and memory impairments', 'tau', 'BACE1', 'Oxidative stress', 'neurodegenerative diseases'\n\nNeighbor-based Evidence 2: 'AD' associates with 'glycogen synthase kinase 3beta', 'memory deficit', 'tauopathies', 'MAPT', 'altered neuronal ion transport', 'oxidative stress', 'Co-infection', 'cerebral ischaemic injury', 'memory loss and impaired cognitive function', 'brain volume loss and memory decline', 'weight loss', 'cyclin-dependent kinase reduction', 'toxicity', 'copper', 'amyloid-beta', 'mitochondrial morphology', 'PATIENTS', 'amyloid-beta peptide (Abeta) deposition', 'memory symptoms', 'brain atrophy', 'Abeta peptide', 'Amyloid Precursor Protein (amyloid precursor protein)', 'neurodegenerative disorder', 'phosphorylation reduction', 'presenilin-1', 'beta amyloid', 'loss of dendritic spines', 'FBD', 'women', 'ADAOO', 'patients', 'interleukin (IL)-1beta', 'cognitive decline', 'altered blood-brain barrier permeability', 'altered immune response', 'altered gene expression', 'cognitive deficits', 'Creutzfeldt-Jakob disease', 'Mayo', 'TBI', 'tau', 'Spiroplasma sp', 'C-reactive protein', 'Tg2576', 'neurodegenerative diseases', 'synaptopathy', 'human', 'WMH', 'altered brain structure', 'phosphorylated protein kinase B', 'lipids (lipid)', 'CCT5', 'atrophy', 'DA', 'memory dysfunction', 'neuroinflammation', 'memory impairment', 'Pax6', 'CAD (coronary artery disease)', 'CRFR1', 'Notch1', 'plaques', 'kinase activation reduction', 'altered cerebral blood flow', 'Abeta deposition', 'altered structural connectivity', 'protein kinase C activation', 'altered neurotransmitter levels', 'gliosis', 'CBR1', 'synapse dysfunction', 'death', 'reactive oxygen species', 'phosphoinositide 3-kinase', 'argyrophilic grains', 'anxiety', 'neurodegeneration', 'GADD34', 'cerebral amyloidosis', 'hippocampal atrophy', 'persons', 'neurotoxicity', 'patient', 'triglycerides (TG)', 'amyloidosis', 'Tau aggregation', 'Abeta42', 'thioflavin-S', 'glutamine synthetase', 'Musashi-1', 'amyloid plaques', 'P301S', 'phosphoinositide 3-kinase reduction', 'TAR DNA binding protein-43', 'tauopathy', 'dystrophic neurites', 'cerebral amyloid angiopathy', 'FDD', 'MCI', 'APP/PS1 mice', 'cognitive neurology', 'senile plaques', 'apolipoprotein E', 'phosphorylated protein kinase B reduction', 'neurotoxic', 'transgenic mice', 'PS1', 'impaired insulin signaling', 'people', 'neurodegenerative disease', 'neuroplasticity impairment', 'amyloid-beta (Abeta)', 'cyclin-dependent kinase', 'deficits in learning and memory abilities', 'C-terminal fragment-beta', 'altered lipid metabolism', 'APOE (apolipoprotein E)', 'cognitive dysfunction', 'neuronal degeneration', 'synaptic dysfunction', 'altered neurotrophin levels', 'PDIA3', 'altered neurogenesis', 'Apolipoprotein E', 'water', 'metabolic dysfunctions', 'mitochondrial dysfunction', 'CAA', 'memory loss', 'ORM impairment', 'DOWN SYNDROME', 'neurological diseases', 'altered brain metabolism', 'mitochondrial damage', 'altered functional connectivity', 'amyloid beta', 'Abeta plaque deposition', 'brain', 'cerebral amyloid angiopathy (CAA)', 'estrogen withdrawal', 'cognitive and synaptic deficits', 'tau pathology', 'diabetes', 'Encephalopathies', 'PIB', 'memory deficits', 'peroxiredoxin 3', 'altered cerebrovascular function', 'psychiatric disorders', 'Cache County Dementia', 'mice', 'altered calcium homeostasis', 'altered protein expression', 'Tau', 'altered synaptic plasticity', 'mouse', 'Mice', 'cholesterol', 'altered neurovascular coupling', 'learning deficits', 'dysfunction', 'Alzheimer's disease', 'amyloidogenic disorder', 'neuron loss', 'APP phosphorylation reduction', 'cognitive impairments', 'cerebrospinal fluid biomarkers', 'O-GlcNAcylation', 'cognitive impairment', 'protein kinase C activation reduction', 'Abeta', 'neuron loss and memory deficits', 'neuritic dystrophy', 'Glucose hypometabolism', 'ADAS', 'Abeta plaque', 'cognitive failure', 'dendritic spine loss', 'transgenic mice (mice)', 'glycogen synthase kinase 3beta reduction', 'APOE', 'Plaque', 'concurrent pathologies', 'Apolipoprotein E (APOE)', 'inflammation', 'cognitive and/or functional performance', 'Abeta aggregates', 'Mouse', 'neuronal loss', 'neurofibrillary tangles', 'dementia', 'memory impairment by estrogen deficiency', 'ENO1'\n\nNeighbor-based Evidence 3: 'AD' treats with 'phloroglucinol', 'cognitive deficits', 'cognitive loss', 'Water', 'neurodegenerative diseases', 'Abeta toxicity', 'reactive oxygen species', 'neurodegeneration', 'Neurotoxicity', 'neurotoxicity', 'attenuated the behavior impairment', 'behavioral dysfunction', 'VK3', 'Alzheimer-like cognitive deficits', 'dementia', 'PPARgamma agonists', 'ankG', 'VK3-9', 'neurotoxic', 'hyperforin', 'Kanamycin', 'mitochondrial dysfunction', 'impairment of spatial learning and memory', 'ginsenoside Rd', 'Abeta aggregation', 'RS 67333', 'Abeta fibrillogenesis', 'off-pathway oligomers', 'mice', 'neuronal dysfunction', 'Mice', 'beta-secretase inhibitor', 'insulin', 'Alzheimer's disease', 'diosmin', 'cholinesterase inhibitor', 'brain deficits', 'tacrine', 'BACE1 inhibitors', '7d', 'Abeta', 'n-3 PUFAs', 'Diosmetin', 'Transgenic Mice', 'chalcones', 'THH', 'amyloid-beta aggregation inhibitor', 'mice (mouse)', 'Neuronal Injury', 'aid', 'SSP-002392', 'Neuropep-4', 'AD'\n\nNeighbor-based Evidence 4: 'AD' treatment includes 'TUDCA', 'metal', 'insulin-like growth factor (IGF) signaling', 'tropisetron', 'deep learning', 'N-acetylcysteine', 'MB', '3H3', 'NEP', 'flavonoids', 'reserpine', 'protoporphyrin IX', 'retardation', 'neuron-specific IGF-1R knockout', 'neuronal IGF resistance', 'Abeta', 'participant', 'bexarotene', 'fasudil', 'alpha-lipoic acid', 'curcumin', 'IGF-1R ablation', 'Rg1', 'thiethylperazine', 'MDR-1339', 'patients', 'secondary prevention', 'HBMVECs-Ex', 'redox-proteomic approach', 'nobiletin', 'vaccine', 'insulin-like growth factor I (IGF-I)', 'alpha-tocopherol', 'PBS', 'EPR imaging'\n\nNeighbor-based Evidence 5: 'AD' causes 'oxidative stress', 'PS2-related side effect', 'dysfunctions', 'tumor necrosis factor-alpha', 'cognitive loss', 'brain atrophy', 'progressive dementia', 'misfolding', 'impaired cognitive function and memory loss', 'cortical atrophy', 'synaptic depression', 'neuroinflammation', 'memory impairment', 'cognitive decline', 'LTP', 'neuropathologies', 'cognitive deficit', 'impaired insulin', 'neuronal cell death', 'AbetaPP-carboxyterminal fragments', 'amyloid beta-protein', 'cognitive deficits', 'hyperglycemia', 'neurodegenerative diseases', 'vascular dysfunction', 'lysosomal enzymes', 'memory deficits (memory impairment)', 'memory impairments', 'cognitive deterioration', 'anxiety', 'neurodegeneration', 'behavioral abnormalities', 'neurotoxicity', 'amyloidosis', 'neuronal iron homeostasis disruption', 'impairment of spatial cognitive function', 'impairment of learning and memory', 'fibrillation', 'aggregation', 'Abeta deposition', 'phosphorylated tau (pThr231, pSer396, pThr181, and pSer202)', 'cytotoxicity', 'impairments', 'cell death', 'cognitive impairment and dementia', 'neurotoxicity and memory impairment', 'learning and memory deficits', 'memory defect', 'neuronal endosomal dysfunction', 'behavioral dysfunction', 'neuronal degeneration', 'neurodegenerative disease', 'cognitive dysfunction', 'decrease in synaptic proteins', 'vitamin K deficiency', 'synaptic dysfunction', 'altered neurogenesis', 'vascular insufficiencies', 'BACE1 expression', 'infectious disease', 'memory loss', 'interleukin-6', 'hippocampal dysfunction', 'cell degeneration', 'reactive gliosis', 'cognitive deficits (cognitive impairment)', 'neuronal damage', 'Dementia', 'neurodegeneration syndromes', 'mitochondrial dysfunction', 'memory deficits', 'hippocampal neuronal loss', 'Abeta fibrillation', 'neurodegenerative disorders', 'axonal degeneration', 'cognitive decline in patients', 'learning and memory impairment', 'learning and memory decline', 'neuronal degenerative disease', 'stress', 'amyloid plaque', 'phosphorylated tau (Ser396)', 'brain derived neurotrophic factor', 'Cognitive impairment', 'depressive', 'glucose intolerance', 'hyperinsulinemia', 'obesity', 'lipid peroxidation', 'neurotoxic', 'synaptic loss', 'MR hypointensities', 'depression', 'Alzheimer's disease-related neuronal damage', 'synapse loss', 'brain diseases', 'hypercholesterolemia', 'Abeta aggregation', 'psychiatric', 'infarcts', 'inflammation', 'degeneration', 'memory deficiency', 'deficits', 'Abeta accumulation in the brain', 'Abeta', 'death', 'metabolic syndrome', 'meningoencephalitis', 'damage to neurons', 'impairment of cognitive functions', 'memory decline', 'brain deposits', 'neuronal death', 'amnesia', 'cognitive symptoms', 'synaptic degeneration', 'toxicity', 'spine loss', 'neuronal loss', 'Abeta accumulation', 'amyloid-beta plaques', 'neurotoxic aggregates', 'neurodegenerative disorder', 'multifactorial syndrome', 'Abeta-induced cytotoxicity', 'memory deficit', 'dementia', 'neuronal dysfunction', 'brain infections', 'Abeta plaque load', 'LTP impairments'",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.9429672360420227,
      0.7109739780426025,
      0.702234148979187,
      1.0,
      0.6846673488616943,
      1.0,
      0.727749228477478,
      0.6205008029937744,
      0.7637331485748291
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "45ce4c2a-1dd7-42e4-bdf0-7458eb61f8af",
    "question": "All of the following casues subcoical dementia except -",
    "opa": "Alzhimer's disease",
    "opb": "Parkinsonism",
    "opc": "HIV encephalopathy",
    "opd": "Progressive supra nuclear palsy",
    "cop": 0,
    "choice_type": "multi",
    "exp": "The pa of brain affected in Alzheimer's disease is cerebral coex and hippocampus. In parkinsonism, basal ganglia, coex and even the brainstem(subcoex) is affected. In progressive supranuclear palsy and HIV encephalopathy there is subcoical dementia. Reference Harrison20th edition pg 2456",
    "subject_name": "Medicine",
    "topic_name": "C.N.S",
    "entity": "1. subcortical dementia\n2. Alzheimer's disease\n3. Parkinsonism\n4. HIV encephalopathy\n5. Progressive supra nuclear palsy",
    "prediction": "B",
    "path": "Reranked Triple1: HIV-associated neurocognitive disorders \u2014\u2014> disease\nReranked Triple2: HIV-associated neurocognitive disorders \u2014\u2014> Alzheimer's disease\nReranked Triple3: HIV-associated neurocognitive disorders \u2014\u2014> Parkinson's disease\nReranked Triple4: Alzheimer's disease \u2014\u2014> CAUSES \u2014\u2014> dementia\nReranked Triple5: Parkinsonism \u2014\u2014> causes \u2014\u2014> neuronal damage",
    "neighbor_input": "Reranked Triple1: AD->CAUSES->neurodegeneration,cognitive lesion,impairment of spatial learning and memory,dementia,lamin A (lamin) toxicity,proteinopathy,behavioral deficits,brain damage,Abeta aggregation,hypoxia,Alzheimer's disease,cognitive impairment,neurofibrillary tangle pathology,cognitive disorders,Abeta,astrogliosis,dysfunctional microglia,neuronal loss,brain disorder,neurodegenerative disorder,brain deficits,learning and memory impairments,tau,BACE1,Oxidative stress,neurodegenerative diseases \u2014\u2014> Subcortical dementia\nReranked Triple2: AD->TREATMENT->TUDCA,metal,insulin-like growth factor (IGF) signaling,tropisetron,deep learning,N-acetylcysteine,MB,3H3,NEP,flavonoids,reserpine,protoporphyrin IX,retardation,neuron-specific IGF-1R knockout,neuronal IGF resistance,Abeta,participant,bexarotene,fasudil,alpha-lipoic acid,curcumin,IGF-1R ablation,Rg1,thiethylperazine,MDR-1339,patients,secondary prevention,HBMVECs-Ex,redox-proteomic approach,nobiletin,vaccine,insulin-like growth factor I (IGF-I),alpha-tocopherol,PBS,EPR imaging \u2014\u2014> Subcortical dementia\nReranked Triple3: AD->ASSOCIATES->glycogen synthase kinase 3beta,memory deficit,tauopathies,MAPT,altered neuronal ion transport,oxidative stress,Co-infection,cerebral ischaemic injury,memory loss and impaired cognitive function,brain volume loss and memory decline,weight loss,cyclin-dependent kinase reduction,toxicity,copper,amyloid-beta,mitochondrial morphology,PATIENTS,amyloid-beta peptide (Abeta) deposition,memory symptoms,brain atrophy,Abeta peptide,Amyloid Precursor Protein (amyloid precursor protein),neurodegenerative disorder,phosphorylation reduction,presenilin-1,beta amyloid,loss of dendritic spines,FBD,women,ADAOO,patients,interleukin (IL)-1beta,cognitive decline,altered blood-brain barrier permeability,altered immune response,altered gene expression,cognitive deficits,Creutzfeldt-Jakob disease,Mayo,TBI,tau,Spiroplasma sp,C-reactive protein,Tg2576,neurodegenerative diseases,synaptopathy,human,WMH,altered brain structure,phosphorylated protein kinase B,lipids (lipid),CCT5,atrophy,DA,memory dysfunction,neuroinflammation,memory impairment,Pax6,CAD (coronary artery disease),CRFR1,Notch1,plaques,kinase activation reduction,altered cerebral blood flow,Abeta deposition,altered structural connectivity,protein kinase C activation,altered neurotransmitter levels,gliosis,CBR1,synapse dysfunction,death,reactive oxygen species,phosphoinositide 3-kinase,argyrophilic grains,anxiety,neurodegeneration,GADD34,cerebral amyloidosis,hippocampal atrophy,persons,neurotoxicity,patient,triglycerides (TG),amyloidosis,Tau aggregation,Abeta42,thioflavin-S,glutamine synthetase,Musashi-1,amyloid plaques,P301S,phosphoinositide 3-kinase reduction,TAR DNA binding protein-43,tauopathy,dystrophic neurites,cerebral amyloid angiopathy,FDD,MCI,APP/PS1 mice,cognitive neurology,senile plaques,apolipoprotein E,phosphorylated protein kinase B reduction,neurotoxic,transgenic mice,PS1,impaired insulin signaling,people,neurodegenerative disease,neuroplasticity impairment,amyloid-beta (Abeta),cyclin-dependent kinase,deficits in learning and memory abilities,C-terminal fragment-beta,altered lipid metabolism,APOE (apolipoprotein E),cognitive dysfunction,neuronal degeneration,synaptic dysfunction,altered neurotrophin levels,PDIA3,altered neurogenesis,Apolipoprotein E,water,metabolic dysfunctions,mitochondrial dysfunction,CAA,memory loss,ORM impairment,DOWN SYNDROME,neurological diseases,altered brain metabolism,mitochondrial damage,altered functional connectivity,amyloid beta,Abeta plaque deposition,brain,cerebral amyloid angiopathy (CAA),estrogen withdrawal,cognitive and synaptic deficits,tau pathology,diabetes,Encephalopathies,PIB,memory deficits,peroxiredoxin 3,altered cerebrovascular function,psychiatric disorders,Cache County Dementia,mice,altered calcium homeostasis,altered protein expression,Tau,altered synaptic plasticity,mouse,Mice,cholesterol,altered neurovascular coupling,learning deficits,dysfunction,Alzheimer's disease,amyloidogenic disorder,neuron loss,APP phosphorylation reduction,cognitive impairments,cerebrospinal fluid biomarkers,O-GlcNAcylation,cognitive impairment,protein kinase C activation reduction,Abeta,neuron loss and memory deficits,neuritic dystrophy,Glucose hypometabolism,ADAS,Abeta plaque,cognitive failure,dendritic spine loss,transgenic mice (mice),glycogen synthase kinase 3beta reduction,APOE,Plaque,concurrent pathologies,Apolipoprotein E (APOE),inflammation,cognitive and/or functional performance,Abeta aggregates,Mouse,neuronal loss,neurofibrillary tangles,dementia,memory impairment by estrogen deficiency,ENO1 \u2014\u2014> Subcortical dementia\nReranked Triple4: AD->causes->oxidative stress,PS2-related side effect,dysfunctions,tumor necrosis factor-alpha,cognitive loss,brain atrophy,progressive dementia,misfolding,impaired cognitive function and memory loss,cortical atrophy,synaptic depression,neuroinflammation,memory impairment,cognitive decline,LTP,neuropathologies,cognitive deficit,impaired insulin,neuronal cell death,AbetaPP-carboxyterminal fragments,amyloid beta-protein,cognitive deficits,hyperglycemia,neurodegenerative diseases,vascular dysfunction,lysosomal enzymes,memory deficits (memory impairment),memory impairments,cognitive deterioration,anxiety,neurodegeneration,behavioral abnormalities,neurotoxicity,amyloidosis,neuronal iron homeostasis disruption,impairment of spatial cognitive function,impairment of learning and memory,fibrillation,aggregation,Abeta deposition,phosphorylated tau (pThr231, pSer396, pThr181, and pSer202),cytotoxicity,impairments,cell death,cognitive impairment and dementia,neurotoxicity and memory impairment,learning and memory deficits,memory defect,neuronal endosomal dysfunction,behavioral dysfunction,neuronal degeneration,neurodegenerative disease,cognitive dysfunction,decrease in synaptic proteins,vitamin K deficiency,synaptic dysfunction,altered neurogenesis,vascular insufficiencies,BACE1 expression,infectious disease,memory loss,interleukin-6,hippocampal dysfunction,cell degeneration,reactive gliosis,cognitive deficits (cognitive impairment),neuronal damage,Dementia,neurodegeneration syndromes,mitochondrial dysfunction,memory deficits,hippocampal neuronal loss,Abeta fibrillation,neurodegenerative disorders,axonal degeneration,cognitive decline in patients,learning and memory impairment,learning and memory decline,neuronal degenerative disease,stress,amyloid plaque,phosphorylated tau (Ser396),brain derived neurotrophic factor,Cognitive impairment,depressive,glucose intolerance,hyperinsulinemia,obesity,cognitive impairments,lipid peroxidation,cognitive impairment,Neurotoxic,synaptic loss,MR hypointensities,depression,Alzheimer's disease-related neuronal damage,synapse loss,brain diseases,hypercholesterolemia,Abeta aggregation,psychiatric,infarcts,inflammation,degeneration,memory deficiency,deficits,Abeta accumulation in the brain,Abeta,death,metabolic syndrome,meningoencephalitis,damage to neurons,impairment of cognitive functions,memory decline,brain deposits,neuronal death,amnesia,cognitive symptoms,synaptic degeneration,toxicity,spine loss,neuronal loss,Abeta accumulation,amyloid-beta plaques,neurotoxic aggregates,neurodegenerative disorder,multifactorial syndrome,Abeta-induced cytotoxicity,memory deficit,dementia,neuronal dysfunction,brain infections,Abeta plaque load,LTP impairments \u2014\u2014> Subcortical dementia\nReranked Triple5: AD->treats->phloroglucinol,cognitive deficits,cognitive loss,Water,neurodegenerative diseases,Abeta toxicity,reactive oxygen species,neurodegeneration,Neurotoxicity,neurotoxicity,attenuated the behavior impairment,behavioral dysfunction,VK3,Alzheimer-like cognitive deficits,dementia,PPARgamma agonists,ankG,VK3-9,neurotoxic,hyperforin,Kanamycin,mitochondrial dysfunction,impairment of spatial learning and memory,ginsenoside Rd,Abeta aggregation,RS 67333,Abeta fibrillogenesis,off-pathway oligomers,mice,neuronal dysfunction,Mice,beta-secretase inhibitor,insulin,Alzheimer's disease,diosmin,cholinesterase inhibitor,brain deficits,tacrine,BACE1 inhibitors,7d,Abeta,n-3 PUFAs,Diosmetin,Transgenic Mice,chalcones,THH,amyloid-beta aggregation inhibitor,mice (mouse),Neuronal Injury,aid,SSP-002392,Neuropep-4,AD \u2014\u2014> Subcortical dementia",
    "response_of_KG_list_path": "Path-based Evidence 1: The condition 'HIV-associated neurocognitive disorders' is classified as a 'disease'.\n\nPath-based Evidence 2: The condition 'HIV-associated neurocognitive disorders' is associated with 'Alzheimer's disease'.\n\nPath-based Evidence 3: The condition 'HIV-associated neurocognitive disorders' is associated with 'Parkinson's disease'.\n\nPath-based Evidence 4: The condition 'Alzheimer's disease' has 'CAUSES' that lead to 'dementia'.\n\nPath-based Evidence 5: 'Parkinsonism' has 'causes' that result in 'neuronal damage'.",
    "response_of_KG_neighbor": "Sure, here are the converted natural language representations of the knowledge graph information:\n\nNeighbor-based Evidence 1:\n- 'AD' causes 'neurodegeneration', 'cognitive lesion', 'impairment of spatial learning and memory', 'dementia', 'lamin A (lamin) toxicity', 'proteinopathy', 'behavioral deficits', 'brain damage', 'Abeta aggregation', 'hypoxia', 'Alzheimer's disease', 'cognitive impairment', 'neurofibrillary tangle pathology', 'cognitive disorders', 'Abeta', 'astrogliosis', 'dysfunctional microglia', 'neuronal loss', 'brain disorder', 'neurodegenerative disorder', 'brain deficits', 'learning and memory impairments', 'tau', 'BACE1', 'Oxidative stress', 'neurodegenerative diseases' leading to 'Subcortical dementia'.\n\nNeighbor-based Evidence 2:\n- 'AD' treatment includes 'TUDCA', 'metal', 'insulin-like growth factor (IGF) signaling', 'tropisetron', 'deep learning', 'N-acetylcysteine', 'MB', '3H3', 'NEP', 'flavonoids', 'reserpine', 'protoporphyrin IX', 'retardation', 'neuron-specific IGF-1R knockout', 'neuronal IGF resistance', 'Abeta', 'participant', 'bexarotene', 'fasudil', 'alpha-lipoic acid', 'curcumin', 'IGF-1R ablation', 'Rg1', 'thiethylperazine', 'MDR-1339', 'patients', 'secondary prevention', 'HBMVECs-Ex', 'redox-proteomic approach', 'nobiletin', 'vaccine', 'insulin-like growth factor I (IGF-I)', 'alpha-tocopherol', 'PBS', 'EPR imaging' for 'Subcortical dementia'.\n\nNeighbor-based Evidence 3:\n- 'AD' associates with 'glycogen synthase kinase 3beta', 'memory deficit', 'tauopathies', 'MAPT', 'altered neuronal ion transport', 'oxidative stress', 'Co-infection', 'cerebral ischaemic injury', 'memory loss and impaired cognitive function', 'brain volume loss and memory decline', 'weight loss', 'copper', 'amyloid-beta', 'mitochondrial morphology', 'PATIENTS', 'amyloid-beta peptide (Abeta) deposition', 'memory symptoms', 'brain atrophy', 'Abeta peptide', 'Amyloid Precursor Protein (amyloid precursor protein)', 'neurodegenerative disorder', 'phosphorylation reduction', 'presenilin-1', 'beta amyloid', 'loss of dendritic spines', 'FBD', 'women', 'ADAOO', 'patients', 'interleukin (IL)-1beta', 'cognitive decline', and more, ultimately leading to 'Subcortical dementia'.\n\nNeighbor-based Evidence 4:\n- 'AD' causes 'oxidative stress', 'PS2-related side effect', 'dysfunctions', 'tumor necrosis factor-alpha', 'cognitive loss', 'brain atrophy', 'progressive dementia', 'misfolding', 'impaired cognitive function and memory loss', 'cortical atrophy', 'synaptic depression', 'neuroinflammation', 'memory impairment', 'cognitive decline', 'LTP', 'neuropathologies', 'cognitive deficit', 'impaired insulin', 'neuronal cell death', 'AbetaPP-carboxyterminal fragments', 'amyloid beta-protein', 'cognitive deficits', 'hyperglycemia', 'neurodegenerative diseases', 'vascular dysfunction', 'lysosomal enzymes', 'memory deficits', 'memory impairments', 'cognitive deterioration', 'anxiety', 'neurodegeneration', 'behavioral abnormalities', 'neurotoxicity', and more, ultimately leading to 'Subcortical dementia'.\n\nNeighbor-based Evidence 5:\n- 'AD' treatment involves 'phloroglucinol', 'cognitive deficits', 'cognitive loss', 'Water', 'neurodegenerative diseases', 'Abeta toxicity', 'reactive oxygen species', 'neurodegeneration', 'Neurotoxicity', 'attenuated the behavior impairment', 'behavioral dysfunction', 'VK3', 'Alzheimer-like cognitive deficits', 'dementia', 'PPARgamma agonists', 'ankG', 'VK3-9', 'neurotoxic', 'hyperforin', 'Kanamycin', 'mitochondrial dysfunction', 'impairment of spatial learning and memory', 'ginsenoside Rd', 'Abeta aggregation', 'RS 67333', 'Abeta fibrillogenesis', 'off-pathway oligomers', 'mice', 'neuronal dysfunction', 'beta-secretase inhibitor', 'insulin', 'Alzheimer's disease', 'diosmin', 'cholinesterase inhibitor', 'brain deficits', 'tacrine', 'BACE1 inhibitors', '7d', 'Abeta', 'n-3 PUFAs', 'Diosmetin', 'Transgenic Mice', 'chalcones', 'THH', 'amyloid-beta aggregation inhibitor', and more, ultimately leading to 'Subcortical dementia'.",
    "entity_confidence_scores": [
      0.882514476776123,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.8460202217102051,
      0.7963900566101074,
      0.828045129776001
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "756a6c5e-1347-422c-a4e3-b3f5d04390c9",
    "question": "Biochemical etiology of Alzheimer's disease relates it to :",
    "opa": "Acetylcholine",
    "opb": "GABA",
    "opc": "Serotinin",
    "opd": "Dopamine",
    "cop": 0,
    "choice_type": "single",
    "exp": "A i.e. Acetyl choline",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. Biochemical etiology\n3. Acetylcholine\n4. GABA\n5. Serotonin\n6. Dopamine",
    "prediction": "A",
    "path": "Reranked Triple1: Alzheimer Disease \u2014\u2014> CAUSES \u2014\u2014> dementia\nReranked Triple2: dementia \u2014\u2014> caused by \u2014\u2014> tau\nReranked Triple3: tau \u2014\u2014> associates \u2014\u2014> Alzheimer Disease\nReranked Triple4: Alzheimer Disease \u2014\u2014> causes \u2014\u2014> brain atrophy\nReranked Triple5: Alzheimer Disease \u2014\u2014> ASSOCIATES \u2014\u2014> Abeta (amyloid-beta)",
    "neighbor_input": "Reranked Triple1: AD->treats->cholinesterase inhibitor\nReranked Triple2: AD->TREATMENT->tacrine\nReranked Triple3: AD->TREATMENT->cholinesterase inhibitor\nReranked Triple4: AD->TREATMENT->curcumin\nReranked Triple5: AD->ASSOCIATES->memory loss and impaired cognitive function",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer Disease' CAUSES 'dementia'.\nPath-based Evidence 2: 'dementia' is caused by 'tau'.\nPath-based Evidence 3: 'tau' ASSOCIATES with 'Alzheimer Disease'.\nPath-based Evidence 4: 'Alzheimer Disease' causes 'brain atrophy'.\nPath-based Evidence 5: 'Alzheimer Disease' ASSOCIATES with 'Abeta (amyloid-beta)'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' treats 'cholinesterase inhibitor'.\nNeighbor-based Evidence 2: 'AD' is treated with 'tacrine'.\nNeighbor-based Evidence 3: 'AD' is treated with 'cholinesterase inhibitor'.\nNeighbor-based Evidence 4: 'AD' is treated with 'curcumin'.\nNeighbor-based Evidence 5: 'AD' associates with 'memory loss and impaired cognitive function'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.7273221015930176,
      1.0,
      1.0,
      1.0,
      0.8863632082939148,
      0.7717458009719849,
      0.651431679725647,
      1.0,
      1.0000001192092896,
      1.0,
      1.0,
      0.910812497138977
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "aec70ca2-9d8c-47e4-9532-212757f79593",
    "question": "Alzheimer's Disease is associated with :",
    "opa": "Delerium",
    "opb": "Delusion",
    "opc": "Dementia",
    "opd": "Depression",
    "cop": 2,
    "choice_type": "single",
    "exp": "Answer is C (Dementia): Alzheimer's Disease is the most common cause of Dementia in elderly.Clinically, AD most often presents with subtle onset of memory loss followed by slowly progressive dementia that has a course of several years.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Alzheimer's Disease\n2. Delerium\n3. Delusion\n4. Dementia\n5. Depression",
    "prediction": "C",
    "path": "Reranked Triple1: Alzheimer Disease \u2014\u2014> associates \u2014\u2014> dementia  \nReranked Triple2: Alzheimer Disease \u2014\u2014> has symptom \u2014\u2014> delusions  \nReranked Triple3: Depression \u2014\u2014> associates \u2014\u2014> Alzheimer Disease  \nReranked Triple4: Depression \u2014\u2014> is associated with \u2014\u2014> cognitive decline  \nReranked Triple5: Depression \u2014\u2014> DISEASE TYPE \u2014\u2014> depressive disorder  ",
    "neighbor_input": "Reranked Triple1: AD -> ASSOCIATES -> dementia  \nReranked Triple2: AD -> CAUSES -> cognitive impairment  \nReranked Triple3: AD -> TREATMENT -> depression  \nReranked Triple4: AD -> CAUSES -> behavioral deficits  \nReranked Triple5: AD -> CAUSES -> cognitive decline  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer Disease' 'associates' 'dementia'.\n\nPath-based Evidence 2: 'Alzheimer Disease' 'has symptom' 'delusions'.\n\nPath-based Evidence 3: 'Depression' 'associates' 'Alzheimer Disease'.\n\nPath-based Evidence 4: 'Depression' 'is associated with' 'cognitive decline'.\n\nPath-based Evidence 5: 'Depression' 'DISEASE TYPE' 'depressive disorder'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' is associated with 'dementia'.  \nNeighbor-based Evidence 2: 'AD' causes 'cognitive impairment'.  \nNeighbor-based Evidence 3: 'AD' has treatment for 'depression'.  \nNeighbor-based Evidence 4: 'AD' causes 'behavioral deficits'.  \nNeighbor-based Evidence 5: 'AD' causes 'cognitive decline'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0,
      0.6239832639694214,
      1.000000238418579,
      1.0000001192092896,
      1.0,
      0.8745613098144531,
      1.0
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "fb0eec29-958e-4401-aef1-e1d3b6a12e07",
    "question": "Which ONE feature could help to differenciate Alzheimer's Dementia from Delirium in a 70 year old man with Urinary Tract Infection?",
    "opa": "Memory Disturbances",
    "opb": "Apraxia",
    "opc": "Delusion",
    "opd": "Delusion",
    "cop": 3,
    "choice_type": "single",
    "exp": "Delirium is broadly defined as an acute decline in attention and cognition. It is characterized by altered sensorium, confusion, stupor, and fluctuations of consciousness. Dementia is defined as a progressive impairment of cognitive functions occurring in clear consciousness (i.e. in the absence of delirium).",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Alzheimer's Dementia\n2. Delirium\n3. 70 year old man\n4. Urinary Tract Infection\n5. Memory Disturbances\n6. Apraxia\n7. Delusion",
    "prediction": "A",
    "path": "Reranked Triple1: Alzheimer's dementia -> associates -> cognitive decline  \nReranked Triple2: cognitive decline -> associated with -> AD  \nReranked Triple3: AD -> resembles -> Alzheimer's disease  \nReranked Triple4: delusion -> in -> patients  \nReranked Triple5: Alzheimer's disease -> has symptom -> delusions  ",
    "neighbor_input": "Reranked Triple1: Alzheimer's dementia -> symptom -> death  \nReranked Triple2: Alzheimer's dementia -> ASSOCIATES -> cognitive decline  \nReranked Triple3: Alzheimer's dementia -> associated with -> amnestic syndrome  \nReranked Triple4: Alzheimer's dementia -> associates -> dementia  \nReranked Triple5: Alzheimer's dementia -> cause -> neurodegeneration  \n\nAnswer: A.Memory Disturbances",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer's dementia' is known to 'associate' with 'cognitive decline'.\n\nPath-based Evidence 2: 'Cognitive decline' is 'associated with' 'AD'.\n\nPath-based Evidence 3: 'AD' 'resembles' 'Alzheimer's disease'.\n\nPath-based Evidence 4: 'Delusion' occurs 'in' 'patients'.\n\nPath-based Evidence 5: 'Alzheimer's disease' 'has symptom' 'delusions'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Alzheimer's dementia' is a 'symptom' of 'death'.\n\nNeighbor-based Evidence 2: 'Alzheimer's dementia' 'ASSOCIATES' with 'cognitive decline'.\n\nNeighbor-based Evidence 3: 'Alzheimer's dementia' is 'associated with' 'amnestic syndrome'.\n\nNeighbor-based Evidence 4: 'Alzheimer's dementia' 'associates' with 'dementia'.\n\nNeighbor-based Evidence 5: 'Alzheimer's dementia' is a 'cause' of 'neurodegeneration'.",
    "entity_confidence_scores": [
      1.000000238418579,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      0.9999999403953552,
      0.7707369327545166,
      1.0000001192092896,
      0.6758190393447876,
      1.0,
      1.0,
      1.0000001192092896,
      0.8082404136657715,
      1.0000001192092896,
      0.7298930883407593,
      0.7964770793914795,
      0.633560061454773,
      0.6898353099822998,
      1.0,
      1.0
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "c6ad86d7-40ae-4046-96c8-01a31b6a31cb",
    "question": "Neurotransmitter playing major pa in the pathogenesis of Alzheimer's disease ?",
    "opa": "Serotonine",
    "opb": "Norepinephrine",
    "opc": "Acetylcholine",
    "opd": "Dopamine",
    "cop": 2,
    "choice_type": "single",
    "exp": "Ans. is 'c' i.e., Acetylcholine Neurotransmitters in Alzheimer's disease Acetylcholine has a major role in memory functions and deficiency in cholinergic functioning is associatedwith memory disturbances paicularly sho term memory. In Alzheimer's disease there loss of cells in the nucleus basalis of meyernet results in marked reduction in choline acetyltransferase (CHAT), an enzymeinvolved in the synthesis of acetylcholine --> Decreased Acetylcholine. The other impoant neurotransmitter involved is norepinephrine --> There is decrease in nor-epinephrine containing neurons in the locus ceruleus. Two other neuroactive peptides have been implicated in AD --> Somatostatin and coicotropin, both of which have decreased concentration.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Neurotransmitter\n2. Alzheimer's disease\n3. Serotonine\n4. Norepinephrine\n5. Acetylcholine\n6. Dopamine",
    "prediction": "C",
    "path": "Reranked Triple1: alzheimer disease \u2014\u2014> CAUSES \u2014\u2014> dementia  \nReranked Triple2: dementia \u2014\u2014> caused by \u2014\u2014> tau  \nReranked Triple3: tau \u2014\u2014> associates \u2014\u2014> Alzheimer Disease  \nReranked Triple4: serotonin \u2014\u2014> reduced in \u2014\u2014> rats  \nReranked Triple5: serotonin \u2014\u2014> decreases \u2014\u2014> norepinephrine  \n\nAnswer: C. Acetylcholine",
    "neighbor_input": "Reranked Triple1: neurotransmitters \u2014\u2014> activate \u2014\u2014> alpha7nAChR-positive neurons  \nReranked Triple2: neurotransmitters \u2014\u2014> activate \u2014\u2014> GABAR-positive neurons  \nReranked Triple3: AD \u2014\u2014> causes \u2014\u2014> cognitive decline  \nReranked Triple4: AD \u2014\u2014> causes \u2014\u2014> neurodegeneration  \nReranked Triple5: AD \u2014\u2014> treats \u2014\u2014> cognitive deficits  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'alzheimer disease' 'CAUSED' 'dementia'.\n\nPath-based Evidence 2: 'dementia' 'caused by' 'tau'.\n\nPath-based Evidence 3: 'tau' 'associates' 'Alzheimer Disease'.\n\nPath-based Evidence 4: 'serotonin' 'reduced in' 'rats'.\n\nPath-based Evidence 5: 'serotonin' 'decreases' 'norepinephrine'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'neurotransmitters' 'activate' 'alpha7nAChR-positive neurons'.\n\nNeighbor-based Evidence 2: 'neurotransmitters' 'activate' 'GABAR-positive neurons'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'cognitive decline'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'neurodegeneration'.\n\nNeighbor-based Evidence 5: 'AD' 'treats' 'cognitive deficits'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      0.9202996492385864,
      0.8773843050003052,
      0.8702182769775391,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.9430060386657715,
      1.0000001192092896,
      1.0,
      1.0,
      1.0,
      0.910812497138977
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "0119fec0-c567-4783-b5e6-a8e693b28399",
    "question": "A 90-year-old woman with mild diabetes and Alzheimer disease dies in her sleep. At autopsy, hepatocytes are noted to contain golden cytoplasmic granules that do not stain with Prussian blue. Which of the following best accounts for pigment accumulation in the liver of this patient?",
    "opa": "Advanced age",
    "opb": "Alzheimer disease",
    "opc": "Congestive heart failure",
    "opd": "Diabetic ketoacidosis",
    "cop": 0,
    "choice_type": "single",
    "exp": "Advanced age. Substances that cannot be metabolized accumulate in cells. Examples include (1) endogenous substrates that are not processed because a key enzyme is missing (lysosomal storage diseases), (2) insoluble endogenous pigments (lipofuscin and melanin), and (3) exogenous particulates (silica and carbon). Lipofuscin is a \"wear and tear\" pigment of aging that accumulates in organs such as the brain, heart, and liver. None of the other choices are associated with lipofuscin accumulation.Diagnosis: Aging, lipofuscin",
    "subject_name": "Pathology",
    "topic_name": "Cellular Pathology",
    "entity": "1. diabetes\n2. Alzheimer disease\n3. autopsy\n4. hepatocytes\n5. liver\n6. cytoplasmic granules\n7. Prussian blue\n8. pigment accumulation\n9. advanced age\n10. congestive heart failure\n11. diabetic ketoacidosis",
    "prediction": "D",
    "path": "Reranked Triple1: Diabetic->is a->disease \u2014\u2014> NAME->Alzheimer's disease\nReranked Triple2: AD->correlates with->diabetes mellitus \u2014\u2014> associates->alzheimer disease\nReranked Triple3: AD->correlates with->diabetes mellitus \u2014\u2014> Alzheimer disease->CAUSES->dementia\nReranked Triple4: diabetes mellitus->associates->alzheimer disease \u2014\u2014> alzheimer disease->CAUSES->dementia\nReranked Triple5: alzheimer disease->CAUSES->dementia \u2014\u2014> caused by->AD",
    "neighbor_input": "Reranked Triple1: diabetes mellitus \u2014\u2014> pathogenesis \u2014\u2014> increased platelet activation\nReranked Triple2: diabetes mellitus \u2014\u2014> associates \u2014\u2014> obesity\nReranked Triple3: diabetes mellitus \u2014\u2014> affects \u2014\u2014> rat\nReranked Triple4: diabetes mellitus \u2014\u2014> cerebrovascular health indicator \u2014\u2014> vascular health\nReranked Triple5: diabetes mellitus \u2014\u2014> ASSOCIATES \u2014\u2014> alzheimer disease",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Diabetic' is a 'disease' named 'Alzheimer's disease'.\nPath-based Evidence 2: 'AD' correlates with 'diabetes mellitus' which associates 'Alzheimer disease'.\nPath-based Evidence 3: 'AD' correlates with 'diabetes mellitus' which 'Alzheimer disease' causes 'dementia'.\nPath-based Evidence 4: 'Diabetes mellitus' associates 'Alzheimer disease' which 'Alzheimer disease' causes 'dementia'.\nPath-based Evidence 5: 'Alzheimer disease' causes 'dementia' which is caused by 'AD'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Diabetes mellitus' is linked to 'increased platelet activation' through the relationship 'pathogenesis'.\nNeighbor-based Evidence 2: 'Diabetes mellitus' is associated with 'obesity'.\nNeighbor-based Evidence 3: 'Diabetes mellitus' affects 'rat'.\nNeighbor-based Evidence 4: 'Diabetes mellitus' is a cerebrovascular health indicator for 'vascular health'.\nNeighbor-based Evidence 5: 'Diabetes mellitus' is associated with 'Alzheimer's disease'.",
    "entity_confidence_scores": [
      1.0,
      0.6596330404281616,
      0.8405250310897827,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0,
      0.7348365783691406,
      0.9257240295410156,
      0.6446938514709473,
      1.0000001192092896,
      0.7185409069061279,
      1.0,
      0.7725170850753784,
      0.74434494972229,
      1.0,
      0.7338776588439941,
      1.0,
      0.6089299917221069,
      0.8405250310897827
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "9ae84629-c861-4149-8925-458802d4313b",
    "question": "Following are predispositions to Alzheimer\\'s disease except -",
    "opa": "Down's syndrome",
    "opb": "Head trauma",
    "opc": "Smoking",
    "opd": "Low education group",
    "cop": 2,
    "choice_type": "multi",
    "exp": "Risk factors for Alzheimer's disease:- Old age, female sex, positive family history, head trauma, low educational status, depression, metabolic (diabetes, hypercholesterolemia, elevated homocysteine), hypertension, CVA (stroke), Heavy metals (mercury, aluminium), genetic factors, down's syndrome.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. Down's syndrome\n3. Head trauma\n4. Smoking\n5. Low education group",
    "prediction": "C",
    "path": "Reranked Triple1: Smoking status \u2014\u2014> interacts \u2014\u2014> age\nReranked Triple2: Smoking status \u2014\u2014> interacts \u2014\u2014> dementia\nReranked Triple3: Smoking status \u2014\u2014> interacts \u2014\u2014> Alzheimer's disease\nReranked Triple4: Smoking status \u2014\u2014> interacts \u2014\u2014> nicotine\nReranked Triple5: Alzheimer's disease \u2014\u2014> CAUSES \u2014\u2014> dementia",
    "neighbor_input": "Reranked Triple1: AD->ASSOCIATES->Down's syndrome\nReranked Triple2: AD->ASSOCIATES->Head trauma\nReranked Triple3: AD->ASSOCIATES->Smoking\nReranked Triple4: AD->ASSOCIATES->Low education group\nReranked Triple5: AD->CAUSES->neurodegeneration",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Smoking status' interacts with 'age'.\nPath-based Evidence 2: 'Smoking status' interacts with 'dementia'.\nPath-based Evidence 3: 'Smoking status' interacts with 'Alzheimer's disease'.\nPath-based Evidence 4: 'Smoking status' interacts with 'nicotine'.\nPath-based Evidence 5: 'Alzheimer's disease' CAUSES 'dementia'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' is associated with 'Down's syndrome'.\nNeighbor-based Evidence 2: 'AD' is associated with 'Head trauma'.\nNeighbor-based Evidence 3: 'AD' is associated with 'Smoking'.\nNeighbor-based Evidence 4: 'AD' is associated with 'Low education group'.\nNeighbor-based Evidence 5: 'AD' causes 'neurodegeneration'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.9999999403953552,
      0.796008288860321,
      0.796008288860321,
      1.0,
      0.9198420643806458,
      1.0,
      0.9091010093688965,
      1.0,
      0.7607807517051697,
      0.7249429225921631,
      0.6977973580360413,
      0.6977973580360413,
      0.5193231105804443
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "827b937e-8cff-479b-b7c5-b3a7f3cde5ed",
    "question": "Which of the following drug is not used for the treatment of Alzheimer's disease:",
    "opa": "Tacrine.",
    "opb": "Physostigmine.",
    "opc": "Rivastigmine.",
    "opd": "Donepezil.",
    "cop": 1,
    "choice_type": "single",
    "exp": "Alzhiemer's\n\nTacrine\nDonepezil\nRivastigmine\nGallantamine",
    "subject_name": "Pharmacology",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. Tacrine\n3. Physostigmine\n4. Rivastigmine\n5. Donepezil",
    "prediction": "A",
    "path": "Reranked Triple1: staurosporine \u2014\u2014> TREATMENT \u2014\u2014> apoptosis\nReranked Triple2: staurosporine \u2014\u2014> inhibits \u2014\u2014> caspase-3\nReranked Triple3: caspase-3 \u2014\u2014> upregulated \u2014\u2014> Abeta\nReranked Triple4: Abeta \u2014\u2014> interacts \u2014\u2014> donepezil\nReranked Triple5: tau \u2014\u2014> associates \u2014\u2014> Alzheimer Disease",
    "neighbor_input": "Reranked Triple1: AD->TREATMENT->TUDCA \u2014\u2014> metal  \nReranked Triple2: AD->TREATMENT->TUDCA \u2014\u2014> insulin-like growth factor (IGF) signaling  \nReranked Triple3: AD->TREATMENT->TUDCA \u2014\u2014> deep learning  \nReranked Triple4: AD->TREATMENT->TUDCA \u2014\u2014> N-acetylcysteine  \nReranked Triple5: AD->TREATMENT->TUDCA \u2014\u2014> MB  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'staurosporine' is a 'TREATMENT' for 'apoptosis'.\nPath-based Evidence 2: 'staurosporine' 'inhibits' 'caspase-3'.\nPath-based Evidence 3: 'caspase-3' is 'upregulated' by 'Abeta'.\nPath-based Evidence 4: 'Abeta' 'interacts' with 'donepezil'.\nPath-based Evidence 5: 'tau' 'associates' with 'Alzheimer Disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' is related to 'TUDCA' through the treatment relationship.  \nNeighbor-based Evidence 2: 'AD' is associated with 'TUDCA' through the treatment relationship, specifically involving 'insulin-like growth factor (IGF) signaling'.  \nNeighbor-based Evidence 3: 'AD' has a treatment involving 'TUDCA', which is connected to 'deep learning'.  \nNeighbor-based Evidence 4: 'AD' is treated with 'TUDCA', which is also linked to 'N-acetylcysteine'.  \nNeighbor-based Evidence 5: 'AD' treatment includes 'TUDCA', which is connected to 'MB'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.685027539730072,
      0.669137716293335,
      1.0,
      0.6304964423179626,
      1.0,
      0.6575609445571899
    ],
    "question_types": [
      "treatment",
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "ca01187e-8e28-410a-965f-3b8af99558d6",
    "question": "The following is not a feature of Alzheimer's disease:",
    "opa": "Neurofibrillary tangles",
    "opb": "Senile (neuritic) plaques",
    "opc": "Amyloid Angiopathy",
    "opd": "Lewy bodies",
    "cop": 3,
    "choice_type": "single",
    "exp": "(D) Lewy bodies# 'Lewy bodies' are intraneuronal, intracytoplasmic, eosinophilic inclusions that have a dense core surrounded by a pale halo. They are composed by Neurofilaments and contain epitopes recognized by antibodies against neuro filament proteins, Ubiqutin and a-synuclein (presynaptic protein)> They are characteristically seen in idiopathic parkinsons disease (and not in Alzheimer's disease)> Alzheimer's disease is the most common cause of dementia in the Western world and is characterized by the following clinical, pathological and biochemical triad.> Clinically:w Subtle onset memory loss followed byw Slowly progressive dementia over several years> PathologicallyGross Diffuse atrophy of cerebral cortex Secondary enlargement of ventricular system> Microscopic Neuritic plaques containing b amyloid Neurofibrillary tangles Amyloid angiopathy accumulation of b amyloid in arterial walls of cerebral blood vessels.> Biochemically Decrease in cerebral cortical levels of acetyl choline (choline acetyl transferase (CAT) and nicotinic cholinergic receptors are also reduced) [Reduction in ACH is related to degeneration of nucleus basalis of Meynert> Lewy bodies are not mentioned as feature of Alzheimer's disease. Diffuse Lewy body disease Dementia + Large number of Lewy bodies in cortical neurons + No other pathological findings Diffuse Lewy body variant of Alzheimer's disease (and not in Alzheimer's disease) Dementia + Large number of Lewy bodies in cortical neurons + Neurofibrillary tangles and amyloid plaques.",
    "subject_name": "Pathology",
    "topic_name": "Misc.",
    "entity": "1. Alzheimer's disease\n2. Neurofibrillary tangles\n3. Senile (neuritic) plaques\n4. Amyloid Angiopathy\n5. Lewy bodies",
    "prediction": "D",
    "path": "Reranked Triple1: neurofibrillary tangles \u2014\u2014> ASSOCIATES \u2014\u2014> Alzheimer's disease  \nReranked Triple2: neurofibrillary tangles \u2014\u2014> characterized by \u2014\u2014> senile plaques (SP)  \nReranked Triple3: neurofibrillary tangles \u2014\u2014> FORM BY \u2014\u2014> microtubule-associated protein tau  \nReranked Triple4: neurofibrillary tangles \u2014\u2014> ASSOCIATES \u2014\u2014> Alzheimer's disease  \nReranked Triple5: senile plaques (SP) \u2014\u2014> ASSOCIATES \u2014\u2014> Alzheimer's disease  \n\nAnswer:  \nBased on the reranked triples, we see that neurofibrillary tangles and senile plaques are associated with Alzheimer's disease. The other options (C. Amyloid Angiopathy and D. Lewy bodies) are not mentioned in the context of the knowledge graph, suggesting they might not be features of Alzheimer's disease. Among the multiple choices, D. Lewy bodies is the least associated with Alzheimer's disease based on the provided information.",
    "neighbor_input": "Reranked Triple1: AD -> CAUSES -> neurofibrillary tangle pathology \u2014\u2014> Alzheimer's disease\nReranked Triple2: AD -> CAUSES -> amyloid-beta peptide (Abeta) deposition \u2014\u2014> Alzheimer's disease\nReranked Triple3: AD -> CAUSES -> amyloid-beta aggregation \u2014\u2014> Alzheimer's disease\nReranked Triple4: AD -> ASSOCIATES -> senile plaques \u2014\u2014> Alzheimer's disease\nReranked Triple5: AD -> ASSOCIATES -> amyloidosis \u2014\u2014> Alzheimer's disease\n\nAnswer: D. Lewy bodies",
    "response_of_KG_list_path": "Path-based Evidence 1: 'neurofibrillary tangles' 'ASSOCIATES' 'Alzheimer's disease'.\n\nPath-based Evidence 2: 'neurofibrillary tangles' 'characterized by' 'senile plaques (SP)'.\n\nPath-based Evidence 3: 'neurofibrillary tangles' 'FORM BY' 'microtubule-associated protein tau'.\n\nPath-based Evidence 4: 'neurofibrillary tangles' 'ASSOCIATES' 'Alzheimer's disease'.\n\nPath-based Evidence 5: 'senile plaques (SP)' 'ASSOCIATES' 'Alzheimer's disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Alzheimer's disease' 'CAUS' 'neurofibrillary tangle pathology' is a known cause of 'Alzheimer's disease'.\n\nNeighbor-based Evidence 2: 'Alzheimer's disease' 'CAUS' 'amyloid-beta peptide (Abeta) deposition' is identified as a cause of 'Alzheimer's disease'.\n\nNeighbor-based Evidence 3: 'Alzheimer's disease' 'CAUS' 'amyloid-beta aggregation' is associated with the causation of 'Alzheimer's disease'.\n\nNeighbor-based Evidence 4: 'Alzheimer's disease' 'ASSOCIATES' 'senile plaques' is often found in association with 'Alzheimer's disease'.\n\nNeighbor-based Evidence 5: 'Alzheimer's disease' 'ASSOCIATES' 'amyloidosis' is linked with 'Alzheimer's disease'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0,
      0.9538915157318115,
      0.9499473571777344,
      1.000000238418579
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "942e6690-f26d-4a86-9235-1c4e9b550153",
    "question": "Dementia of Alzheimer's type is not associated with one of the following :",
    "opa": "Depressive symptoms",
    "opb": "Delusions",
    "opc": "Apraxia and aphasia",
    "opd": "Cerebral infarcts",
    "cop": 3,
    "choice_type": "single",
    "exp": "D i.e.Cerebral infarcts",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Dementia of Alzheimer's type\n2. Depressive symptoms\n3. Delusions\n4. Apraxia and aphasia\n5. Cerebral infarcts",
    "prediction": "D",
    "path": "Reranked Triple1: delusions -> affects -> patients  \nReranked Triple2: patients -> have -> aphasia syndromes  \nReranked Triple3: dementia of the Alzheimer type -> patients -> Abeta  \nReranked Triple4: Abeta -> causes -> AD  \nReranked Triple5: Abeta -> treats -> AD  ",
    "neighbor_input": "Reranked Triple1: AD -> has symptom -> depressive symptoms\nReranked Triple2: AD -> has symptom -> aphasia\nReranked Triple3: AD -> has symptom -> cognitive decline\nReranked Triple4: AD -> has symptom -> memory loss\nReranked Triple5: AD -> has symptom -> behavioral symptoms",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Delusions' can 'affect' 'patients'.\n\nPath-based Evidence 2: 'Patients' 'have' 'aphasia syndromes'.\n\nPath-based Evidence 3: 'Dementia of the Alzheimer type' is associated with 'patients' who have 'Abeta'.\n\nPath-based Evidence 4: 'Abeta' 'causes' 'AD'.\n\nPath-based Evidence 5: 'Abeta' 'treats' 'AD'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'has symptom' 'depressive symptoms'.\n\nNeighbor-based Evidence 2: 'AD' 'has symptom' 'aphasia'.\n\nNeighbor-based Evidence 3: 'AD' 'has symptom' 'cognitive decline'.\n\nNeighbor-based Evidence 4: 'AD' 'has symptom' 'memory loss'.\n\nNeighbor-based Evidence 5: 'AD' 'has symptom' 'behavioral symptoms'.",
    "entity_confidence_scores": [
      0.9736135005950928,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.9381810426712036,
      1.0,
      1.000000238418579,
      1.0,
      0.6450759768486023,
      1.0,
      0.8186885714530945,
      1.0000001192092896
    ],
    "question_types": [
      "symptom",
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "86f6db79-95a7-47e7-a928-5e21c102ae44",
    "question": "Which of the following is not associated with dementia: March 2011",
    "opa": "Forgetfulness",
    "opb": "Alteration of consciousness",
    "opc": "Reduced personal care",
    "opd": "Loss of neurons in brain",
    "cop": 1,
    "choice_type": "single",
    "exp": "Ans. B: Alteration of consciousnessThere is impairment of judgement and impulse control, and also impairment of abstract thinking There is however usually no impairment of consciousness in dementia (unlike in delirium) Dementia:Chronic onsetNo disturbance of consciousnessCognitive impairmentPersonality alterationImpaired memoryImpaired judgmentAbsent diurnal variation",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. dementia\n2. Forgetfulness\n3. Alteration of consciousness\n4. Reduced personal care\n5. Loss of neurons\n6. brain",
    "prediction": "B",
    "path": [],
    "neighbor_input": "Reranked Triple1: AD -> causes -> alteration of consciousness \u2014\u2014> cognitive impairment\nReranked Triple2: AD -> causes -> forgetfulness \u2014\u2014> cognitive impairment\nReranked Triple3: AD -> causes -> loss of neurons in brain \u2014\u2014> dementia\nReranked Triple4: AD -> causes -> reduced personal care \u2014\u2014> cognitive decline\nReranked Triple5: AD -> causes -> cognitive dysfunction \u2014\u2014> dementia\n\nAnswer: B. Alteration of consciousness is not typically associated with dementia in the same context as the other options.",
    "response_of_KG_list_path": [],
    "response_of_KG_neighbor": "Based on the knowledge graph information provided, here are the conversions to natural language:\n\nNeighbor-based Evidence 1: 'AD' 'causes' 'alteration of consciousness', which is linked to 'cognitive impairment'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'forgetfulness', which is also related to 'cognitive impairment'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'loss of neurons in brain', leading to 'dementia'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'reduced personal care', contributing to 'cognitive decline'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'cognitive dysfunction', which is associated with 'dementia'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.7334573864936829,
      0.7334573268890381,
      0.64045250415802,
      0.6245853900909424,
      1.0000001192092896,
      1.0
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "eb03d2e3-a264-461b-a3dc-fa87b40c00f0",
    "question": "An elderly man presents with tremors and gives a family history of dementia, The diagnosis is",
    "opa": "Alzhiemer's disease",
    "opb": "Parkinsonism dementia-ALS complex",
    "opc": "Huntington's chorea",
    "opd": "Pick's disease",
    "cop": 1,
    "choice_type": "single",
    "exp": "(B) Parkinsonism dementia-ALS complex # Amyotrophic lateral sclerosis (ALS) or Lou Gehrig's Disease or Maladie de Charcot or motor neurone disease) is a progressive, fatal, neurodegenerative disease caused by the degeneration of motor neurons, the nerve cells in the central nervous system that control voluntary muscle movement> The disorder causes muscle weakness and atrophy throughout the body as both the upper & lower motor neurons degenerate and die, ceasing to send messages to muscles> Unable to function, the muscles gradually weaken, atrophy, and develop fasciculations (twitches) because of denervation. Eventually, the brain completely loses its ability to initiate and control voluntary movement.> Frontotemporal dementia with Parkinsonism-17 (FTDP-17) is a type of progressively worsening dementia that affects the frontal (front) and temporal (side) regions of the brain. It includes some instances of what was once called 'Pick's disease'.> Symptoms may include personality changes with loss of social niceties, diminished cognitive capacity and parkinsonism (lack of facial expression, slow movements, rigidity and balance problems).",
    "subject_name": "Medicine",
    "topic_name": "Miscellaneous",
    "entity": "1. elderly man\n2. tremors\n3. family history\n4. dementia\n5. Alzheimer's disease\n6. Parkinsonism dementia-ALS complex\n7. Huntington's chorea\n8. Pick's disease",
    "prediction": "B",
    "path": "Reranked Triple1: Dementia \u2014\u2014> Alzheimer's disease  \nReranked Triple2: Tremors \u2014\u2014> Parkinsonism dementia-ALS complex  \nReranked Triple3: Family history \u2014\u2014> Huntington's chorea  \nReranked Triple4: Dementia \u2014\u2014> Pick's disease  \nReranked Triple5: Tremors \u2014\u2014> Parkinson's disease  ",
    "neighbor_input": "Reranked Triple1: AD -> CAUSES -> dementia  \nReranked Triple2: AD -> CAUSES -> cognitive impairment  \nReranked Triple3: Tremor -> involves -> cerebellum  \nReranked Triple4: AD -> CAUSES -> neurodegeneration  \nReranked Triple5: AD -> CAUSES -> cognitive decline  ",
    "response_of_KG_list_path": "Path-based Evidence 1: The relationship between 'Dementia' and 'Alzheimer's disease' indicates that 'Dementia' can be associated with 'Alzheimer's disease'.\n\nPath-based Evidence 2: The connection between 'Tremors' and 'Parkinsonism dementia-ALS complex' suggests that 'Tremors' may lead to or be a symptom of 'Parkinsonism dementia-ALS complex'.\n\nPath-based Evidence 3: The link between 'Family history' and 'Huntington's chorea' implies that having a 'Family history' can be a risk factor for developing 'Huntington's chorea'.\n\nPath-based Evidence 4: The association of 'Dementia' with 'Pick's disease' shows that 'Dementia' can also be related to 'Pick's disease'.\n\nPath-based Evidence 5: The relationship between 'Tremors' and 'Parkinson's disease' indicates that 'Tremors' are a common symptom associated with 'Parkinson's disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'CAUSES' 'dementia'.\n\nNeighbor-based Evidence 2: 'AD' 'CAUSES' 'cognitive impairment'.\n\nNeighbor-based Evidence 3: 'Tremor' 'involves' 'cerebellum'.\n\nNeighbor-based Evidence 4: 'AD' 'CAUSES' 'neurodegeneration'.\n\nNeighbor-based Evidence 5: 'AD' 'CAUSES' 'cognitive decline'.",
    "entity_confidence_scores": [
      0.7431753873825073,
      0.8343079686164856,
      0.8343079686164856,
      0.7767001390457153,
      0.6527183055877686,
      0.617055356502533,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.7840577960014343,
      0.8395751714706421,
      0.808238685131073,
      1.0000001192092896,
      0.6205008029937744
    ],
    "question_types": [
      "symptom",
      "diagnosis"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "e2b8998e-1f83-4c94-8383-9538ce40fc62",
    "question": "True about dementia is A/E",
    "opa": "Hallucination are not common",
    "opb": "Clouding of consciousness is common",
    "opc": "Nootropics have limited role",
    "opd": "All",
    "cop": 1,
    "choice_type": "multi",
    "exp": "B i.e. Clouding of consciousness is common Clouding of consciousness is a characteristic feature delirium & is helpful in differentiating it from dementiaQ. Two most common causes of dementia are Alzheimer's & multi infarct; both of which are irreversible.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. dementia\n2. Hallucination \n3. Clouding of consciousness \n4. Nootropics",
    "prediction": "C",
    "path": [],
    "neighbor_input": "Reranked Triple1: AD->causes->clouding of consciousness \u2014\u2014> not common in dementia  \nReranked Triple2: AD->causes->hallucination \u2014\u2014> not common in dementia  \nReranked Triple3: AD->treats->nootropics \u2014\u2014> have limited role in dementia  \nReranked Triple4: AD->ASSOCIATES->dementia \u2014\u2014> does not commonly include clouding of consciousness  \nReranked Triple5: AD->causes->cognitive impairment \u2014\u2014> typically does not include hallucination or clouding of consciousness  ",
    "response_of_KG_list_path": [],
    "response_of_KG_neighbor": "1. Neighbor-based Evidence 1: 'Alzheimer's Disease' 'causes' 'clouding of consciousness' is not commonly seen in 'dementia'.\n\n2. Neighbor-based Evidence 2: 'Alzheimer's Disease' 'causes' 'hallucination', which is also not common in 'dementia'.\n\n3. Neighbor-based Evidence 3: 'Alzheimer's Disease' 'treats' 'nootropics', but these have a limited role in 'dementia'.\n\n4. Neighbor-based Evidence 4: 'Alzheimer's Disease' 'ASSOCIATES' with 'dementia', although it does not typically include 'clouding of consciousness'.\n\n5. Neighbor-based Evidence 5: 'Alzheimer's Disease' 'causes' 'cognitive impairment', which typically does not include 'hallucination' or 'clouding of consciousness'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.8674484491348267,
      0.8674484491348267,
      0.5455856323242188,
      0.6790475845336914,
      0.6790474653244019,
      0.640125036239624
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "770bc4d9-4695-4113-ac7b-533831d71d08",
    "question": "Dementia is seen in all except :",
    "opa": "Schizophrenia",
    "opb": "Head injury",
    "opc": "Huntington's chorea",
    "opd": "Frontal lobe tumour",
    "cop": 0,
    "choice_type": "multi",
    "exp": "A i.e. Schizophrenia",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Dementia\n2. Schizophrenia\n3. Head injury\n4. Huntington's chorea\n5. Frontal lobe tumour",
    "prediction": "A",
    "path": [],
    "neighbor_input": "Reranked Triple1: Schizophrenia \u2014\u2014> NOT associated with dementia  \nReranked Triple2: Head injury \u2014\u2014> can lead to dementia  \nReranked Triple3: Huntington's chorea \u2014\u2014> associated with dementia  \nReranked Triple4: Frontal lobe tumour \u2014\u2014> associated with dementia  \nReranked Triple5: Cognitive impairment \u2014\u2014> can occur in various conditions including dementia",
    "response_of_KG_list_path": [],
    "response_of_KG_neighbor": "Sure! Here are the natural language conversions based on the knowledge graph information:\n\nNeighbor-based Evidence 1: 'Schizophrenia' is 'NOT associated with' dementia.\n\nNeighbor-based Evidence 2: 'Head injury' 'can lead to' dementia.\n\nNeighbor-based Evidence 3: 'Huntington's chorea' is 'associated with' dementia.\n\nNeighbor-based Evidence 4: 'Frontal lobe tumour' is 'associated with' dementia.\n\nNeighbor-based Evidence 5: 'Cognitive impairment' 'can occur in' various conditions including dementia.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0,
      1.0,
      0.8395751714706421,
      0.808238685131073,
      0.7436690330505371
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "565639f7-7fc1-4b47-8ce6-71ba792c05f7",
    "question": "The following are preventable risk factors for dementia",
    "opa": "Hypeension",
    "opb": "Apo E4",
    "opc": "Age",
    "opd": "Lowered Homocysteine",
    "cop": 0,
    "choice_type": "single",
    "exp": "Many risk factors for dementia have been identified in recent years, most of which are common, and several are associated with both AD and VaD, as well as with atherosclerosis.These include age, hypeension, diabetes mellitus, dyslipidemia, hyperhomocysteinemia, obesity, smoking, coronary aery disease, and low level of education and occupational attainment. It is impoant to note that many of these risk factors seem to exe their critical effects already in midlife In senescence, the changes mayhave disappeared. Most elderly are not overweight any more, have stopped smoking (if they ever did), and even their cholesterol levels are lower than they have ever been. It is impoant to realize that an interaction exists between these factors. Ref Harrison20th edition pg 2297",
    "subject_name": "Medicine",
    "topic_name": "C.N.S",
    "entity": "1. Dementia\n2. Hypertension\n3. Apo E4\n4. Age\n5. Homocysteine",
    "prediction": "A",
    "path": [],
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> causes \u2014\u2014> cognitive decline  \nReranked Triple2: AD \u2014\u2014> causes \u2014\u2014> vascular dysfunction  \nReranked Triple3: AD \u2014\u2014> causes \u2014\u2014> cognitive impairment  \nReranked Triple4: AD \u2014\u2014> causes \u2014\u2014> neurodegeneration  \nReranked Triple5: AD \u2014\u2014> associates \u2014\u2014> hypertension  ",
    "response_of_KG_list_path": [],
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' causes 'cognitive decline'.  \nNeighbor-based Evidence 2: 'AD' causes 'vascular dysfunction'.  \nNeighbor-based Evidence 3: 'AD' causes 'cognitive impairment'.  \nNeighbor-based Evidence 4: 'AD' causes 'neurodegeneration'.  \nNeighbor-based Evidence 5: 'AD' associates with 'hypertension'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.8563955426216125,
      0.8761035203933716,
      0.647192120552063,
      0.9572594165802002,
      1.0000001192092896,
      0.8959727883338928,
      1.0,
      1.0,
      1.0000001192092896
    ],
    "question_types": [
      "prevention"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "725f91fa-60dc-41fd-82a1-197a19283d8f",
    "question": "The nucleus involved in Alzheimer's disease is -",
    "opa": "Basal nucleus of Mayernet",
    "opb": "Raphe nucleus",
    "opc": "Superior salivary nucleus",
    "opd": "Basal lobe of cerebellum",
    "cop": 0,
    "choice_type": "single",
    "exp": "Alzheimer disease \n\nAlzheimer disease (AD) is the most common cause of dementia in the elderly.\nAlzheimer's disease is associated with a decrease in cerebral cortical levels of Acetylcholine.\nReduction of Acetylcholine is related to degeneration of cholinergic neurons that project to many areas of cortex.\nThis degeneration occurs in the nucleus basalis of Mayernet.",
    "subject_name": "Pathology",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. Basal nucleus of Mayernet\n3. Raphe nucleus\n4. Superior salivary nucleus\n5. Basal lobe of cerebellum",
    "prediction": "D",
    "path": "Reranked Triple1: Alzheimer disease \u2014\u2014> associates with -> dementia  \nReranked Triple2: dementia \u2014\u2014> caused by -> tau  \nReranked Triple3: Alzheimer disease \u2014\u2014> causes -> brain atrophy  \nReranked Triple4: AD \u2014\u2014> correlates with -> diabetes mellitus  \nReranked Triple5: AD \u2014\u2014> resembles -> Alzheimers disease",
    "neighbor_input": "Reranked Triple1: AD->CAUSES->neurodegeneration\nReranked Triple2: AD->ASSOCIATES->glycogen synthase kinase 3beta\nReranked Triple3: AD->treats->phloroglucinol\nReranked Triple4: AD->TREATMENT->TUDCA\nReranked Triple5: AD->ASSOCIATES->MAPT",
    "response_of_KG_list_path": "Path-based Evidence 1: The condition 'Alzheimer disease' is known to 'associate with' 'dementia'.\n\nPath-based Evidence 2: 'Dementia' is 'caused by' 'tau'.\n\nPath-based Evidence 3: 'Alzheimer disease' 'causes' 'brain atrophy'.\n\nPath-based Evidence 4: 'AD' 'correlates with' 'diabetes mellitus'.\n\nPath-based Evidence 5: 'AD' 'resembles' 'Alzheimer's disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' causes 'neurodegeneration'.\nNeighbor-based Evidence 2: 'AD' associates with 'glycogen synthase kinase 3beta'.\nNeighbor-based Evidence 3: 'AD' treats with 'phloroglucinol'.\nNeighbor-based Evidence 4: 'AD' treatment is 'TUDCA'.\nNeighbor-based Evidence 5: 'AD' associates with 'MAPT'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.7458378672599792,
      0.7261062860488892,
      0.7261061668395996,
      0.836044192314148,
      0.7716284990310669
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "f50757d5-ae47-4f4f-91db-56b12dd091aa",
    "question": "In Alzheimer's disease, the characteristic lesion is seen in",
    "opa": "Amygdaloid complex",
    "opb": "Nucleus of Meynert",
    "opc": "Basal ganglia",
    "opd": "Periventricle",
    "cop": 1,
    "choice_type": "single",
    "exp": "(B) Nucleus of Meynert # Pathology in Alzeihmer's disease:> The most severe pathology is usually found in the hippocampus, temporal cortex, and nucleus basalis of Meynert (lateral septum).> The most important microscopic findings are neuritic \"senile\" plaques and NFTs.> These lesions accumulate in small numbers during normal aging of the brain but occur in excess in AD.> Neuritic plaques contain a central core that includes A p amyloid, proteoglycans, Apo E4, a1 antichymotrypsin, and other proteins.> A amyloid is a protein of 39 to 42 amino acids that is derived proteolytically from a larger transmembrane protein, amyloid precursor protein (APP), which has neurotrophic and neuroprotective activity.> The normal function of A p amyloid is unknown.> Soluble amyloid fibrils may represent the initial pathologic event in AD leading to formation of neuritic plaques.> The plaque core is surrounded by the debris of degenerating neurons, microglia, and macrophages.> The accumulation of amyloid in cerebral arterioles, termed amyloid angiopathy, may lead to cerebral lobar hemorrhages.",
    "subject_name": "Medicine",
    "topic_name": "Miscellaneous",
    "entity": "1. Alzheimer's disease\n2. Amygdaloid complex\n3. Nucleus of Meynert\n4. Basal ganglia\n5. Periventricle",
    "prediction": "A",
    "path": "Reranked Triple1: amygdala \u2014\u2014> part of \u2014\u2014> brain\nReranked Triple2: brain \u2014\u2014> ASSOCIATES \u2014\u2014> mouse\nReranked Triple3: mouse \u2014\u2014> has \u2014\u2014> AD\nReranked Triple4: AD \u2014\u2014> TREATMENT \u2014\u2014> curcumin\nReranked Triple5: curcumin \u2014\u2014> binds \u2014\u2014> hypothalamus",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> cognitive lesion\nReranked Triple2: AD \u2014\u2014> neurodegeneration\nReranked Triple3: AD \u2014\u2014> dementia\nReranked Triple4: AD \u2014\u2014> brain damage\nReranked Triple5: AD \u2014\u2014> Alzheimer's disease",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Amygdala' is part of the 'brain'.\nPath-based Evidence 2: 'Brain' ASSOCIATES with 'mouse'.\nPath-based Evidence 3: 'Mouse' has 'AD'.\nPath-based Evidence 4: 'AD' is TREATED with 'curcumin'.\nPath-based Evidence 5: 'Curcumin' binds to the 'hypothalamus'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' is related to 'cognitive lesion'.\nNeighbor-based Evidence 2: 'AD' is related to 'neurodegeneration'.\nNeighbor-based Evidence 3: 'AD' is related to 'dementia'.\nNeighbor-based Evidence 4: 'AD' is related to 'brain damage'.\nNeighbor-based Evidence 5: 'AD' is related to 'Alzheimer's disease'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.7696682810783386,
      0.7779178619384766,
      0.7779178619384766,
      0.6691462993621826,
      1.0000001192092896,
      0.6335706114768982,
      0.6960955858230591,
      0.8278590440750122,
      0.6208553314208984
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "6c081de1-7100-4396-b626-7519d4ca82d6",
    "question": "All of the following neurotransmitter deficiencies are observed in Alzheimer's disease, Except",
    "opa": "Acetylcholine",
    "opb": "Serotonine",
    "opc": "Noradrenaline",
    "opd": "Dopamine",
    "cop": 3,
    "choice_type": "multi",
    "exp": "Answer is D (Dopamine):Dopamine deficiency is not a feature of Alzheimer's disease.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. neurotransmitter deficiencies\n3. Acetylcholine\n4. Serotonine\n5. Noradrenaline\n6. Dopamine",
    "prediction": "B",
    "path": "Reranked Triple1: serotonin \u2014\u2014> reduced in\nReranked Triple2: serotonin \u2014\u2014> treats\nReranked Triple3: serotonin \u2014\u2014> reduced in\nReranked Triple4: serotonin \u2014\u2014> treats\nReranked Triple5: serotonin \u2014\u2014> reduced in",
    "neighbor_input": "Reranked Triple1: AD->treats->phloroglucinol \u2014\u2014> cognitive deficits\nReranked Triple2: AD->treats->phloroglucinol \u2014\u2014> cognitive loss\nReranked Triple3: AD->treats->phloroglucinol \u2014\u2014> dementia\nReranked Triple4: AD->treats->phloroglucinol \u2014\u2014> Alzheimer-like cognitive deficits\nReranked Triple5: AD->treats->phloroglucinol \u2014\u2014> reactive oxygen species",
    "response_of_KG_list_path": "Path-based Evidence 1: 'serotonin' 'reduced in' \nPath-based Evidence 2: 'serotonin' 'treats' \nPath-based Evidence 3: 'serotonin' 'reduced in' \nPath-based Evidence 4: 'serotonin' 'treats' \nPath-based Evidence 5: 'serotonin' 'reduced in'",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' treats 'phloroglucinol' for 'cognitive deficits'.\nNeighbor-based Evidence 2: 'AD' treats 'phloroglucinol' for 'cognitive loss'.\nNeighbor-based Evidence 3: 'AD' treats 'phloroglucinol' for 'dementia'.\nNeighbor-based Evidence 4: 'AD' treats 'phloroglucinol' for 'Alzheimer-like cognitive deficits'.\nNeighbor-based Evidence 5: 'AD' treats 'phloroglucinol' for 'reactive oxygen species'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.7538900971412659,
      1.0,
      0.9430060386657715,
      1.0,
      0.7705323100090027,
      1.0,
      1.0,
      0.910812497138977
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "a689cfb6-e6ec-441b-814a-7192896b440a",
    "question": "Subcortical dementia is seen in all except -",
    "opa": "Parkinsonism",
    "opb": "Alzheimer's disease",
    "opc": "Wilson's disease",
    "opd": "Huntingtons chorea",
    "cop": 1,
    "choice_type": "multi",
    "exp": "Subcortical dementia is seen in parkinsonism, Huntington's disease, Wilson's disease, progressive supranuclear palsy, idiopathic basal ganglion calcification (Fahr's disease), thalamic lesions, multiple sclerosis, HIV associated dementia and multisystem atrophy.\nAlzheimer's disease causes cortical dementia.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Subcortical dementia\n2. Parkinsonism\n3. Alzheimer's disease\n4. Wilson's disease\n5. Huntington's chorea",
    "prediction": "B",
    "path": "Reranked Triple1: Wilson's disease \u2014\u2014> causes \u2014\u2014> copper intoxication\nReranked Triple2: Wilson's disease \u2014\u2014> resembles \u2014\u2014> Alzheimer's disease\nReranked Triple3: Wilson's disease \u2014\u2014> caused by \u2014\u2014> amyloid-beta precursor protein\nReranked Triple4: Wilson's disease \u2014\u2014> GENE PRODUCT \u2014\u2014> protein\nReranked Triple5: Wilson's disease \u2014\u2014> has \u2014\u2014> amyloid-beta precursor protein",
    "neighbor_input": "Reranked Triple1: Parkinsonism \u2014\u2014> causes \u2014\u2014> Neurodegenerative disease\nReranked Triple2: Parkinsonism \u2014\u2014> causes \u2014\u2014> Cardiovascular disease\nReranked Triple3: Parkinsonism \u2014\u2014> associates \u2014\u2014> variant amyloid deposits\nReranked Triple4: Parkinsonism \u2014\u2014> associated with \u2014\u2014> dopamine transporter\nReranked Triple5: Parkinsonism \u2014\u2014> caused by \u2014\u2014> 6-hydroxydopamine",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Wilson's disease' 'causes' 'copper intoxication'.\n\nPath-based Evidence 2: 'Wilson's disease' 'resembles' 'Alzheimer's disease'.\n\nPath-based Evidence 3: 'Wilson's disease' 'is caused by' 'amyloid-beta precursor protein'.\n\nPath-based Evidence 4: 'Wilson's disease' 'GENE PRODUCT' 'is a protein'.\n\nPath-based Evidence 5: 'Wilson's disease' 'has' 'amyloid-beta precursor protein'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Parkinsonism' causes 'Neurodegenerative disease'.\nNeighbor-based Evidence 2: 'Parkinsonism' causes 'Cardiovascular disease'.\nNeighbor-based Evidence 3: 'Parkinsonism' associates with 'variant amyloid deposits'.\nNeighbor-based Evidence 4: 'Parkinsonism' is associated with 'dopamine transporter'.\nNeighbor-based Evidence 5: 'Parkinsonism' is caused by '6-hydroxydopamine'.",
    "entity_confidence_scores": [
      0.882514476776123,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.8395751714706421,
      0.808238685131073
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "6ea53a50-5944-4326-8e91-6406cb3cb0e4",
    "question": "In Alzheimer\u2019s disease, plaque is made up of:",
    "opa": "Tau protein",
    "opb": "Beta amyloid",
    "opc": "Huntington",
    "opd": "Alpha synuclein",
    "cop": 1,
    "choice_type": "single",
    "exp": "(Refer: Robbins Pathologic Basis of Disease, 8thedition, pg no: 1313-1317)\nMorphology of Alzheimer's disease\n\nCortical atrophy especially in frontal, temporal and parietallobes.\nCompensatory ventricular enlargement due to loss ofparenchyma and reduced brain volume - (hydrocephalus exvacuo).\nStructures involved early - medial temporal lobe, including hippocampus entorhinal cortex and amygdala.\nProgressive severe neuronal loss and reactive gliosis",
    "subject_name": "Unknown",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. plaque\n3. Tau protein\n4. Beta amyloid\n5. Huntington\n6. Alpha synuclein",
    "prediction": "B",
    "path": "Reranked Triple1: Alzheimer disease \u2014\u2014> CAUSES \u2014\u2014> dementia  \nReranked Triple2: dementia \u2014\u2014> caused by \u2014\u2014> tau  \nReranked Triple3: Alzheimer disease \u2014\u2014> associates \u2014\u2014> tau  \nReranked Triple4: Alzheimer disease \u2014\u2014> causes \u2014\u2014> brain atrophy  \nReranked Triple5: AD \u2014\u2014> correlates with \u2014\u2014> diabetes mellitus  ",
    "neighbor_input": "Reranked Triple1: AD -> causes -> amyloid-beta plaques  \nReranked Triple2: amyloid-beta plaques -> comprises -> beta amyloid  \nReranked Triple3: AD -> causes -> beta amyloid  \nReranked Triple4: AD -> associates -> amyloid-beta  \nReranked Triple5: AD -> causes -> tau pathology  \n\nAnswer: B. Beta amyloid",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer disease' 'CAUSES' 'dementia'.\n\nPath-based Evidence 2: 'dementia' 'caused by' 'tau'.\n\nPath-based Evidence 3: 'Alzheimer disease' 'associates' 'tau'.\n\nPath-based Evidence 4: 'Alzheimer disease' 'causes' 'brain atrophy'.\n\nPath-based Evidence 5: 'AD' 'correlates with' 'diabetes mellitus'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'amyloid-beta plaques'.\n\nNeighbor-based Evidence 2: 'amyloid-beta plaques' 'comprises' 'beta amyloid'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'beta amyloid'.\n\nNeighbor-based Evidence 4: 'AD' 'associates' 'amyloid-beta'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'tau pathology'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.8603709936141968,
      0.8603709936141968,
      1.0,
      0.8382810950279236,
      1.0,
      0.9567092657089233,
      1.0,
      0.8395751714706421,
      0.9474924802780151,
      1.0,
      0.7870264649391174,
      0.8690527677536011,
      0.9708695411682129,
      0.9708695411682129,
      0.9708695411682129
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "4473b22f-4fca-4408-a77c-d0fa79a0d220",
    "question": "Protein involved in Alzheimer's disease",
    "opa": "Presel in - II",
    "opb": "ApoE gene",
    "opc": "Amyloid portion",
    "opd": "All of the above",
    "cop": 3,
    "choice_type": "multi",
    "exp": "(D) All of the above",
    "subject_name": "Psychiatry",
    "topic_name": "Miscellaneous",
    "entity": "1. Alzheimer's disease\n2. Protein\n3. Preselin-II\n4. ApoE gene\n5. Amyloid portion",
    "prediction": "D",
    "path": "Reranked Triple1: presenilin-1 \u2014\u2014> causes \u2014\u2014> Alzheimer disease (AD)  \nReranked Triple2: presenilin-1 \u2014\u2014> regulates \u2014\u2014> Abeta  \nReranked Triple3: ApoE \u2014\u2014> regulates \u2014\u2014> ApoE genotype  \nReranked Triple4: presenilin-1 \u2014\u2014> interacts \u2014\u2014> ApoE  \nReranked Triple5: ApoE \u2014\u2014> disease associated with \u2014\u2014> Alzheimer disease (AD)  \n\nAnswer: D.All of the above",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> causes \u2014\u2014> amyloid beta-protein  \nReranked Triple2: AD \u2014\u2014> causes \u2014\u2014> ApoE  \nReranked Triple3: AD \u2014\u2014> treats \u2014\u2014> Abeta aggregation  \nReranked Triple4: AD \u2014\u2014> associates \u2014\u2014> amyloid-beta peptide (Abeta) deposition  \nReranked Triple5: AD \u2014\u2014> associates \u2014\u2014> ApoE (apolipoprotein E)  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'presenilin-1' 'causes' 'Alzheimer disease (AD)'.\n\nPath-based Evidence 2: 'presenilin-1' 'regulates' 'Abeta'.\n\nPath-based Evidence 3: 'ApoE' 'regulates' 'ApoE genotype'.\n\nPath-based Evidence 4: 'presenilin-1' 'interacts' 'ApoE'.\n\nPath-based Evidence 5: 'ApoE' 'disease associated with' 'Alzheimer disease (AD)'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'amyloid beta-protein'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'ApoE'.\n\nNeighbor-based Evidence 3: 'AD' 'treats' 'Abeta aggregation'.\n\nNeighbor-based Evidence 4: 'AD' 'associates' 'amyloid-beta peptide (Abeta) deposition'.\n\nNeighbor-based Evidence 5: 'AD' 'associates' 'ApoE (apolipoprotein E)'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.7201132774353027,
      0.8890658020973206,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      0.811469554901123
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "50bc0b65-931a-418b-a2b7-7e82df4e042d",
    "question": "All of the following are known predisposing factors for Alzheimer's disease except -",
    "opa": "Down-syndrome",
    "opb": "Low education level",
    "opc": "Smoking",
    "opd": "Female sex",
    "cop": 2,
    "choice_type": "multi",
    "exp": null,
    "subject_name": "Medicine",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. Down-syndrome\n3. Low education level\n4. Smoking\n5. Female sex",
    "prediction": "C",
    "path": "Reranked Triple1: Down's syndrome \u2014\u2014> TYPE -> neurological disorder  \nReranked Triple2: Down's syndrome -> involves -> brain atrophy  \nReranked Triple3: Down's syndrome -> associates -> amyloidosis  \nReranked Triple4: nicotine -> treats -> AD  \nReranked Triple5: nicotine -> treats -> Alzheimer's disease  \n\nAnswer: B. Low education level is the only one not explicitly linked to being a predisposing factor for Alzheimer's disease in the provided knowledge graph.",
    "neighbor_input": "Reranked Triple1: Down syndrome \u2014\u2014> AD (Alzheimer's disease) association\nReranked Triple2: Low education level \u2014\u2014> cognitive decline\nReranked Triple3: Smoking \u2014\u2014> neurodegenerative diseases\nReranked Triple4: Female sex \u2014\u2014> risk factor for Alzheimer's disease\nReranked Triple5: cognitive impairment \u2014\u2014> AD (Alzheimer's disease) association",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Down's syndrome' 'is a type of' 'neurological disorder'.\n\nPath-based Evidence 2: 'Down's syndrome' 'involves' 'brain atrophy'.\n\nPath-based Evidence 3: 'Down's syndrome' 'is associated with' 'amyloidosis'.\n\nPath-based Evidence 4: 'nicotine' 'treats' 'AD'.\n\nPath-based Evidence 5: 'nicotine' 'treats' 'Alzheimer's disease'.",
    "response_of_KG_neighbor": "Based on the provided knowledge graph information, here are the natural language conversions:\n\nNeighbor-based Evidence 1: 'Down syndrome' has an 'AD (Alzheimer's disease) association'.\n\nNeighbor-based Evidence 2: 'Low education level' is linked to 'cognitive decline'.\n\nNeighbor-based Evidence 3: 'Smoking' is associated with 'neurodegenerative diseases'.\n\nNeighbor-based Evidence 4: 'Female sex' is identified as a 'risk factor for Alzheimer's disease'.\n\nNeighbor-based Evidence 5: 'Cognitive impairment' has an 'AD (Alzheimer's disease) association'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.9350342750549316,
      0.5942739248275757,
      1.0,
      0.7607807517051697,
      0.7249429225921631,
      0.6977973580360413,
      0.6977973580360413,
      0.7105591893196106,
      0.7105591893196106
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "dffc22c1-a676-4751-8b2e-0878f6ed20d2",
    "question": "Nucleus involved in Alzheimer's disease is",
    "opa": "Superior salivary nucleus",
    "opb": "Nucleus Natalia if Meynet",
    "opc": "Ventro medial nucleus of thalamus",
    "opd": "All of the above",
    "cop": 1,
    "choice_type": "multi",
    "exp": "Refer Robbins page no 1290",
    "subject_name": "Anatomy",
    "topic_name": "General anatomy",
    "entity": "1. Alzheimer's disease\n2. Superior salivary nucleus\n3. Nucleus Natalia if Meynet\n4. Ventro medial nucleus of thalamus",
    "prediction": "B",
    "path": "Reranked Triple1: Alzheimer disease \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple2: dementia \u2014\u2014> caused by \u2014\u2014> tau  \nReranked Triple3: AD \u2014\u2014> correlates with \u2014\u2014> diabetes mellitus  \nReranked Triple4: Alzheimer Disease \u2014\u2014> associates \u2014\u2014> AD  \nReranked Triple5: Alzheimer Disease \u2014\u2014> resembles \u2014\u2014> Alzheimers disease  ",
    "neighbor_input": "Reranked Triple1: AD -> causes -> cognitive impairment  \nReranked Triple2: AD -> causes -> neurodegeneration  \nReranked Triple3: AD -> causes -> memory deficit  \nReranked Triple4: AD -> causes -> dementia  \nReranked Triple5: AD -> causes -> synaptic dysfunction  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer disease' 'causes' 'dementia'.\n\nPath-based Evidence 2: 'dementia' 'caused by' 'tau'.\n\nPath-based Evidence 3: 'AD' 'correlates with' 'diabetes mellitus'.\n\nPath-based Evidence 4: 'Alzheimer Disease' 'associates' 'AD'.\n\nPath-based Evidence 5: 'Alzheimer Disease' 'resembles' 'Alzheimers disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'cognitive impairment'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'neurodegeneration'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'memory deficit'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'dementia'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'synaptic dysfunction'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.6115130186080933,
      0.6829975843429565,
      0.8227489590644836
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "8ff88bba-6fd2-42a9-8fe1-66fade7bb471",
    "question": "Nucleus involved in Alzheimer's disease is:",
    "opa": "Nucleus Basalis of Meyne",
    "opb": "Superior salivary nucleus",
    "opc": "Ventromedial nucleus of thalamus",
    "opd": "All of the above",
    "cop": 0,
    "choice_type": "multi",
    "exp": "The brain of Alzheimer's disease patients shows severe neuronal loss in the nucleus basalis of Meyne. This pa is the major source of cholinergic input to cerebral cortex.",
    "subject_name": "Pathology",
    "topic_name": "Neurodegenerative Disorder",
    "entity": "1. Alzheimer's disease\n2. Nucleus Basalis of Meynert \n3. Superior salivary nucleus \n4. Ventromedial nucleus of thalamus",
    "prediction": "A",
    "path": "Reranked Triple1: Alzheimer disease \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple2: dementia \u2014\u2014> caused by \u2014\u2014> tau  \nReranked Triple3: Alzheimer disease \u2014\u2014> associates \u2014\u2014> AD  \nReranked Triple4: AD \u2014\u2014> correlates with \u2014\u2014> diabetes mellitus  \nReranked Triple5: Alzheimer disease \u2014\u2014> associates \u2014\u2014> brain atrophy  ",
    "neighbor_input": "Reranked Triple1: AD -> causes -> cognitive impairment  \nReranked Triple2: AD -> causes -> neurodegeneration  \nReranked Triple3: AD -> causes -> behavioral deficits  \nReranked Triple4: AD -> causes -> memory loss  \nReranked Triple5: AD -> causes -> dementia  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer disease' 'causes' 'dementia'.\n\nPath-based Evidence 2: 'dementia' 'caused by' 'tau'.\n\nPath-based Evidence 3: 'Alzheimer disease' 'associates' 'AD'.\n\nPath-based Evidence 4: 'AD' 'correlates with' 'diabetes mellitus'.\n\nPath-based Evidence 5: 'Alzheimer disease' 'associates' 'brain atrophy'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'cognitive impairment'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'neurodegeneration'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'behavioral deficits'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'memory loss'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'dementia'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.82715904712677,
      0.6489728689193726,
      0.8501597046852112
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "9dfbf6e3-afb2-413b-87c5-7cabb4f48d8a",
    "question": "A 70 year old male patient dies with severe dementia. Autopsy demonstrates marked atrophy of the frontal and temporal lobes, with relative sparing of the rest of the brain. Which of the following microscopic features would be most useful in establishing the diagnosis?",
    "opa": "Enlarged presynaptic axon terminals surrounding a central core of extracellular amyloid-like substance",
    "opb": "Intracytoplasmic spherules composed of paired helical filaments",
    "opc": "Intracytoplasmic spherules that stain brightly eosinophilic",
    "opd": "Intranuclear and intracytoplasmic inclusion bodies in enlarged cells",
    "cop": 1,
    "choice_type": "single",
    "exp": "Selective frontal and temporal atrophy in a demented patient suggests Pick's disease. Microscopically, severe neuronal loss and astrocytosis are seen. The characteristic microscopic finding in this disorder is the presence of Pick's bodies, which are intracytoplasmic spherules composed of paired helical filaments, seen best with silver stains. 1st choice describes senile plaques. These are seen in Alzheimer disease as well as in some normal elderly individuals. 2nd choice describes Lewy bodies, seen in Parkinson's disease. 4th choice describes the inclusion bodies typically seen in glial cells and endothelial cells in cytomegalovirus encephalopathy. Ref: Ropper A.H., Samuels M.A. (2009). Chapter 39. Degenerative Diseases of the Nervous System. In A.H. Ropper, M.A. Samuels (Eds), Adams and Victor's Principles of Neurology, 9e.",
    "subject_name": "Medicine",
    "topic_name": null,
    "entity": "1. patient \n2. dementia \n3. Autopsy \n4. atrophy \n5. frontal lobe \n6. temporal lobe \n7. brain \n8. microscopic features \n9. diagnosis \n10. presynaptic axon terminals \n11. extracellular amyloid-like substance \n12. Intracytoplasmic spherules \n13. paired helical filaments \n14. eosinophilic \n15. intranuclear inclusion bodies \n16. intracytoplasmic inclusion bodies \n17. enlarged cells",
    "prediction": "B",
    "path": "Reranked Triple1: Alzheimer disease \u2014\u2014> DISEASE OF \u2014\u2014> Patient  \nReranked Triple2: Alzheimer disease \u2014\u2014> interacts \u2014\u2014> paired helical filament tau  \nReranked Triple3: paired helical filament tau \u2014\u2014> METABOLIC PERTURBATION \u2014\u2014> AD  \nReranked Triple4: sphingomyelins \u2014\u2014> METABOLIC PERTURBATION \u2014\u2014> AD  \nReranked Triple5: Alzheimer disease \u2014\u2014> DIAGNOSIS \u2014\u2014> AD  ",
    "neighbor_input": "Reranked Triple1: patient -> has disease -> Alzheimer's disease  \nReranked Triple2: patient -> has disease -> dementia  \nReranked Triple3: patient -> has -> atrophy  \nReranked Triple4: patient -> has -> cognitive impairment  \nReranked Triple5: patient -> has -> memory impairment  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer disease' is a 'DISEASE OF' 'Patient'.\n\nPath-based Evidence 2: 'Alzheimer disease' 'interacts' with 'paired helical filament tau'.\n\nPath-based Evidence 3: 'paired helical filament tau' causes a 'METABOLIC PERTURBATION' in 'AD'.\n\nPath-based Evidence 4: 'sphingomyelins' cause a 'METABOLIC PERTURBATION' in 'AD'.\n\nPath-based Evidence 5: 'Alzheimer disease' is related to the 'DIAGNOSIS' of 'AD'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: The 'patient' 'has disease' 'Alzheimer's disease'.  \nNeighbor-based Evidence 2: The 'patient' 'has disease' 'dementia'.  \nNeighbor-based Evidence 3: The 'patient' 'has' 'atrophy'.  \nNeighbor-based Evidence 4: The 'patient' 'has' 'cognitive impairment'.  \nNeighbor-based Evidence 5: The 'patient' 'has' 'memory impairment'.",
    "entity_confidence_scores": [
      1.0,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0,
      0.7348365783691406,
      1.0,
      1.0,
      1.0,
      0.9287086725234985,
      0.897533655166626,
      0.8949093818664551,
      0.8890469074249268,
      0.8716716766357422,
      0.8707143068313599,
      1.0000001192092896,
      0.8871150016784668,
      0.9128051996231079,
      1.0,
      0.7078962326049805,
      1.0000001192092896,
      0.7904350757598877,
      1.0,
      0.643872082233429,
      1.0000001192092896,
      0.7327340245246887,
      0.8242402076721191,
      0.8328537344932556,
      0.6019102931022644,
      0.8312710523605347,
      0.6786996126174927,
      0.6135005354881287,
      0.7515902519226074,
      0.6381944417953491
    ],
    "question_types": [
      "diagnosis"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "b1cec855-6931-405e-860e-04296bc75773",
    "question": "Alzheimer's disease is associated with:September 2012",
    "opa": "Delerium",
    "opb": "Delusion",
    "opc": "Dementia",
    "opd": "All of the above",
    "cop": 2,
    "choice_type": "multi",
    "exp": "Ans. C i.e. DementiaAlzheimer's dementiaCoical (NOT subcoical) dementia,Progressive,Associated with Apo E gene,Neurofibrillary tangles are seen andDonepezil is used in management",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. Delerium\n3. Delusion\n4. Dementia",
    "prediction": "D",
    "path": "Reranked Triple1: Alzheimer's disease \u2014\u2014> has symptom \u2014\u2014> delusions  \nReranked Triple2: Alzheimer's disease \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple3: delusion \u2014\u2014> in \u2014\u2014> patients with Alzheimer's disease  \nReranked Triple4: dementia \u2014\u2014> caused by \u2014\u2014> Alzheimer's disease  \nReranked Triple5: Alzheimer's disease \u2014\u2014> treats \u2014\u2014> delusion  \n\nAnswer: D.All of the above",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple2: AD \u2014\u2014> associates \u2014\u2014> cognitive impairment  \nReranked Triple3: AD \u2014\u2014> associates \u2014\u2014> memory loss  \nReranked Triple4: AD \u2014\u2014> causes \u2014\u2014> cognitive deficits  \nReranked Triple5: AD \u2014\u2014> causes \u2014\u2014> behavioral dysfunction  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer's disease' 'has symptom' 'delusions'.\n\nPath-based Evidence 2: 'Alzheimer's disease' 'causes' 'dementia'.\n\nPath-based Evidence 3: 'delusion' 'in' 'patients with Alzheimer's disease'.\n\nPath-based Evidence 4: 'dementia' 'caused by' 'Alzheimer's disease'.\n\nPath-based Evidence 5: 'Alzheimer's disease' 'treats' 'delusion'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'dementia'.\n\nNeighbor-based Evidence 2: 'AD' 'associates' 'cognitive impairment'.\n\nNeighbor-based Evidence 3: 'AD' 'associates' 'memory loss'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'cognitive deficits'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'behavioral dysfunction'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0,
      0.6239832639694214
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "b70b91a2-829c-4333-a25d-47b0137fd0ca",
    "question": "Features of Alzheimer's disease are all except?",
    "opa": "Narrowing of ventricles",
    "opb": "Hirano bodies",
    "opc": "amyloid",
    "opd": "neuritic plaques",
    "cop": 0,
    "choice_type": "multi",
    "exp": "Ans. (a) Narrowing of ventricles(Ref: Anderson 10th ed.2740, Ref: Robbins 9th/pg 1287-88; 8th/pg 1313)Compensatory ventricular enlargement due to extensive cortical atrophy is called hydrocephalus ex vacuo.This is seen in Alzheimer's and pick's disease.*The pathologic hallmark Q are plaques (both neuritic and senile) and tangles_ Option d is true*Vascular amyloid in cerebral amyloid angiopathy is Ab40-Option c is true*Hirano bodies Q and Granulovacuolar degeneration Q are other features seen in AD.-Option b is true",
    "subject_name": "Pathology",
    "topic_name": "Central Nervous System",
    "entity": "1. Alzheimer's disease\n2. ventricles\n3. Hirano bodies\n4. amyloid\n5. neuritic plaques",
    "prediction": "B",
    "path": "Reranked Triple1: Alzheimer's disease -> causes -> brain atrophy  \nReranked Triple2: Alzheimer's disease -> associates -> dementia  \nReranked Triple3: Alzheimer's disease -> correlates with -> diabetes mellitus  \nReranked Triple4: tau -> causes -> dementia  \nReranked Triple5: Alzheimer's disease -> resembles -> Alzheimers disease  \n\nAnswer: A.Narrowing of ventricles",
    "neighbor_input": "Reranked Triple1: AD -> causes -> Hirano bodies \u2014\u2014> none\nReranked Triple2: AD -> associates -> narrowing of ventricles \u2014\u2014> none\nReranked Triple3: AD -> causes -> amyloid \u2014\u2014> associated feature\nReranked Triple4: AD -> causes -> neuritic plaques \u2014\u2014> associated feature\nReranked Triple5: AD -> causes -> cognitive impairment \u2014\u2014> associated feature",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer's disease' 'causes' 'brain atrophy'.\n\nPath-based Evidence 2: 'Alzheimer's disease' 'associates' 'dementia'.\n\nPath-based Evidence 3: 'Alzheimer's disease' 'correlates with' 'diabetes mellitus'.\n\nPath-based Evidence 4: 'tau' 'causes' 'dementia'.\n\nPath-based Evidence 5: 'Alzheimer's disease' 'resembles' 'Alzheimer's disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'Hirano bodies', with no associated features.\n\nNeighbor-based Evidence 2: 'AD' 'associates' 'narrowing of ventricles', with no associated features.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'amyloid', which is an associated feature.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'neuritic plaques', which is an associated feature.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'cognitive impairment', which is an associated feature.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.7480196952819824,
      0.7058601379394531,
      0.6659548878669739,
      0.6024529337882996,
      1.0,
      1.0,
      0.9999999403953552,
      1.0
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "2d95d991-861b-47d6-ab55-c2eb7cddc57a",
    "question": "Which is the earliest site that get affected by Alzheimer's disease?",
    "opa": "Amygdala",
    "opb": "Nucleus basalis of mayernet",
    "opc": "Red nucleus",
    "opd": "Posterior commissurie",
    "cop": 1,
    "choice_type": "single",
    "exp": "Nucleus basalis of mayernet is the largest collection of cholinergic neuron in the brain.It is the earliest site to get affected by Alzheimer's disease.",
    "subject_name": "Pathology",
    "topic_name": null,
    "entity": "1. Alzheimer's disease \n2. Amygdala \n3. Nucleus basalis of Mayernet \n4. Red nucleus \n5. Posterior commissure",
    "prediction": "B",
    "path": "Reranked Triple1: amygdala -> part of -> brain  \nReranked Triple2: amygdala -> associates -> mouse  \nReranked Triple3: mouse -> model of -> AD  \nReranked Triple4: AD -> treatment -> curcumin  \nReranked Triple5: curcumin -> binds -> hypothalamus  \n\nAnswer: A. Amygdala",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> causes \u2014\u2014> cognitive impairment  \nReranked Triple2: AD \u2014\u2014> causes \u2014\u2014> brain atrophy  \nReranked Triple3: AD \u2014\u2014> causes \u2014\u2014> memory loss  \nReranked Triple4: AD \u2014\u2014> causes \u2014\u2014> neurodegeneration  \nReranked Triple5: AD \u2014\u2014> associates \u2014\u2014> cognitive decline  ",
    "response_of_KG_list_path": "Path-based Evidence 1: The 'amygdala' is a 'part of' the 'brain'.\n\nPath-based Evidence 2: The 'amygdala' 'associates' with the 'mouse'.\n\nPath-based Evidence 3: The 'mouse' is a 'model of' 'AD'.\n\nPath-based Evidence 4: 'AD' has a 'treatment' involving 'curcumin'.\n\nPath-based Evidence 5: 'Curcumin' 'binds' to the 'hypothalamus'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'cognitive impairment'.  \nNeighbor-based Evidence 2: 'AD' 'causes' 'brain atrophy'.  \nNeighbor-based Evidence 3: 'AD' 'causes' 'memory loss'.  \nNeighbor-based Evidence 4: 'AD' 'causes' 'neurodegeneration'.  \nNeighbor-based Evidence 5: 'AD' 'associates' 'cognitive decline'.  ",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.7779178619384766,
      0.836787760257721,
      0.6746446490287781,
      0.6746446490287781,
      0.836044192314148,
      0.6336098909378052
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "fe819a6b-c920-4a50-8a20-8dfadd2712f2",
    "question": "Which drug is not used now in Alzheimer's disease?",
    "opa": "Tacrine",
    "opb": "Galantamine",
    "opc": "Donepezil",
    "opd": "Rivastigmine",
    "cop": 0,
    "choice_type": "single",
    "exp": "Ans. (A) Tacrine(Ref: KDT 8th/e p119, 518)Because of hepatotoxicity, and requirement of frequent dosing, tacrine is less often used than other agents.",
    "subject_name": "Pharmacology",
    "topic_name": "A.N.S.",
    "entity": "1. Alzheimer's disease\n2. Tacrine\n3. Galantamine\n4. Donepezil\n5. Rivastigmine",
    "prediction": "A",
    "path": "Reranked Triple1: tacrine \u2014\u2014> treats \u2014\u2014> AD (Alzheimer's disease)  \nReranked Triple2: rivastigmine \u2014\u2014> treats \u2014\u2014> AD (Alzheimer's disease)  \nReranked Triple3: galantamine \u2014\u2014> treats \u2014\u2014> AD (Alzheimer's disease)  \nReranked Triple4: rivastigmine \u2014\u2014> treats \u2014\u2014> Alzheimer's disease  \nReranked Triple5: rivastigmine \u2014\u2014> CAUSES \u2014\u2014> death  \n\nAnswer: A. Tacrine",
    "neighbor_input": "Reranked Triple1: AD -> TREATMENT -> tacrine \u2014\u2014> patients  \nReranked Triple2: AD -> TREATMENT -> donepezil \u2014\u2014> patients  \nReranked Triple3: AD -> TREATMENT -> galantamine \u2014\u2014> patients  \nReranked Triple4: AD -> TREATMENT -> rivastigmine \u2014\u2014> patients  \nReranked Triple5: AD -> TREATMENT -> TUDCA \u2014\u2014> patients  \n\nAnswer: Tacrine is not used now in Alzheimer's disease.",
    "response_of_KG_list_path": "Path-based Evidence 1: 'tacrine' treats 'AD (Alzheimer's disease)'  \nPath-based Evidence 2: 'rivastigmine' treats 'AD (Alzheimer's disease)'  \nPath-based Evidence 3: 'galantamine' treats 'AD (Alzheimer's disease)'  \nPath-based Evidence 4: 'rivastigmine' treats 'Alzheimer's disease'  \nPath-based Evidence 5: 'rivastigmine' CAUSES 'death'",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' is associated with the 'TREATMENT' of 'tacrine' for 'patients'.  \nNeighbor-based Evidence 2: 'AD' is associated with the 'TREATMENT' of 'donepezil' for 'patients'.  \nNeighbor-based Evidence 3: 'AD' is associated with the 'TREATMENT' of 'galantamine' for 'patients'.  \nNeighbor-based Evidence 4: 'AD' is associated with the 'TREATMENT' of 'rivastigmine' for 'patients'.  \nNeighbor-based Evidence 5: 'AD' is associated with the 'TREATMENT' of 'TUDCA' for 'patients'.  ",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0,
      1.0,
      1.0,
      0.6575609445571899,
      1.0,
      0.6304964423179626
    ],
    "question_types": [
      "treatment",
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "5d9e2ca0-c565-465a-b1dc-b3ddaaee591f",
    "question": "An elderly man with history of frequent falls presents to ED with features of dementia, ataxia, difficulty in downward gaze. What is the most likely diagnosis?",
    "opa": "Parkinsons disease",
    "opb": "Progressive supranuclear palsy",
    "opc": "Multi infarct dementia",
    "opd": "Alzheimers disease",
    "cop": 1,
    "choice_type": "multi",
    "exp": "Progressive supranuclear palsy (PSP) is a degenerative disease that involves the brainstem, basal ganglia, limbic structures and selected areas of coex. Clinically, this disorder begins with falls and executive or subtle personality changes such as mental rigidity, impulsivity, or apathy. A progressive oculomotor syndrome ensues that begins with square wave jerks, followed by slowed saccades (veical worse than horizontal) before resulting in progressive supranuclear ophthalmoparesis. Dysahria, dysphagia, and symmetric axial rigidity can be prominent features that emerge at any point in the illness. A stiff, unstable posture with hyperextension of the neck and a slow, jerky, toppling gait is characteristic. The oculomotor disorder is supranuclear.The dementia overlaps with Fronto temporal dementia, featuring apathy, frontal-executive dysfunction, poor judgment, slowed thought processes, impaired verbal fluency and difficulty with sequential actions and with shifting from one task to another. Response to l-dopa is limited or absent. Death occurs within 5-10 years of onset. Ref: Harrison's Internal Medicine, 18th Edition, Pages 3311, 3317-3326, 3309, 3305",
    "subject_name": "Medicine",
    "topic_name": null,
    "entity": "1. Elderly man\n2. Falls\n3. ED (Emergency Department)\n4. Dementia\n5. Ataxia\n6. Downward gaze\n7. Diagnosis\n8. Parkinson's disease\n9. Progressive supranuclear palsy\n10. Multi infarct dementia\n11. Alzheimer's disease",
    "prediction": "B",
    "path": "Reranked Triple1: progressive supranuclear palsy \u2014\u2014> pathology \u2014\u2014> tauopathy  \nReranked Triple2: progressive supranuclear palsy \u2014\u2014> patient \u2014\u2014> human  \nReranked Triple3: progressive supranuclear palsy \u2014\u2014> associates \u2014\u2014> AD (Alzheimer's disease)  \nReranked Triple4: progressive supranuclear palsy \u2014\u2014> INVOLVED IN \u2014\u2014> DISEASE  \nReranked Triple5: stroke dementia \u2014\u2014> is a kind of \u2014\u2014> dementia  ",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> causes \u2014\u2014> cognitive decline  \nReranked Triple2: AD \u2014\u2014> causes \u2014\u2014> memory impairment  \nReranked Triple3: AD \u2014\u2014> causes \u2014\u2014> neurodegeneration  \nReranked Triple4: EDS \u2014\u2014> associated with \u2014\u2014> cognitive decline  \nReranked Triple5: AD \u2014\u2014> causes \u2014\u2014> dementia  ",
    "response_of_KG_list_path": "Path-based Evidence 1: The condition 'progressive supranuclear palsy' is associated with the 'pathology' of 'tauopathy'.\n\nPath-based Evidence 2: The condition 'progressive supranuclear palsy' affects 'patients' who are 'human'.\n\nPath-based Evidence 3: The condition 'progressive supranuclear palsy' is known to be associated with 'AD (Alzheimer's disease)'.\n\nPath-based Evidence 4: The condition 'progressive supranuclear palsy' is 'INVOLVED IN' a 'DISEASE'.\n\nPath-based Evidence 5: The condition 'stroke dementia' 'is a kind of' 'dementia'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'cognitive decline'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'memory impairment'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'neurodegeneration'.\n\nNeighbor-based Evidence 4: 'EDS' 'associated with' 'cognitive decline'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'dementia'.",
    "entity_confidence_scores": [
      0.7431753873825073,
      1.0000001192092896,
      1.0,
      0.68001389503479,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      0.7327340245246887,
      1.0,
      1.000000238418579,
      1.0,
      1.0,
      0.7699403762817383,
      0.7601462602615356,
      1.0000001192092896,
      0.7321019172668457,
      1.0000001192092896,
      0.7321019172668457,
      1.0000001192092896,
      0.7216620445251465,
      1.0000001192092896,
      1.0000001192092896
    ],
    "question_types": [
      "definition",
      "symptom",
      "diagnosis"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "9619678d-c5df-48e7-a4f7-5a4c445035d6",
    "question": "Which of the following statements about Alzheimer's disease are true?",
    "opa": "Onset before 45 years of age is rare",
    "opb": "Long-term memory is affected before sho term memory",
    "opc": "Staining shows Tau protein in senile plaques",
    "opd": "MRI shows atrophy in frontal and parietal lobes",
    "cop": 0,
    "choice_type": "multi",
    "exp": "The first statement is correct. Onset is usually after 65 years of age. Second statement is incorrect, long-term memory gets affected in advanced stages only. Third statement is also incorrect as senile plaques contain amyloid bet (Ab) and not tau proteins. The last statement can be argued upon. Alzheimer's disease is usually described as disease of temporal and parietal lobe and MRI usually shows atrophy in temporal and parietal lobe. Although we must remember that frontal coex does get involved in the advanced phases",
    "subject_name": "Psychiatry",
    "topic_name": "Organic Mental Disorders",
    "entity": "1. Alzheimer's disease\n2. age\n3. long-term memory\n4. short term memory\n5. staining\n6. Tau protein\n7. senile plaques\n8. MRI\n9. atrophy\n10. frontal lobes\n11. parietal lobes",
    "prediction": "A",
    "path": "Reranked Triple1: Alzheimer disease \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple2: dementia \u2014\u2014> caused by \u2014\u2014> tau  \nReranked Triple3: neuritic plaques \u2014\u2014> has \u2014\u2014> amyloid-beta  \nReranked Triple4: atrophy \u2014\u2014> MEASURED BY \u2014\u2014> MRI  \nReranked Triple5: MRI \u2014\u2014> shows \u2014\u2014> atrophy in frontal and parietal lobes  ",
    "neighbor_input": "Reranked Triple1: AD -> causes -> cognitive decline  \nReranked Triple2: AD -> causes -> tau  \nReranked Triple3: AD -> causes -> brain atrophy  \nReranked Triple4: AD -> causes -> memory impairment  \nReranked Triple5: AD -> associates -> neurodegenerative disease  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer disease' 'causes' 'dementia'.\n\nPath-based Evidence 2: 'dementia' 'caused by' 'tau'.\n\nPath-based Evidence 3: 'neuritic plaques' 'has' 'amyloid-beta'.\n\nPath-based Evidence 4: 'atrophy' 'MEASURED BY' 'MRI'.\n\nPath-based Evidence 5: 'MRI' 'shows' 'atrophy in frontal and parietal lobes'.",
    "response_of_KG_neighbor": "Based on the provided knowledge graph, here is the natural language conversion:\n\nNeighbor-based Evidence 1: 'AD' 'causes' 'cognitive decline'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'tau'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'brain atrophy'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'memory impairment'.\n\nNeighbor-based Evidence 5: 'AD' 'associates' 'neurodegenerative disease'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.7356430888175964,
      0.6360185146331787,
      0.6266595125198364,
      1.0,
      0.8084526062011719,
      1.0,
      0.8382810950279236,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      0.7249187231063843,
      0.8622931241989136,
      0.8477286696434021,
      0.7133614420890808,
      0.7702330350875854,
      0.7043747901916504,
      1.0,
      1.0,
      0.967292308807373,
      0.897533655166626,
      0.9412471055984497,
      0.8832904100418091
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "22837d57-8ff8-4939-86d9-8c8c5fb34d5e",
    "question": "Which of the following neurotransmitters are decreased in alzheimers disease?",
    "opa": "Acetylcholine",
    "opb": "Norepinephrine",
    "opc": "Coicotropin",
    "opd": "All the above",
    "cop": 3,
    "choice_type": "multi",
    "exp": "Ans. is 'd' i.e., All the aboveRef - Niraj Ahuja &/e p. 25; Dementia by Brown and Hilhn like p. 60 ]Neurotransmitters in Alzheimer's disease:Acetylcholine has a major role in memory functions and deficiency in cholinergic functioning is associated with memory disturbances paicularly sho term memory.In Alzheimer's disease there loss of cells in the nucleus basalis of meyer net results in marked reduction in choline acetyltransferase (CHAT), an enzyme involved in the synthesis of acetylcholine + Decreased Acetylcholine.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. neurotransmitters\n2. alzheimers disease\n3. Acetylcholine\n4. Norepinephrine\n5. Coicotropin",
    "prediction": "A",
    "path": "Reranked Triple1: alzheimer disease -> CAUSES -> dementia  \nReranked Triple2: dementia -> caused by -> tau  \nReranked Triple3: dementia -> associated with -> tau  \nReranked Triple4: alzheimer disease -> CAUSES -> dementia  \nReranked Triple5: tau -> associates -> Alzheimer Disease  ",
    "neighbor_input": "Reranked Triple1: Alzheimers disease \u2014\u2014> associates \u2014\u2014> dementia  \nReranked Triple2: Alzheimers disease \u2014\u2014> hallmark \u2014\u2014> amyloid plaques  \nReranked Triple3: AD \u2014\u2014> causes \u2014\u2014> cognitive decline  \nReranked Triple4: AD \u2014\u2014> causes \u2014\u2014> memory deficits  \nReranked Triple5: AD \u2014\u2014> causes \u2014\u2014> neurodegeneration  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer disease' is known to 'CAUSE' 'dementia'.\n\nPath-based Evidence 2: 'Dementia' is 'caused by' 'tau'.\n\nPath-based Evidence 3: 'Dementia' is 'associated with' 'tau'.\n\nPath-based Evidence 4: 'Alzheimer disease' is known to 'CAUSE' 'dementia' (repeat of Path-based Evidence 1).\n\nPath-based Evidence 5: 'Tau' 'associates' with 'Alzheimer Disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Alzheimers disease' is known to 'associate' with 'dementia'.\n\nNeighbor-based Evidence 2: 'Alzheimers disease' has a 'hallmark' of 'amyloid plaques'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'cognitive decline'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'memory deficits'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'neurodegeneration'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      0.6811833381652832
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "a8a105be-b964-4bba-9a01-077255b18f8a",
    "question": "A 77-year-old man is brought to the hospital by his granddaughter for evaluation of confusion. He has no focal findings and his neuro-imaging studies are normal. Further investigations reveal a urinary tract infection, and the man improves somewhat after treatment, but still exhibits poor judgment and bizarre behavior. Pressing the family for information, the intern unearths a history of 8 years of progressive bizarre behavior. The man has undressed himself and made sexual advances to young female relatives, has urinated in hallways, and pushed food into his mouth with alarming speed. Which of the following is the most likely diagnosis?",
    "opa": "Alzheimer's disease",
    "opb": "frontotemporal dementia",
    "opc": "dementia with diffuse Lewy bodies",
    "opd": "vascular dementia",
    "cop": 1,
    "choice_type": "multi",
    "exp": "The progressive nature of the disorder suggests a degenerative dementia, and the predominance of disinhibited behavior suggests the frontal lobes are involved. Frontal dementias can result from trauma, tumor, or ischemia, but this history suggests a degenerative disorder. Alzheimer's can involve the frontal lobes and mimic a frontal dementia.",
    "subject_name": "Medicine",
    "topic_name": "C.N.S.",
    "entity": "1. age (77-year-old)\n2. gender (man)\n3. symptom (confusion)\n4. neuro-imaging studies\n5. medical condition (urinary tract infection)\n6. behavior (poor judgment, bizarre behavior, undressed himself, made sexual advances, urinated in hallways, pushed food into his mouth with alarming speed)\n7. medical diagnosis (Alzheimer's disease, frontotemporal dementia, dementia with diffuse Lewy bodies, vascular dementia)",
    "prediction": "B",
    "path": [],
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> treats \u2014\u2014> cognitive deficits  \nReranked Triple2: AD \u2014\u2014> treats \u2014\u2014> behavioral dysfunction  \nReranked Triple3: AD \u2014\u2014> TREATMENT \u2014\u2014> tropisetron  \nReranked Triple4: AD \u2014\u2014> TREATMENT \u2014\u2014> N-acetylcysteine  \nReranked Triple5: AD \u2014\u2014> TREATMENT \u2014\u2014> curcumin  ",
    "response_of_KG_list_path": [],
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'treats' 'cognitive deficits'.\n\nNeighbor-based Evidence 2: 'AD' 'treats' 'behavioral dysfunction'.\n\nNeighbor-based Evidence 3: 'AD' 'TREATMENT' 'tropisetron'.\n\nNeighbor-based Evidence 4: 'AD' 'TREATMENT' 'N-acetylcysteine'.\n\nNeighbor-based Evidence 5: 'AD' 'TREATMENT' 'curcumin'.",
    "entity_confidence_scores": [
      0.7222142219543457,
      0.781611442565918,
      0.6889141798019409,
      1.0000001192092896,
      0.8105871081352234,
      0.8273171186447144,
      0.6758190393447876,
      1.0,
      1.0,
      0.768595814704895,
      1.000000238418579,
      1.0000001192092896,
      0.7327340245246887,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896
    ],
    "question_types": [
      "treatment",
      "diagnosis"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "dfd81151-ace6-4bb3-a06c-75f49e9a990c",
    "question": "All of the following casues subcortical dementia except-",
    "opa": "Alzhimer's disease",
    "opb": "Parkinsonism",
    "opc": "HIV encephalopathy",
    "opd": "Progressive supra nuclear palsy",
    "cop": 0,
    "choice_type": "multi",
    "exp": null,
    "subject_name": "Medicine",
    "topic_name": null,
    "entity": "1. Subcortical dementia\n2. Alzheimer's disease\n3. Parkinsonism\n4. HIV encephalopathy\n5. Progressive supra nuclear palsy",
    "prediction": "A",
    "path": "Reranked Triple1: Alzheimer\u2019s disease -> causes -> brain atrophy  \nReranked Triple2: Parkinsonism -> causes -> neuronal damage  \nReranked Triple3: HIV-associated neurocognitive disorders -> disease -> Alzheimer\u2019s disease  \nReranked Triple4: Parkinson's disease -> associates -> progressive supranuclear palsy  \nReranked Triple5: HIV-associated neurocognitive disorders -> associates -> Parkinson's disease",
    "neighbor_input": "Reranked Triple1: AD -> causes -> Alzheimer's disease \nReranked Triple2: AD -> causes -> cognitive decline \nReranked Triple3: AD -> causes -> dementia \nReranked Triple4: AD -> causes -> neurodegeneration \nReranked Triple5: AD -> causes -> cognitive impairment \n\nAnswer: The answer is A. Alzheimer's disease, as it is associated with dementia, unlike the other options which are forms of subcortical dementia.",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer\u2019s disease' is known to 'cause' 'brain atrophy'.\n\nPath-based Evidence 2: 'Parkinsonism' is known to 'cause' 'neuronal damage'.\n\nPath-based Evidence 3: 'HIV-associated neurocognitive disorders' is a type of 'disease' that leads to 'Alzheimer\u2019s disease'.\n\nPath-based Evidence 4: 'Parkinson's disease' 'associates' with 'progressive supranuclear palsy'.\n\nPath-based Evidence 5: 'HIV-associated neurocognitive disorders' 'associates' with 'Parkinson's disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'Alzheimer's disease'.  \nNeighbor-based Evidence 2: 'AD' 'causes' 'cognitive decline'.  \nNeighbor-based Evidence 3: 'AD' 'causes' 'dementia'.  \nNeighbor-based Evidence 4: 'AD' 'causes' 'neurodegeneration'.  \nNeighbor-based Evidence 5: 'AD' 'causes' 'cognitive impairment'.  ",
    "entity_confidence_scores": [
      0.882514476776123,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.8460202217102051,
      0.7963900566101074,
      0.828045129776001
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "5fefcf37-95d9-4054-adf9-7639351386c7",
    "question": "Which of the following drugs should not be used with rivastigmine in patients with alzheimer's disease -",
    "opa": "SSRI",
    "opb": "Tricyclic antidepressant",
    "opc": "RIMA",
    "opd": "Atypical antidepressants",
    "cop": 1,
    "choice_type": "single",
    "exp": "Ans. is 'b' i.e., Tricyclic antidepressant Rivastigmine (cholinesterase inhibitor) should not be used with drugs that have cholinergic antagonistic activity like tricyclic antidepressants (TCA) as the combination is counter productive.",
    "subject_name": "Pharmacology",
    "topic_name": null,
    "entity": "1. drug\n2. rivastigmine\n3. alzheimer's disease\n4. SSRI\n5. Tricyclic antidepressant\n6. RIMA\n7. Atypical antidepressants",
    "prediction": "B",
    "path": "Reranked Triple1: Rivastigmine \u2014\u2014> should not be used with Tricyclic antidepressant\nReranked Triple2: Rivastigmine \u2014\u2014> should not be used with RIMA\nReranked Triple3: Rivastigmine \u2014\u2014> can be used with SSRI\nReranked Triple4: Rivastigmine \u2014\u2014> can be used with Atypical antidepressants\nReranked Triple5: Patients with Alzheimer's disease \u2014\u2014> often treated with Rivastigmine",
    "neighbor_input": "Reranked Triple1: rivastigmine -> interact with -> TNF-alpha,gliosis,IL-1beta  \nReranked Triple2: rivastigmine -> modulates -> P-gp (P-glycoprotein)  \nReranked Triple3: rivastigmine -> treat -> Alzheimer's disease  \nReranked Triple4: rivastigmine -> treats -> AD (Alzheimer's disease)  \nReranked Triple5: staurosporine -> TREATMENT -> apoptosis  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Rivastigmine' 'should not be used with' 'Tricyclic antidepressant'.\n\nPath-based Evidence 2: 'Rivastigmine' 'should not be used with' 'RIMA'.\n\nPath-based Evidence 3: 'Rivastigmine' 'can be used with' 'SSRI'.\n\nPath-based Evidence 4: 'Rivastigmine' 'can be used with' 'Atypical antidepressants'.\n\nPath-based Evidence 5: 'Patients with Alzheimer's disease' 'often treated with' 'Rivastigmine'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: The compound 'rivastigmine' is known to 'interact with' the proteins and factors 'TNF-alpha', 'gliosis', and 'IL-1beta'.\n\nNeighbor-based Evidence 2: 'Rivastigmine' 'modulates' the activity of 'P-gp' (P-glycoprotein).\n\nNeighbor-based Evidence 3: 'Rivastigmine' is utilized to 'treat' the condition 'Alzheimer's disease'.\n\nNeighbor-based Evidence 4: 'Rivastigmine' is effective in 'treating' 'AD' (Alzheimer's disease).\n\nNeighbor-based Evidence 5: The compound 'staurosporine' is associated with 'TREATMENT' of 'apoptosis'.",
    "entity_confidence_scores": [
      0.9999999403953552,
      1.0,
      0.6544378995895386,
      0.7847082018852234,
      0.7727140188217163,
      1.0,
      0.6304964423179626,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.7225785255432129,
      0.7225784063339233,
      0.6237913370132446,
      0.6220862865447998,
      0.6219239234924316,
      0.5638227462768555,
      0.5037606954574585
    ],
    "question_types": [
      "treatment",
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "2290add3-d1dd-4d9f-8b86-f6526633b97b",
    "question": "False regarding Alzheimer's disease (AD) is:",
    "opa": "Number of senile neural plaques correlates (increases) with age",
    "opb": "Presence of tau protein suggest neurodegeneration",
    "opc": "Number of neurofibrillary tangles is associated with the severity of dementia",
    "opd": "Extracellular inclusion (lesion) can occur in the absence of intracellular inclusions to make pathological diagnosis of AD",
    "cop": 3,
    "choice_type": "multi",
    "exp": "Please remember that the neuropathological diagnosis of Alzheimer's disease requires extensive presence of both senile plaques (extra cellular deposits) and neurofibrillary tangles (intracellular inclusion) Alzheimer's disease: Pathophysiological Findings: Diffuse atrophy, Flattened Coical Sulci & Dilated Cerebral ventricles * Primarily involve Parietal and temporal Lobes * Atrophy stas In Medical Temporal Lobe (Entorhinal/Perirhinal Coex & Hippocampus) and spreads to Lateral & Medial parietal Lobes, Lateral Temporal Lobes & Lateral Frontal Coex Microscopic Findings: 1) Senile plaques or Neuritic plaques or Amyloid plaques Extracellular in location Ab protein 2) Neurofibrillary Tangles: Intracellular Deposits Tau proteins Neuropathological Diagnosis of AD : Extensive presence of both Senile plaques & NFT 3) Granulovacuolar Degeneration & Hirano bodies (Eosinophilic Inclusions) - Abnormalities In Cytoplasm of Hippocampal Neurons Can be present in Elderly without dementia's",
    "subject_name": "Psychiatry",
    "topic_name": "Organic Mental Disorders",
    "entity": "1. Alzheimer's disease (AD)\n2. neural plaques\n3. age\n4. tau protein\n5. neurodegeneration\n6. neurofibrillary tangles\n7. severity\n8. dementia\n9. extracellular inclusion\n10. intracellular inclusions\n11. pathological diagnosis",
    "prediction": "D",
    "path": "Reranked Triple1: neuritic plaques \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple2: neurofibrillary tangles \u2014\u2014> FORM BY \u2014\u2014> microtubule-associated protein tau  \nReranked Triple3: neurofibrillary tangles \u2014\u2014> ASSOCIATED WITH \u2014\u2014> Neurofibrillary tangles  \nReranked Triple4: Pain \u2014\u2014> associates \u2014\u2014> Patients  \nReranked Triple5: Patients \u2014\u2014> has \u2014\u2014> cognitive decline  ",
    "neighbor_input": "Reranked Triple1: Alzheimer's disease (AD) \u2014\u2014> associated with \u2014\u2014> tau (Tau)  \nReranked Triple2: Alzheimer's disease (AD) \u2014\u2014> causes \u2014\u2014> neurodegeneration  \nReranked Triple3: Alzheimer's disease (AD) \u2014\u2014> associates \u2014\u2014> memory deficits  \nReranked Triple4: Alzheimer's disease (AD) \u2014\u2014> associated with \u2014\u2014> amyloid precursor protein  \nReranked Triple5: Alzheimer's disease (AD) \u2014\u2014> causes \u2014\u2014> dementia  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Neuritic plaques' 'causes' 'dementia'.\n\nPath-based Evidence 2: 'Neurofibrillary tangles' 'FORM BY' 'microtubule-associated protein tau'.\n\nPath-based Evidence 3: 'Neurofibrillary tangles' 'ASSOCIATED WITH' 'Neurofibrillary tangles'.\n\nPath-based Evidence 4: 'Pain' 'associates' 'Patients'.\n\nPath-based Evidence 5: 'Patients' 'has' 'cognitive decline'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Alzheimer's disease (AD)' is 'associated with' 'tau (Tau)'.\n\nNeighbor-based Evidence 2: 'Alzheimer's disease (AD)' 'causes' 'neurodegeneration'.\n\nNeighbor-based Evidence 3: 'Alzheimer's disease (AD)' 'associates' 'memory deficits'.\n\nNeighbor-based Evidence 4: 'Alzheimer's disease (AD)' is 'associated with' 'amyloid precursor protein'.\n\nNeighbor-based Evidence 5: 'Alzheimer's disease (AD)' 'causes' 'dementia'.",
    "entity_confidence_scores": [
      0.9999998807907104,
      1.0,
      1.000000238418579,
      0.9999998807907104,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.8370298743247986,
      1.0000001192092896,
      1.0,
      1.0,
      0.8382810950279236,
      1.0,
      1.0,
      1.0,
      1.0,
      1.0000001192092896,
      0.6503896117210388,
      1.0,
      1.0,
      0.6792087554931641,
      0.647641658782959,
      0.6396219730377197,
      0.8573166728019714,
      0.8683019876480103,
      0.712374746799469,
      0.8176352977752686,
      0.7327340245246887
    ],
    "question_types": [
      "diagnosis"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "bb315dcf-c947-42bc-a2b4-40319cc9e1da",
    "question": "In Alzheimer disease, seen are:a)  Neurofibrillary tanglesb)  Neuritic plaquesc)  Pick's proteind)  Amyloid angiopathye)  Senile plaques",
    "opa": "abcd",
    "opb": "bcde",
    "opc": "acde",
    "opd": "abde",
    "cop": 3,
    "choice_type": "single",
    "exp": null,
    "subject_name": "Pathology",
    "topic_name": null,
    "entity": "1. Alzheimer disease\n2. Neurofibrillary tangles\n3. Neuritic plaques\n4. Pick's protein\n5. Amyloid angiopathy\n6. Senile plaques",
    "prediction": "D",
    "path": "Reranked Triple1: Neurofibrillary tangles \u2014\u2014> Alzheimer's disease  \nReranked Triple2: Alzheimer's disease \u2014\u2014> associated with \u2014\u2014> neuritic plaques  \nReranked Triple3: Cerebral amyloid angiopathy \u2014\u2014> involves \u2014\u2014> Abeta  \nReranked Triple4: Abeta \u2014\u2014> found in \u2014\u2014> Senile plaques  \nReranked Triple5: Cerebral amyloid angiopathy \u2014\u2014> DEPOSITION SITE \u2014\u2014> Senile plaques  \n\nAnswer: D.abde",
    "neighbor_input": "Reranked Triple1: AD -> causes -> neurofibrillary tangle pathology\nReranked Triple2: AD -> causes -> amyloid beta-protein\nReranked Triple3: AD -> causes -> amyloid plaques\nReranked Triple4: AD -> associates -> amyloid-beta peptide (Abeta) deposition\nReranked Triple5: AD -> causes -> senile plaques",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Neurofibrillary tangles' are associated with 'Alzheimer's disease'.\n\nPath-based Evidence 2: 'Alzheimer's disease' is 'associated with' 'neuritic plaques'.\n\nPath-based Evidence 3: 'Cerebral amyloid angiopathy' 'involves' 'Abeta'.\n\nPath-based Evidence 4: 'Abeta' is 'found in' 'Senile plaques'.\n\nPath-based Evidence 5: 'Cerebral amyloid angiopathy' is a 'DEPOSITION SITE' for 'Senile plaques'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'neurofibrillary tangle pathology'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'amyloid beta-protein'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'amyloid plaques'.\n\nNeighbor-based Evidence 4: 'AD' 'associates' 'amyloid-beta peptide (Abeta) deposition'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'senile plaques'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0,
      1.0,
      0.6884418725967407,
      1.0000001192092896,
      1.0000001192092896,
      0.9499473571777344,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "dcbad171-157c-4a52-8c37-35ff9c150b02",
    "question": "A 36-year-old male patient has a family history of dementia want Genetic testing type",
    "opa": "Genetic carrier test",
    "opb": "Pre symptomatic test",
    "opc": "Post symptomatic test",
    "opd": "Genetic pre symptomatic test",
    "cop": 0,
    "choice_type": "single",
    "exp": "(A) Genetic carrier test [Harrison18 -3307; Harrison17 - 2541, Harrison16 - 2399",
    "subject_name": "Medicine",
    "topic_name": "Miscellaneous",
    "entity": "1. patient\n2. family history\n3. dementia\n4. Genetic testing\n5. carrier test\n6. pre symptomatic test\n7. post symptomatic test",
    "prediction": "D",
    "path": "Reranked Triple1: Patient -> has disease -> Alzheimer's disease  \nReranked Triple2: Alzheimer's disease -> associated with -> familial  \nReranked Triple3: Patient -> has -> Alzheimer's disease  \nReranked Triple4: Alzheimer's disease -> DISEASE OF -> Patient  \nReranked Triple5: Patient -> has disease -> dementia  ",
    "neighbor_input": "Reranked Triple1: patient -> has symptom -> dementia  \nReranked Triple2: patient -> has disease -> Alzheimer disease  \nReranked Triple3: patient -> has disease -> Alzheimer's disease  \nReranked Triple4: patient -> HAS DISEASE -> dementia  \nReranked Triple5: patient -> has symptom -> atrophy  ",
    "response_of_KG_list_path": "Path-based Evidence 1: The patient 'Patient' has the disease 'Alzheimer's disease'.\n\nPath-based Evidence 2: The disease 'Alzheimer's disease' is associated with the type 'familial'.\n\nPath-based Evidence 3: The patient 'Patient' has 'Alzheimer's disease'.\n\nPath-based Evidence 4: The disease 'Alzheimer's disease' is a 'DISEASE OF' the patient 'Patient'.\n\nPath-based Evidence 5: The patient 'Patient' has the disease 'dementia'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: The patient 'has symptom' dementia.  \nNeighbor-based Evidence 2: The patient 'has disease' Alzheimer disease.  \nNeighbor-based Evidence 3: The patient 'has disease' Alzheimer's disease.  \nNeighbor-based Evidence 4: The patient 'HAS DISEASE' dementia.  \nNeighbor-based Evidence 5: The patient 'has symptom' atrophy.  ",
    "entity_confidence_scores": [
      1.0,
      1.0,
      0.6527183055877686,
      0.617055356502533,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.6708993315696716,
      0.6200742721557617
    ],
    "question_types": [
      "symptom",
      "diagnosis"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "0f3c6f0b-0fb1-4ea9-8cf0-2905b460220a",
    "question": "All are examples of cortical dementia except -",
    "opa": "Alzheimer's disease",
    "opb": "Multiple sclerosis",
    "opc": "Creutzfeldt Jacob disease",
    "opd": "Pick's disease",
    "cop": 1,
    "choice_type": "multi",
    "exp": "In multiple sclerosis, subcortical dementia occurs.\nAlzheimer's disease, Pick's disease and CJD cause cortical dementia.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Cortical dementia\n2. Alzheimer's disease\n3. Multiple sclerosis\n4. Creutzfeldt Jacob disease\n5. Pick's disease",
    "prediction": "B",
    "path": "Reranked Triple1: cortical dysfunction \u2014\u2014> ASSOCIATES \u2014\u2014> Abeta  \nReranked Triple2: Abeta \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple3: alzheimer disease \u2014\u2014> CAUSES \u2014\u2014> dementia  \nReranked Triple4: Creutzfeldt-Jakob disease \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple5: Pick's disease \u2014\u2014> causes \u2014\u2014> atypical dementia  \n\nAnswer: B. Multiple sclerosis",
    "neighbor_input": "Reranked Triple1: vascular dementia -> CAUSES -> dementia  \nReranked Triple2: vascular dementia -> ASSOCIATES -> Alzheimer's Disease  \nReranked Triple3: vascular dementia -> causes -> cognitive impairment  \nReranked Triple4: vascular dementia -> causes -> amyloid-beta  \nReranked Triple5: cortical dysfunction -> ASSOCIATES -> Abeta  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'cortical dysfunction' 'ASSOCIATES' 'Abeta'.\n\nPath-based Evidence 2: 'Abeta' 'causes' 'dementia'.\n\nPath-based Evidence 3: 'alzheimer disease' 'CAUSES' 'dementia'.\n\nPath-based Evidence 4: 'Creutzfeldt-Jakob disease' 'causes' 'dementia'.\n\nPath-based Evidence 5: 'Pick's disease' 'causes' 'atypical dementia'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'vascular dementia' is known to 'CAUSES' 'dementia'.  \nNeighbor-based Evidence 2: 'vascular dementia' 'ASSOCIATES' with 'Alzheimer's Disease'.  \nNeighbor-based Evidence 3: 'vascular dementia' 'causes' 'cognitive impairment'.  \nNeighbor-based Evidence 4: 'vascular dementia' 'causes' 'amyloid-beta'.  \nNeighbor-based Evidence 5: 'cortical dysfunction' 'ASSOCIATES' with 'Abeta'.",
    "entity_confidence_scores": [
      0.8266110420227051,
      1.0,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.9487361907958984,
      0.6887068748474121,
      1.000000238418579,
      1.0000001192092896,
      0.6205008029937744,
      0.5583708882331848
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "7b9f525c-6bab-4201-a81b-362cfcc89c68",
    "question": "All of the following are Anticholinesteroses used in Alzheimer's disease except",
    "opa": "Rivastimine",
    "opb": "Galantamine",
    "opc": "Memantine",
    "opd": "Donepezil",
    "cop": 2,
    "choice_type": "multi",
    "exp": "Memantine is used to treat Alzeihmer's disease but it is not an anticholinesterase.It acts by blocking NMDA receptors.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Anticholinesteroses \n2. Alzheimer's disease \n3. Rivastigmine \n4. Galantamine \n5. Memantine \n6. Donepezil",
    "prediction": "C",
    "path": "Reranked Triple1: rivastigmine -> treats -> AD (Alzheimer's disease)  \nReranked Triple2: rivastigmine -> TREATMENT -> apoptosis  \nReranked Triple3: rivastigmine -> interacts -> galantamine  \nReranked Triple4: galantamine -> treats -> AD (Alzheimer's disease)  \nReranked Triple5: memantine -> NOT associated -> Anticholinesterases  \n\nAnswer: C. Memantine",
    "neighbor_input": "Reranked Triple1: AD -> treats -> Memantine \u2014\u2014> neurodegenerative diseases  \nReranked Triple2: AD -> treats -> Donepezil \u2014\u2014> cognitive deficits  \nReranked Triple3: AD -> treats -> Rivastigmine \u2014\u2014> cognitive impairment  \nReranked Triple4: AD -> treats -> Galantamine \u2014\u2014> cognitive loss  \nReranked Triple5: AD -> treats -> cognitive dysfunction \u2014\u2014> Alzheimer's disease  ",
    "response_of_KG_list_path": "Path-based Evidence 1: The medication 'rivastigmine' 'treats' 'AD (Alzheimer's disease)'.\n\nPath-based Evidence 2: The medication 'rivastigmine' 'TREATMENT' 'apoptosis'.\n\nPath-based Evidence 3: The medication 'rivastigmine' 'interacts' with 'galantamine'.\n\nPath-based Evidence 4: The medication 'galantamine' 'treats' 'AD (Alzheimer's disease)'.\n\nPath-based Evidence 5: The medication 'memantine' is 'NOT associated' with 'Anticholinesterases'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'treats' 'Memantine' for 'neurodegenerative diseases'.\n\nNeighbor-based Evidence 2: 'AD' 'treats' 'Donepezil' for 'cognitive deficits'.\n\nNeighbor-based Evidence 3: 'AD' 'treats' 'Rivastigmine' for 'cognitive impairment'.\n\nNeighbor-based Evidence 4: 'AD' 'treats' 'Galantamine' for 'cognitive loss'.\n\nNeighbor-based Evidence 5: 'AD' 'treats' 'cognitive dysfunction' related to 'Alzheimer's disease'.",
    "entity_confidence_scores": [
      0.607603132724762,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.6304964423179626,
      1.0,
      1.0,
      1.0000001192092896,
      1.0,
      0.6575609445571899
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "d2f23a62-f0ff-4787-9e03-d893ee4f98de",
    "question": "Characteristic feature of subcoical dementia is",
    "opa": "Memory loss",
    "opb": "Aphasia",
    "opc": "Dyslexia",
    "opd": "Tactile agnosia",
    "cop": 0,
    "choice_type": "single",
    "exp": "A i.e. Memory loss Aphasia, Agnosia, Dyslexia are characteristic features of coical dementia. So we are only left with memory loss for sub coical dementia.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. subcortical dementia\n2. Memory loss\n3. Aphasia \n4. Dyslexia \n5. Tactile agnosia",
    "prediction": "A",
    "path": "Reranked Triple1: memory loss \u2014\u2014> causes \u2014\u2014> Abeta  \nReranked Triple2: memory loss \u2014\u2014> caused by \u2014\u2014> Abeta  \nReranked Triple3: memory loss \u2014\u2014> causes \u2014\u2014> Abeta  \nReranked Triple4: Abeta \u2014\u2014> causes \u2014\u2014> memory deficit  \nReranked Triple5: memory loss \u2014\u2014> associated with \u2014\u2014> memory deficit  ",
    "neighbor_input": "Reranked Triple1: memory loss \u2014\u2014> causes \u2014\u2014> Abeta  \nReranked Triple2: memory loss \u2014\u2014> caused by \u2014\u2014> Abeta  \nReranked Triple3: memory loss \u2014\u2014> ASSOCIATES \u2014\u2014> dementia  \nReranked Triple4: memory loss \u2014\u2014> associates with \u2014\u2014> AD (Alzheimer's disease)  \nReranked Triple5: memory loss \u2014\u2014> involves \u2014\u2014> synapse loss  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Memory loss' 'causes' 'Abeta'.\n\nPath-based Evidence 2: 'Memory loss' 'caused by' 'Abeta'.\n\nPath-based Evidence 3: 'Memory loss' 'causes' 'Abeta'.\n\nPath-based Evidence 4: 'Abeta' 'causes' 'memory deficit'.\n\nPath-based Evidence 5: 'Memory loss' 'associated with' 'memory deficit'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Memory loss' is known to 'cause' 'Abeta'.\n\nNeighbor-based Evidence 2: 'Memory loss' is 'caused by' 'Abeta'.\n\nNeighbor-based Evidence 3: 'Memory loss' 'associates' with 'dementia'.\n\nNeighbor-based Evidence 4: 'Memory loss' 'associates with' 'AD (Alzheimer's disease)'.\n\nNeighbor-based Evidence 5: 'Memory loss' 'involves' 'synapse loss'.",
    "entity_confidence_scores": [
      0.882514476776123,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.9252252578735352,
      0.8978093862533569,
      1.0,
      0.7517754435539246,
      1.0000001192092896
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "8a56ef41-62d6-42a2-a8e9-9f51a2a5e11e",
    "question": "Drug of choice for treatment of Alzheimer's disease is:",
    "opa": "Atropine",
    "opb": "Donepezil",
    "opc": "Physostigmine",
    "opd": "Fluoxetine",
    "cop": 1,
    "choice_type": "single",
    "exp": "(Ref: Katzung 14th ed. P 1063)DOC for Alzheimer's disease: Donepezil (reversible AchEsterase inhibitor)Other Ach Esterase inhibitor used in treatment of Alzheimer's disease is Gallantamine, Rivastigmine.",
    "subject_name": "Pharmacology",
    "topic_name": "D.O.C",
    "entity": "1. Alzheimer's disease\n2. Atropine\n3. Donepezil\n4. Physostigmine\n5. Fluoxetine",
    "prediction": "B",
    "path": "Reranked Triple1: AD (Alzheimer's disease) \u2014\u2014> treats \u2014\u2014> donepezil  \nReranked Triple2: donepezil \u2014\u2014> is a \u2014\u2014> medication  \nReranked Triple3: AD (Alzheimer's disease) \u2014\u2014> correlates with \u2014\u2014> dementia  \nReranked Triple4: dementia \u2014\u2014> caused by \u2014\u2014> alzheimer disease  \nReranked Triple5: alzheimer disease \u2014\u2014> associates \u2014\u2014> diabetes mellitus  ",
    "neighbor_input": "Reranked Triple1: AD -> TREATMENT -> Donepezil  \nReranked Triple2: AD -> TREATMENT -> Physostigmine  \nReranked Triple3: AD -> TREATMENT -> Fluoxetine  \nReranked Triple4: AD -> TREATMENT -> Atropine  \nReranked Triple5: AD -> TREATMENT -> cognitive deficits  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer's disease' \u2018treats\u2019 'donepezil'.\n\nPath-based Evidence 2: 'donepezil' \u2018is a\u2019 'medication'.\n\nPath-based Evidence 3: 'Alzheimer's disease' \u2018correlates with\u2019 'dementia'.\n\nPath-based Evidence 4: 'dementia' \u2018caused by\u2019 'Alzheimer's disease'.\n\nPath-based Evidence 5: 'Alzheimer's disease' \u2018associates\u2019 'diabetes mellitus'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' is associated with the 'TREATMENT' of 'Donepezil'.\n\nNeighbor-based Evidence 2: 'AD' is associated with the 'TREATMENT' of 'Physostigmine'.\n\nNeighbor-based Evidence 3: 'AD' is associated with the 'TREATMENT' of 'Fluoxetine'.\n\nNeighbor-based Evidence 4: 'AD' is associated with the 'TREATMENT' of 'Atropine'.\n\nNeighbor-based Evidence 5: 'AD' is associated with the 'TREATMENT' of 'cognitive deficits'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.6631777882575989,
      1.0,
      0.6575609445571899,
      0.685027539730072,
      0.669137716293335,
      1.0000001192092896
    ],
    "question_types": [
      "treatment"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "147eb98b-6308-43ea-a140-21e187d2ced8",
    "question": "Which one of the following drug is used in Alzheimer's disease :",
    "opa": "Tacrine",
    "opb": "Pemoline",
    "opc": "Doxapram",
    "opd": "Methylphenidate",
    "cop": 0,
    "choice_type": "single",
    "exp": null,
    "subject_name": "Pharmacology",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. Tacrine\n3. Pemoline\n4. Doxapram\n5. Methylphenidate",
    "prediction": "A",
    "path": "Reranked Triple1: AD -> correlates with -> diabetes mellitus  \nReranked Triple2: alzheimer disease -> CAUSES -> dementia  \nReranked Triple3: alzheimer disease -> causes -> brain atrophy  \nReranked Triple4: doxycycline -> prevents toxicity of -> Abeta  \nReranked Triple5: tau -> associates -> Alzheimer Disease  ",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> TREATMENT \u2014\u2014> tacrine  \nReranked Triple2: AD \u2014\u2014> TREATMENT \u2014\u2014> TUDCA  \nReranked Triple3: AD \u2014\u2014> TREATMENT \u2014\u2014> N-acetylcysteine  \nReranked Triple4: AD \u2014\u2014> TREATMENT \u2014\u2014> curcumin  \nReranked Triple5: AD \u2014\u2014> TREATMENT \u2014\u2014> alpha-lipoic acid  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'AD' 'correlates with' 'diabetes mellitus'.\n\nPath-based Evidence 2: 'alzheimer disease' 'CAUSES' 'dementia'.\n\nPath-based Evidence 3: 'alzheimer disease' 'causes' 'brain atrophy'.\n\nPath-based Evidence 4: 'doxycycline' 'prevents toxicity of' 'Abeta'.\n\nPath-based Evidence 5: 'tau' 'associates' 'Alzheimer Disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' has a 'TREATMENT' involving 'tacrine'.\n\nNeighbor-based Evidence 2: 'AD' has a 'TREATMENT' involving 'TUDCA'.\n\nNeighbor-based Evidence 3: 'AD' has a 'TREATMENT' involving 'N-acetylcysteine'.\n\nNeighbor-based Evidence 4: 'AD' has a 'TREATMENT' involving 'curcumin'.\n\nNeighbor-based Evidence 5: 'AD' has a 'TREATMENT' involving 'alpha-lipoic acid'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.7038015127182007,
      0.6408367156982422,
      0.7194746732711792,
      0.6980038285255432,
      0.732306957244873
    ],
    "question_types": [
      "treatment"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "a594a4ed-5192-4978-bb24-103e5d2e4fb8",
    "question": "Dementia of Alzheimer's type is not associated with one of the following -",
    "opa": "Depressive symptoms",
    "opb": "Delusions",
    "opc": "Apraxia and aphasia",
    "opd": "Cerebral infarcts",
    "cop": 3,
    "choice_type": "single",
    "exp": "Cerebral infarct is seen in vascular dementia (not in Alzheimer's disease).\nAll the other symptoms given in options can occur in Alzheimer's disease.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Dementia of Alzheimer's type\n2. Depressive symptoms\n3. Delusions\n4. Apraxia\n5. Aphasia\n6. Cerebral infarcts",
    "prediction": "D",
    "path": "Reranked Triple1: delusions -> affects -> patients -> diagnosed with -> Alzheimer's disease -> has symptom -> apraxia  \nReranked Triple2: delusions -> affects -> patients -> with -> Alzheimer's disease -> has symptom -> apraxia  \nReranked Triple3: dementia of the Alzheimer type -> patients -> Abeta -> causes -> AD  \nReranked Triple4: dementia of the Alzheimer type -> patients -> Abeta -> treats -> AD  \nReranked Triple5: delusions -> affects -> patients -> treats -> Alzheimer's disease -> has symptom -> apraxia  ",
    "neighbor_input": "Reranked Triple1: dementia of the Alzheimer type -> has symptom -> cerebral infarcts  \nReranked Triple2: AD -> has symptom -> depressive symptoms  \nReranked Triple3: AD -> has symptom -> aphasia  \nReranked Triple4: AD -> has symptom -> cognitive impairment  \nReranked Triple5: AD -> has symptom -> delusions  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Delusions' 'affects' 'patients' who are 'diagnosed with' 'Alzheimer's disease' and 'has symptom' 'apraxia'.\n\nPath-based Evidence 2: 'Delusions' 'affects' 'patients' who are 'with' 'Alzheimer's disease' and 'has symptom' 'apraxia'.\n\nPath-based Evidence 3: 'Dementia of the Alzheimer type' 'patients' 'Abeta' 'causes' 'AD'.\n\nPath-based Evidence 4: 'Dementia of the Alzheimer type' 'patients' 'Abeta' 'treats' 'AD'.\n\nPath-based Evidence 5: 'Delusions' 'affects' 'patients' who 'treat' 'Alzheimer's disease' and 'has symptom' 'apraxia'.",
    "response_of_KG_neighbor": "Based on the provided knowledge graph information, here are the natural language conversions:\n\nNeighbor-based Evidence 1: 'dementia of the Alzheimer type' 'has symptom' 'cerebral infarcts'.\n\nNeighbor-based Evidence 2: 'AD' 'has symptom' 'depressive symptoms'.\n\nNeighbor-based Evidence 3: 'AD' 'has symptom' 'aphasia'.\n\nNeighbor-based Evidence 4: 'AD' 'has symptom' 'cognitive impairment'.\n\nNeighbor-based Evidence 5: 'AD' 'has symptom' 'delusions'.",
    "entity_confidence_scores": [
      0.9736135005950928,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.9381810426712036,
      1.0,
      1.000000238418579,
      1.0,
      0.6450759768486023,
      1.0,
      1.0000001192092896,
      0.7298930883407593,
      0.7964770793914795,
      0.633560061454773,
      0.6898353099822998,
      0.5880182981491089,
      0.5017680525779724,
      1.0,
      1.0000001192092896
    ],
    "question_types": [
      "symptom",
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "4c6ce2b4-faa3-4b0d-bf48-5941521ea008",
    "question": "Dementia is a feature of which disease?",
    "opa": "Whipple",
    "opb": "Celiac",
    "opc": "Tropical sprue",
    "opd": "Chron",
    "cop": 0,
    "choice_type": "single",
    "exp": "Whipple : Other features are nystagmus, ophthalmoplegia, joint pains.",
    "subject_name": "Surgery",
    "topic_name": null,
    "entity": "1. Dementia\n2. Whipple\n3. Celiac\n4. Tropical sprue\n5. Chron",
    "prediction": "A",
    "path": [],
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple2: AD \u2014\u2014> treats \u2014\u2014> dementia  \nReranked Triple3: AD \u2014\u2014> ASSOCIATES \u2014\u2014> dementia  \nReranked Triple4: AD \u2014\u2014> CAUSES \u2014\u2014> cognitive decline  \nReranked Triple5: AD \u2014\u2014> causes \u2014\u2014> cognitive impairment  ",
    "response_of_KG_list_path": [],
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'dementia'.  \nNeighbor-based Evidence 2: 'AD' 'treats' 'dementia'.  \nNeighbor-based Evidence 3: 'AD' 'ASSOCIATES' 'dementia'.  \nNeighbor-based Evidence 4: 'AD' 'CAUSES' 'cognitive decline'.  \nNeighbor-based Evidence 5: 'AD' 'causes' 'cognitive impairment'.  ",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0,
      1.0,
      1.0
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "d1602f44-34be-4f72-9c8d-371bd518b4cd",
    "question": "A 72-year-old man is brought to the clinic by his daughter because she is concerned about his memory. A careful history, mini mental status, and physical examination confirm your suspicions of the patient having Alzheimer disease. Which of the following investigations is included in the initial work up for reversible causes of dementia?",
    "opa": "electroencephalogram (EEG)",
    "opb": "urine tests for heavy metals",
    "opc": "thyroid function tests",
    "opd": "red blood cell (RBC) folate",
    "cop": 2,
    "choice_type": "single",
    "exp": "Besides hypothyroidism, other tests to rule out reversible causes might include serum electrolytes, B12 levels, CBC, Venereal Disease Research Laboratory (VDRL), and CT or MRI. Diagnosis of Alzheimer disease remains a diagnosis of exclusion. However, the insidious and subtle onset, with few focal signs (except for higher mental functioning) and a slowly progressive course are characteristic. Careful attention to the pattern of cognitive defects also improves diagnostic accuracy. The intensity of investigation will depend on numerous factors, including age, presence of atypical findings, and the timing of presentation. There is as yet no definite consensus on the most appropriate plan of investigation.",
    "subject_name": "Medicine",
    "topic_name": "Miscellaneous",
    "entity": "1. patient (72-year-old man)\n2. clinic\n3. daughter\n4. memory\n5. history\n6. mini mental status\n7. physical examination\n8. Alzheimer disease\n9. investigations\n10. reversible causes\n11. electroencephalogram (EEG)\n12. urine tests\n13. heavy metals\n14. thyroid function tests\n15. red blood cell (RBC) folate",
    "prediction": "C",
    "path": "Reranked Triple1: thyroid cancers \u2014\u2014> diagnoses \u2014\u2014> patients with Alzheimer's disease  \nReranked Triple2: patients \u2014\u2014> has symptom \u2014\u2014> tau  \nReranked Triple3: tau \u2014\u2014> correlates \u2014\u2014> Amyloid-beta  \nReranked Triple4: patients \u2014\u2014> has \u2014\u2014> AD  \nReranked Triple5: patients \u2014\u2014> rat (rats) \u2014\u2014> has trait \u2014\u2014> hypothyroid  ",
    "neighbor_input": "Reranked Triple1: patients -> has disease -> Alzheimer's disease  \nReranked Triple2: patients -> associated with -> cognitive impairment (cognitive decline)  \nReranked Triple3: patients -> associated with -> neurodegenerative disorders  \nReranked Triple4: patients -> with -> depression  \nReranked Triple5: patients -> has disease -> dementia  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Thyroid cancers' are diagnosed in 'patients with Alzheimer's disease'.\n\nPath-based Evidence 2: 'Patients' have the symptom 'tau'.\n\nPath-based Evidence 3: 'Tau' correlates with 'Amyloid-beta'.\n\nPath-based Evidence 4: 'Patients' have 'AD' (Alzheimer's Disease).\n\nPath-based Evidence 5: 'Patients' with 'hypothyroid' traits are associated with 'rats'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Patients' 'have disease' 'Alzheimer's disease'.\n\nNeighbor-based Evidence 2: 'Patients' 'associated with' 'cognitive impairment (cognitive decline)'.\n\nNeighbor-based Evidence 3: 'Patients' 'associated with' 'neurodegenerative disorders'.\n\nNeighbor-based Evidence 4: 'Patients' 'with' 'depression'.\n\nNeighbor-based Evidence 5: 'Patients' 'have disease' 'dementia'.",
    "entity_confidence_scores": [
      0.684508204460144,
      0.6903693675994873,
      0.6305551528930664,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.6667444705963135,
      0.7301366329193115,
      0.7348365783691406,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.6530424356460571,
      0.7013178467750549,
      0.6648846864700317,
      0.6879606246948242,
      0.6371057033538818,
      0.6731107234954834,
      0.6286761164665222,
      0.6198825240135193,
      0.6773883104324341,
      0.6481890082359314,
      0.6199196577072144,
      0.7755240201950073,
      0.8129289746284485
    ],
    "question_types": [
      "causation",
      "diagnosis"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "62cf49be-4f9f-43cc-8009-c8ba07cfb30b",
    "question": "Not seen in Alzheimer's Disease?",
    "opa": "Cerebral atrophy",
    "opb": "Ventricular shrinkage",
    "opc": "Sun downing",
    "opd": "Apraxia",
    "cop": 1,
    "choice_type": "single",
    "exp": "Ans. is 'b' i.e., Ventricular shrinkage [Ref: Harrison's 19th/e p. 2598-99 & 18th/e chapter 371\\o MRI in Alzheimer's disease does not demonstrate ventricular shreinkage or Atrophy.o MRI in Alzheimer's disease demonstrate: -# Hippocampas atrophy# Posterior predominant cortical atrophy.o Topographical distribution of neurofibrillary tangles in Alzheimer's disease# Entorhinal cortex - hippocampus# Limbic and temporal cortical areas# Association areas of the neocortex.Various neurological abnormalities are seen in Alzhiemer's disease.o The sequence of neurological disabilities may not follow any described order and one or another deficit may take preceedence but usually the disease preceedes in the following four observed patterns.Korsakoff amnestic stateGradual development of forgetfulness is the major symptomo Small day to day happenings are not rememberedo Seldom used names are particularly elusiveo Little used words from an earlier period of life also tends to be lost.o Appointments are forgotten and possessions misplaced.o Questions repeated again and again.o Once the memory disorder has become pronounced', other failures in cerebral function become increasingly apparent.Dvsnomiao Patients speech is halting because offailure to recall the needed wordo The same difficulty interrupts writingo Vocabulary becomes restricted and expressive language becomes stereotyped and inflexibleo The range of vocabulary and accuracy of spellings are reduced.o Repetition of every spoken phrase (echolalia)o Deterioration of speech ultimately progresses to anomic aphasiao Fault in balancing the checkbook ultimately progresses to a point where the patient can no longer carry out simple calculations (acalculia or dyscalculia)Visuospatial orientation becomes defectiveo Cars cannot be parked; the arms do not find the correct sleeves of the jacket or shirt.o Prosopagnosia (impaired facial recognition). Difficulty in recognizing familiar faceso The patient forgets how to use common objects and tools while retaining the necessary motor and coordination for these activitie (Apraxia)Paranoia and other personality changeso Restlessness and agitation occurs later in the diseaseo Paranoid delusional state and hallucinations may occuro Depression",
    "subject_name": "Medicine",
    "topic_name": "Dementia",
    "entity": "1. Alzheimer's Disease\n2. Cerebral atrophy\n3. Ventricular shrinkage\n4. Sun downing\n5. Apraxia",
    "prediction": "B",
    "path": "Reranked Triple1: Alzheimer Disease \u2014\u2014> causes \u2014\u2014> brain atrophy  \nReranked Triple2: Alzheimer Disease \u2014\u2014> CAUSES \u2014\u2014> dementia  \nReranked Triple3: dementia \u2014\u2014> caused by \u2014\u2014> tau  \nReranked Triple4: AD \u2014\u2014> resembles \u2014\u2014> Alzheimers disease  \nReranked Triple5: Alzheimer Disease \u2014\u2014> associates \u2014\u2014> participants  \n\nAnswer: C. Sun downing",
    "neighbor_input": "Reranked Triple1: AD -> causes -> brain atrophy \u2014\u2014> cerebral atrophy  \nReranked Triple2: AD -> causes -> cognitive dysfunction \u2014\u2014> apraxia  \nReranked Triple3: AD -> causes -> cognitive decline \u2014\u2014> apraxia  \nReranked Triple4: AD -> causes -> neurodegeneration \u2014\u2014> cerebral atrophy  \nReranked Triple5: AD -> causes -> synaptic dysfunction \u2014\u2014> apraxia  \n\nAnswer: B. Ventricular shrinkage is not typically associated with Alzheimer's Disease.",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer Disease' 'causes' 'brain atrophy'.\n\nPath-based Evidence 2: 'Alzheimer Disease' 'CAUSES' 'dementia'.\n\nPath-based Evidence 3: 'dementia' 'caused by' 'tau'.\n\nPath-based Evidence 4: 'AD' 'resembles' 'Alzheimers disease'.\n\nPath-based Evidence 5: 'Alzheimer Disease' 'associates' 'participants'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'brain atrophy', which is also known as 'cerebral atrophy'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'cognitive dysfunction', leading to 'apraxia'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'cognitive decline', resulting in 'apraxia'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'neurodegeneration', which is associated with 'cerebral atrophy'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'synaptic dysfunction', which can lead to 'apraxia'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.7199079990386963,
      1.0000001192092896,
      0.7298930883407593,
      0.7964770793914795,
      0.633560061454773,
      0.6898353099822998,
      0.5880182981491089,
      0.5017680525779724
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "07317fc2-68f9-4029-9494-35d5eb7a7e2b",
    "question": "Most common cause dementia in an adult is",
    "opa": "Alzheimer's",
    "opb": "Multi-infarct",
    "opc": "Pick disease",
    "opd": "Metabolic cause",
    "cop": 0,
    "choice_type": "single",
    "exp": "Dementia is a chronic organic mental disorder characterised by impairment of intellectual function, impairment of memory, deterioration of personality with lack of personal care Alzheimer&;s is the commonest cause of dementia seen in about 70% of all cases of dementia in USA. It is more commonly seen in women (Ref: a sho textbook of psychiatry, Niraj Ahuja,7th edition, pg no23)",
    "subject_name": "Psychiatry",
    "topic_name": "Organic mental disorders",
    "entity": "1. Dementia\n2. Alzheimer's\n3. Multi-infarct\n4. Pick disease\n5. Metabolic cause",
    "prediction": "A",
    "path": "Reranked Triple1: Alzheimer disease \u2014\u2014> has symptom \u2014\u2014> infarction  \nReranked Triple2: infarcts \u2014\u2014> associates \u2014\u2014> participants  \nReranked Triple3: infarcts \u2014\u2014> associates \u2014\u2014> Alzheimer disease  \nReranked Triple4: Alzheimer disease \u2014\u2014> has phenotype \u2014\u2014> infarction  \nReranked Triple5: Alzheimer disease \u2014\u2014> has symptom \u2014\u2014> infarction  ",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple2: AD \u2014\u2014> caused by \u2014\u2014> neurodegeneration  \nReranked Triple3: AD \u2014\u2014> cause \u2014\u2014> Alzheimer's disease  \nReranked Triple4: AD \u2014\u2014> causes \u2014\u2014> cognitive impairment  \nReranked Triple5: AD \u2014\u2014> treats \u2014\u2014> dementia  ",
    "response_of_KG_list_path": "Path-based Evidence 1: The condition 'Alzheimer disease' 'has symptom' 'infarction'.\n\nPath-based Evidence 2: The entity 'infarcts' 'associates' 'participants'.\n\nPath-based Evidence 3: The entity 'infarcts' 'associates' 'Alzheimer disease'.\n\nPath-based Evidence 4: The condition 'Alzheimer disease' 'has phenotype' 'infarction'.\n\nPath-based Evidence 5: The condition 'Alzheimer disease' 'has symptom' 'infarction'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'dementia'.\n\nNeighbor-based Evidence 2: 'AD' 'caused by' 'neurodegeneration'.\n\nNeighbor-based Evidence 3: 'AD' 'cause' 'Alzheimer's disease'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'cognitive impairment'.\n\nNeighbor-based Evidence 5: 'AD' 'treats' 'dementia'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.7321019172668457,
      0.7850020527839661,
      1.0000001192092896,
      0.7687584161758423,
      0.7321019172668457,
      0.7216620445251465,
      1.0000001192092896,
      0.7111704349517822,
      1.0000001192092896,
      0.6205008029937744,
      0.8337430953979492,
      1.0,
      0.6907686591148376,
      1.0,
      0.8001323342323303
    ],
    "question_types": [
      "causation"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "167ec92f-6b05-4a5c-a6a6-e997c0f41467",
    "question": "Which of these cells is often malfunctioning in Alzheimer's disease?",
    "opa": "Microglia",
    "opb": "Radial glia",
    "opc": "Dendrites",
    "opd": "Oligodendrocytes",
    "cop": 0,
    "choice_type": "single",
    "exp": "Alzheimer's disease characterized by: * A ss amyloid deposition * Taupathy * Malfunctioning of microglial cells which play role in phagocytosis & security in brain. IOC - Functional MRI DOC - DONEPEZIL",
    "subject_name": "Medicine",
    "topic_name": "Guillian Barre syndrome & Alzheimer's disease",
    "entity": "1. Alzheimer's disease\n2. Microglia\n3. Radial glia\n4. Dendrites\n5. Oligodendrocytes",
    "prediction": "A",
    "path": "Reranked Triple1: alzheimer disease \u2014\u2014> CAUSES \u2014\u2014> dementia  \nReranked Triple2: dementia \u2014\u2014> caused by \u2014\u2014> tau  \nReranked Triple3: alzheimer disease \u2014\u2014> ASSOCATES \u2014\u2014> AD  \nReranked Triple4: AD \u2014\u2014> correlates with \u2014\u2014> diabetes mellitus  \nReranked Triple5: alzheimer disease \u2014\u2014> causes \u2014\u2014> brain atrophy",
    "neighbor_input": "Reranked Triple1: AD -> causes -> dysfunctional microglia  \nReranked Triple2: AD -> associates -> altered immune response  \nReranked Triple3: AD -> causes -> neuroinflammation  \nReranked Triple4: AD -> causes -> astrogliosis  \nReranked Triple5: AD -> associates -> neurodegenerative disorder  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer disease' 'CAUSES' 'dementia'.\n\nPath-based Evidence 2: 'dementia' 'caused by' 'tau'.\n\nPath-based Evidence 3: 'Alzheimer disease' 'ASSOCIATES' 'AD'.\n\nPath-based Evidence 4: 'AD' 'correlates with' 'diabetes mellitus'.\n\nPath-based Evidence 5: 'Alzheimer disease' 'causes' 'brain atrophy'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'dysfunctional microglia'.\n\nNeighbor-based Evidence 2: 'AD' 'associates' 'altered immune response'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'neuroinflammation'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'astrogliosis'.\n\nNeighbor-based Evidence 5: 'AD' 'associates' 'neurodegenerative disorder'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0,
      0.6599381566047668,
      0.6599381566047668,
      1.0,
      1.0000001192092896
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "4a7f404f-400f-40fb-a248-ec578dd2b31b",
    "question": "All are reversible causes of dementia except ?",
    "opa": "Hypothyroidism",
    "opb": "Hydrocephalus",
    "opc": "Meningoencephalitis",
    "opd": "Alzheimer's disease",
    "cop": 3,
    "choice_type": "multi",
    "exp": "Ans. is 'd' i.e., Alzhimer's disease Reversible causes of dementia 1) Surgically treatable :- Normal pressure hydrocephalus, brain tumors (frontal lobe tumor), meningioma, subdural hematoma due to head injury, hydrocephalus. 2) Medically treatable :- Depression, hypothyroidism, alcohol abuse, vitamin B n/folate/Niacin deficiency, any metabolic or endocrine disturbance, neurosyphilis, Hashimoto's encephalopathy, Wilson's disease, celiac disease, whipple's disease, chronic meningoencephalitis, drugs and toxin (toxic dementia). Irreversible causes of dementia :- Alzheimer's disease, vascular (multi-infarct) dementia, Parkinsonism, Huntington's chorea, Lewy body dementia, Pick's disease.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. reversible causes\n2. dementia\n3. Hypothyroidism\n4. Hydrocephalus\n5. Meningoencephalitis\n6. Alzheimer's disease",
    "prediction": "D",
    "path": [],
    "neighbor_input": "Reranked Triple1: AD -> causes -> dementia  \nReranked Triple2: AD -> caused by -> neurodegenerative diseases  \nReranked Triple3: AD -> cause -> Alzheimer's disease  \nReranked Triple4: AD -> causes -> cognitive impairment  \nReranked Triple5: AD -> causes -> neurodegeneration  \n\nAnswer: D. Alzheimer's disease",
    "response_of_KG_list_path": [],
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'dementia'.  \nNeighbor-based Evidence 2: 'AD' 'caused by' 'neurodegenerative diseases'.  \nNeighbor-based Evidence 3: 'AD' 'cause' 'Alzheimer's disease'.  \nNeighbor-based Evidence 4: 'AD' 'causes' 'cognitive impairment'.  \nNeighbor-based Evidence 5: 'AD' 'causes' 'neurodegeneration'.",
    "entity_confidence_scores": [
      0.6530424356460571,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.903645396232605,
      1.0,
      1.0,
      1.0000001192092896,
      1.0000001192092896
    ],
    "question_types": [
      "causation",
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "ebc1e933-ccca-4b93-a1b8-6539c0942a67",
    "question": "Most common cause of dementia is -",
    "opa": "Alzhiemer's disease",
    "opb": "Vascular dementia",
    "opc": "Wilson's disease",
    "opd": "Pick's disease",
    "cop": 0,
    "choice_type": "single",
    "exp": "Ans. is 'a' i.e., Alzhiemer's diseaseCauses of dementiaReversible causes Surgically treatableo Normal pressure hydrocephaluso Brain tumors (frontal lobe tumor)o Meningiomao Subdural hematoma (Head injury)o HydrocephalusMedically treatable o Hypothyroidismo Depressiono HIV infectiono Alcohol abuseo Vitamin B12 , Folate. Niacin deficiencyo Any metabolic or endocrine disturbanceo Neurosyphiliso Hashimoto's encephalopathyo Wilson's diseaseo Celiac disease or Whipple's diseaseo Chronic meningoencephalitiso Drugs and toxin (toxic dementia)Irreversible causeso Alzheimer s diseaseo Vascular (Multi-infarct) dementia o Parkinson's diseaseo Huntington's choreao Creutzfeld Jakob diseaseo Lewy body dementiao Pick's diseaseo Overall Alzheimer's disease is the most common cause. Vascular dementia is the 2nd most common cause.",
    "subject_name": "Psychiatry",
    "topic_name": "Dementia Due to Metabolic Causes",
    "entity": "1. dementia\n2. Alzhiemer's disease\n3. Vascular dementia\n4. Wilson's disease\n5. Pick's disease",
    "prediction": "A",
    "path": "Reranked Triple1: Alzheimer's disease \u2014\u2014> most common cause of dementia  \nReranked Triple2: Vascular dementia \u2014\u2014> cause of dementia  \nReranked Triple3: Wilson's disease \u2014\u2014> risk factor for dementia  \nReranked Triple4: Pick's disease \u2014\u2014> type of dementia  \nReranked Triple5: Alzheimer's disease \u2014\u2014> neurodegenerative disorder  ",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple2: AD \u2014\u2014> cause \u2014\u2014> Alzheimer's disease  \nReranked Triple3: AD \u2014\u2014> caused by \u2014\u2014> neurodegenerative diseases  \nReranked Triple4: AD \u2014\u2014> CAUSES \u2014\u2014> cognitive impairment  \nReranked Triple5: AD \u2014\u2014> causes \u2014\u2014> cognitive decline  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer's disease' is the 'most common cause of dementia'.\n\nPath-based Evidence 2: 'Vascular dementia' is a 'cause of dementia'.\n\nPath-based Evidence 3: 'Wilson's disease' is a 'risk factor for dementia'.\n\nPath-based Evidence 4: 'Pick's disease' is a 'type of dementia'.\n\nPath-based Evidence 5: 'Alzheimer's disease' is a 'neurodegenerative disorder'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'dementia'.\n\nNeighbor-based Evidence 2: 'AD' 'cause' 'Alzheimer's disease'.\n\nNeighbor-based Evidence 3: 'AD' 'caused by' 'neurodegenerative diseases'.\n\nNeighbor-based Evidence 4: 'AD' 'CAUSES' 'cognitive impairment'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'cognitive decline'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.8596497774124146,
      1.0,
      0.8961988091468811,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.6205008029937744
    ],
    "question_types": [
      "causation"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "50a3d51e-725b-446a-b840-8f0028ae3109",
    "question": "Delirium is differentiated from dementia by:",
    "opa": "Ataxia",
    "opb": "Apraxia",
    "opc": "Alexia",
    "opd": "Altered sensorium",
    "cop": 3,
    "choice_type": "single",
    "exp": "Altered sensorium",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Delirium\n2. Dementia\n3. Ataxia\n4. Apraxia\n5. Alexia\n6. Altered sensorium",
    "prediction": "D",
    "path": "Reranked Triple1: delirium -> differentiated from -> dementia  \nReranked Triple2: dementia -> associated with -> cognitive decline  \nReranked Triple3: cognitive decline -> associated with -> Alzheimer's disease  \nReranked Triple4: Alzheimer's disease -> has symptom -> apraxia  \nReranked Triple5: altered sensorium -> differentiates -> delirium  \n\nAnswer: D. Altered sensorium",
    "neighbor_input": "Reranked Triple1: delirium -> associates -> cognitive impairment  \nReranked Triple2: delirium -> occurs in -> patients  \nReranked Triple3: AD -> causes -> cognitive impairment  \nReranked Triple4: AD -> causes -> dementia  \nReranked Triple5: delirium -> cause -> neuronal damage  ",
    "response_of_KG_list_path": "Path-based Evidence 1: The condition 'delirium' is 'differentiated from' the condition 'dementia'. \n\nPath-based Evidence 2: The condition 'dementia' is 'associated with' 'cognitive decline'. \n\nPath-based Evidence 3: 'Cognitive decline' is 'associated with' 'Alzheimer's disease'. \n\nPath-based Evidence 4: 'Alzheimer's disease' 'has symptom' 'apraxia'. \n\nPath-based Evidence 5: The condition 'altered sensorium' 'differentiates' 'delirium'.",
    "response_of_KG_neighbor": "Based on the provided knowledge graph information, here are the natural language conversions:\n\nNeighbor-based Evidence 1: 'delirium' is associated with 'cognitive impairment'.  \nNeighbor-based Evidence 2: 'delirium' occurs in 'patients'.  \nNeighbor-based Evidence 3: 'AD' causes 'cognitive impairment'.  \nNeighbor-based Evidence 4: 'AD' causes 'dementia'.  \nNeighbor-based Evidence 5: 'delirium' causes 'neuronal damage'.  ",
    "entity_confidence_scores": [
      0.9999999403953552,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      0.7298930883407593,
      0.7964770793914795,
      0.633560061454773,
      0.6898353099822998
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "0ac0dc58-bec1-46e6-bcfa-a9ad7d29c4b7",
    "question": "A patient died of alzheimer's disease. At autopsy, heart contains yellow brown finely granular pigment which are/due to:",
    "opa": "Hemosiderin-iron overload",
    "opb": "Lipochrome-wear and tear",
    "opc": "Glcoge-gylcogen storage disorder",
    "opd": "Fat-athlerosclerosis",
    "cop": 1,
    "choice_type": "single",
    "exp": "Ans. (b) Lipochrome-wear and tear(Ref: Robbins 9th/pg 64; 8th/pg37)* Lipofuschin: Perinuclear Q brown-coloured pigment, Seen in aging Q, protein energy malnutrition Q and cancer cahcexia.",
    "subject_name": "Pathology",
    "topic_name": "Cellular Pathology",
    "entity": "1. Patient\n2. Alzheimer's disease\n3. Autopsy\n4. Heart\n5. Yellow brown finely granular pigment\n6. Hemosiderin\n7. Iron overload\n8. Lipochrome\n9. Wear and tear\n10. Glcoge\n11. Glycogen storage disorder\n12. Fat\n13. Athlerosclerosis",
    "prediction": "B",
    "path": "Reranked Triple1: Alzheimer disease \u2014\u2014> causes \u2014\u2014> brain atrophy  \nReranked Triple2: alzheimer disease \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple3: dementia \u2014\u2014> caused by \u2014\u2014> tau  \nReranked Triple4: tau \u2014\u2014> associates \u2014\u2014> Alzheimer Disease  \nReranked Triple5: Alzheimer Disease \u2014\u2014> resembles \u2014\u2014> Alzheimers disease  ",
    "neighbor_input": "Reranked Triple1: patient -> has disease -> Alzheimer's disease  \nReranked Triple2: patient -> has disease -> dementia  \nReranked Triple3: patient -> has -> cerebrovascular disease  \nReranked Triple4: patient -> has -> cardiovascular death  \nReranked Triple5: patient -> has -> memory impairment  ",
    "response_of_KG_list_path": "Path-based Evidence 1: The condition 'Alzheimer disease' 'causes' 'brain atrophy'.\n\nPath-based Evidence 2: The condition 'Alzheimer disease' 'causes' 'dementia'.\n\nPath-based Evidence 3: The condition 'dementia' is 'caused by' 'tau'.\n\nPath-based Evidence 4: The protein 'tau' 'associates' with 'Alzheimer Disease'.\n\nPath-based Evidence 5: The condition 'Alzheimer Disease' 'resembles' 'Alzheimer's disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: The 'patient' 'has disease' 'Alzheimer's disease'.\n\nNeighbor-based Evidence 2: The 'patient' 'has disease' 'dementia'.\n\nNeighbor-based Evidence 3: The 'patient' 'has' 'cerebrovascular disease'.\n\nNeighbor-based Evidence 4: The 'patient' 'has' 'cardiovascular death'.\n\nNeighbor-based Evidence 5: The 'patient' 'has' 'memory impairment'.",
    "entity_confidence_scores": [
      1.0,
      1.0,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0,
      0.7348365783691406,
      0.6422242522239685,
      0.6978039145469666,
      0.7634483575820923,
      1.0,
      0.6285325288772583,
      0.6266816854476929,
      0.7206766605377197,
      0.7252330780029297,
      0.7252330780029297,
      0.7617309093475342,
      0.7116177082061768,
      0.7116177082061768,
      0.7116175889968872,
      0.7639085054397583
    ],
    "question_types": [
      "causation"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "0346fe2c-5307-4671-b8d2-4da4d8940442",
    "question": "Subcoical dementia is seen in all except ?",
    "opa": "Parkinsonism",
    "opb": "Alzheimer's disease",
    "opc": "Wilson's disease",
    "opd": "Huntingtons chorea",
    "cop": 1,
    "choice_type": "multi",
    "exp": "Ans.B. Alzheimer's diseaseSubcoical dementia is seen in parkinsonism, Huntington's disease, wilson's disease, progressive supranuclear palsy, idiopathic basal ganglion calcification (Fahr's disease), thalamic lesions, multiple sclerosis, HIV associated dementia and multisYstem atroPhY.Alzheimer's disease causes coical dementia.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Subcortical dementia\n2. Parkinsonism\n3. Alzheimer's disease\n4. Wilson's disease\n5. Huntington's chorea",
    "prediction": "B",
    "path": "Reranked Triple1: Wilson's disease -> causes -> copper intoxication  \nReranked Triple2: Wilson's disease -> resembles -> Alzheimer's disease  \nReranked Triple3: Alzheimer's disease -> causes -> dementia  \nReranked Triple4: Alzheimer's disease -> associates -> AD  \nReranked Triple5: Alzheimer's disease -> caused by -> amyloid-beta precursor protein  \n\nAnswer: C. Wilson's disease",
    "neighbor_input": "Reranked Triple1: Parkinsonism -> associated with -> dopamine transporter  \nReranked Triple2: Parkinsonism -> causes -> Neurodegenerative disease  \nReranked Triple3: Parkinsonism -> causes -> neuronal damage  \nReranked Triple4: Parkinsonism -> associates -> variant amyloid deposits  \nReranked Triple5: Parkinsonism -> causes -> cardiovascular disease  \n\nAnswer: C. Wilson's disease",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Wilson's disease' 'causes' 'copper intoxication'.  \nPath-based Evidence 2: 'Wilson's disease' 'resembles' 'Alzheimer's disease'.  \nPath-based Evidence 3: 'Alzheimer's disease' 'causes' 'dementia'.  \nPath-based Evidence 4: 'Alzheimer's disease' 'associates' 'AD'.  \nPath-based Evidence 5: 'Alzheimer's disease' 'caused by' 'amyloid-beta precursor protein'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Parkinsonism' is 'associated with' 'dopamine transporter'.\n\nNeighbor-based Evidence 2: 'Parkinsonism' 'causes' 'Neurodegenerative disease'.\n\nNeighbor-based Evidence 3: 'Parkinsonism' 'causes' 'neuronal damage'.\n\nNeighbor-based Evidence 4: 'Parkinsonism' 'associates' 'variant amyloid deposits'.\n\nNeighbor-based Evidence 5: 'Parkinsonism' 'causes' 'cardiovascular disease'.",
    "entity_confidence_scores": [
      0.882514476776123,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.8395751714706421,
      0.808238685131073
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "312ca7f9-9e67-431a-903e-159e988f3dfb",
    "question": "Which drug is not used in Alzheimer's disease",
    "opa": "Tacrine",
    "opb": "Gallantamine",
    "opc": "Donepezil",
    "opd": "Rivastigmine",
    "cop": 0,
    "choice_type": "multi",
    "exp": "Refer kDT 6/e p 102,472,473 Because of hepatotoxicity, and requirement of frequent dosing, Tekken is less often used than other agents",
    "subject_name": "Pharmacology",
    "topic_name": "Autonomic nervous system",
    "entity": "1. Alzheimer's disease\n2. Tacrine\n3. Gallantamine\n4. Donepezil\n5. Rivastigmine",
    "prediction": "A",
    "path": "Reranked Triple1: Tacrine \u2014\u2014> inhibits -> Abeta  \nReranked Triple2: Tacrine \u2014\u2014> is not mentioned in the context of treating Alzheimer's disease  \nReranked Triple3: Rivastigmine \u2014\u2014> TREATS -> AD  \nReranked Triple4: Rivastigmine \u2014\u2014> treats -> Alzheimer's disease  \nReranked Triple5: Riluzole \u2014\u2014> TREATS -> AD  \n\nAnswer: A. Tacrine",
    "neighbor_input": "Reranked Triple1: AD -> TREATMENT -> tacrine \u2014\u2014> patients  \nReranked Triple2: AD -> TREATMENT -> donepezil \u2014\u2014> patients  \nReranked Triple3: AD -> TREATMENT -> galantamine \u2014\u2014> patients  \nReranked Triple4: AD -> TREATMENT -> rivastigmine \u2014\u2014> patients  \nReranked Triple5: AD -> TREATMENT -> TUDCA \u2014\u2014> patients  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Tacrine' 'inhibits' 'Abeta'.\n\nPath-based Evidence 2: 'Tacrine' 'is not mentioned in the context of treating' 'Alzheimer's disease'.\n\nPath-based Evidence 3: 'Rivastigmine' 'TREATS' 'AD'.\n\nPath-based Evidence 4: 'Rivastigmine' 'treats' 'Alzheimer's disease'.\n\nPath-based Evidence 5: 'Riluzole' 'TREATS' 'AD'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' is associated with the 'TREATMENT' of 'tacrine' for 'patients'.  \nNeighbor-based Evidence 2: 'AD' is associated with the 'TREATMENT' of 'donepezil' for 'patients'.  \nNeighbor-based Evidence 3: 'AD' is associated with the 'TREATMENT' of 'galantamine' for 'patients'.  \nNeighbor-based Evidence 4: 'AD' is associated with the 'TREATMENT' of 'rivastigmine' for 'patients'.  \nNeighbor-based Evidence 5: 'AD' is associated with the 'TREATMENT' of 'TUDCA' for 'patients'.  ",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.6049656271934509,
      1.0,
      0.6575609445571899,
      1.0,
      0.6304964423179626
    ],
    "question_types": [
      "treatment",
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "f0cbf9f8-1597-42d7-bc36-412c097c3c7c",
    "question": "Protein involved in Alzheimer's disease-",
    "opa": "ApoE gene",
    "opb": "Presell in - II",
    "opc": "Amyloid portion",
    "opd": "All",
    "cop": 3,
    "choice_type": "multi",
    "exp": "https://en.wikipedia.org/wiki/Alzheimer%27s_diseaseCauseThe cause for most Alzheimer's cases is still mostly unknown except for 1% to 5% of cases where genetic differences have been identified.Several competing hypotheses exist trying to explain the cause of the disease:GeneticsThe genetic heritability of Alzheimer's disease (and memory components thereof), based on reviews of twin and family studies, range from 49% to 79%. Around 0.1% of the cases are familial forms of autosomal (not sex-linked) dominant inheritance, which have an onset before age 65. This form of the disease is known as early onset familial Alzheimer's disease. Most of autosomal dominant familial AD can be attributed to mutations in one of three genes: those encoding amyloid precursor protein (APP) and presenilins 1 and 2. Most mutations in the APP and presenilin genes increase the production of a small protein called Ab42, which is the main component of senile plaques. Some of the mutations merely alter the ratio between Ab42 and the other major forms--particularly Ab40--without increasing Ab42 levels. This suggests that presenilin mutations can cause disease even if they lower the total amount of Ab produced and may point to other roles of presenilin or a role for alterations in the function of APP and/or its fragments other than Ab. There exist variants of the APP gene which are protective.Most cases of Alzheimer's disease do not exhibit autosomal-dominant inheritance and are termed sporadic AD, in which environmental and genetic differences may act as risk factors. The best known genetic risk factor is the inheritance of the e4 allele of theapolipoprotein E (APOE). Between 40 and 80% of people with AD possess at least one APOEe4 allele. The APOEe4 allele increases the risk of the disease by three times in heterozygotes and by 15 times in homozygotes. Like many human diseases, environmental effects and genetic modifiers result in incomplete penetrance. For example, certain Nigerian populations do not show the relationship between dose of APOEe4 and incidence or age-of-onset for Alzheimer's disease seen in other human populations. Early attempts to screen up to 400 candidate genes for association with late-onset sporadic AD (LOAD) resulted in a low yield. More recent genome-wide association studies (GWAS) have found 19 areas in genes that appear to affect the risk. These genes include: CASS4, CELF1, FERMT2, HLA-DRB5, INPP5D, MEF2C, NME8, PTK2B, SORL1, ZCWPW1, SlC24A4, CLU, PICALM, CR1, BIN1, MS4A, ABCA7, EPHA1, and CD2AP.Mutations in the TREM2 gene have been associated with a 3 to 5 times higher risk of developing Alzheimer's disease. A suggested mechanism of action is that when TREM2 is mutated, white blood cells in the brain are no longer able to control the amount of beta amyloid present.Cholinergic hypothesisThe oldest, on which most currently available drug therapies are based, is the cholinergic hypothesis, which proposes that AD is caused by reduced synthesis of the neurotransmitter acetylcholine. The cholinergic hypothesis has not maintained widespread support, largely because medications intended to treat acetylcholine deficiency have not been very effective. Other cholinergic effects have also been proposed, for example, initiation of large-scale aggregation of amyloid, leading to generalisedneuroinflammation.Amyloid hypothesisIn 1991, the amyloid hypothesis postulated that extracellular amyloid beta (Ab) deposits are the fundamental cause of the disease. Support for this postulate comes from the location of the gene for the amyloid precursor protein (APP) on chromosome 21, together with the fact that people with trisomy 21 (Down Syndrome) who have an extra gene copy almost universally exhibit at least the earliest symptoms of AD by 40 years of age. Also, a specific isoform of apolipoprotein, APOE4, is a major genetic risk factor for AD. Whilst apolipoproteins enhance the breakdown of beta amyloid, some isoforms are not very effective at this task (such as APOE4), leading to excess amyloid buildup in the brain. Further evidence comes from the finding that transgenic mice that express a mutant form of the human APP gene develop fibrillar amyloid plaques and Alzheimer's-like brain pathology with spatial learning deficits.An experimental vaccine was found to clear the amyloid plaques in early human trials, but it did not have any significant effect on dementia. Researchers have been led to suspect non-plaque Ab oligomers (aggregates of many monomers) as the primary pathogenic form of Ab. These toxic oligomers, also referred to as amyloid-derived diffusible ligands (ADDLs), bind to a surface receptor on neurons and change the structure of the synapse, thereby disrupting neuronal communication. One receptor for Aboligomers may be the prion protein, the same protein that has been linked to mad cow disease and the related human condition, Creutzfeldt-Jakob disease, thus potentially linking the underlying mechanism of these neurodegenerative disorders with that of Alzheimer's disease. One study found possible evidence of human to human transmission.In 2009, this theory was updated, suggesting that a close relative of the beta-amyloid protein, and not necessarily the beta-amyloid itself, may be a major culprit in the disease. The theory holds that an amyloid-related mechanism that prunes neuronal connections in the brain in the fast-growth phase of early life may be triggered by ageing-related processes in later life to cause the neuronal withering of Alzheimer's disease. N-APP, a fragment of APP from the peptide's N-terminus, is adjacent to beta-amyloid and is cleaved from APP by one of the same enzymes. N-APP triggers the self-destruct pathway by binding to a neuronal receptor called death receptor 6 (DR6, also known as TNFRSF21). DR6 is highly expressed in the human brain regions most affected by Alzheimer's, so it is possible that the N-APP/DR6 pathway might be hijacked in the ageing brain to cause damage. In this model, beta-amyloid plays a complementary role, by depressing synaptic function.Tau hypothesisIn Alzheimer's disease, changes in tau protein lead to the disintegration of microtubules in brain cells.The tau hypothesis proposes that tau protein abnormalities initiate the disease cascade. In this model, hyperphosphorylated tau begins to pair with other threads of tau. Eventually, they form neurofibrillary tangles inside nerve cell bodies. When this occurs, the microtubules disintegrate, destroying the structure of the cell's cytoskeleton which collapses the neuron's transport system. This may result first in malfunctions in biochemical communication between neurons and later in the death of the cells.Other hypothesesA neurovascular hypothesis has been proposed which state that poor functioning of the blood brain barrier may be involved.The cellular homeostasis of biometals such as ionic copper, iron, and zinc is disrupted in AD, though it remains unclear whether this is produced by or causes the changes in proteins. These ions affect and are affected by tau, APP, and APOE, and their dysregulation may cause oxidative stress that may contribute to the pathology. Some studies have shown an increased risk of developing AD withenvironmental factors such as the intake of metals, particularly aluminium. The quality of some of these studies has been criticised, and the link remains controversial. The majority of researchers do not support a causal connection with aluminium.Smoking is a significant AD risk factor. Systemic markers of the innate immune system are risk factors for late-onset AD.There is tentative evidence that exposure to air pollution may be a contributing factor to the development of Alzheimer's disease.An infection with Spirochetes (a bacteria) in gum disease may cause dementia and may be involved in the pathogenesis of Alzheimer's disease.Another scientific hypothesis is retrogenesis. Retrogenesis deals with the development and progress of Alzheimer's disease. This hypothesis considers the act of white matter atrophy occurring in the human nervous system",
    "subject_name": "Psychiatry",
    "topic_name": "Degenerative Disorders",
    "entity": "1. Alzheimer's disease\n2. Protein\n3. ApoE gene\n4. Presellin-II\n5. Amyloid portion",
    "prediction": "D",
    "path": "Reranked Triple1: alzheimer disease \u2014\u2014> CAUSES \u2014\u2014> dementia  \nReranked Triple2: alzheimer disease \u2014\u2014> associates \u2014\u2014> tau  \nReranked Triple3: alzheimer disease \u2014\u2014> associates \u2014\u2014> Abeta (amyloid-beta)  \nReranked Triple4: Abeta (amyloid-beta) \u2014\u2014> regulates \u2014\u2014> AD  \nReranked Triple5: AD \u2014\u2014> resembles \u2014\u2014> Alzheimers disease  \n\nAnswer: C. Amyloid portion",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> associates \u2014\u2014> Apolipoprotein E (APOE)  \nReranked Triple2: AD \u2014\u2014> causes \u2014\u2014> amyloid-beta  \nReranked Triple3: AD \u2014\u2014> causes \u2014\u2014> amyloid-beta aggregation  \nReranked Triple4: AD \u2014\u2014> causes \u2014\u2014> amyloid plaque  \nReranked Triple5: AD \u2014\u2014> causes \u2014\u2014> Abeta accumulation in the brain  ",
    "response_of_KG_list_path": "Path-based Evidence 1: The condition 'alzheimer disease' is known to 'CAUSE' 'dementia'.\n\nPath-based Evidence 2: The condition 'alzheimer disease' 'associates' with 'tau'.\n\nPath-based Evidence 3: The condition 'alzheimer disease' 'associates' with 'Abeta (amyloid-beta)'.\n\nPath-based Evidence 4: The entity 'Abeta (amyloid-beta)' 'regulates' 'AD'.\n\nPath-based Evidence 5: The entity 'AD' 'resembles' 'Alzheimers disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' is associated with 'Apolipoprotein E (APOE)'.\n\nNeighbor-based Evidence 2: 'AD' causes 'amyloid-beta'.\n\nNeighbor-based Evidence 3: 'AD' causes 'amyloid-beta aggregation'.\n\nNeighbor-based Evidence 4: 'AD' causes 'amyloid plaque'.\n\nNeighbor-based Evidence 5: 'AD' causes 'Abeta accumulation in the brain'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.8890658020973206,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      0.7696847915649414,
      0.811469554901123
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "6060d207-e2c5-4651-afc7-10cb2a2b592d",
    "question": "The following is not a feature of Alzheimer's disease",
    "opa": "Neurofibrillary tangles",
    "opb": "Senile plaques",
    "opc": "Amyloid angiopathy",
    "opd": "Lewy bodies",
    "cop": 3,
    "choice_type": "single",
    "exp": "Reference Robbins page no 1290",
    "subject_name": "Anatomy",
    "topic_name": "General anatomy",
    "entity": "1. Alzheimer's disease\n2. Neurofibrillary tangles\n3. Senile plaques\n4. Amyloid angiopathy\n5. Lewy bodies",
    "prediction": "D",
    "path": "Reranked Triple1: Lewy bodies \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple2: Cerebral amyloid angiopathy \u2014\u2014> correlates \u2014\u2014> tau  \nReranked Triple3: Cerebral amyloid angiopathy \u2014\u2014> has \u2014\u2014> human  \nReranked Triple4: Neurofibrillary tangles \u2014\u2014> associates \u2014\u2014> Alzheimer's disease  \nReranked Triple5: Senile plaques \u2014\u2014> found in \u2014\u2014> dementia  ",
    "neighbor_input": "Reranked Triple1: AD -> ASSOCIATES -> neurofibrillary tangles \u2014\u2014> Alzheimer's disease\nReranked Triple2: AD -> ASSOCIATES -> senile plaques \u2014\u2014> Alzheimer's disease\nReranked Triple3: AD -> ASSOCIATES -> amyloid-beta peptide (Abeta) deposition \u2014\u2014> Alzheimer's disease\nReranked Triple4: AD -> ASSOCIATES -> amyloid angiopathy \u2014\u2014> Alzheimer's disease\nReranked Triple5: AD -> ASSOCIATES -> Lewy bodies \u2014\u2014> NOT Alzheimer's disease",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Lewy bodies' are known to 'cause' 'dementia'.\n\nPath-based Evidence 2: 'Cerebral amyloid angiopathy' 'correlates' with 'tau'.\n\nPath-based Evidence 3: 'Cerebral amyloid angiopathy' 'has' 'human'.\n\nPath-based Evidence 4: 'Neurofibrillary tangles' 'associate' with 'Alzheimer's disease'.\n\nPath-based Evidence 5: 'Senile plaques' are 'found in' 'dementia'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' is associated with 'neurofibrillary tangles', which are related to 'Alzheimer's disease'.\n\nNeighbor-based Evidence 2: 'AD' is associated with 'senile plaques', which are related to 'Alzheimer's disease'.\n\nNeighbor-based Evidence 3: 'AD' is associated with 'amyloid-beta peptide (Abeta) deposition', which is related to 'Alzheimer's disease'.\n\nNeighbor-based Evidence 4: 'AD' is associated with 'amyloid angiopathy', which is related to 'Alzheimer's disease'.\n\nNeighbor-based Evidence 5: 'AD' is associated with 'Lewy bodies', which are not related to 'Alzheimer's disease'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.9499473571777344,
      1.000000238418579
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "65d5ecdd-7fb0-45b1-bf9d-1fcb5e919852",
    "question": "Dementia is seen in all except",
    "opa": "Schizophrenia",
    "opb": "Alzheimer's disease",
    "opc": "Huntington's chorea",
    "opd": "Pick's disease",
    "cop": 0,
    "choice_type": "multi",
    "exp": "Common causes of dementia are Parenchymatous brain diseases (Alzheimer&;s disease, Pick&;s disease, Parkinson&;s disease, Huntington&;s chorea, Lewy body dementia) Vascular dementia Toxic dementia- Psychotropic drugs Metabolic dementia- Wilson&;s disease Endocrine causes- Thyroid, parathyroid, adrenal dysfunction Deficiency dementia- Pernicious anaemia Dementia due to infections- Neurosyphilis Neoplastic dementia Traumatic dementia- Chronic subdural haematoma Hydrocephalic dementia- Normal pressure hydrocephalus (Ref: A sho textbook of psychiatry, Niraj Ahuja, 7th edition, pg no.24)",
    "subject_name": "Psychiatry",
    "topic_name": "Organic mental disorders",
    "entity": "1. Dementia\n2. Schizophrenia\n3. Alzheimer's disease\n4. Huntington's chorea\n5. Pick's disease",
    "prediction": "A",
    "path": "Reranked Triple1: Alzheimer's disease \u2014\u2014> dementia  \nReranked Triple2: Huntington's chorea \u2014\u2014> dementia  \nReranked Triple3: Pick's disease \u2014\u2014> dementia  \nReranked Triple4: Schizophrenia \u2014\u2014> not associated with dementia  \nReranked Triple5: dementia \u2014\u2014> cognitive decline  \n\nAnswer: A. Schizophrenia",
    "neighbor_input": "Reranked Triple1: AD -> causes -> dementia \u2014\u2014> Alzheimer's disease\nReranked Triple2: AD -> causes -> dementia \u2014\u2014> Pick's disease\nReranked Triple3: AD -> causes -> neurodegenerative diseases \u2014\u2014> Huntington's chorea\nReranked Triple4: AD -> causes -> cognitive impairment \u2014\u2014> Alzheimer's disease\nReranked Triple5: AD -> causes -> cognitive impairment \u2014\u2014> Pick's disease\n\nAnswer: A. Schizophrenia",
    "response_of_KG_list_path": "Path-based Evidence 1: The condition 'Alzheimer's disease' is associated with the relationship 'leads to' the condition 'dementia'.\n\nPath-based Evidence 2: The condition 'Huntington's chorea' is associated with the relationship 'leads to' the condition 'dementia'.\n\nPath-based Evidence 3: The condition 'Pick's disease' is associated with the relationship 'leads to' the condition 'dementia'.\n\nPath-based Evidence 4: The condition 'Schizophrenia' is associated with the relationship 'is not associated with' the condition 'dementia'.\n\nPath-based Evidence 5: The condition 'dementia' is associated with the relationship 'leads to' 'cognitive decline'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'dementia', specifically 'Alzheimer's disease'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'dementia', specifically 'Pick's disease'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'neurodegenerative diseases', specifically 'Huntington's chorea'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'cognitive impairment', specifically 'Alzheimer's disease'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'cognitive impairment', specifically 'Pick's disease'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.8395751714706421,
      0.808238685131073,
      1.0000001192092896,
      0.6205008029937744,
      0.5583708882331848
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "2c0ae22e-848f-491a-850b-519ca6a97f60",
    "question": "Which part of the brain is most commonly effected in Alzheimer's disease?",
    "opa": "Locus ceruleus",
    "opb": "Entorhinal cortex",
    "opc": "Frontal cortex",
    "opd": "Cerebellum",
    "cop": 1,
    "choice_type": "single",
    "exp": "\"Entorbinal cortex / Medial temporal lobe\" is most commonly affected in Alzheimer's disease.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. brain\n3. Locus ceruleus\n4. Entorhinal cortex\n5. Frontal cortex\n6. Cerebellum",
    "prediction": "B",
    "path": "Reranked Triple1: entorhinal cortex \u2014\u2014> is a part of \u2014\u2014> brain  \nReranked Triple2: locus ceruleus degeneration \u2014\u2014> in \u2014\u2014> mice  \nReranked Triple3: locus ceruleus degeneration \u2014\u2014> TREATMENT \u2014\u2014> Abeta  \nReranked Triple4: Abeta \u2014\u2014> affects \u2014\u2014> entorhinal cortex  \nReranked Triple5: entorhinal cortex \u2014\u2014> has \u2014\u2014> cortex  \n\nAnswer: B. Entorhinal cortex",
    "neighbor_input": "Reranked Triple1: AD->causes->hippocampal dysfunction\nReranked Triple2: AD->causes->neuronal loss\nReranked Triple3: AD->CAUSES->neuronal degeneration\nReranked Triple4: AD->ASSOCIATES->neurodegenerative diseases\nReranked Triple5: AD->ASSOCIATES->memory loss",
    "response_of_KG_list_path": "Path-based Evidence 1: The 'entorhinal cortex' 'is a part of' the 'brain'.\n\nPath-based Evidence 2: The 'locus ceruleus degeneration' occurs 'in' 'mice'.\n\nPath-based Evidence 3: The 'locus ceruleus degeneration' has a 'TREATMENT' related to 'Abeta'.\n\nPath-based Evidence 4: The 'Abeta' 'affects' the 'entorhinal cortex'.\n\nPath-based Evidence 5: The 'entorhinal cortex' 'has' a 'cortex'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' causes 'hippocampal dysfunction'.  \nNeighbor-based Evidence 2: 'AD' causes 'neuronal loss'.  \nNeighbor-based Evidence 3: 'AD' causes 'neuronal degeneration'.  \nNeighbor-based Evidence 4: 'AD' associates with 'neurodegenerative diseases'.  \nNeighbor-based Evidence 5: 'AD' associates with 'memory loss'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.8087888360023499,
      1.0000001192092896,
      1.0000001192092896,
      0.8035867214202881,
      1.0000001192092896,
      1.0,
      1.0,
      1.0000001192092896,
      0.7078962326049805,
      0.695589005947113,
      0.9999998807907104,
      0.9287086725234985,
      1.0000001192092896
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "354adbce-193b-4f4f-a05f-4f73655b0abd",
    "question": "Drug used in Alzheimer's disease except:",
    "opa": "Rivastigmine",
    "opb": "Memantine",
    "opc": "Donapezil",
    "opd": "Clonidine",
    "cop": 3,
    "choice_type": "multi",
    "exp": "Ans: D (Clonidine) Ref: Synopsis of Psychiatry, Kaplan & Sadock, 10th edition.p.343.Expanation:Alzheimer's disease / dementia is the most common type of dementia across the globe (In India. Vascular dementia is MC).Dementia is a chronic, progressive condition characterized by:Decline in memory (Short term)Executive dysfunction (Agnosia. Aphasia and Apraxia).While many are irreversible, some have reversible causes- alcohol, head injury, deficiency states, metabolic and endocrinopathies.Alzheimer's dementia is due to progressive loss of neurons starting from basal nucleus (of Meynert) which in turn due to accumulation of neurofibrillary tangles (intracellular tau proteins) & amyloid plaques (extracellular Bamyloid) deposition.Since basal nucleus is the main place in brain where acetylcholine is synthesized (Ach is responsible for transferring immediate memory into short term memory), decline of memory is seen.Recently, aluminum has been implicated for Alzheimer's disease.Cortical dementiaSub-cortical dementiaMemory loss is early Aohassa is pronounced e.g., Alzheimer's dementiaMood & motor symptoms first Memory disturbance is late e.g., Parkinson. Lewy body diseaseThe aim of treatment of Alzheimer's disease is preservation of existing cholinergic neurons (or at least Ach by preventing its degradation - which in turn done by inhibition of Ach-estrase).The drugs used:1. Ach precursors- Choline. Lecithine2. AchE inhibitors- Donapezil. Rivastigmine, Galantamine (DRG)3. Antiglutamates - Memantine4. New drugs - Selegefine (MAOI-B type), Ondensetron, Estrogen. NSAlDs.Clonidine is a central sympatholytic (a), used to treat essential hypertension, diabetic neuropathy, Opioid withdrawal, menopausal symptoms (hot flushes).",
    "subject_name": "Psychiatry",
    "topic_name": "Degenerative Disorders",
    "entity": "1. Alzheimer's disease\n2. Rivastigmine\n3. Memantine\n4. Donapezil\n5. Clonidine",
    "prediction": "D",
    "path": "Reranked Triple1: rivastigmine \u2014\u2014> treats \u2014\u2014> AD (Alzheimer's disease)  \nReranked Triple2: donepezil \u2014\u2014> reduces \u2014\u2014> Abeta  \nReranked Triple3: donepezil \u2014\u2014> treats \u2014\u2014> AD (Alzheimer's disease)  \nReranked Triple4: AD (Alzheimer's disease) \u2014\u2014> correlates with \u2014\u2014> diabetes mellitus  \nReranked Triple5: AD (Alzheimer's disease) \u2014\u2014> resembles \u2014\u2014> Alzheimers disease  \n\nAnswer: D. Clonidine",
    "neighbor_input": "Reranked Triple1: AD -> TREATMENT -> Rivastigmine \u2014\u2014> patients  \nReranked Triple2: AD -> TREATMENT -> Memantine \u2014\u2014> patients  \nReranked Triple3: AD -> TREATMENT -> Donapezil \u2014\u2014> patients  \nReranked Triple4: AD -> TREATMENT -> Clonidine \u2014\u2014> not associated  \nReranked Triple5: AD -> TREATMENT -> cognitive loss \u2014\u2014> related to treatment options  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'rivastigmine' 'treats' 'AD (Alzheimer's disease)'.  \nPath-based Evidence 2: 'donepezil' 'reduces' 'Abeta'.  \nPath-based Evidence 3: 'donepezil' 'treats' 'AD (Alzheimer's disease)'.  \nPath-based Evidence 4: 'AD (Alzheimer's disease)' 'correlates with' 'diabetes mellitus'.  \nPath-based Evidence 5: 'AD (Alzheimer's disease)' 'resembles' 'Alzheimers disease'.  ",
    "response_of_KG_neighbor": "Certainly! Here is the conversion of the knowledge graph information into natural language:\n\nNeighbor-based Evidence 1: 'AD' is associated with the 'TREATMENT' of 'Rivastigmine' for 'patients'.\n\nNeighbor-based Evidence 2: 'AD' is associated with the 'TREATMENT' of 'Memantine' for 'patients'.\n\nNeighbor-based Evidence 3: 'AD' is associated with the 'TREATMENT' of 'Donapezil' for 'patients'.\n\nNeighbor-based Evidence 4: 'AD' is associated with the 'TREATMENT' of 'Clonidine', which is 'not associated' with 'patients'.\n\nNeighbor-based Evidence 5: 'AD' is related to 'cognitive loss', which is 'related to treatment options'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.6304964423179626,
      1.0000001192092896,
      0.8044598698616028,
      0.7565894722938538
    ],
    "question_types": [
      "treatment",
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "19ced4f8-3179-4251-a98d-ddec199089a6",
    "question": "Risk factors for Alzheimer's include:-",
    "opa": "Klinefelter syndrome",
    "opb": "Noonam syndrome",
    "opc": "Down's syndrome",
    "opd": "Turner syndrome",
    "cop": 2,
    "choice_type": "single",
    "exp": "Alzheimer disease is associated with deposition of amyloid beta(AB) plaque which is produce from amyloid associated protein(APP) which is coded from gene present on chromosome 21. This is called pre senile dementia or premature Alzheimer. Noonan syndrome : defect in gene PTPN11, KRAS, SOS1 leading to defect in signaling protein. Patient have pulmonary valve stenosis, VSD or hyperophic cardiomyopathy.",
    "subject_name": "Pathology",
    "topic_name": "NEET 2019",
    "entity": "1. Alzheimer's\n2. Klinefelter syndrome\n3. Noonan syndrome\n4. Down's syndrome\n5. Turner syndrome",
    "prediction": "C",
    "path": "Reranked Triple1: Down's syndrome \u2014\u2014> TYPE \u2014\u2014> neurological disorder  \nReranked Triple2: Down's syndrome \u2014\u2014> involves \u2014\u2014> brain atrophy  \nReranked Triple3: brain atrophy \u2014\u2014> occurs in \u2014\u2014> Alzheimer's disease  \nReranked Triple4: Alzheimer's disease \u2014\u2014> associates with \u2014\u2014> trisomy 21  \nReranked Triple5: Alzheimer's disease \u2014\u2014> correlates with \u2014\u2014> diabetes mellitus  ",
    "neighbor_input": "Reranked Triple1: Alzheimer's -> associated with -> dementia  \nReranked Triple2: Alzheimer's -> causes -> protein misfolded proteins  \nReranked Triple3: Alzheimer's -> causes -> protein fibrillization  \nReranked Triple4: Alzheimer's -> disease -> neurodegenerative  \nReranked Triple5: Alzheimer's -> USES -> amyloid PET  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Down's syndrome' is a type of 'neurological disorder'.\n\nPath-based Evidence 2: 'Down's syndrome' involves 'brain atrophy'.\n\nPath-based Evidence 3: 'Brain atrophy' occurs in 'Alzheimer's disease'.\n\nPath-based Evidence 4: 'Alzheimer's disease' associates with 'trisomy 21'.\n\nPath-based Evidence 5: 'Alzheimer's disease' correlates with 'diabetes mellitus'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Alzheimer's' is 'associated with' 'dementia'.\n\nNeighbor-based Evidence 2: 'Alzheimer's' 'causes' 'protein misfolded proteins'.\n\nNeighbor-based Evidence 3: 'Alzheimer's' 'causes' 'protein fibrillization'.\n\nNeighbor-based Evidence 4: 'Alzheimer's' is a 'disease' that is 'neurodegenerative'.\n\nNeighbor-based Evidence 5: 'Alzheimer's' 'USES' 'amyloid PET'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.9999998807907104,
      1.0000001192092896,
      0.9999999403953552,
      0.796008288860321,
      0.796008288860321,
      1.0,
      0.9198420643806458
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "b450a626-3393-4a5c-8e3e-dfa2351a0091",
    "question": "The nucleus involved in Alzheimer's disease is ?",
    "opa": "Basal nucleus of Mayernet",
    "opb": "Raphe nucleus",
    "opc": "Superior salivary nucleus",
    "opd": "Basal lobe of cerebellum",
    "cop": 0,
    "choice_type": "single",
    "exp": "Ans is 'a' i.e., Basal nucleus of Mayernet Alzheimer disease o Alzheimer disease (AD) is the most common cause of dementia in the elderly. o Alzeimer's disease is associated with a decrease in cerebral coical levels of Acetylcholine. o Reduction of Acetylcholine is releated to degeneration of cholinergic neurons that project to many areas of coex. o This degeneration occurs in the nucleus basalis of Meyernet.",
    "subject_name": "Pathology",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. Basal nucleus of Mayernet\n3. Raphe nucleus\n4. Superior salivary nucleus\n5. Basal lobe of cerebellum",
    "prediction": "A",
    "path": "Reranked Triple1: Alzheimer disease -> associates -> dementia  \nReranked Triple2: dementia -> caused by -> tau  \nReranked Triple3: tau -> associates -> Alzheimer Disease  \nReranked Triple4: Alzheimer Disease -> causes -> brain atrophy  \nReranked Triple5: AD -> correlates with -> diabetes mellitus",
    "neighbor_input": "Reranked Triple1: AD -> causes -> cognitive impairment  \nReranked Triple2: AD -> causes -> neurodegeneration  \nReranked Triple3: AD -> causes -> behavioral dysfunction  \nReranked Triple4: AD -> causes -> brain atrophy  \nReranked Triple5: AD -> causes -> memory loss  \n\nAnswer:",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer disease' is known to 'associate' with 'dementia'.\n\nPath-based Evidence 2: 'Dementia' is 'caused by' 'tau'.\n\nPath-based Evidence 3: 'Tau' is known to 'associate' with 'Alzheimer Disease'.\n\nPath-based Evidence 4: 'Alzheimer Disease' 'causes' 'brain atrophy'.\n\nPath-based Evidence 5: 'AD' 'correlates with' 'diabetes mellitus'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'cognitive impairment'.  \nNeighbor-based Evidence 2: 'AD' 'causes' 'neurodegeneration'.  \nNeighbor-based Evidence 3: 'AD' 'causes' 'behavioral dysfunction'.  \nNeighbor-based Evidence 4: 'AD' 'causes' 'brain atrophy'.  \nNeighbor-based Evidence 5: 'AD' 'causes' 'memory loss'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.7458378672599792,
      0.7261062860488892,
      0.7261061668395996,
      0.836044192314148,
      0.7716284990310669
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "fc6a7940-35aa-4c0c-9938-46bcd0fc8578",
    "question": "Alzheimer's disease associated chromosome is",
    "opa": "2",
    "opb": "6",
    "opc": "12",
    "opd": "19",
    "cop": 3,
    "choice_type": "single",
    "exp": "In familial Alzheimer disease and down syndrome. The gene encoding APP on chromosome 21 is involved.\nThe genitic locus on chromosome 19 that encodes apolipoprotein E (ADOE) has a strong inthences on the risk of developing AD.",
    "subject_name": "Pathology",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. chromosome 2\n3. chromosome 6\n4. chromosome 12\n5. chromosome 19",
    "prediction": "D",
    "path": "Reranked Triple1: Alzheimer disease \u2014\u2014> associates \u2014\u2014> AD  \nReranked Triple2: AD \u2014\u2014> correlates with \u2014\u2014> diabetes mellitus  \nReranked Triple3: Alzheimer disease \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple4: dementia \u2014\u2014> caused by \u2014\u2014> tau  \nReranked Triple5: Alzheimer Disease \u2014\u2014> associates \u2014\u2014> participants  \n\nAnswer:",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> causes \u2014\u2014> amyloid-beta peptide (Abeta) deposition  \nReranked Triple2: AD \u2014\u2014> associates \u2014\u2014> tauopathies  \nReranked Triple3: AD \u2014\u2014> causes \u2014\u2014> neurodegeneration  \nReranked Triple4: AD \u2014\u2014> causes \u2014\u2014> cognitive impairment  \nReranked Triple5: AD \u2014\u2014> treats \u2014\u2014> cognitive deficits  \n\nAnswer: A.2",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer disease' 'associates' with 'AD'.\n\nPath-based Evidence 2: 'AD' 'correlates with' 'diabetes mellitus'.\n\nPath-based Evidence 3: 'Alzheimer disease' 'causes' 'dementia'.\n\nPath-based Evidence 4: 'dementia' 'caused by' 'tau'.\n\nPath-based Evidence 5: 'Alzheimer Disease' 'associates' with 'participants'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'amyloid-beta peptide (Abeta) deposition'.\n\nNeighbor-based Evidence 2: 'AD' 'associates' 'tauopathies'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'neurodegeneration'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'cognitive impairment'.\n\nNeighbor-based Evidence 5: 'AD' 'treats' 'cognitive deficits'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.8243193626403809,
      0.8286762833595276,
      0.803590714931488,
      0.7966217994689941,
      0.8807259798049927,
      0.8343526124954224,
      1.0000001192092896,
      0.8612135648727417
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "3d2d2cac-f9aa-43ac-8dc8-1073f4652dd3",
    "question": "Which of the following imaging techniques is best able to measure regional brain substrate uptake and metabolic kinetics?",
    "opa": "magnetic resonance imaging (MRI)",
    "opb": "computed tomography (CT)",
    "opc": "positron emission tomography (PET)",
    "opd": "serial thallium scintigrams",
    "cop": 2,
    "choice_type": "multi",
    "exp": "PET scans use glucose analogues to demonstrate metabolic activity. They are rarely available, however, and functional MRI scans are now being used extensively to assess areas of brain activity.",
    "subject_name": "Medicine",
    "topic_name": "C.N.S.",
    "entity": "1. imaging technique\n2. regional brain substrate uptake\n3. metabolic kinetics\n4. magnetic resonance imaging (MRI)\n5. computed tomography (CT)\n6. positron emission tomography (PET)\n7. serial thallium scintigrams",
    "prediction": "C",
    "path": [],
    "neighbor_input": "Reranked Triple1: brain FDG uptake \u2014\u2014> measure \u2014\u2014> abnormal metabolism  \nReranked Triple2: brain FDG uptake \u2014\u2014> represent \u2014\u2014> an early biomarker  \nReranked Triple3: MRI \u2014\u2014> dependant \u2014\u2014> method  \nReranked Triple4: MRI \u2014\u2014> requires \u2014\u2014> MR acquisition  \nReranked Triple5: MRI-1 \u2014\u2014> measured in \u2014\u2014> 2005-06  ",
    "response_of_KG_list_path": [],
    "response_of_KG_neighbor": "1. Neighbor-based Evidence 1: The 'brain FDG uptake' is used to 'measure' 'abnormal metabolism'.  \n2. Neighbor-based Evidence 2: The 'brain FDG uptake' can 'represent' 'an early biomarker'.  \n3. Neighbor-based Evidence 3: The 'MRI' is a 'dependant' 'method'.  \n4. Neighbor-based Evidence 4: The 'MRI' 'requires' 'MR acquisition'.  \n5. Neighbor-based Evidence 5: The 'MRI-1' was 'measured in' '2005-06'.  ",
    "entity_confidence_scores": [
      0.8013985753059387,
      0.6518883109092712,
      0.7063567638397217,
      0.6599264144897461,
      0.81475830078125,
      0.7249187231063843,
      0.7326101064682007,
      0.7050031423568726,
      0.6905187368392944,
      0.6557797789573669,
      0.850297749042511,
      0.850297749042511
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "bb915472-8ea4-464f-b415-1d3bae8dd16e",
    "question": "All of the following cause subcoical dementia, Except:",
    "opa": "Alzheimer's disease",
    "opb": "Porkinsonism",
    "opc": "HIV encephalopathy",
    "opd": "Progressive Supranuclear palsy",
    "cop": 0,
    "choice_type": "multi",
    "exp": "Answer is A (Alzheimer's disease):` Dementia from Alzheimer's disease (Dementia of Alzheimer's Type) is the classical proto-type of coical dementias. Alzheimer's dementia is the most common coical dementia.",
    "subject_name": "Medicine",
    "topic_name": null,
    "entity": "1. subcortical dementia\n2. Alzheimer's disease\n3. Parkinsonism\n4. HIV encephalopathy\n5. Progressive Supranuclear palsy",
    "prediction": "B",
    "path": "Reranked Triple1: Alzheimer's disease -> causes -> dementia  \nReranked Triple2: Parkinsonism -> causes -> neuronal damage  \nReranked Triple3: HIV-associated neurocognitive disorders -> disease -> Alzheimer's disease  \nReranked Triple4: Progressive supranuclear palsy -> ASSOCIATE -> Alzheimer's disease  \nReranked Triple5: Progressive supranuclear palsy -> pathology -> tauopathy  \n\nAnswer: C. HIV encephalopathy",
    "neighbor_input": "Reranked Triple1: AD->causes->neurodegeneration \u2014\u2014> subcortical dementia\nReranked Triple2: AD->causes->cognitive lesion \u2014\u2014> subcortical dementia\nReranked Triple3: AD->CAUSES->neurodegenerative diseases \u2014\u2014> subcortical dementia\nReranked Triple4: AD->caused by->neurodegeneration \u2014\u2014> subcortical dementia\nReranked Triple5: AD->cause->Alzheimer's disease \u2014\u2014> NOT subcortical dementia",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer's disease' is known to 'cause' 'dementia'.\n\nPath-based Evidence 2: 'Parkinsonism' is known to 'cause' 'neuronal damage'.\n\nPath-based Evidence 3: 'HIV-associated neurocognitive disorders' is classified as a 'disease' related to 'Alzheimer's disease'.\n\nPath-based Evidence 4: 'Progressive supranuclear palsy' is 'associated' with 'Alzheimer's disease'.\n\nPath-based Evidence 5: 'Progressive supranuclear palsy' is characterized by 'pathology' related to 'tauopathy'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' causes 'neurodegeneration' which leads to 'subcortical dementia'.\nNeighbor-based Evidence 2: 'AD' causes 'cognitive lesion' which leads to 'subcortical dementia'.\nNeighbor-based Evidence 3: 'AD' CAUSES 'neurodegenerative diseases' which leads to 'subcortical dementia'.\nNeighbor-based Evidence 4: 'AD' is caused by 'neurodegeneration' which leads to 'subcortical dementia'.\nNeighbor-based Evidence 5: 'AD' causes 'Alzheimer's disease', but this does not lead to 'subcortical dementia'.",
    "entity_confidence_scores": [
      0.882514476776123,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.8460202217102051,
      0.7963900566101074,
      1.0,
      1.0
    ],
    "question_types": [
      "causation",
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "bd8ebdba-d6cb-4cb1-9439-63f0cde1ebd3",
    "question": "A 77-year-old man is brought to the hospital by his granddaughter for evaluation of confusion. He has no focal findings and his neuro-imaging studies are normal. Further investigations reveal a urinary tract infection, and the man improves somewhat after treatment, but still exhibits poor judgment and bizarre behavior. Pressing the family for information, the intern unearths a history of 8 years of progressive bizarre behavior. The man has undressed himself, made inappropriate sexual comments, has urinated in hallways, and pushed food into his mouth with alarming speed. Which of the following is the most likely diagnosis?",
    "opa": "Alzheimer disease",
    "opb": "frontotemporal dementia",
    "opc": "dementia with diffuse Lewy bodies",
    "opd": "vascular dementia",
    "cop": 1,
    "choice_type": "multi",
    "exp": "The progressive nature of the disorder suggests a degenerative dementia, and the predominance of disinhibited behavior suggests the frontal lobes are involved. Frontal dementias can result from trauma, tumor, or ischemia, but this history suggests a degenerative disorder. Alzheimer's can involve the frontal lobes and mimic a frontal dementia.",
    "subject_name": "Medicine",
    "topic_name": "C.N.S.",
    "entity": "1. 77-year-old man\n2. granddaughter\n3. confusion\n4. neuro-imaging studies\n5. urinary tract infection\n6. poor judgment\n7. bizarre behavior\n8. family history\n9. progressive bizarre behavior\n10. undressing behavior\n11. inappropriate sexual comments\n12. hallway urination\n13. fast food consumption\n14. diagnosis options \n15. Alzheimer disease \n16. frontotemporal dementia \n17. dementia with diffuse Lewy bodies \n18. vascular dementia",
    "prediction": "B",
    "path": "Reranked Triple1: AD \u2014\u2014> CAUSES \u2014\u2014> dementia\nReranked Triple2: Pick's disease \u2014\u2014> involves \u2014\u2014> amyloid-beta\nReranked Triple3: amyloid-beta \u2014\u2014> ASSOCIATES \u2014\u2014> mouse\nReranked Triple4: mouse \u2014\u2014> ASSOCIATES \u2014\u2014> humans\nReranked Triple5: mouse \u2014\u2014> has feature \u2014\u2014> amyloid precursor protein",
    "neighbor_input": "Reranked Triple1: AD->TREATMENT->TUDCA\nReranked Triple2: AD->TREATMENT->metal\nReranked Triple3: AD->TREATMENT->insulin-like growth factor (IGF) signaling\nReranked Triple4: AD->TREATMENT->tropisetron\nReranked Triple5: AD->TREATMENT->deep learning",
    "response_of_KG_list_path": "Path-based Evidence 1: 'AD' CAUSES 'dementia'.\nPath-based Evidence 2: 'Pick's disease' involves 'amyloid-beta'.\nPath-based Evidence 3: 'amyloid-beta' ASSOCIATES 'mouse'.\nPath-based Evidence 4: 'mouse' ASSOCIATES 'humans'.\nPath-based Evidence 5: 'mouse' has feature 'amyloid precursor protein'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' is connected to 'TUDCA' through the 'TREATMENT' relationship.\n\nNeighbor-based Evidence 2: 'AD' is connected to 'metal' through the 'TREATMENT' relationship.\n\nNeighbor-based Evidence 3: 'AD' is connected to 'insulin-like growth factor (IGF) signaling' through the 'TREATMENT' relationship.\n\nNeighbor-based Evidence 4: 'AD' is connected to 'tropisetron' through the 'TREATMENT' relationship.\n\nNeighbor-based Evidence 5: 'AD' is connected to 'deep learning' through the 'TREATMENT' relationship.",
    "entity_confidence_scores": [
      1.0000001192092896,
      0.8105871081352234,
      1.0000001192092896,
      0.6758190393447876,
      1.0,
      1.0,
      0.6690828800201416,
      0.6527183055877686,
      0.617055356502533,
      0.6002026200294495,
      0.6377595067024231,
      0.7171330451965332,
      0.7327340245246887,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.833743155002594,
      0.951228141784668,
      1.0,
      0.8961988091468811
    ],
    "question_types": [
      "treatment",
      "diagnosis"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "a9be722d-92e6-4c1f-b13f-45c53aefa0ef",
    "question": "Dementia is seen in all except:",
    "opa": "Schizophrenia",
    "opb": "Alzheimer's disease",
    "opc": "Huntington's chorea",
    "opd": "Pick's ds",
    "cop": 0,
    "choice_type": "multi",
    "exp": "A i.e. Schizophrenia",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Dementia\n2. Schizophrenia\n3. Alzheimer's disease\n4. Huntington's chorea\n5. Pick's ds",
    "prediction": "A",
    "path": [],
    "neighbor_input": "Reranked Triple1: AD->ASSOCIATES->glycogen synthase kinase 3beta \u2014\u2014> memory deficit\nReranked Triple2: AD->CAUSES->neuropathologies \u2014\u2014> cognitive deficit\nReranked Triple3: AD->CAUSES->neurodegeneration \u2014\u2014> cognitive lesion\nReranked Triple4: AD->CAUSES->neurofibrillary tangle pathology \u2014\u2014> cognitive disorders\nReranked Triple5: AD->CAUSES->Alzheimer's disease \u2014\u2014> cognitive impairment",
    "response_of_KG_list_path": [],
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'ASSOCIATES' with 'glycogen synthase kinase 3beta' leading to 'memory deficit'.\n\nNeighbor-based Evidence 2: 'AD' 'CAUSES' 'neuropathologies' resulting in 'cognitive deficit'.\n\nNeighbor-based Evidence 3: 'AD' 'CAUSES' 'neurodegeneration' causing 'cognitive lesion'.\n\nNeighbor-based Evidence 4: 'AD' 'CAUSES' 'neurofibrillary tangle pathology' leading to 'cognitive disorders'.\n\nNeighbor-based Evidence 5: 'AD' 'CAUSES' 'Alzheimer's disease' resulting in 'cognitive impairment'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.8395751714706421,
      0.808238685131073,
      0.6911654472351074
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "c662eb05-4c20-4e54-9ecc-9aa9b6acc1a4",
    "question": "The annual conversion rate to dementia in patients with mild congnitive impairment is -",
    "opa": "10%",
    "opb": "20%",
    "opc": "30%",
    "opd": "40%",
    "cop": 0,
    "choice_type": "single",
    "exp": null,
    "subject_name": "Medicine",
    "topic_name": null,
    "entity": "1. dementia\n2. mild cognitive impairment.",
    "prediction": "B",
    "path": [],
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> causes \u2014\u2014> cognitive decline  \nReranked Triple2: AD \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple3: AD \u2014\u2014> associates \u2014\u2014> cognitive impairment  \nReranked Triple4: AD \u2014\u2014> causes \u2014\u2014> cognitive deficits  \nReranked Triple5: AD \u2014\u2014> treats \u2014\u2014> cognitive deficits  ",
    "response_of_KG_list_path": [],
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'cognitive decline'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'dementia'.\n\nNeighbor-based Evidence 3: 'AD' 'associates' 'cognitive impairment'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'cognitive deficits'.\n\nNeighbor-based Evidence 5: 'AD' 'treats' 'cognitive deficits'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.905754804611206
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "3cce4696-e65e-4360-a1b9-3c9d3912cedc",
    "question": "A patient of Alzheimer's disease is on rivastigmine therapy and develops symptoms of depression. Use of which of the following drug would decrease efficacy of rivostigmine -",
    "opa": "TCAs",
    "opb": "SSRI",
    "opc": "MAO inhibitor",
    "opd": "RIMA",
    "cop": 0,
    "choice_type": "single",
    "exp": "Ans. is 'a' i.e., TCAs o Cholinergic transmission is diminished in Alzheimer's disease. o All agents that benefit the conduction act to enhance acetyhcholine activity by inhibition of the acetylcholinesterase which metabolises and inactivates acetylcholine. o Consequently acetylcholine remains usable for longer. o Rivastigmine acts in similar way. o Tricyclic antidepressants (TCAs) have anticholinergic propey, therefore they counteract that cholinergic effect of rivastigmine.",
    "subject_name": "Pharmacology",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. rivastigmine\n3. depression\n4. drug\n5. TCAs\n6. SSRI\n7. MAO inhibitor\n8. RIMA",
    "prediction": "A",
    "path": "Reranked Triple1: rivastigmine \u2014\u2014> treats \u2014\u2014> AD (Alzheimer's disease)  \nReranked Triple2: rivastigmine \u2014\u2014> treat \u2014\u2014> Alzheimer's disease  \nReranked Triple3: rivastigmine \u2014\u2014> CAUSES \u2014\u2014> death  \nReranked Triple4: rivastigmine \u2014\u2014> treats \u2014\u2014> AD (Alzheimer's disease)  \nReranked Triple5: rivastigmine \u2014\u2014> treat \u2014\u2014> Alzheimer's disease  ",
    "neighbor_input": "Reranked Triple1: AD -> TREATMENT -> rivastigmine\nReranked Triple2: AD -> TREATMENT -> SSRI\nReranked Triple3: AD -> TREATMENT -> MAO inhibitor\nReranked Triple4: AD -> TREATMENT -> TCAs\nReranked Triple5: AD -> TREATMENT -> RIMA",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Rivastigmine' 'treats' 'AD (Alzheimer's disease)'.\n\nPath-based Evidence 2: 'Rivastigmine' 'treat' 'Alzheimer's disease'.\n\nPath-based Evidence 3: 'Rivastigmine' 'CAUSES' 'death'.\n\nPath-based Evidence 4: 'Rivastigmine' 'treats' 'AD (Alzheimer's disease)'.\n\nPath-based Evidence 5: 'Rivastigmine' 'treat' 'Alzheimer's disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' is treated with 'rivastigmine'.\n\nNeighbor-based Evidence 2: 'AD' is treated with 'SSRI'.\n\nNeighbor-based Evidence 3: 'AD' is treated with 'MAO inhibitor'.\n\nNeighbor-based Evidence 4: 'AD' is treated with 'TCAs'.\n\nNeighbor-based Evidence 5: 'AD' is treated with 'RIMA'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.6304964423179626,
      1.000000238418579,
      1.0000001192092896,
      1.0,
      0.8745613098144531,
      1.0,
      0.9999999403953552,
      1.0,
      0.6544378995895386,
      0.7847082018852234,
      0.7727140188217163,
      0.7061693072319031,
      0.7225785255432129,
      0.7225784063339233,
      0.6545583009719849
    ],
    "question_types": [
      "treatment",
      "symptom"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "9e5df75e-019e-441a-867d-32c7929fd0a1",
    "question": "Which is the pathognomic feature of Alzheimer\u2019s disease?",
    "opa": "Lewy bodies",
    "opb": "Ballooned neurons",
    "opc": "Plaques and tangles",
    "opd": "Pick bodies",
    "cop": 2,
    "choice_type": "multi",
    "exp": "Ref. Robbins Pathology. 9th edition. Page. 1289\n\u00a0\n\nGrossly, brain atrophy (narrowed gyri and widened sulci) is predominant in the frontal and superior temporal lobes.\nAlzheimer microscopically characterized by numerous neuro brillary tangles and senile plaques with a central core of amyloid alpha protein\nSilver stains demonstrate tangles and plaques and Congo red shows amyloid deposition in plaques and vascular walls (amyloid angiopathy).\nThere are also numerous Hirano bodies, and granulovacuolar degeneration is found in more than 10 of the neurons of the hippocampus.",
    "subject_name": "Unknown",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. Lewy bodies\n3. Ballooned neurons\n4. Plaques and tangles\n5. Pick bodies",
    "prediction": "C",
    "path": "Reranked Triple1: Alzheimer Disease \u2014\u2014> CAUSES \u2014\u2014> dementia\nReranked Triple2: Alzheimer Disease \u2014\u2014> associates \u2014\u2014> brain atrophy\nReranked Triple3: Lewy bodies \u2014\u2014> found in \u2014\u2014> brain\nReranked Triple4: Lewy bodies \u2014\u2014> has \u2014\u2014> Abeta\nReranked Triple5: Lewy bodies \u2014\u2014> has \u2014\u2014> amyloid precursor protein",
    "neighbor_input": "Reranked Triple1: AD->CAUSES->neurodegeneration\nReranked Triple2: AD->CAUSES->Alzheimer's disease\nReranked Triple3: AD->ASSOCIATES->Plaque\nReranked Triple4: AD->ASSOCIATES->neurofibrillary tangles\nReranked Triple5: AD->ASSOCIATES->memory impairment by estrogen deficiency",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer Disease' CAUSES 'dementia'\nPath-based Evidence 2: 'Alzheimer Disease' associates 'brain atrophy'\nPath-based Evidence 3: 'Lewy bodies' found in 'brain'\nPath-based Evidence 4: 'Lewy bodies' has 'Abeta'\nPath-based Evidence 5: 'Lewy bodies' has 'amyloid precursor protein'",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'CAUSES' 'neurodegeneration'\nNeighbor-based Evidence 2: 'AD' 'CAUSES' 'Alzheimer's disease'\nNeighbor-based Evidence 3: 'AD' 'ASSOCIATES' 'Plaque'\nNeighbor-based Evidence 4: 'AD' 'ASSOCIATES' 'neurofibrillary tangles'\nNeighbor-based Evidence 5: 'AD' 'ASSOCIATES' 'memory impairment by estrogen deficiency'",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.000000238418579,
      0.6595027446746826,
      0.727749228477478,
      0.6205008029937744
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "76a44434-1dab-496c-83f9-1d8df36393ae",
    "question": "Features of Alzheimer&;s disease are all Except",
    "opa": "Narrowing of ventricles",
    "opb": "Hirano bodies",
    "opc": "Amyloid",
    "opd": "Neuritic plaques",
    "cop": 0,
    "choice_type": "multi",
    "exp": "Hirano bodies are intracellular aggregates of actin and actin-associated proteins. Hirano bodies are found in the nerve cells of individuals afflicted with ceain neurodegenerative disorders, such as Alzheimer's disease and Creutzfeldt-Jakob disease. Senile plaques (also known as neuritic plaques) are extracellular deposits of amyloid beta in the grey matter of the brain. Alzheimer's disease is a progressive disorder that causes brain cells to waste away (degenerate) and die. Alzheimer's disease is the most common cause of dementia -- a continuous decline in thinking, behavioral and social skills that disrupts a person's ability to function independently Refer robbins 9/e p834",
    "subject_name": "Pathology",
    "topic_name": "Nervous system",
    "entity": "1. Alzheimer's disease\n2. ventricles\n3. Hirano bodies\n4. Amyloid\n5. Neuritic plaques",
    "prediction": "A",
    "path": "Reranked Triple1: ventricular cerebrospinal -> contains -> tau\nReranked Triple2: tau -> associates -> Alzheimer Disease\nReranked Triple3: Alzheimer Disease -> causes -> brain atrophy\nReranked Triple4: brain atrophy -> ASSOCIATES -> AD\nReranked Triple5: AD -> resembles -> Alzheimers disease",
    "neighbor_input": "Reranked Triple1: AD->ASSOCIATES->amyloid \u2014\u2014> amyloid plaques\nReranked Triple2: AD->CAUSES->Abeta \u2014\u2014> Abeta accumulation in the brain\nReranked Triple3: AD->CAUSES->neurodegeneration \u2014\u2014> brain damage\nReranked Triple4: AD->CAUSES->tau \u2014\u2014> neurofibrillary tangle pathology\nReranked Triple5: AD->ASSOCIATES->neurodegenerative diseases \u2014\u2014> neuritic dystrophy",
    "response_of_KG_list_path": "Path-based Evidence 1: 'ventricular cerebrospinal' contains 'tau'\n\nPath-based Evidence 2: 'tau' associates 'Alzheimer Disease'\n\nPath-based Evidence 3: 'Alzheimer Disease' causes 'brain atrophy'\n\nPath-based Evidence 4: 'brain atrophy' ASSOCIATES 'AD'\n\nPath-based Evidence 5: 'AD' resembles 'Alzheimers disease'",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'ASSOCIATES' with 'amyloid' leading to 'amyloid plaques'.\nNeighbor-based Evidence 2: 'AD' 'CAUSES' 'Abeta' resulting in 'Abeta accumulation in the brain'.\nNeighbor-based Evidence 3: 'AD' 'CAUSES' 'neurodegeneration' causing 'brain damage'.\nNeighbor-based Evidence 4: 'AD' 'CAUSES' 'tau' leading to 'neurofibrillary tangle pathology'.\nNeighbor-based Evidence 5: 'AD' 'ASSOCIATES' with 'neurodegenerative diseases' linked to 'neuritic dystrophy'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.7480196952819824,
      0.7058601379394531,
      0.6659548878669739,
      0.6024529337882996,
      1.0,
      1.0,
      0.9999999403953552,
      1.0
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "4437b65c-cb2e-4f84-a004-fc6999cb19eb",
    "question": "All the following are features of Alzheimer's disease except:",
    "opa": "Cerebellar atrophy",
    "opb": "Common in 5th and 6th decade",
    "opc": "Atrophied gyri widened sulci",
    "opd": "Progressive dementia",
    "cop": 0,
    "choice_type": "multi",
    "exp": "In Alzheimer's, the disease process usually spares cerebellum. Especially neurofibrillary tangles are never seen in cerebellum. Alzheimer's D/s (Dementia of Alzheimer type) Pathophysiological Findings: Diffuse atrophy, Flattened Coical Sulci & Dilated Cerebral ventricles Primarily involve Parietal and temporal Lobes Atrophy stas In Medical Temporal Lobe (Entorhinal/Perirhinal Coex & Hippocampus) and spreads to Lateral & Medial parietal Lobes, Lateral Temporal Lobes & Lateral Frontal Coex",
    "subject_name": "Psychiatry",
    "topic_name": "Organic Mental Disorders",
    "entity": "1. Alzheimer's disease\n2. Cerebellar atrophy\n3. 5th decade\n4. 6th decade\n5. Atrophied gyri\n6. Wide sulci\n7. Progressive dementia",
    "prediction": "A",
    "path": "Reranked Triple1: cerebellar dysfunction \u2014\u2014> associated with \u2014\u2014> atrophy component\nReranked Triple2: cerebellar dysfunction \u2014\u2014> associated with \u2014\u2014> ataxia\nReranked Triple3: cerebellar dysfunction \u2014\u2014> associated with \u2014\u2014> cognitive decline\nReranked Triple4: ataxia \u2014\u2014> associated with \u2014\u2014> cognitive decline\nReranked Triple5: atrophy component \u2014\u2014> associates \u2014\u2014> Alzheimer's disease",
    "neighbor_input": "Reranked Triple1: AD->CAUSES->cognitive loss \u2014\u2014> brain atrophy\nReranked Triple2: AD->CAUSES->neurodegenerative diseases \u2014\u2014> cognitive dysfunction\nReranked Triple3: AD->treats->phloroglucinol \u2014\u2014> cognitive deficits\nReranked Triple4: AD->ASSOCIATES->glycogen synthase kinase 3beta \u2014\u2014> memory loss and impaired cognitive function\nReranked Triple5: AD->ASSOCIATES->amyloid-beta \u2014\u2014> Tau",
    "response_of_KG_list_path": "Path-based Evidence 1: 'cerebellar dysfunction' is associated with 'atrophy component'.\nPath-based Evidence 2: 'cerebellar dysfunction' is associated with 'ataxia'.\nPath-based Evidence 3: 'cerebellar dysfunction' is associated with 'cognitive decline'.\nPath-based Evidence 4: 'ataxia' is associated with 'cognitive decline'.\nPath-based Evidence 5: 'atrophy component' associates with 'Alzheimer's disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'CAUSES' 'cognitive loss' \u2014\u2014> 'brain atrophy'\n\nNeighbor-based Evidence 2: 'AD' 'CAUSES' 'neurodegenerative diseases' \u2014\u2014> 'cognitive dysfunction'\n\nNeighbor-based Evidence 3: 'AD' 'treats' 'phloroglucinol' \u2014\u2014> 'cognitive deficits'\n\nNeighbor-based Evidence 4: 'AD' 'ASSOCIATES' 'glycogen synthase kinase 3beta' \u2014\u2014> 'memory loss and impaired cognitive function'\n\nNeighbor-based Evidence 5: 'AD' 'ASSOCIATES' 'amyloid-beta' \u2014\u2014> 'Tau'",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.8508630990982056,
      0.5975096225738525,
      0.5098117589950562,
      1.0,
      0.9130909442901611
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "cb0198e4-297b-4749-875f-2c4697ae7fdb",
    "question": "70 years old female patient with Alzheimer's disease was lost in a market and was found only on the next day. The patient has not drunk or eaten anything for the past 24 hours. On examination, she is mildly confused and dehydrated. Blood glucose levels are normal. Which one of the following hormone is responsible for normal blood glucose levels and acts on the intracellular receptors?",
    "opa": "Epinephrine",
    "opb": "Cortisol",
    "opc": "Growth hormone",
    "opd": "Glucagon",
    "cop": 1,
    "choice_type": "single",
    "exp": "Answer: b) Cortisol.EFFECTS OF HYPOGLYCEMIA (Insulin Shock)* Complete inhibition of insuling secretion occurs below the blood sugar levels 80mg/dl.* Glucagon, GH, Epinephrine secretion occurs below the blood sugar levels of 70mg/dl.* COMA- levels less than 30mg/dl.* CONVULSIONS-levels less than 20mg/dl.* PERMAMENT BRAIN DAMAGE & DEATH- levels less than 10mg/dl.Effects of glucon & epinephrine: rapid short lived.Effects of growth hormone & cortisol: slow, long lasting. HormonesMechanism of actionExamplesProtein (peptide) hormonesCombines with cell surface receptors and may increase adenylyl cyclase activity via G proteins & increases intracellular cAMP.Calcitonin, ACTH, PTH, Glucagon, LH, FSH, ADH,TSH, SomatostatinModify guanylate cyclase activity via G proteins & alters intracellular cAMPNO, ANP, Guanylin| intracellular Ca2+/ IP3 / DAGOxytocin, Ach, GnRH| kinase/ Phosphatase activityInsulin, Prolactin, GH,IGF-I &IIIncrease serine or threonine kinase activityinhibin, activinSteroid hormonesBinds & forms a complex with cytoplasmic receptor. Complex enters the nucleus & regulates protein synthesis.Androgen, Estrogen, Progesterone, Cortisol Aldosterone, Vit-A & DThyroid hormonesBinds & forms a complex with nuclear receptor & regulates protein synthesisThyroxine",
    "subject_name": "Physiology",
    "topic_name": "Nervous System",
    "entity": "1. Alzheimer's disease\n2. patient\n3. market\n4. examination\n5. blood glucose levels\n6. hormone\n7. intracellular receptors\n8. Epinephrine\n9. Cortisol\n10. Growth hormone\n11. Glucagon",
    "prediction": "D",
    "path": "Reranked Triple1: blood glucose \u2014\u2014> regulates \u2014\u2014> lipids\nReranked Triple2: blood glucose \u2014\u2014> covaries \u2014\u2014> cortisol\nReranked Triple3: cortisol \u2014\u2014> TYPE \u2014\u2014> Hormone",
    "neighbor_input": "Reranked Triple1: AD->treats->Water\nReranked Triple2: AD->treats->Phloroglucinol\nReranked Triple3: AD->treats->Neurodegenerative diseases\nReranked Triple4: AD->treats->Abeta toxicity\nReranked Triple5: AD->treats->Reactive oxygen species",
    "response_of_KG_list_path": "Path-based Evidence 1: 'blood glucose' regulates 'lipids'.\n\nPath-based Evidence 2: 'blood glucose' covaries 'cortisol'.\n\nPath-based Evidence 3: 'cortisol' is of type 'Hormone'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' treats 'Water'.\nNeighbor-based Evidence 2: 'AD' treats 'Phloroglucinol'.\nNeighbor-based Evidence 3: 'AD' treats 'Neurodegenerative diseases'.\nNeighbor-based Evidence 4: 'AD' treats 'Abeta toxicity'.\nNeighbor-based Evidence 5: 'AD' treats 'Reactive oxygen species'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0,
      1.0,
      0.9169156551361084,
      0.8918074369430542,
      1.0000001192092896,
      1.0000001192092896,
      0.7629498243331909,
      1.0,
      0.8006935119628906,
      0.8006933927536011,
      1.000000238418579,
      0.6737372875213623,
      1.0,
      1.0000001192092896,
      0.8533504009246826
    ],
    "question_types": [
      "diagnosis",
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "d6651092-c4d1-4d8f-8468-f09c1e159601",
    "question": "A 60 yr old man with C/O progressive dementia for the past 6 months with intermittent jerky movement involving whole body from 2 days. EEG showed sharp bipolar spikes. Diagnosis is",
    "opa": "Alzheimer's",
    "opb": "Creutzfeld Jakob disease",
    "opc": "Lewy body dementia",
    "opd": "Herpes simplex encephalitis",
    "cop": 1,
    "choice_type": "single",
    "exp": "EEG findings... 1) Periodic sharp wave complex = Creutz feldt kacob disease 2) periodic lateralizing discharge =Herpes simplex encephalitis Ref Harrison20th edition pg 2456",
    "subject_name": "Medicine",
    "topic_name": "C.N.S",
    "entity": "1. Age: 60\n2. Symptoms: progressive dementia, intermittent jerky movement involving whole body\n3. Medical exam: EEG showed sharp bipolar spikes\n4. Possible diagnoses: Alzheimer's, Creutzfeld Jakob disease, Lewy body dementia, Herpes simplex encephalitis",
    "prediction": "B",
    "path": [],
    "neighbor_input": "Reranked Triple1: dementia symptoms \u2014\u2014> progressive dementia\nReranked Triple2: dementia symptoms \u2014\u2014> intermittent jerky movement\nReranked Triple3: Alzheimer \u2014\u2014> progressive dementia\nReranked Triple4: Alzheimer \u2014\u2014> intermittent jerky movement\nReranked Triple5: EEG \u2014\u2014> sharp bipolar spikes",
    "response_of_KG_list_path": [],
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'dementia symptoms' are related to 'progressive dementia'.\nNeighbor-based Evidence 2: 'dementia symptoms' are related to 'intermittent jerky movement'.\nNeighbor-based Evidence 3: 'Alzheimer' is related to 'progressive dementia'.\nNeighbor-based Evidence 4: 'Alzheimer' is related to 'intermittent jerky movement'.\nNeighbor-based Evidence 5: 'EEG' is related to 'sharp bipolar spikes'.",
    "entity_confidence_scores": [
      0.6909050345420837,
      0.7223883271217346,
      0.6119945645332336,
      0.7443830370903015,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896
    ],
    "question_types": [
      "diagnosis"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "b704afdf-1ce5-4c6f-915c-a80caf428d53",
    "question": "All of the following drugs are used in treatment of dementia except?",
    "opa": "Memantine",
    "opb": "Duloxetine",
    "opc": "Galantamine",
    "opd": "Donepezil",
    "cop": 1,
    "choice_type": "multi",
    "exp": "Ans. B. DuloxetineManagement of patient with Dementia:Mini Mental status examination (MMSE)- score of <24 suggestive of dementia* Treat the cause* CHOLINESTERASE INHIBITORS: FDA for treatment of AD cholinesterase inhibitors: Tacrine, donepezil, rivastigmine, and galantamine. Reversible inhibitors of enzyme acetylcholinesterase, which degrades ACh in synaptic cleft, thereby increasing availability of intra synaptic ACh.* MEMANTINE: noncompetitive NMDA receptor antagonist that may modulate excitatory signaling & have neuro- protective actions. FDA approved for use only in moderate to severe AD. Has demonstrated efficacy for both cognitive & functional improvements over placebo.",
    "subject_name": "Psychiatry",
    "topic_name": "Pharmacotherapy In Psychiatry",
    "entity": "1. drugs\n2. dementia\n3. Memantine\n4. Duloxetine\n5. Galantamine\n6. Donepezil",
    "prediction": "B",
    "path": "I'm sorry, but I cannot provide the relevant information without the knowledge graph. Could you please provide the knowledge graph for me to generate the reranked triples?",
    "neighbor_input": "Reranked Triple1: AD->caused by->nitrosative stress\nReranked Triple2: AD->CAUSES->neurodegeneration\nReranked Triple3: AD->causes->neuroinflammation\nReranked Triple4: AD->TREATMENT->TUDCA\nReranked Triple5: AD->TREATMENT->metal",
    "response_of_KG_list_path": "I'm sorry, but without the knowledge graph information, I'm unable to provide specific path-based evidence. If you could provide the knowledge graph, I'd be happy to generate the natural language representations for you.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' is caused by 'nitrosative stress'.\n\nNeighbor-based Evidence 2: 'AD' causes 'neurodegeneration'.\n\nNeighbor-based Evidence 3: 'AD' causes 'neuroinflammation'.\n\nNeighbor-based Evidence 4: 'AD' is treated with 'TUDCA'.\n\nNeighbor-based Evidence 5: 'AD' is treated with 'metal'.",
    "entity_confidence_scores": [
      0.8533504009246826,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.7558508515357971,
      0.7558507919311523,
      1.0,
      1.0,
      1.0,
      0.6575609445571899
    ],
    "question_types": [
      "treatment",
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "6da395f3-88bc-408a-ba53-67b805158067",
    "question": "Amyloid pressure protein is cleaved by ______ and ________ in Alzheimer's disease",
    "opa": "\u03b1 secretase , \u03b3  secretase",
    "opb": "\u03b1 secretase ,  \u03b2 secretase",
    "opc": "\u03b2 secretase ,  \u03b3 secretase",
    "opd": "\u03b2 secretase , \u03b1  secretase",
    "cop": 2,
    "choice_type": "single",
    "exp": "Amyloid precersor protein(APP) is normaly cleaved by\u00a0\u03b1\u00a0and\u00a0\u00a0\u03b2 secretases.\nIn Alzeihmer's disease it is cleaved by\u00a0\u00a0\u03b2 and\u00a0\u03b3 secretases and forms AB peptide that deposit to form senile plaques.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Amyloid pressure protein \n2. \u03b1 secretase \n3. \u03b3 secretase\n4. Alzheimer's disease \n5. \u03b2 secretase",
    "prediction": "C",
    "path": "Reranked Triple1: Alzheimer Disease \u2014\u2014> ASSOCIATES \u2014\u2014> tau\nReranked Triple2: tau \u2014\u2014> associates \u2014\u2014> Alzheimer Disease\nReranked Triple3: Alzheimer Disease \u2014\u2014> CAUSES \u2014\u2014> dementia\nReranked Triple4: dementia \u2014\u2014> caused by \u2014\u2014> tau\nReranked Triple5: Alzheimer Disease \u2014\u2014> ASSOCIATES \u2014\u2014> participants",
    "neighbor_input": "Reranked Triple1: gamma-secretase \u2014\u2014> cleaves \u2014\u2014> amyloid precursor protein\nReranked Triple2: gamma-secretase \u2014\u2014> REGULATES \u2014\u2014> cleavage\nReranked Triple3: gamma-secretase \u2014\u2014> regulates \u2014\u2014> amyloid-beta\nReranked Triple4: beta-secretase-1 \u2014\u2014> ASSOCIATED WITH \u2014\u2014> Alzheimer's disease\nReranked Triple5: beta-secretase-1 \u2014\u2014> ASSOCIATED WITH \u2014\u2014> amyloid-beta peptides",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer Disease' ASSOCIATES 'tau'\nPath-based Evidence 2: 'tau' associates 'Alzheimer Disease'\nPath-based Evidence 3: 'Alzheimer Disease' CAUSES 'dementia'\nPath-based Evidence 4: 'dementia' caused by 'tau'\nPath-based Evidence 5: 'Alzheimer Disease' ASSOCIATES 'participants'",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'gamma-secretase' cleaves 'amyloid precursor protein'.\nNeighbor-based Evidence 2: 'gamma-secretase' REGULATES cleavage.\nNeighbor-based Evidence 3: 'gamma-secretase' regulates 'amyloid-beta'.\nNeighbor-based Evidence 4: 'beta-secretase-1' is ASSOCIATED WITH Alzheimer's disease.\nNeighbor-based Evidence 5: 'beta-secretase-1' is ASSOCIATED WITH amyloid-beta peptides.",
    "entity_confidence_scores": [
      0.8174296021461487,
      0.9220848083496094,
      0.9127435684204102,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.9475033283233643
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "32bd578d-78e1-4da5-8bdb-3c4d78d56af3",
    "question": "Progressive cognitive impairment in Alzheimer's disease is characterized by -",
    "opa": "Nominal aphasia",
    "opb": "Recent memory loss",
    "opc": "No behavioral abnormalities",
    "opd": "All",
    "cop": 1,
    "choice_type": "multi",
    "exp": "Alzheimer's disease is characterized by early impairment of recent memory.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Progressive cognitive impairment\n2. Alzheimer's disease\n3. Nominal aphasia\n4. Recent memory loss\n5. Behavioral abnormalities",
    "prediction": "B",
    "path": "Reranked Triple1: Alzheimer disease \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple2: dementia \u2014\u2014> caused by \u2014\u2014> tau  \nReranked Triple3: Alzheimer disease \u2014\u2014> associates \u2014\u2014> AD  \nReranked Triple4: AD \u2014\u2014> correlates with \u2014\u2014> diabetes mellitus  \nReranked Triple5: AD \u2014\u2014> resembles \u2014\u2014> Alzheimer's disease  ",
    "neighbor_input": "Reranked Triple1: AD -> causes -> cognitive decline  \nReranked Triple2: AD -> causes -> memory loss  \nReranked Triple3: AD -> causes -> behavioral abnormalities  \nReranked Triple4: AD -> causes -> cognitive impairment  \nReranked Triple5: AD -> causes -> recent memory loss  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer disease' 'causes' 'dementia'.\n\nPath-based Evidence 2: 'dementia' 'caused by' 'tau'.\n\nPath-based Evidence 3: 'Alzheimer disease' 'associates' 'AD'.\n\nPath-based Evidence 4: 'AD' 'correlates with' 'diabetes mellitus'.\n\nPath-based Evidence 5: 'AD' 'resembles' 'Alzheimer's disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' cognitive decline.  \nNeighbor-based Evidence 2: 'AD' 'causes' memory loss.  \nNeighbor-based Evidence 3: 'AD' 'causes' behavioral abnormalities.  \nNeighbor-based Evidence 4: 'AD' 'causes' cognitive impairment.  \nNeighbor-based Evidence 5: 'AD' 'causes' recent memory loss.",
    "entity_confidence_scores": [
      0.8889167308807373,
      0.9402773380279541,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.7585411667823792,
      0.8933066129684448,
      1.0000001192092896,
      1.0,
      0.876495361328125
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "a9d49caa-e082-45fb-a1a2-1ca46db47fc7",
    "question": "Which is the pathognomic feature of Alzheimer's disease?",
    "opa": "Lewy bodies",
    "opb": "Pick bodies",
    "opc": "Ballooned neurons",
    "opd": "Plaque and tangles",
    "cop": 3,
    "choice_type": "multi",
    "exp": "Ans. d. Plaque and tanglesRef: Robbins and Cotran Pathologic Basis of Disease 9th Ed; Page No-1290Alzheimer disease is the most important cause of dementia in elderly.It usually begins after age of 50 years.Most cases are sporadic; only 5-10 of cases are familial.Pneumonia is the most common cause of death.Grossly:Cortical atrophy with narrowed gyri and widened sulci especially in the frontal, temporal, and parietal lobes.Hydrocephalus ex vacuo also occurs due to cortical atrophy.Earliest sites involved are medial temporal lobe structure.Morphologic AbnormalitiesNeurofibrillary tangles (NFT):NFT are bundles of helical filaments in neural cytoplasm.It is hypo phosphorylated tau protein.Especially seen in the cerebral cortex.It is clearly visible by sliver (Bielschowsky) staining.Neuritic (senile) plaques:They are spherical collections of dilated, tortuous, neuritic processes (dystrophic neutrites) within the cerebral cortex, hippocampus, and amygdala.A distinctive peptide structure is present around central amyloid core.Non-specific findings.Increased number of neuritic plaque correlates advanced age and severity of dementia.Granulovacuolar degeneration: is the intraneuronal cytoplasmic granule-containing small and clear vacuoles occurring within the pyramidal cells of the hippocampusAmyloid angiopathy: Almost Invariably accompanies Alzheimer disease. There is vascular p-amyloid deposition.Hirano bodies: Are the intracytoplasmic proximal dendritic eosinophilic inclusions containing actin protein.EtiologyAbnormal amyloid gene expression is the most favored etiologic concept today.Ap40 Aggregates are directly neurotoxic and it will induce synaptic damage of nucleus basalis of mayernet. This will decreases the brain content of the enzyme and its product acetylcholine, especially in the cerebral cortex and hippocampus. Acetylcholine plays a role in learning, and drugs that block its action adversely affect short-term memory.The APP gene located on chromosome 21; it encoded for amyloid precursor protein, a precursor to the Ab peptide. Mutations in the APP gene have been linked to familial Alzheimer disease.Down syndrome patients (trisomy 21) experience early onset Alzheimer disease secondary to gene dosage effect.Other genetic abnormalitiesInheritance of the[?]4 allele of apoprotein E is located in chromosome 19; is associated with greater frequency in patients with Alzheimer disease.Mutations in genes coding for presenilins. Presenilin-1 located in chromosome 14 and presenilin-2 located in chromosome 1 have been associated with many kindreds with familial early onset Alzheimer disease.",
    "subject_name": "Pathology",
    "topic_name": "Central Nervous System",
    "entity": "1. Alzheimer's disease\n2. Lewy bodies\n3. Pick bodies\n4. Ballooned neurons\n5. Plaque and tangles",
    "prediction": "D",
    "path": "Reranked Triple1: Alzheimer's disease \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple2: Alzheimer's disease \u2014\u2014> associates \u2014\u2014> brain atrophy  \nReranked Triple3: Alzheimer's disease \u2014\u2014> resembles \u2014\u2014> Lewy bodies  \nReranked Triple4: Alzheimer's disease \u2014\u2014> associated with \u2014\u2014> apolipoprotein E4  \nReranked Triple5: Alzheimer's disease \u2014\u2014> model \u2014\u2014> mouse  ",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> causes \u2014\u2014> neurofibrillary tangle pathology  \nReranked Triple2: AD \u2014\u2014> causes \u2014\u2014> amyloid-beta aggregation  \nReranked Triple3: AD \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple4: AD \u2014\u2014> causes \u2014\u2014> cognitive impairment  \nReranked Triple5: AD \u2014\u2014> causes \u2014\u2014> tauopathies  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer's disease' 'causes' 'dementia'.\n\nPath-based Evidence 2: 'Alzheimer's disease' 'associates' 'brain atrophy'.\n\nPath-based Evidence 3: 'Alzheimer's disease' 'resembles' 'Lewy bodies'.\n\nPath-based Evidence 4: 'Alzheimer's disease' 'associated with' 'apolipoprotein E4'.\n\nPath-based Evidence 5: 'Alzheimer's disease' 'model' 'mouse'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'neurofibrillary tangle pathology'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'amyloid-beta aggregation'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'dementia'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'cognitive impairment'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'tauopathies'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.000000238418579,
      0.6205008029937744,
      0.6595027446746826,
      0.7734591364860535
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "8fbb7a9e-582f-42ca-9d14-7add2c154405",
    "question": "Not a feature of dementia is",
    "opa": "Loss of sensorium",
    "opb": "Disturbances in language function",
    "opc": "Wearing of diy clothes",
    "opd": "Loss of neurons in brain",
    "cop": 0,
    "choice_type": "single",
    "exp": "A i.e. Loss of Sensorium- Memory impairment (ex. forgetfulness) is typically an early & prominent feature in dementia.- No matter how severe the disorientation seems (d/t memory impairment),However, patients show no impairment in their level of consciousness.- Lability of emotions, sloppy grooming, uninhibited remarks, silly jokes or a dull, apathetic or vacuous facial expression & manner suggest dementia especially when coupled with memory impairment.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. dementia\n2. Loss of sensorium\n3. Disturbances in language function\n4. Wearing of diy clothes\n5. Loss of neurons in brain",
    "prediction": "C",
    "path": [],
    "neighbor_input": "Reranked Triple1: AD -> causes -> loss of neurons in brain \u2014\u2014> dementia  \nReranked Triple2: AD -> causes -> disturbances in language function \u2014\u2014> cognitive decline  \nReranked Triple3: AD -> causes -> memory impairment \u2014\u2014> cognitive deficits  \nReranked Triple4: AD -> causes -> cognitive dysfunction \u2014\u2014> dementia  \nReranked Triple5: AD -> causes -> cognitive impairment \u2014\u2014> neurodegenerative diseases  \n\nAnswer: C. Wearing of diy clothes is not a feature of dementia.",
    "response_of_KG_list_path": [],
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' causes loss of neurons in brain, leading to 'dementia'.  \nNeighbor-based Evidence 2: 'AD' causes disturbances in language function, resulting in 'cognitive decline'.  \nNeighbor-based Evidence 3: 'AD' causes memory impairment, leading to 'cognitive deficits'.  \nNeighbor-based Evidence 4: 'AD' causes cognitive dysfunction, resulting in 'dementia'.  \nNeighbor-based Evidence 5: 'AD' causes cognitive impairment, leading to 'neurodegenerative diseases'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.7542390823364258,
      0.9467442035675049,
      1.0000001192092896
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "0d70e595-e388-478e-bd22-0ba5800bb5e3",
    "question": "The following is not a features of  Alzheimer's disease",
    "opa": "Neuro fibrillory tangles",
    "opb": "Senile (neuritic) plaques",
    "opc": "Amyloid angiopathy",
    "opd": "Lewy bodies",
    "cop": 3,
    "choice_type": "single",
    "exp": "Lewy bodies are commonly found in Parkinsonism.",
    "subject_name": "Pathology",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. Neuro fibrillory tangles\n3. Senile (neuritic) plaques\n4. Amyloid angiopathy\n5. Lewy bodies",
    "prediction": "D",
    "path": "Reranked Triple1: Neurofibrillary tangles \u2014\u2014> Alzheimer's disease  \nReranked Triple2: Senile plaques (SP) \u2014\u2014> Alzheimer's disease  \nReranked Triple3: Alzheimer's disease \u2014\u2014> characterized by -> senile plaques (SP)  \nReranked Triple4: Alzheimer's disease \u2014\u2014> associates -> participants  \nReranked Triple5: Alzheimer's disease \u2014\u2014> correlates with -> diabetes mellitus  \n\nAnswer: Based on the reranked triples, options A (Neurofibrillary tangles) and B (Senile plaques) are features associated with Alzheimer's disease. C (Amyloid angiopathy) is not directly mentioned in the graph, and D (Lewy bodies) is also not included in the relevant triples, suggesting it is not a feature of Alzheimer's disease.",
    "neighbor_input": "Reranked Triple1: AD -> causes -> neurofibrillary tangle pathology \u2014\u2014> cognitive impairment\nReranked Triple2: AD -> causes -> amyloid-beta peptide (Abeta) deposition \u2014\u2014> dementia\nReranked Triple3: AD -> causes -> amyloid plaque \u2014\u2014> cognitive dysfunction\nReranked Triple4: AD -> associates -> tauopathies \u2014\u2014> cognitive deficits\nReranked Triple5: AD -> associates -> amyloid angiopathy \u2014\u2014> neurodegenerative disorder",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Neurofibrillary tangles' is associated with 'Alzheimer's disease'.\n\nPath-based Evidence 2: 'Senile plaques (SP)' is associated with 'Alzheimer's disease'.\n\nPath-based Evidence 3: 'Alzheimer's disease' is 'characterized by' 'senile plaques (SP)'.\n\nPath-based Evidence 4: 'Alzheimer's disease' 'associates' with 'participants'.\n\nPath-based Evidence 5: 'Alzheimer's disease' 'correlates with' 'diabetes mellitus'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' is associated with the relationship 'causes' the 'neurofibrillary tangle pathology,' which leads to 'cognitive impairment.'\n\nNeighbor-based Evidence 2: 'AD' is associated with the relationship 'causes' the 'amyloid-beta peptide (Abeta) deposition,' resulting in 'dementia.'\n\nNeighbor-based Evidence 3: 'AD' is associated with the relationship 'causes' the 'amyloid plaque,' contributing to 'cognitive dysfunction.'\n\nNeighbor-based Evidence 4: 'AD' is associated with the relationship 'associates' with 'tauopathies,' which results in 'cognitive deficits.'\n\nNeighbor-based Evidence 5: 'AD' is associated with the relationship 'associates' with 'amyloid angiopathy,' leading to 'neurodegenerative disorder.'",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.9113084077835083,
      0.9538915157318115,
      0.9499473571777344,
      1.000000238418579
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "597bd08b-0cef-4db3-9220-9a88b0fc2ada",
    "question": "All are reversible causes of dementia except",
    "opa": "Hypothyroidism",
    "opb": "Hydrocephalus",
    "opc": "Meningoencephalitis",
    "opd": "Alzheimer's disease",
    "cop": 3,
    "choice_type": "multi",
    "exp": "Alzheimer&;s is the commonest cause of dementia The diagnosis of Alzheimer&;s dementia is by an exclusion of all other causes of dementia as there is no distinct diagnostic clinical features or laboratory investigations. At present Alzheimer&;s dementia is not considered a treatable disorder (Ref: a sho textbook of psychiatry, Niraj Ahuja, 7th edition, pg no.23)",
    "subject_name": "Psychiatry",
    "topic_name": "Organic mental disorders",
    "entity": "1. dementia\n2. Hypothyroidism\n3. Hydrocephalus\n4. Meningoencephalitis\n5. Alzheimer's disease",
    "prediction": "D",
    "path": [],
    "neighbor_input": "Reranked Triple1: AD->treats->phloroglucinol \u2014\u2014> cognitive deficits\nReranked Triple2: AD->treats->phloroglucinol \u2014\u2014> cognitive loss\nReranked Triple3: AD->treats->phloroglucinol \u2014\u2014> Alzheimer-like cognitive deficits\nReranked Triple4: AD->treats->phloroglucinol \u2014\u2014> dementia\nReranked Triple5: AD->treats->phloroglucinol \u2014\u2014> neurodegenerative diseases",
    "response_of_KG_list_path": [],
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'treats' 'phloroglucinol' which helps with 'cognitive deficits'.\n\nNeighbor-based Evidence 2: 'AD' 'treats' 'phloroglucinol' which addresses 'cognitive loss'.\n\nNeighbor-based Evidence 3: 'AD' 'treats' 'phloroglucinol' that alleviates 'Alzheimer-like cognitive deficits'.\n\nNeighbor-based Evidence 4: 'AD' 'treats' 'phloroglucinol' which is beneficial for 'dementia'.\n\nNeighbor-based Evidence 5: 'AD' 'treats' 'phloroglucinol' that can aid in 'neurodegenerative diseases'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.903645396232605,
      1.0,
      1.0,
      1.0000001192092896,
      1.0000001192092896
    ],
    "question_types": [
      "causation",
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "81965fdd-45c1-4e4b-8c17-b15e7b757c49",
    "question": "All of the following are features of dementia, EXCEPT:",
    "opa": "Insidious in onset",
    "opb": "Usually irreversible",
    "opc": "Clouding of consciousness present",
    "opd": "Hallucinations are rare",
    "cop": 2,
    "choice_type": "multi",
    "exp": "Dementia is a persistent progressive impairment in intellectual function. It is associated with loss of memory and at least one of the following cognitive domains such as aphasia, apraxia, agnosia and impaired executive function. Clouding of consciousness is not seen in dementia, it is seen in delirium. Ref: Current Medical Diagnosis and Treatment 2012, chapter 4.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Dementia\n2. Insidious onset\n3. Irreversible\n4. Clouding of consciousness\n5. Hallucinations",
    "prediction": "C",
    "path": "Reranked Triple1: Dementia -> has feature -> Insidious in onset  \nReranked Triple2: Dementia -> has feature -> Usually irreversible  \nReranked Triple3: Dementia -> does not have feature -> Clouding of consciousness present  \nReranked Triple4: Dementia -> has feature -> Hallucinations are rare  \nReranked Triple5: Clouding of consciousness -> is typically associated with -> Delirium  ",
    "neighbor_input": "Reranked Triple1: AD -> has symptom -> clouding of consciousness (not associated with dementia) \u2014\u2014> cognitive decline\nReranked Triple2: AD -> has symptom -> hallucinations are rare (associated with dementia) \u2014\u2014> behavioral symptoms\nReranked Triple3: AD -> has symptom -> forebrain atrophy (associated with dementia) \u2014\u2014> cognitive impairment\nReranked Triple4: AD -> has symptom -> cognitive deterioration (associated with dementia) \u2014\u2014> cognitive deficits\nReranked Triple5: AD -> has symptom -> memory loss (associated with dementia) \u2014\u2014> cognitive dysfunction",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Dementia' 'has feature' 'Insidious in onset'.\n\nPath-based Evidence 2: 'Dementia' 'has feature' 'Usually irreversible'.\n\nPath-based Evidence 3: 'Dementia' 'does not have feature' 'Clouding of consciousness present'.\n\nPath-based Evidence 4: 'Dementia' 'has feature' 'Hallucinations are rare'.\n\nPath-based Evidence 5: 'Clouding of consciousness' 'is typically associated with' 'Delirium'.",
    "response_of_KG_neighbor": "Based on the knowledge graph information provided, here are the conversions to natural language:\n\nNeighbor-based Evidence 1: The condition 'AD' is associated with the symptom 'clouding of consciousness', which is not linked to 'dementia', and this can lead to 'cognitive decline'.\n\nNeighbor-based Evidence 2: The condition 'AD' is associated with the symptom 'hallucinations are rare', which is linked to 'dementia', and this can result in 'behavioral symptoms'.\n\nNeighbor-based Evidence 3: The condition 'AD' is associated with the symptom 'forebrain atrophy', which is linked to 'dementia', and this can cause 'cognitive impairment'.\n\nNeighbor-based Evidence 4: The condition 'AD' is associated with the symptom 'cognitive deterioration', which is linked to 'dementia', and this can lead to 'cognitive deficits'.\n\nNeighbor-based Evidence 5: The condition 'AD' is associated with the symptom 'memory loss', which is linked to 'dementia', and this can result in 'cognitive dysfunction'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.702251136302948,
      0.5461381673812866,
      0.5145741105079651,
      0.5455856323242188,
      0.6790475845336914,
      0.6790474653244019,
      1.0000001192092896,
      0.8575767278671265
    ],
    "question_types": [
      "symptom",
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "8d42055b-08a5-4e86-b7a9-fd7f02e9b3a4",
    "question": "The annual Conversion rate to dementia in patients with mild congnitive impairment is",
    "opa": "10%",
    "opb": "20%",
    "opc": "30%",
    "opd": "40%",
    "cop": 0,
    "choice_type": "single",
    "exp": "The term mild cognitive impairment (MCI) has been used to describe the transition between normal cognition and Alzheimer dementia. Mild cognitive impairment is recognized as an impoant public health problem as a dementia risk. Annual conversion rates often range from 10% to 15% in clinic samples. Ref Harrison20th edition pg 2765",
    "subject_name": "Medicine",
    "topic_name": "C.N.S",
    "entity": "1. Dementia\n2. Mild cognitive impairment",
    "prediction": "B",
    "path": [],
    "neighbor_input": "Reranked Triple1: patients -> develop -> dementia\nReranked Triple2: cognitive impairment -> leads to -> dementia\nReranked Triple3: mild cognitive impairment -> increases risk of -> dementia\nReranked Triple4: dementia -> associated with -> cognitive decline\nReranked Triple5: patients -> with -> mild cognitive impairment",
    "response_of_KG_list_path": [],
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'patients' 'develop' 'dementia'.\n\nNeighbor-based Evidence 2: 'cognitive impairment' 'leads to' 'dementia'.\n\nNeighbor-based Evidence 3: 'mild cognitive impairment' 'increases risk of' 'dementia'.\n\nNeighbor-based Evidence 4: 'dementia' 'associated with' 'cognitive decline'.\n\nNeighbor-based Evidence 5: 'patients' 'with' 'mild cognitive impairment'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.905754804611206
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "8f292f5a-ecde-412e-b7ca-1454010dd7af",
    "question": "55yr old man with dementia was given a natural alkaloid which of the following?",
    "opa": "Tacrine",
    "opb": "Donepezil",
    "opc": "Galantamine",
    "opd": "Rivastigmine",
    "cop": 2,
    "choice_type": "single",
    "exp": "Ans. is 'c' i.e., Galantamine Galantamine: It is a natural alkaloid which selectively inhibits cereral acetylcholinesterase and has some direct agonistic action on nicotinic receptors as well. It has produced cognitive and behavioural benefits in alzheimers disease.",
    "subject_name": "Pharmacology",
    "topic_name": null,
    "entity": "1. dementia\n2. natural alkaloid\n3. Tacrine\n4. Donepezil\n5. Galantamine\n6. Rivastigmine",
    "prediction": "C",
    "path": "Reranked Triple1: tacrine \u2014\u2014> treats \u2014\u2014> AD (Alzheimer's disease)  \nReranked Triple2: rivastigmine \u2014\u2014> treats \u2014\u2014> AD (Alzheimer's disease)  \nReranked Triple3: donepezil \u2014\u2014> treats \u2014\u2014> AD (Alzheimer's disease)  \nReranked Triple4: galantamine \u2014\u2014> treats \u2014\u2014> AD (Alzheimer's disease)  \nReranked Triple5: rivastigmine \u2014\u2014> CAUSES \u2014\u2014> death (induced by staurosporine)  ",
    "neighbor_input": "Reranked Triple1: AD -> treats -> Tacrine\nReranked Triple2: AD -> treats -> Donepezil\nReranked Triple3: AD -> treats -> Galantamine\nReranked Triple4: AD -> treats -> Rivastigmine\nReranked Triple5: AD -> TREATMENT -> cognitive deficits",
    "response_of_KG_list_path": "Path-based Evidence 1: 'tacrine' 'treats' 'AD (Alzheimer's disease)'.\n\nPath-based Evidence 2: 'rivastigmine' 'treats' 'AD (Alzheimer's disease)'.\n\nPath-based Evidence 3: 'donepezil' 'treats' 'AD (Alzheimer's disease)'.\n\nPath-based Evidence 4: 'galantamine' 'treats' 'AD (Alzheimer's disease)'.\n\nPath-based Evidence 5: 'rivastigmine' 'CAUSES' 'death (induced by staurosporine)'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'treats' 'Tacrine'.\n\nNeighbor-based Evidence 2: 'AD' 'treats' 'Donepezil'.\n\nNeighbor-based Evidence 3: 'AD' 'treats' 'Galantamine'.\n\nNeighbor-based Evidence 4: 'AD' 'treats' 'Rivastigmine'.\n\nNeighbor-based Evidence 5: 'AD' 'TREATMENT' 'cognitive deficits'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.8015903234481812,
      1.0,
      1.0,
      0.6575609445571899,
      1.0,
      1.0,
      1.0,
      0.6304964423179626
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "26895128-bc9f-4b40-b735-2024874caa69",
    "question": "Regarding Alzheimer's disease which is/are not true :",
    "opa": "Initial loss of long term memory",
    "opb": "Delayed loss of sho term memory",
    "opc": "Step ladder pattern",
    "opd": "All",
    "cop": 3,
    "choice_type": "multi",
    "exp": "A. i.e. Initial loss of long term memory B. i.e. Delayed loss of sho term memory C. i.e. Step ladder pattern",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. long term memory\n3. short term memory",
    "prediction": "B",
    "path": "Reranked Triple1: Alzheimer disease -> CAUSES -> dementia  \nReranked Triple2: dementia -> caused by -> tau  \nReranked Triple3: Alzheimer disease -> associates -> AD  \nReranked Triple4: AD -> correlates with -> diabetes mellitus  \nReranked Triple5: Alzheimer disease -> causes -> brain atrophy  ",
    "neighbor_input": "Reranked Triple1: AD -> causes -> cognitive decline \u2014\u2014> cognitive deficits\nReranked Triple2: AD -> causes -> cognitive impairment \u2014\u2014> memory deficits\nReranked Triple3: AD -> causes -> memory impairment \u2014\u2014> cognitive dysfunction\nReranked Triple4: AD -> causes -> impairment of learning and memory \u2014\u2014> cognitive loss\nReranked Triple5: AD -> causes -> neurodegeneration \u2014\u2014> Alzheimer's disease-related neuronal damage",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer disease' is known to 'CAUSE' 'dementia'.\n\nPath-based Evidence 2: 'Dementia' is 'caused by' 'tau'.\n\nPath-based Evidence 3: 'Alzheimer disease' is 'associated with' 'AD'.\n\nPath-based Evidence 4: 'AD' 'correlates with' 'diabetes mellitus'.\n\nPath-based Evidence 5: 'Alzheimer disease' 'causes' 'brain atrophy'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'cognitive decline', which leads to 'cognitive deficits'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'cognitive impairment', resulting in 'memory deficits'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'memory impairment', leading to 'cognitive dysfunction'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'impairment of learning and memory', which results in 'cognitive loss'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'neurodegeneration', associated with 'Alzheimer's disease-related neuronal damage'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.6152992248535156,
      0.5980503559112549,
      0.5855745077133179
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "35e5ba94-9c20-4ec5-862b-13b01be5aad5",
    "question": "All the following are featuring Alzheimer's disease except:",
    "opa": "Cerebellar atrophy",
    "opb": "Common in 5th and 6th decade",
    "opc": "Atrophied gyri widened sulci",
    "opd": "Peogressive dementia",
    "cop": 0,
    "choice_type": "multi",
    "exp": "A i.e. Cerebellar atrophy",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. Cerebellar atrophy\n3. 5th and 6th decade\n4. Atrophied gyri\n5. Widened sulci\n6. Progressive dementia",
    "prediction": "A",
    "path": "Reranked Triple1: Alzheimer's disease -> CAUSES -> dementia  \nReranked Triple2: Alzheimer's disease -> associates -> brain atrophy  \nReranked Triple3: Alzheimer disease -> associates -> AD  \nReranked Triple4: AD -> resembles -> Alzheimers disease  \nReranked Triple5: dementia -> caused by -> tau  ",
    "neighbor_input": "Reranked Triple1: AD -> causes -> cerebellar atrophy \u2014\u2014> not associated with Alzheimer's disease\nReranked Triple2: AD -> causes -> dementia \u2014\u2014> progressive dementia is associated with Alzheimer's disease\nReranked Triple3: AD -> causes -> atrophied gyri widened sulci \u2014\u2014> associated with Alzheimer's disease\nReranked Triple4: AD -> causes -> cognitive decline \u2014\u2014> associated with Alzheimer's disease\nReranked Triple5: AD -> causes -> common in 5th and 6th decade \u2014\u2014> associated with Alzheimer's disease",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer's disease' is known to 'CAUSE' 'dementia'.\n\nPath-based Evidence 2: 'Alzheimer's disease' 'associates' with 'brain atrophy'.\n\nPath-based Evidence 3: 'Alzheimer disease' 'associates' with 'AD'.\n\nPath-based Evidence 4: 'AD' 'resembles' 'Alzheimer's disease'.\n\nPath-based Evidence 5: 'dementia' is 'caused by' 'tau'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'cerebellar atrophy', which is not associated with 'Alzheimer's disease'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'dementia', where progressive dementia is associated with 'Alzheimer's disease'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'atrophied gyri widened sulci', which is associated with 'Alzheimer's disease'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'cognitive decline', and this is associated with 'Alzheimer's disease'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'common in 5th and 6th decade', which is associated with 'Alzheimer's disease'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.8508630990982056,
      0.5570242404937744,
      0.5975096225738525,
      0.5254132747650146,
      1.0,
      0.9130909442901611
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "3d2672e7-310f-4fe5-a0bd-431c2ed6f082",
    "question": "In Alzheimer's disease, the plaque is made up of: (E. REPEAT 2010)-",
    "opa": "Tau protein",
    "opb": "Beta amyloid",
    "opc": "Huntington",
    "opd": "Alpha synnuclein",
    "cop": 1,
    "choice_type": "single",
    "exp": "Ans-BRef: Robbins Pathologic Basis of Disease. 8th edition. Pages 1313-7Explanation:MORPHOLOGY OF ALZHEIMER'S DISEASECortical atrophy especially in frontal, temporal and parietal lobes.Compensatory ventricular enlargement due to loss of parenchyma and reduced brain volume - (hydrocephalus ex vacuo).Structures involved early - medial temporal lobe, including the hippocampus, entorhinal cortex, and amygdala.The major microscopic abnormalities: o Neuritic (senile) plaques.o Neurofibrillary tangles.Progressive severe neuronal loss and reactive gliosis.Neuritic PlaquesFocal, spherical collections of dilated, tortuous, neuritic processes (dystrophic neurites) often around a central amyloid core, surrounded by a clear halo.Size from 20 to 200 mm in diameter.Microglial cells and reactive astrocytes are present at their periphery.Plaques are found in the hippocampus, amygdala, and neocortex.The amyloid core, stained by Congo Red. contains several abnormal proteins.The dominant component of the amyloid plaque core is Ab. a peptide derived from, amyloid precursor protein (APP).Other proteins include:o Components of the complement cascadeo Pro-inflammatory cytokineso al-antichymotrypsino Apolipoproteins.Neurofibrillary TanglesBundles of filaments in the cytoplasm of the neurons that displace or encircle the nucleus.In pyramidal neurons, they have an elongated \"flame\" shape: in rounder cells, the basket weave of fibers around the nucleus takes a rounded contour (\"globose\" tangles).H&E staining: Basophilic fibrillar structures.Very well demonstrated by silver (Bielschowsky) staining.They are commonly found in cortical neurons, especially in the entorhinal cortex, pyramidal cells of the hippocampus, the amygdala, the basal forebrain, and the raphe nuclei. They are insoluble and resistant to clearance remaining visible in tissue sections as \"ghost\" or \"tombstone\" tangles long after the death of the parent neuron.Ultrastructurally, they are composed of paired helical filaments along with some straight filaments.A major component of paired helical filaments is abnormally hyperphosphorylated forms of the protein tau. an axonal microtubule-associated protein that enhances microtubule assembly.Other components include MAP2 (microtubule-associated protein-2) and ubiquitin.Paired helical filaments are also found in the dystrophic neurites that form the outer portions of neuritic plaques and in axons coursing through the affected gray matter as neuropil threads.Other FeaturesCerebral amyloid angiopathy (CAA).Granulovacuolar degeneration: Small (~5 mm in diameter), clear intraneuronal cytoplasmic vacuoles, each of which contains an argyrophilic granule.Hirano bodies are elongated, glassy, eosinophilic bodies consisting of paracrystalline arrays of beaded filaments, with actin as their major component, found most commonly within hippocampal pyramidal cells.Pathologic changes are evident earliest in the entorhinal cortex, then spread through the hippocampal formation and isocortex, and then extend into the neocortex.NIA-Reagan criteria used in the diagnosis.Remember:Amyloid plaques - Extracellular IJ amyloid.Neurofibrillary tangles - Intracellular tau proteins.",
    "subject_name": "Unknown",
    "topic_name": null,
    "entity": "1. Alzheimer's disease \n2. plaque \n3. Tau protein \n4. Beta amyloid \n5. Huntington \n6. Alpha synnuclein",
    "prediction": "B",
    "path": "Reranked Triple1: Alzheimer's disease \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple2: Alzheimer's disease \u2014\u2014> associates \u2014\u2014> Huntington's disease  \nReranked Triple3: tau \u2014\u2014> caused by \u2014\u2014> Alzheimer's disease  \nReranked Triple4: Alzheimer's disease \u2014\u2014> resembles \u2014\u2014> AD  \nReranked Triple5: tau \u2014\u2014> correlates with \u2014\u2014> Alzheimer's disease  \n\nAnswer: B. Beta amyloid",
    "neighbor_input": "Reranked Triple1: AD -> causes -> amyloid beta-protein  \nReranked Triple2: AD -> causes -> Abeta aggregation  \nReranked Triple3: AD -> causes -> amyloid-beta plaques  \nReranked Triple4: AD -> associates -> beta amyloid  \nReranked Triple5: AD -> causes -> Abeta deposition  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer's disease' 'causes' 'dementia'.\n\nPath-based Evidence 2: 'Alzheimer's disease' 'associates' 'Huntington's disease'.\n\nPath-based Evidence 3: 'tau' 'caused by' 'Alzheimer's disease'.\n\nPath-based Evidence 4: 'Alzheimer's disease' 'resembles' 'AD'.\n\nPath-based Evidence 5: 'tau' 'correlates with' 'Alzheimer's disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'amyloid beta-protein'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'Abeta aggregation'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'amyloid-beta plaques'.\n\nNeighbor-based Evidence 4: 'AD' 'associates' 'beta amyloid'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'Abeta deposition'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.8603709936141968,
      0.8603709936141968,
      1.0,
      0.8382810950279236,
      1.0,
      0.9567092657089233,
      1.0,
      0.8395751714706421,
      0.9474924802780151,
      1.0,
      0.7870264649391174,
      0.8690527677536011,
      0.7243181467056274
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "1abbe85f-c871-4942-87cf-92207c2951aa",
    "question": "A 68 year old man is admitted to the hospital for delirium associated with a urinary tract infection. Upon adequate treatment of the infection, the patient's mental status improved significantly, though he is noted to remain paly disoriented. He also has an impairment in sho-term memory, difficulties in naming simple objects, and impaired concentration. His family members confirm an 8-month history of gradual progressive decline in cognitive abilities, which they attribute to old-age. However, the man is no longer able to manage his finances and has gotten lost while driving to the grocery store on two occasions. Prior to discharge from the hospital, the nursing staff repos that the patient continues to have urinary incontinence, though his infection has resolved. He is also noted to have a very unsteady gait, requiring assistance when walking. No other obvious signs or symptoms are present. Which disorder most likely accounts for this patient's dementia?",
    "opa": "Creutzfeldt-Jakob disease",
    "opb": "Huntington disease",
    "opc": "Normal pressure hydrocephalus",
    "opd": "Parkinson disease",
    "cop": 2,
    "choice_type": "single",
    "exp": "Normal pressure hydrocephalus is a potentially reversible cause of dementia that causes gait disturbances (unsteady or shuffling gait), urinary incontinence, and dementia. Enlargement of the ventricles with increased cerebrospinal fluid (CSF) pressure is found, and therapeutic lumbar punctures may significantly improve symptoms. Creutzfeldt-Jakob disease is a rare diffuse degenerative disease that usually affects people in their 50s, and the usual course is about one year. The terminal stage is characterized by severe dementia, generalized hypeonicity, and profound speech disturbances. It is one of several diseases presumably caused by prions. Huntington disease is a hereditary disease associated with progressive degeneration of the basal ganglia and the cerebral coex. It is transmitted in an autosomal dominant pattern. The onset of Huntington disease occurs between 35 and 50 years of age, or later in rare cases. This disease is characterized by progressive dementia, muscular hypeonicity, and bizarre choreiform movements. Parkinson disease is characterized primarily by motor dysfunction, but dementia may be a pa of the disorder. The characteristic motor symptoms (bradykinesia, flat facies, resting tremor, shuffling gait, etc) are caused by degeneration of the nigrostriatal dopaminergic tract. Ref: Ropper A.H., Samuels M.A. (2009). Chapter 30. Disturbances of Cerebrospinal Fluid and Its Circulation, Including Hydrocephalus, Pseudotumor Cerebri, and Low-Pressure Syndromes. In A.H. Ropper, M.A. Samuels (Eds), Adams and Victor's Principles of Neurology, 9e.",
    "subject_name": "Medicine",
    "topic_name": null,
    "entity": "1. 68 year old man\n2. delirium\n3. urinary tract infection\n4. mental status\n5. short-term memory\n6. cognitive abilities\n7. old-age\n8. finances\n9. urinary incontinence\n10. gait\n11. Creutzfeldt-Jakob disease\n12. Huntington disease\n13. Normal pressure hydrocephalus\n14. Parkinson disease",
    "prediction": "C",
    "path": "Reranked Triple1: Huntington's disease -> AFFECTS -> human  \nReranked Triple2: Alzheimer\u2019s disease -> DISEASE FOR -> short-term memory deficit  \nReranked Triple3: cognitive skills -> declines -> age  \nReranked Triple4: NH -> USED TO TREAT -> cerebral ischemia  \nReranked Triple5: hydrocephalus -> exists in -> human  ",
    "neighbor_input": "Reranked Triple1: delirium -> cause -> neuronal damage  \nReranked Triple2: delirium -> associates -> cognitive impairment  \nReranked Triple3: memory impairment -> caused by -> Abeta, estrogen deficiency, AD  \nReranked Triple4: memory impairment -> causes -> cognitive impairment, Alzheimer's disease  \nReranked Triple5: delirium -> occurs in -> patients  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Huntington's disease' AFFECTS 'human'.  \nPath-based Evidence 2: 'Alzheimer\u2019s disease' DISEASE FOR 'short-term memory deficit'.  \nPath-based Evidence 3: 'cognitive skills' declines with age.  \nPath-based Evidence 4: 'NH' USED TO TREAT 'cerebral ischemia'.  \nPath-based Evidence 5: 'hydrocephalus' exists in 'human'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Delirium' is a condition that is caused by 'neuronal damage'.\n\nNeighbor-based Evidence 2: 'Delirium' is associated with 'cognitive impairment'.\n\nNeighbor-based Evidence 3: 'Memory impairment' is caused by 'Abeta', 'estrogen deficiency', and 'Alzheimer's disease'.\n\nNeighbor-based Evidence 4: 'Memory impairment' leads to 'cognitive impairment' and 'Alzheimer's disease'.\n\nNeighbor-based Evidence 5: 'Delirium' occurs in 'patients'.",
    "entity_confidence_scores": [
      0.7287312150001526,
      0.9999999403953552,
      1.0000001192092896,
      0.6758190393447876,
      1.0,
      1.0,
      0.7110244035720825,
      0.6733563542366028,
      0.6568610668182373,
      0.62498539686203,
      1.000000238418579,
      0.6204914450645447,
      1.0000001192092896,
      0.8703271150588989,
      0.7812318801879883,
      0.658111572265625,
      1.0000001192092896,
      0.7964770793914795,
      1.000000238418579,
      1.0000001192092896,
      0.808238685131073,
      1.0,
      1.0,
      0.7870264649391174,
      0.8690527677536011,
      0.5480656027793884,
      0.9169323444366455,
      0.7333592176437378,
      0.7333592176437378,
      1.000000238418579
    ],
    "question_types": [
      "treatment",
      "symptom",
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "e3ec1238-42c2-41ab-9eeb-0c76961b66db",
    "question": "Alzheimer's disease - associated chromosome is -",
    "opa": "2",
    "opb": "6",
    "opc": "12",
    "opd": "19",
    "cop": 3,
    "choice_type": "single",
    "exp": "Ans. is 'd' i.e., 19 Chromosomes associated with Alzheimer's diseaseo Early onset disease (30-60 years)o Chromosome 21o Amyloid precursor protein (AAP) o Chromosome 14o Presenilin 1 o Chromosome 1o Presenilin 2o Late onset disease (>65 years)o Chromosome 19o Apolipoprotein E gene (APOE e4)",
    "subject_name": "Pathology",
    "topic_name": "Neurodegenerative Diseases",
    "entity": "1. Alzheimer's disease\n2. chromosome 2\n3. chromosome 6\n4. chromosome 12\n5. chromosome 19",
    "prediction": "D",
    "path": "Reranked Triple1: alzheimer disease \u2014\u2014> associates \u2014\u2014> AD  \nReranked Triple2: AD \u2014\u2014> correlates with \u2014\u2014> diabetes mellitus  \nReranked Triple3: alzheimer disease \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple4: dementia \u2014\u2014> caused by \u2014\u2014> tau  \nReranked Triple5: alzheimer disease \u2014\u2014> resembles \u2014\u2014> AD  \n\nAnswer:",
    "neighbor_input": "Reranked Triple1: Alzheimer's disease \u2014\u2014> associated chromosome -> 19  \nReranked Triple2: Alzheimer's disease \u2014\u2014> genetic factors -> amyloid precursor protein (APP)  \nReranked Triple3: Alzheimer's disease \u2014\u2014> genetic factors -> presenilin-1 (PS1)  \nReranked Triple4: Alzheimer's disease \u2014\u2014> genetic factors -> apolipoprotein E (APOE)  \nReranked Triple5: Alzheimer's disease \u2014\u2014> causes -> neurodegeneration  \n\nAnswer: D.19",
    "response_of_KG_list_path": "Path-based Evidence 1: 'alzheimer disease' is associated with 'AD'.\n\nPath-based Evidence 2: 'AD' correlates with 'diabetes mellitus'.\n\nPath-based Evidence 3: 'alzheimer disease' causes 'dementia'.\n\nPath-based Evidence 4: 'dementia' is caused by 'tau'.\n\nPath-based Evidence 5: 'alzheimer disease' resembles 'AD'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Alzheimer's disease' is 'associated chromosome' with '19'.  \nNeighbor-based Evidence 2: 'Alzheimer's disease' has 'genetic factors' including 'amyloid precursor protein (APP)'.  \nNeighbor-based Evidence 3: 'Alzheimer's disease' has 'genetic factors' including 'presenilin-1 (PS1)'.  \nNeighbor-based Evidence 4: 'Alzheimer's disease' has 'genetic factors' including 'apolipoprotein E (APOE)'.  \nNeighbor-based Evidence 5: 'Alzheimer's disease' 'causes' 'neurodegeneration'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.8243193626403809,
      0.8286762833595276,
      0.803590714931488,
      0.7966217994689941,
      0.8807259798049927,
      0.8343526124954224,
      1.0000001192092896,
      0.8612135648727417
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "a7a3dc92-c16f-48da-b953-5cdb766700f1",
    "question": "The nucleus involved in Alzheimer's disease is:",
    "opa": "Basal nucleus of Meyernet",
    "opb": "Raphe nucleus",
    "opc": "Superior salivary nucleus",
    "opd": "Basal lobe of cerebellum",
    "cop": 0,
    "choice_type": "single",
    "exp": "Ans. (a) Basal nucleus of Meyernet(Ref: Harrison 18th ed: 3306, 17th pg 2541)AD is associated with decrease in cerebral cortical level of acetylcholine. This degeneration occurs in nucleus basalis of Meyernet Q",
    "subject_name": "Pathology",
    "topic_name": "Central Nervous System",
    "entity": "1. Alzheimer's disease\n2. Basal nucleus of Meyernet\n3. Raphe nucleus\n4. Superior salivary nucleus\n5. Basal lobe of cerebellum",
    "prediction": "A",
    "path": "Reranked Triple1: alzheimer disease \u2014\u2014> CAUSES \u2014\u2014> dementia  \nReranked Triple2: dementia \u2014\u2014> caused by \u2014\u2014> tau  \nReranked Triple3: alzheimer disease \u2014\u2014> associates \u2014\u2014> AD  \nReranked Triple4: AD \u2014\u2014> correlates with \u2014\u2014> diabetes mellitus  \nReranked Triple5: alzheimer disease \u2014\u2014> causes \u2014\u2014> brain atrophy  ",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> causes \u2014\u2014> cognitive decline  \nReranked Triple2: AD \u2014\u2014> causes \u2014\u2014> memory impairment  \nReranked Triple3: AD \u2014\u2014> causes \u2014\u2014> neurodegeneration  \nReranked Triple4: AD \u2014\u2014> causes \u2014\u2014> behavioral deficits  \nReranked Triple5: AD \u2014\u2014> causes \u2014\u2014> cognitive dysfunction  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer disease' is known to 'CAUSE' 'dementia'.\n\nPath-based Evidence 2: 'Dementia' is 'caused by' 'tau'.\n\nPath-based Evidence 3: 'Alzheimer disease' 'associates' with 'AD'.\n\nPath-based Evidence 4: 'AD' 'correlates with' 'diabetes mellitus'.\n\nPath-based Evidence 5: 'Alzheimer disease' 'causes' 'brain atrophy'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'cognitive decline'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'memory impairment'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'neurodegeneration'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'behavioral deficits'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'cognitive dysfunction'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.6960955858230591,
      0.7261062860488892,
      0.7261061668395996,
      0.836044192314148,
      0.7716284990310669
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "c1b28826-2bab-4f3f-b81f-4f605757df5e",
    "question": "Age related dementia has been associated with increased levels of-",
    "opa": "Homocysteine",
    "opb": "Cysteine",
    "opc": "Tourine",
    "opd": "Methionine",
    "cop": 0,
    "choice_type": "single",
    "exp": null,
    "subject_name": "Medicine",
    "topic_name": null,
    "entity": "1. Age related dementia \n2. Homocysteine\n3. Cysteine\n4. Tourine\n5. Methionine",
    "prediction": "A",
    "path": "Reranked Triple1: dementia syndrome -> type -> aphasia  \nReranked Triple2: aphasia -> associated with -> Alzheimer's disease  \nReranked Triple3: Alzheimer's disease -> associates -> homocysteine  \nReranked Triple4: dementia syndrome -> type -> aphasia -> resembles -> Alzheimer's disease  \nReranked Triple5: Alzheimer's disease -> associates -> homocysteine  \n\nAnswer: A. Homocysteine",
    "neighbor_input": "Reranked Triple1: homocysteine \u2014\u2014> risk factor for -> AD  \nReranked Triple2: homocysteine \u2014\u2014> induces -> Hyperhomocysteinemia (HHcy)  \nReranked Triple3: homocysteine \u2014\u2014> modulates -> beta-amyloid  \nReranked Triple4: homocysteine \u2014\u2014> DISEASE -> Alzheimer's disease  \nReranked Triple5: dementia syndrome \u2014\u2014> type -> aphasia  ",
    "response_of_KG_list_path": "Path-based Evidence 1: The condition 'dementia syndrome' is a 'type' of 'aphasia'.  \nPath-based Evidence 2: The condition 'aphasia' is 'associated with' 'Alzheimer's disease'.  \nPath-based Evidence 3: 'Alzheimer's disease' 'associates' with 'homocysteine'.  \nPath-based Evidence 4: The condition 'dementia syndrome' is a 'type' of 'aphasia' that 'resembles' 'Alzheimer's disease'.  \nPath-based Evidence 5: 'Alzheimer's disease' 'associates' with 'homocysteine'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'homocysteine' is a 'risk factor for' 'AD'.\n\nNeighbor-based Evidence 2: 'homocysteine' 'induces' 'Hyperhomocysteinemia (HHcy)'.\n\nNeighbor-based Evidence 3: 'homocysteine' 'modulates' 'beta-amyloid'.\n\nNeighbor-based Evidence 4: 'homocysteine' is classified as a 'DISEASE' associated with 'Alzheimer's disease'.\n\nNeighbor-based Evidence 5: 'dementia syndrome' is a 'type' of 'aphasia'.",
    "entity_confidence_scores": [
      0.879377007484436,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.6312450170516968,
      1.0
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "84e40f05-2fd5-419c-85c9-d290ae41b5a9",
    "question": "A 55-year-old male presented with complaints of apathy, disinhibition, and compulsive behaviour, loss of empathy, overeating, easy forgetfulness and amnesia. There is also a family history of dementia. MRI of the brain was ordered. A brain biopsy was also taken and HPE examination was done. What is the most likely Diagnosis?",
    "opa": "Alzheimer's disease",
    "opb": "Vascular dementia",
    "opc": "Frontotemporal dementia",
    "opd": "Lewy body dementia",
    "cop": 2,
    "choice_type": "single",
    "exp": "The history of early personality changes followed by memory loss along with Pick cell (ballooned cell with dissolution of chromatin suggestive of pick body) is suggestive of Picks disease. MRI shows anterior cingulate and frontoinsular atrophy, spreading to orbital and dorsolateral prefrontal coex. OPTION A- Alzheimer's disease would have early memory loss, later symptoms of personality changes. Option B - Vascular dementia would have focal neurological deficit due to stroke and a step ladder progression. Option D - Lewy body dementia would show fluctuating amnesia with visual hallucination with spontaneous Parkinsonism.",
    "subject_name": "Unknown",
    "topic_name": "Integrated QBank",
    "entity": "1. 55-year-old male\n2. Apathy\n3. Disinhibition\n4. Compulsive behaviour\n5. Loss of empathy\n6. Overeating\n7. Easy forgetfulness\n8. Amnesia\n9. Family history of dementia\n10. MRI of brain\n11. Brain biopsy\n12. HPE examination\n13. Alzheimer's disease\n14. Vascular dementia\n15. Frontotemporal dementia\n16. Lewy body dementia",
    "prediction": "C",
    "path": "Reranked Triple1: amnesia -> has cause -> Abeta1-40  \nReranked Triple2: amnesia -> correlates with -> Alzheimer disease  \nReranked Triple3: Alzheimer Disease -> causes -> dementia  \nReranked Triple4: dementia -> has property -> familial dementia  \nReranked Triple5: tau -> associates with -> patients -> have -> Lewy body dementia  ",
    "neighbor_input": "Reranked Triple1: apathy \u2014\u2014> associated with \u2014\u2014> decreased social functioning, increased caregiver burden  \nReranked Triple2: apathy \u2014\u2014> affects \u2014\u2014> patients  \nReranked Triple3: delirium \u2014\u2014> associates \u2014\u2014> cognitive impairment  \nReranked Triple4: delirium \u2014\u2014> occurs in \u2014\u2014> patients  \nReranked Triple5: apathy \u2014\u2014> associated with \u2014\u2014> loss of empathy, easy forgetfulness, amnesia",
    "response_of_KG_list_path": "Path-based Evidence 1: 'amnesia' 'has cause' 'Abeta1-40'.\n\nPath-based Evidence 2: 'amnesia' 'correlates with' 'Alzheimer disease'.\n\nPath-based Evidence 3: 'Alzheimer Disease' 'causes' 'dementia'.\n\nPath-based Evidence 4: 'dementia' 'has property' 'familial dementia'.\n\nPath-based Evidence 5: 'tau' 'associates with' 'patients' 'have' 'Lewy body dementia'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'apathy' is 'associated with' 'decreased social functioning' and 'increased caregiver burden'.\n\nNeighbor-based Evidence 2: 'apathy' 'affects' 'patients'.\n\nNeighbor-based Evidence 3: 'delirium' 'associates' with 'cognitive impairment'.\n\nNeighbor-based Evidence 4: 'delirium' 'occurs in' 'patients'.\n\nNeighbor-based Evidence 5: 'apathy' is 'associated with' 'loss of empathy', 'easy forgetfulness', and 'amnesia'.",
    "entity_confidence_scores": [
      0.6730055212974548,
      1.0,
      0.6298438310623169,
      0.6294387578964233,
      0.7072092294692993,
      1.000000238418579,
      1.000000238418579,
      0.6770105361938477,
      0.9478477239608765,
      0.667778491973877,
      0.6561866998672485,
      0.680151104927063,
      1.0000001192092896,
      0.8555591106414795,
      0.8484712839126587,
      0.804959237575531,
      0.7011028528213501,
      0.660957932472229,
      0.6203725337982178,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.8961988091468811,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.833743155002594,
      1.0,
      0.9365595579147339
    ],
    "question_types": [
      "definition",
      "symptom",
      "diagnosis"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "ae8a197c-6dc1-4dc7-be61-4e0d3f187e3a",
    "question": "Dementia is/are pesent in all except:",
    "opa": "Alzeimer's disease",
    "opb": "Pick's disease",
    "opc": "Lewy body",
    "opd": "Ganser syndrome",
    "cop": 3,
    "choice_type": "multi",
    "exp": "D i.e. Ganser syndrome",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Dementia\n2. Alzheimer's disease\n3. Pick's disease\n4. Lewy body\n5. Ganser syndrome",
    "prediction": "D",
    "path": "Reranked Triple1: dementia with Lewy bodies \u2014\u2014> pathology \u2014\u2014> tauopathy\nReranked Triple2: tauopathy \u2014\u2014> include \u2014\u2014> Lewy body disease\nReranked Triple3: Lewy body disease \u2014\u2014> associated with \u2014\u2014> cognitive decline\nReranked Triple4: cognitive decline \u2014\u2014> causes \u2014\u2014> dementia\nReranked Triple5: dementia \u2014\u2014> has symptom \u2014\u2014> parkinson's disease",
    "neighbor_input": "Reranked Triple1: Ganser syndrome \u2014\u2014> NOT associated with dementia\nReranked Triple2: Alzheimer's disease \u2014\u2014> associated with dementia\nReranked Triple3: Pick's disease \u2014\u2014> associated with dementia\nReranked Triple4: Lewy body \u2014\u2014> associated with dementia\nReranked Triple5: dementia \u2014\u2014> present in Alzheimer's disease, Pick's disease, and Lewy body, but NOT in Ganser syndrome",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Dementia with Lewy bodies' is a type of 'pathology' that falls under 'tauopathy'.\n\nPath-based Evidence 2: 'Tauopathy' is known to 'include' 'Lewy body disease'.\n\nPath-based Evidence 3: 'Lewy body disease' is 'associated with' 'cognitive decline'.\n\nPath-based Evidence 4: 'Cognitive decline' 'causes' 'dementia'.\n\nPath-based Evidence 5: 'Dementia' 'has symptom' 'parkinson's disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Ganser syndrome' is 'NOT associated with' dementia.\n\nNeighbor-based Evidence 2: 'Alzheimer's disease' is 'associated with' dementia.\n\nNeighbor-based Evidence 3: 'Pick's disease' is 'associated with' dementia.\n\nNeighbor-based Evidence 4: 'Lewy body' is 'associated with' dementia.\n\nNeighbor-based Evidence 5: 'Dementia' is 'present in' 'Alzheimer's disease', 'Pick's disease', and 'Lewy body', but 'NOT in' 'Ganser syndrome'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.6205008029937744,
      0.5583708882331848,
      0.9429672360420227,
      0.7109739780426025,
      0.702234148979187,
      1.0,
      0.6846673488616943,
      1.0,
      0.578016459941864
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "3d21502b-49ff-4de0-97a5-bca05f236b7b",
    "question": "Which apolipoprotein is responsible for Alzheimer's disease:-",
    "opa": "APOE3",
    "opb": "APOE1",
    "opc": "APOE4",
    "opd": "APOE2",
    "cop": 2,
    "choice_type": "single",
    "exp": "Relative risk of Alzheimer's disease is maximum with Apo E4 Apo E Risk of Alzheimer's E2, E2 0.6 E2, E4 2.6 E3, E4 3.2 E4, E4 14.9",
    "subject_name": "Biochemistry",
    "topic_name": "NEET 2019",
    "entity": "1. apolipoprotein \n2. Alzheimer's disease\n3. APOE3 \n4. APOE1 \n5. APOE4 \n6. APOE2",
    "prediction": "C",
    "path": "Reranked Triple1: ApoE3 \u2014\u2014> resembles \u2014\u2014> ApoE4  \nReranked Triple2: ApoE4 \u2014\u2014> upregulates \u2014\u2014> Abeta  \nReranked Triple3: Abeta \u2014\u2014> interacts \u2014\u2014> APOE4  \nReranked Triple4: ApoE2 \u2014\u2014> interacts \u2014\u2014> ApoE  \nReranked Triple5: ApoE3 \u2014\u2014> is neutral with respect to \u2014\u2014> Alzheimer's disease  ",
    "neighbor_input": "Reranked Triple1: apolipoprotein (APOE) \u2014\u2014> associated with \u2014\u2014> AD (Alzheimer's disease)  \nReranked Triple2: APOE \u2014\u2014> binds \u2014\u2014> TREM2  \nReranked Triple3: AD \u2014\u2014> causes \u2014\u2014> neurodegeneration  \nReranked Triple4: AD \u2014\u2014> causes \u2014\u2014> cognitive impairment  \nReranked Triple5: AD \u2014\u2014> treats \u2014\u2014> cognitive deficits  \n\nAnswer: C. APOE4",
    "response_of_KG_list_path": "Path-based Evidence 1: 'ApoE3' 'resembles' 'ApoE4'.\n\nPath-based Evidence 2: 'ApoE4' 'upregulates' 'Abeta'.\n\nPath-based Evidence 3: 'Abeta' 'interacts' 'APOE4'.\n\nPath-based Evidence 4: 'ApoE2' 'interacts' 'ApoE'.\n\nPath-based Evidence 5: 'ApoE3' 'is neutral with respect to' 'Alzheimer's disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: The entity 'apolipoprotein (APOE)' is 'associated with' the entity 'AD (Alzheimer's disease)'.\n\nNeighbor-based Evidence 2: The entity 'APOE' 'binds' to the entity 'TREM2'.\n\nNeighbor-based Evidence 3: The entity 'AD' 'causes' 'neurodegeneration'.\n\nNeighbor-based Evidence 4: The entity 'AD' 'causes' 'cognitive impairment'.\n\nNeighbor-based Evidence 5: The entity 'AD' 'treats' 'cognitive deficits'.",
    "entity_confidence_scores": [
      0.9572594165802002,
      0.8959727883338928,
      0.8721412420272827,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.000000238418579,
      1.000000238418579,
      0.9050863981246948,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "0cebf23b-86b0-45be-b08f-2e22d4581906",
    "question": "Subcoical dementia is seen in all except",
    "opa": "Parkinsonism",
    "opb": "Alzheimer's disease",
    "opc": "Wilson's disease",
    "opd": "Huntingtons chorea",
    "cop": 1,
    "choice_type": "multi",
    "exp": "Coical dementia, ex: Alzheimer's disease, Pick's disease. Site of lesion is Coex(frontal & temporoparieto-occipital association areas, & hippocampus). Subcoical dementia, ex: Huntington's chorea, Parkinson's disease, progressive supranuclear palsy, Wilson's disease. Site of lesion is subcoical grey matter(thalamus, basal ganglia, & rostral brain stem). Reference: A sho textbook of Psychiatry by Niraj Ahuja, 7th edition, page 24.",
    "subject_name": "Psychiatry",
    "topic_name": "Organic mental disorders",
    "entity": "1. Subcortical dementia\n2. Parkinsonism\n3. Alzheimer's disease\n4. Wilson's disease\n5. Huntington's chorea",
    "prediction": "B",
    "path": "Reranked Triple1: Wilson's disease -> causes -> copper intoxication  \nReranked Triple2: Wilson's disease -> resembles -> Alzheimer's disease  \nReranked Triple3: Alzheimer's disease -> causes -> dementia  \nReranked Triple4: Alzheimer's disease -> associates -> AD  \nReranked Triple5: Alzheimer's disease -> caused by -> amyloid-beta precursor protein  ",
    "neighbor_input": "Reranked Triple1: Parkinsonism \u2014\u2014> causes \u2014\u2014> Neurodegenerative disease\nReranked Triple2: Parkinsonism \u2014\u2014> causes \u2014\u2014> cardiovascular disease\nReranked Triple3: Parkinsonism \u2014\u2014> associates \u2014\u2014> variant amyloid deposits\nReranked Triple4: Parkinsonism \u2014\u2014> associated with \u2014\u2014> dopamine transporter\nReranked Triple5: Parkinsonism \u2014\u2014> caused by \u2014\u2014> 6-hydroxydopamine",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Wilson's disease' causes 'copper intoxication'.  \nPath-based Evidence 2: 'Wilson's disease' resembles 'Alzheimer's disease'.  \nPath-based Evidence 3: 'Alzheimer's disease' causes 'dementia'.  \nPath-based Evidence 4: 'Alzheimer's disease' associates with 'AD'.  \nPath-based Evidence 5: 'Alzheimer's disease' is caused by 'amyloid-beta precursor protein'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Parkinsonism' 'causes' 'Neurodegenerative disease'.\n\nNeighbor-based Evidence 2: 'Parkinsonism' 'causes' 'cardiovascular disease'.\n\nNeighbor-based Evidence 3: 'Parkinsonism' 'associates' 'variant amyloid deposits'.\n\nNeighbor-based Evidence 4: 'Parkinsonism' 'associated with' 'dopamine transporter'.\n\nNeighbor-based Evidence 5: 'Parkinsonism' 'caused by' '6-hydroxydopamine'.",
    "entity_confidence_scores": [
      0.882514476776123,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.8395751714706421,
      0.808238685131073
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "75a7ef34-5533-41ae-b00e-0aecb34852a8",
    "question": "Which of the following regarding small vessel disease (SVD), cerebral amyloid angiopathy (CAA) and Alzheimer's disease (AD) is not true?",
    "opa": "SVD is related to CAA",
    "opb": "SVD is not correlated to AD",
    "opc": "SVD is related to AD",
    "opd": "CAA is associated with AD",
    "cop": 2,
    "choice_type": "multi",
    "exp": "Small vessel disease is a condition in which the walls of the small aeries in the hea are damaged. The condition causes signs and symptoms of hea disease, such as chest pain (angina). Small vessel disease is sometimes called coronary microvascular disease or small vessel hea disease. Ref Harrison20th edition pg 1456",
    "subject_name": "Medicine",
    "topic_name": "C.N.S",
    "entity": "1. Small vessel disease (SVD)\n2. Cerebral amyloid angiopathy (CAA)\n3. Alzheimer's disease (AD)",
    "prediction": "B",
    "path": "Reranked Triple1: small vessel disease (SVD) -> affects -> cerebrovascular disease  \nReranked Triple2: small vessel disease (SVD) -> overlaps -> Alzheimer's disease  \nReranked Triple3: small vessel disease (SVD) -> co-occurs with -> Alzheimer disease  \nReranked Triple4: small vessel disease (SVD) -> associates -> cerebral amyloid angiopathy (CAA)  \nReranked Triple5: cerebral amyloid angiopathy (CAA) -> associates -> Alzheimer's disease  ",
    "neighbor_input": "Reranked Triple1: small vessel disease (SVD) \u2014\u2014> affects \u2014\u2014> subcortical vascular cognitive impairment (vascular cognitive impairments), cerebrovascular disease  \nReranked Triple2: cerebral amyloid angiopathy (CAA) \u2014\u2014> causes \u2014\u2014> Alzheimer's disease (AD)  \nReranked Triple3: cerebral amyloid angiopathy (CAA) \u2014\u2014> caused by \u2014\u2014> Abeta  \nReranked Triple4: cerebral amyloid angiopathy (CAA) \u2014\u2014> cause \u2014\u2014> Alzheimer's disease (AD)  \nReranked Triple5: small vessel disease (SVD) \u2014\u2014> affects \u2014\u2014> cerebrovascular disease  \n\nAnswer: B. SVD is not correlated to AD",
    "response_of_KG_list_path": "Path-based Evidence 1: 'small vessel disease (SVD)' 'affects' 'cerebrovascular disease'.\n\nPath-based Evidence 2: 'small vessel disease (SVD)' 'overlaps' 'Alzheimer's disease'.\n\nPath-based Evidence 3: 'small vessel disease (SVD)' 'co-occurs with' 'Alzheimer disease'.\n\nPath-based Evidence 4: 'small vessel disease (SVD)' 'associates' 'cerebral amyloid angiopathy (CAA)'.\n\nPath-based Evidence 5: 'cerebral amyloid angiopathy (CAA)' 'associates' 'Alzheimer's disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'small vessel disease (SVD)' 'affects' 'subcortical vascular cognitive impairment (vascular cognitive impairments)' and 'cerebrovascular disease'.\n\nNeighbor-based Evidence 2: 'cerebral amyloid angiopathy (CAA)' 'causes' 'Alzheimer's disease (AD)'.\n\nNeighbor-based Evidence 3: 'cerebral amyloid angiopathy (CAA)' 'caused by' 'Abeta'.\n\nNeighbor-based Evidence 4: 'cerebral amyloid angiopathy (CAA)' 'cause' 'Alzheimer's disease (AD)'.\n\nNeighbor-based Evidence 5: 'small vessel disease (SVD)' 'affects' 'cerebrovascular disease'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.9999998807907104,
      1.0,
      1.000000238418579,
      0.9999998807907104,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "61634f16-9556-4bbc-b158-b1de46979cd5",
    "question": "NOT a characteristic feature of Alzheimer's disease",
    "opa": "Intranuclear neurofibrillary tangles (NFTs)",
    "opb": "Ab Amyloid extra cellular",
    "opc": "Decreased ACh in Meynert",
    "opd": "Only recent memory loss",
    "cop": 3,
    "choice_type": "single",
    "exp": "(D) Only recent memory loss[?]ALZHEIMER'S DISEASE (Senile Dementia) is a progressive disease that destroys memory and other important mental functions.oMemory loss & confusion are the main symptoms. Aphasia, Amnesia, Agnosia, Acaiculia & Aiexia.Alzheimer's Symptoms10 Warning Signs*. Short term memory loss - forgetting recent events, names and places.1. Memory loss*. Difficulty performing familiar tasks.2. Difficult to performing familiar tasks*. Disorientation especially away from normal surroundings.3. Problems with language*. Increasing problems with planning and managing.4. Disorientation to time & place*. Trouble with language.5. Poor or decreased judgment*. Rapid, unpredictable mood swings.6. Problems with abstract thinking*. Lack of motivation.7. Misplacing things*. Changes in sleep and confusion about the time of day.8. Changes in mood or behavior*. Reduced judgment E.g., being unaware of danger.9. Changes in personality10. Loss of initiative MAKING SENSE OF MEMORY LOSSSymptoms of Alzheimer'sMemory loss from Normal AgingForgetting whole experiencesForgetting part of an experienceRarely able to remember laterOften able to remember laterGradually unable to follow written I spoken directionsUsually able to follow written I spoken directionsGradually unable to use notes as remindersUsually able to use notes as remindersGradually unable to care for oneselfUsually able to care for oneself.oCurrently, there is no cure for Alzheimer's.oDrug & non-drug treatments may help with both cognitive & behavioral symptoms.oTreatments available for Alzheimer's do not slow or stop the progression of the disease, but they may help with the symptoms for a time.oThere are three cholinesterase inhibitors to treat Alzheimer's:-Donepezil; Rivastigmine; Galantamine",
    "subject_name": "Medicine",
    "topic_name": "C.N.S.",
    "entity": "1. Alzheimer's disease\n2. Intranuclear neurofibrillary tangles\n3. Ab Amyloid\n4. ACh in Meynert\n5. Memory loss",
    "prediction": "D",
    "path": "Reranked Triple1: Alzheimer's disease -> associates -> dementia  \nReranked Triple2: dementia -> caused by -> tau  \nReranked Triple3: memory loss -> caused by -> Abeta  \nReranked Triple4: memory loss -> causes -> memory deficit  \nReranked Triple5: Alzheimer Disease -> causes -> brain atrophy  ",
    "neighbor_input": "Reranked Triple1: AD->CAUSES->neurodegeneration,cognitive lesion,impairment of spatial learning and memory,dementia,lamin A (lamin) toxicity,proteinopathy,behavioral deficits,brain damage,Abeta aggregation,hypoxia,Alzheimer's disease,cognitive impairment,neurofibrillary tangle pathology,cognitive disorders,Abeta,astrogliosis,dysfunctional microglia,neuronal loss,brain disorder,neurodegenerative disorder,brain deficits,learning and memory impairments,tau,BACE1,Oxidative stress,neurodegenerative diseases \u2014\u2014> NOT a characteristic feature of Alzheimer's disease\nReranked Triple2: AD->treats->phloroglucinol,cognitive deficits,cognitive loss,Water,neurodegenerative diseases,Abeta toxicity,reactive oxygen species,neurodegeneration,Neurotoxicity,neurotoxicity,attenuated the behavior impairment,behavioral dysfunction,VK3,Alzheimer-like cognitive deficits,dementia,PPARgamma agonists,ankG,VK3-9,neurotoxic,hyperforin,Kanamycin,mitochondrial dysfunction,impairment of spatial learning and memory,ginsenoside Rd,Abeta aggregation,RS 67333,Abeta fibrillogenesis,off-pathway oligomers,mice,neuronal dysfunction,Mice,beta-secretase inhibitor,insulin,Alzheimer's disease,diosmin,cholinesterase inhibitor,brain deficits,tacrine,BACE1 inhibitors,7d,Abeta,n-3 PUFAs,Diosmetin,Transgenic Mice,chalcones,THH,amyloid-beta aggregation inhibitor,mice (mouse),Neuronal Injury,aid,SSP-002392,Neuropep-4,AD \u2014\u2014> NOT a characteristic feature of Alzheimer's disease\nReranked Triple3: AD->TREATMENT->TUDCA,metal,insulin-like growth factor (IGF) signaling,tropisetron,deep learning,N-acetylcysteine,MB,3H3,NEP,flavonoids,reserpine,protoporphyrin IX,retardation,neuron-specific IGF-1R knockout,neuronal IGF resistance,Abeta,participant,bexarotene,fasudil,alpha-lipoic acid,curcumin,IGF-1R ablation,Rg1,thiethylperazine,MDR-1339,patients,secondary prevention,HBMVECs-Ex,redox-proteomic approach,nobiletin,vaccine,insulin-like growth factor I (IGF-I),alpha-tocopherol,PBS,EPR imaging \u2014\u2014> NOT a characteristic feature of Alzheimer's disease\nReranked Triple4: AD->ASSOCIATES->glycogen synthase kinase 3beta,memory deficit,tauopathies,MAPT,altered neuronal ion transport,oxidative stress,Co-infection,cerebral ischaemic injury,memory loss and impaired cognitive function,brain volume loss and memory decline,weight loss,cyclin-dependent kinase reduction,toxicity,copper,amyloid-beta,mitochondrial morphology,PATIENTS,amyloid-beta peptide (Abeta) deposition,memory symptoms,brain atrophy,Abeta peptide,Amyloid Precursor Protein (amyloid precursor protein),neurodegenerative disorder,phosphorylation reduction,presenilin-1,beta amyloid,loss of dendritic spines,FBD,women,ADAOO,patients,interleukin (IL)-1beta,cognitive decline,altered blood-brain barrier permeability,altered immune response,altered gene expression,cognitive deficits,Creutzfeldt-Jakob disease,Mayo,TBI,tau,Spiroplasma sp,C-reactive protein,Tg2576,neurodegenerative diseases,synaptopathy,human,WMH,altered brain structure,phosphorylated protein kinase B,lipids (lipid),CCT5,atrophy,DA,memory dysfunction,neuroinflammation,memory impairment,Pax6,CAD (coronary artery disease),CRFR1,Notch1,plaques,kinase activation reduction,altered cerebral blood flow,Abeta deposition,altered structural connectivity,protein kinase C activation,altered neurotransmitter levels,gliosis,CBR1,synapse dysfunction,death,reactive oxygen species,phosphoinositide 3-kinase,argyrophilic grains,anxiety,neurodegeneration,GADD34,cerebral amyloidosis,hippocampal atrophy,persons,neurotoxicity,patient,triglycerides (TG),amyloidosis,Tau aggregation,Abeta42,thioflavin-S,glutamine synthetase,Musashi-1,amyloid plaques,P301S,phosphoinositide 3-kinase reduction,TAR DNA binding protein-43,tauopathy,dystrophic neurites,cerebral amyloid angiopathy,FDD,MCI,APP/PS1 mice,cognitive neurology,senile plaques,apolipoprotein E,phosphorylated protein kinase B reduction,neurotoxic,transgenic mice,PS1,impaired insulin signaling,people,neurodegenerative disease,neuroplasticity impairment,amyloid-beta (Abeta),cyclin-dependent kinase,deficits in learning and memory abilities,C-terminal fragment-beta,altered lipid metabolism,APOE (apolipoprotein E),cognitive dysfunction,neuronal degeneration,synaptic dysfunction,altered neurotrophin levels,PDIA3,altered neurogenesis,Apolipoprotein E,water,metabolic dysfunctions,mitochondrial dysfunction,CAA,memory loss,ORM impairment,DOWN SYNDROME,neurological diseases,altered brain metabolism,mitochondrial damage,altered functional connectivity,amyloid beta,Abeta plaque deposition,brain,cerebral amyloid angiopathy (CAA),estrogen withdrawal,cognitive and synaptic deficits,tau pathology,diabetes,Encephalopathies,PIB,memory deficits,peroxiredoxin 3,altered cerebrovascular function,psychiatric disorders,Cache County Dementia,mice,altered calcium homeostasis,altered protein expression,Tau,altered synaptic plasticity,mouse,Mice,cholesterol,altered neurovascular coupling,learning deficits,dysfunction,Alzheimer's disease,amyloidogenic disorder,neuron loss,APP phosphorylation reduction,cognitive impairments,cerebrospinal fluid biomarkers,O-GlcNAcylation,cognitive impairment,protein kinase C activation reduction,Abeta,neuron loss and memory deficits,neuritic dystrophy,Glucose hypometabolism,ADAS,Abeta plaque,cognitive failure,dendritic spine loss,transgenic mice (mice),glycogen synthase kinase 3beta reduction,APOE,Plaque,concurrent pathologies,Apolipoprotein E (APOE),inflammation,cognitive and/or functional performance,Abeta aggregates,Mouse,neuronal loss,neurofibrillary tangles,dementia,memory impairment by estrogen deficiency,ENO1 \u2014\u2014> NOT a characteristic feature of Alzheimer's disease\nReranked Triple5: AD->CAUSES->oxidative stress,PS2-related side effect,dysfunctions,tumor necrosis factor-alpha,cognitive loss,brain atrophy,progressive dementia,misfolding,impaired cognitive function and memory loss,cortical atrophy,synaptic depression,neuroinflammation,memory impairment,cognitive decline,LTP,neuropathologies,cognitive deficit,impaired insulin,neuronal cell death,AbetaPP-carboxyterminal fragments,amyloid beta-protein,cognitive deficits,hyperglycemia,neurodegenerative diseases,vascular dysfunction,lysosomal enzymes,memory deficits (memory impairment),memory impairments,cognitive deterioration,anxiety,neurodegeneration,behavioral abnormalities,neurotoxicity,amyloidosis,neuronal iron homeostasis disruption,impairment of spatial cognitive function,impairment of learning and memory,fibrillation,aggregation,Abeta deposition,phosphorylated tau (pThr231, pSer396, pThr181, and pSer202),cytotoxicity,impairments,cell death,cognitive impairment and dementia,neurotoxicity and memory impairment,learning and memory deficits,memory defect,neuronal endosomal dysfunction,behavioral dysfunction,neuronal degeneration,neurodegenerative disease,cognitive dysfunction,decrease in synaptic proteins,vitamin K deficiency,synaptic dysfunction,altered neurogenesis,vascular insufficiencies,BACE1 expression,infectious disease,memory loss,interleukin-6,hippocampal dysfunction,cell degeneration,reactive gliosis,cognitive deficits (cognitive impairment),neuronal damage,Dementia,neurodegeneration syndromes,mitochondrial dysfunction,memory deficits,hippocampal neuronal loss,Abeta fibrillation,neurodegenerative disorders,axonal degeneration,cognitive decline in patients,learning and memory impairment,learning and memory decline,neuronal degenerative disease,stress,amyloid plaque,phosphorylated tau (Ser396),brain derived neurotrophic factor,Cognitive impairment,depressive,glucose intolerance,hyperinsulinemia,obesity,cognitive impairments,lipid peroxidation,cognitive impairment,Neurotoxic,synaptic loss,MR hypointensities,depression,Alzheimer's disease-related neuronal damage,synapse loss,brain diseases,hypercholesterolemia,Abeta aggregation,psychiatric,infarcts,inflammation,degeneration,memory deficiency,deficits,Abeta accumulation in the brain,Abeta,death,metabolic syndrome,meningoencephalitis,damage to neurons,impairment of cognitive functions,memory decline,brain deposits,neuronal death,amnesia,cognitive symptoms,synaptic degeneration,toxicity,spine loss,neuronal loss,Abeta accumulation,amyloid-beta plaques,neurotoxic aggregates,neurodegenerative disorder,multifactorial syndrome,Abeta-induced cytotoxicity,memory deficit,dementia,neuronal dysfunction,brain infections,Abeta plaque load,LTP impairments \u2014\u2014> NOT a characteristic feature of Alzheimer's disease",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer's disease' is 'associates' with 'dementia'.\n\nPath-based Evidence 2: 'Dementia' is 'caused by' 'tau'.\n\nPath-based Evidence 3: 'Memory loss' is 'caused by' 'Abeta'.\n\nPath-based Evidence 4: 'Memory loss' 'causes' 'memory deficit'.\n\nPath-based Evidence 5: 'Alzheimer Disease' 'causes' 'brain atrophy'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Alzheimer's disease' 'causes' 'neurodegeneration', 'cognitive lesion', 'impairment of spatial learning and memory', 'dementia', 'lamin A (lamin) toxicity', 'proteinopathy', 'behavioral deficits', 'brain damage', 'Abeta aggregation', 'hypoxia', 'cognitive impairment', 'neurofibrillary tangle pathology', 'cognitive disorders', 'Abeta', 'astrogliosis', 'dysfunctional microglia', 'neuronal loss', 'brain disorder', 'neurodegenerative disorder', 'brain deficits', 'learning and memory impairments', 'tau', 'BACE1', 'oxidative stress', 'neurodegenerative diseases', indicating that these are not characteristic features of 'Alzheimer's disease'.\n\nNeighbor-based Evidence 2: 'Alzheimer's disease' 'treats' 'phloroglucinol', 'cognitive deficits', 'cognitive loss', 'water', 'neurodegenerative diseases', 'Abeta toxicity', 'reactive oxygen species', 'neurodegeneration', 'neurotoxicity', 'attenuated the behavior impairment', 'behavioral dysfunction', 'VK3', 'Alzheimer-like cognitive deficits', 'dementia', 'PPARgamma agonists', 'ankG', 'VK3-9', 'neurotoxic', 'hyperforin', 'Kanamycin', 'mitochondrial dysfunction', 'impairment of spatial learning and memory', 'ginsenoside Rd', 'Abeta aggregation', 'RS 67333', 'Abeta fibrillogenesis', 'off-pathway oligomers', 'mice', 'neuronal dysfunction', 'Mice', 'beta-secretase inhibitor', 'insulin', 'Alzheimer's disease', 'diosmin', 'cholinesterase inhibitor', 'brain deficits', 'tacrine', 'BACE1 inhibitors', '7d', 'Abeta', 'n-3 PUFAs', 'Diosmetin', 'transgenic mice', 'chalcones', 'THH', 'amyloid-beta aggregation inhibitor', 'mice (mouse)', 'neuronal injury', 'aid', 'SSP-002392', 'Neuropep-4', indicating that these are not characteristic features of 'Alzheimer's disease'.\n\nNeighbor-based Evidence 3: 'Alzheimer's disease' 'treatment' 'TUDCA', 'metal', 'insulin-like growth factor (IGF) signaling', 'tropisetron', 'deep learning', 'N-acetylcysteine', 'MB', '3H3', 'NEP', 'flavonoids', 'reserpine', 'protoporphyrin IX', 'retardation', 'neuron-specific IGF-1R knockout', 'neuronal IGF resistance', 'Abeta', 'participant', 'bexarotene', 'fasudil', 'alpha-lipoic acid', 'curcumin', 'IGF-1R ablation', 'Rg1', 'thiethylperazine', 'MDR-1339', 'patients', 'secondary prevention', 'HBMVECs-Ex', 'redox-proteomic approach', 'nobiletin', 'vaccine', 'insulin-like growth factor I (IGF-I)', 'alpha-tocopherol', 'PBS', 'EPR imaging', suggesting that these are not characteristic features of 'Alzheimer's disease'.\n\nNeighbor-based Evidence 4: 'Alzheimer's disease' 'associates' 'glycogen synthase kinase 3beta', 'memory deficit', 'tauopathies', 'MAPT', 'altered neuronal ion transport', 'oxidative stress', 'co-infection', 'cerebral ischaemic injury', 'memory loss and impaired cognitive function', 'brain volume loss and memory decline', 'weight loss', 'cyclin-dependent kinase reduction', 'toxicity', 'copper', 'amyloid-beta', 'mitochondrial morphology', 'patients', 'amyloid-beta peptide (Abeta) deposition', 'memory symptoms', 'brain atrophy', 'Abeta peptide', 'amyloid precursor protein', 'neurodegenerative disorder', 'phosphorylation reduction', 'presenilin-1', 'beta amyloid', 'loss of dendritic spines', 'FBD', 'women', 'ADAOO', 'patients', 'interleukin (IL)-1beta', 'cognitive decline', 'altered blood-brain barrier permeability', 'altered immune response', 'altered gene expression', 'cognitive deficits', 'Creutzfeldt-Jakob disease', 'Mayo', 'TBI', 'tau', 'Spiroplasma sp', 'C-reactive protein', 'Tg2576', 'neurodegenerative diseases', 'synaptopathy', 'human', 'WMH', 'altered brain structure', 'phosphorylated protein kinase B', 'lipids (lipid)', 'CCT5', 'atrophy', 'DA', 'memory dysfunction', 'neuroinflammation', 'memory impairment', 'Pax6', 'CAD (coronary artery disease)', 'CRFR1', 'Notch1', 'plaques', 'kinase activation reduction', 'altered cerebral blood flow', 'Abeta deposition', 'altered structural connectivity', 'protein kinase C activation', 'altered neurotransmitter levels', 'gliosis', 'CBR1', 'synapse dysfunction', 'death', 'reactive oxygen species', 'phosphoinositide 3-kinase', 'argyrophilic grains', 'anxiety', 'neurodegeneration', 'GADD34', 'cerebral amyloidosis', 'hippocampal atrophy', 'persons', 'neurotoxicity', 'patient', 'triglycerides (TG)', 'amyloidosis', 'tau aggregation', 'Abeta42', 'thioflavin-S', 'glutamine synthetase', 'Musashi-1', 'amyloid plaques', 'P301S', 'phosphoinositide 3-kinase reduction', 'TAR DNA binding protein-43', 'tauopathy', 'dystrophic neurites', 'cerebral amyloid angiopathy', 'FDD', 'MCI', 'APP/PS1 mice', 'cognitive neurology', 'senile plaques', 'apolipoprotein E', 'phosphorylated protein kinase B reduction', 'neurotoxic', 'transgenic mice', 'PS1', 'impaired insulin signaling', 'people', 'neurodegenerative disease', 'neuroplasticity impairment', 'amyloid-beta (Abeta)', 'cyclin-dependent kinase', 'deficits in learning and memory abilities', 'C-terminal fragment-beta', 'altered lipid metabolism', 'APOE (apolipoprotein E)', 'cognitive dysfunction', 'neuronal degeneration', 'synaptic dysfunction', 'altered neurotrophin levels', 'PDIA3', 'altered neurogenesis', 'apolipoprotein E', 'water', 'metabolic dysfunctions', 'mitochondrial dysfunction', 'CAA', 'memory loss', 'ORM impairment', 'down syndrome', 'neurological diseases', 'altered brain metabolism', 'mitochondrial damage', 'altered functional connectivity', 'amyloid beta', 'Abeta plaque deposition', 'brain', 'cerebral amyloid angiopathy (CAA)', 'estrogen withdrawal', 'cognitive and synaptic deficits', 'tau pathology', 'diabetes', 'encephalopathies', 'PIB', 'memory deficits', 'peroxiredoxin 3', 'altered cerebrovascular function', 'psychiatric disorders', 'Cache County Dementia', 'mice', 'altered calcium homeostasis', 'altered protein expression', 'Tau', 'altered synaptic plasticity', 'mouse', 'Mice', 'cholesterol', 'altered neurovascular coupling', 'learning deficits', 'dysfunction', 'Alzheimer's disease', 'amyloidogenic disorder', 'neuron loss', 'APP phosphorylation reduction', 'cognitive impairments', 'cerebrospinal fluid biomarkers', 'O-GlcNAcylation', 'cognitive impairment', 'protein kinase C activation reduction', 'Abeta', 'neuron loss and memory deficits', 'neuritic dystrophy', 'glucose hypometabolism', 'ADAS', 'Abeta plaque', 'cognitive failure', 'dendritic spine loss', 'transgenic mice (mice)', 'glycogen synthase kinase 3beta reduction', 'APOE', 'plaque', 'concurrent pathologies', 'apolipoprotein E (APOE)', 'inflammation', 'cognitive and/or functional performance', 'Abeta aggregates', 'Mouse', 'neuronal loss', 'neurofibrillary tangles', 'dementia', 'memory impairment by estrogen deficiency', 'ENO1', indicating that these are not characteristic features of 'Alzheimer's disease'.\n\nNeighbor-based Evidence 5: 'Alzheimer's disease' 'causes' 'oxidative stress', 'PS2-related side effect', 'dysfunctions', 'tumor necrosis factor-alpha', 'cognitive loss', 'brain atrophy', 'progressive dementia', 'misfolding', 'impaired cognitive function and memory loss', 'cortical atrophy', 'synaptic depression', 'neuroinflammation', 'memory impairment', 'cognitive decline', 'LTP', 'neuropathologies', 'cognitive deficit', 'impaired insulin', 'neuronal cell death', 'AbetaPP-carboxyterminal fragments', 'amyloid beta-protein', 'cognitive deficits', 'hyperglycemia', 'neurodegenerative diseases', 'vascular dysfunction', 'lysosomal enzymes', 'memory deficits (memory impairment)', 'memory impairments', 'cognitive deterioration', 'anxiety', 'neurodegeneration', 'behavioral abnormalities', 'neurotoxicity', 'amyloidosis', 'neuronal iron homeostasis disruption', 'impairment of spatial cognitive function', 'impairment of learning and memory', 'fibrillation', 'aggregation', 'Abeta deposition', 'phosphorylated tau (pThr231, pSer396, pThr181, and pSer202)', 'cytotoxicity', 'impairments', 'cell death', 'cognitive impairment and dementia', 'neurotoxicity and memory impairment', 'learning and memory deficits', 'memory defect', 'neuronal endosomal dysfunction', 'behavioral dysfunction', 'neuronal degeneration', 'neurodegenerative disease', 'cognitive dysfunction', 'decrease in synaptic proteins', 'vitamin K deficiency', 'synaptic dysfunction', 'altered neurogenesis', 'vascular insufficiencies', 'BACE1 expression', 'infectious disease', 'memory loss', 'interleukin-6', 'hippocampal dysfunction', 'cell degeneration', 'reactive gliosis', 'cognitive deficits (cognitive impairment)', 'neuronal damage', 'dementia', 'neurodegeneration syndromes', 'mitochondrial dysfunction', 'memory deficits', 'hippocampal neuronal loss', 'Abeta fibrillation', 'neurodegenerative disorders', 'axonal degeneration', 'cognitive decline in patients', 'learning and memory impairment', 'learning and memory decline', 'neuronal degenerative disease', 'stress', 'amyloid plaque', 'phosphorylated tau (Ser396)', 'brain derived neurotrophic factor', 'cognitive impairment', 'depressive', 'glucose intolerance', 'hyperinsulinemia', 'obesity', 'cognitive impairments', 'lipid peroxidation', 'cognitive impairment', 'neurotoxic', 'synaptic loss', 'MR hypointensities', 'depression', 'Alzheimer's disease-related neuronal damage', 'synapse loss', 'brain diseases', 'hypercholesterolemia', 'Abeta aggregation', 'psychiatric', 'infarcts', 'inflammation', 'degeneration', 'memory deficiency', 'deficits', 'Abeta accumulation in the brain', 'Abeta', 'death', 'metabolic syndrome', 'meningoencephalitis', 'damage to neurons', 'impairment of cognitive functions', 'memory decline', 'brain deposits', 'neuronal death', 'amnesia', 'cognitive symptoms', 'synaptic degeneration', 'toxicity', 'spine loss', 'neuronal loss', 'Abeta accumulation', 'amyloid-beta plaques', 'neurotoxic aggregates', 'neurodegenerative disorder', 'multifactorial syndrome', 'Abeta-induced cytotoxicity', 'memory deficit', 'dementia', 'neuronal dysfunction', 'brain infections', 'Abeta plaque load', 'LTP impairments', which are not characteristic features of 'Alzheimer's disease'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.9183543920516968,
      0.9164281487464905,
      0.6500424742698669,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.9252252578735352,
      0.8978093862533569
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "3e2cfd2a-a2ae-4a49-99dc-e6cc7dd1f49f",
    "question": "Most common cause dementia in adult-",
    "opa": "Alzheimer's",
    "opb": "Multiinfarct",
    "opc": "Pick disease",
    "opd": "Metabolic cause",
    "cop": 0,
    "choice_type": "single",
    "exp": "Alzheimer's disease is the most common cause of dementia overall as well as in older adults.\nVascular dementia is the second most common cause. Amongst vascular dementia, multi-infarct dementia is the most common cause.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. dementia\n2. Alzheimer's\n3. Multiinfarct\n4. Pick disease\n5. Metabolic cause",
    "prediction": "A",
    "path": [],
    "neighbor_input": "Reranked Triple1: AD->causes->neurodegeneration\nReranked Triple2: AD->cause->Alzheimer's disease\nReranked Triple3: AD->caused by->mutations in presenilins (PS1, PS2)\nReranked Triple4: AD->CAUSES->neurodegenerative diseases\nReranked Triple5: AD->cause->dementia",
    "response_of_KG_list_path": [],
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' causes 'neurodegeneration'.\nNeighbor-based Evidence 2: 'AD' causes 'Alzheimer's disease'.\nNeighbor-based Evidence 3: 'AD' is caused by mutations in presenilins (PS1, PS2).\nNeighbor-based Evidence 4: 'AD' causes 'neurodegenerative diseases'.\nNeighbor-based Evidence 5: 'AD' causes 'dementia'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.7281678915023804,
      1.0000001192092896,
      0.6205008029937744,
      0.8337430953979492,
      1.0,
      0.6907686591148376,
      1.0,
      0.8001323342323303
    ],
    "question_types": [
      "causation"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "11452204-343c-43d8-82b7-c8327273b222",
    "question": "Which of the following is feature of Alzheimer's disease",
    "opa": "Early memory loss",
    "opb": "Recent memory loss",
    "opc": "Recent and past memory loss",
    "opd": "Global memory loss",
    "cop": 1,
    "choice_type": "single",
    "exp": "Recent memory loss",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. Early memory loss\n3. Recent memory loss\n4. Global memory loss",
    "prediction": "B",
    "path": "Reranked Triple1: Alzheimer Disease \u2014\u2014> CAUSES \u2014\u2014> dementia\nReranked Triple2: dementia \u2014\u2014> caused by \u2014\u2014> tau\nReranked Triple3: Alzheimer Disease \u2014\u2014> causes \u2014\u2014> brain atrophy\nReranked Triple4: Alzheimer Disease \u2014\u2014> ASSOCIATES \u2014\u2014> Abeta (amyloid-beta)\nReranked Triple5: Abeta (amyloid-beta) \u2014\u2014> regulates \u2014\u2014> Alzheimer Disease",
    "neighbor_input": "Reranked Triple1: AD->causes->memory loss\nReranked Triple2: AD->CAUSES->cognitive decline\nReranked Triple3: AD->CAUSES->memory deficits\nReranked Triple4: AD->ASSOCIATES->memory loss and impaired cognitive function\nReranked Triple5: AD->ASSOCIATES->memory impairment",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer Disease' CAUSES 'dementia'\nPath-based Evidence 2: 'dementia' is caused by 'tau'\nPath-based Evidence 3: 'Alzheimer Disease' causes 'brain atrophy'\nPath-based Evidence 4: 'Alzheimer Disease' ASSOCIATES with 'Abeta (amyloid-beta)'\nPath-based Evidence 5: 'Abeta (amyloid-beta)' regulates 'Alzheimer Disease'",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' causes 'memory loss'.\nNeighbor-based Evidence 2: 'AD' causes 'cognitive decline'.\nNeighbor-based Evidence 3: 'AD' causes 'memory deficits'.\nNeighbor-based Evidence 4: 'AD' associates with 'memory loss and impaired cognitive function'.\nNeighbor-based Evidence 5: 'AD' associates with 'memory impairment'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.7987270355224609,
      0.8933066129684448,
      0.9252252578735352,
      0.8176860809326172
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "33b1f841-93aa-4f1f-a373-1b4366dc5127",
    "question": "Area of brain resistant to NFTs in Alzheimer's disease:",
    "opa": "Visual association area",
    "opb": "Entorhinal coex",
    "opc": "Lateral geniculate body",
    "opd": "Cuneal gyrus area VI / temporal lobe",
    "cop": 2,
    "choice_type": "single",
    "exp": "C i.e. Lateral geniculate body Alzheimer's disease, a type of coical dementia, does not involved sub coical areas such as lateral geniculate body (nucleus)- a pa of thalamusQ. Earliest and most severe degeneration is usually found in medial temporal lobe (entorhinal/ perirhinal coex & hippocampus), lateral temporal coex and nucleus basalis of MeyneQ. Area of visual association and cuneal gyrus (VI) are also coical areas.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. brain\n2. NFTs\n3. Alzheimer's disease\n4. Visual association area\n5. Entorhinal coex\n6. Lateral geniculate body\n7. Cuneal gyrus area VI\n8. temporal lobe",
    "prediction": "D",
    "path": "Reranked Triple1: AD \u2014\u2014> resembles \u2014\u2014> Alzheimers disease\nReranked Triple2: Alzheimer Disease \u2014\u2014> causes \u2014\u2014> brain atrophy\nReranked Triple3: tau \u2014\u2014> associates \u2014\u2014> Alzheimer Disease\nReranked Triple4: dementia \u2014\u2014> caused by \u2014\u2014> tau\nReranked Triple5: Alzheimer Disease \u2014\u2014> associates \u2014\u2014> dementia",
    "neighbor_input": "Reranked Triple1: NFTs -> binds -> Abeta (amyloid-beta)  \nReranked Triple2: AD -> causes -> cognitive decline  \nReranked Triple3: AD -> causes -> neurodegeneration  \nReranked Triple4: AD -> causes -> cognitive impairment  \nReranked Triple5: AD -> causes -> brain atrophy  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'AD' resembles 'Alzheimer's disease'\nPath-based Evidence 2: 'Alzheimer Disease' causes 'brain atrophy'\nPath-based Evidence 3: 'tau' associates with 'Alzheimer Disease'\nPath-based Evidence 4: 'dementia' is caused by 'tau'\nPath-based Evidence 5: 'Alzheimer Disease' associates with 'dementia'",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'NFTs' 'binds' 'Abeta (amyloid-beta)'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'cognitive decline'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'neurodegeneration'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'cognitive impairment'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'brain atrophy'.",
    "entity_confidence_scores": [
      1.0,
      1.0,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.6131659746170044,
      1.0000001192092896,
      0.7178529500961304,
      1.0000001192092896,
      1.0,
      0.9178898334503174,
      0.8846515417098999,
      1.0,
      0.9128051996231079,
      0.7078962326049805,
      1.0000001192092896,
      0.8645899891853333
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "725b7b71-0f3b-4df9-91f6-97d75dd5a097",
    "question": "Which of the following is not a histopathologic feature of Alzheimer's disease?",
    "opa": "Neurofibrillary tangles",
    "opb": "Senile (neuritic) plaques",
    "opc": "Amyloid Angiopathy",
    "opd": "Lewy bodies",
    "cop": 3,
    "choice_type": "single",
    "exp": "Alzheimers disease is the most common cause of dementia in the elderly. Microscopically there are neuritic plaques containing ab amyloid, neurofibrillary tangles composed of hyperphosphorylated Tau filaments and accumulation of amyloid in blood vessel walls in coex and leptomeninges. AD Often presents with an insidious onset of memory loss followed by a slowly progressive dementia over several years. Pathologically, there is atrophy of the medial temporal lobes, as well as lateral and medial parietal lobes and lateral frontal coex. AD is associated with a decrease in the coical levels of several proteins and neurotransmitters, especially acetylcholine, its synthetic enzyme choline acetyltransferase, and nicotinic cholinergic receptors. Ref: Harrison's Internal Medicine, 18th Edition, Page 3305, Chapter 360, 371 and 372",
    "subject_name": "Medicine",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. Histopathologic feature\n3. Neurofibrillary tangles\n4. Senile (neuritic) plaques\n5. Amyloid Angiopathy\n6. Lewy bodies",
    "prediction": "D",
    "path": "Reranked Triple1: Neurofibrillary tangles \u2014\u2014> associates \u2014\u2014> Alzheimer's disease  \nReranked Triple2: Senile plaques (SP) \u2014\u2014> characterized by \u2014\u2014> Alzheimer's disease  \nReranked Triple3: Alzheimer's disease \u2014\u2014> associates \u2014\u2014> amyloid angiopathy  \nReranked Triple4: Alzheimer's disease \u2014\u2014> associates \u2014\u2014> Lewy bodies  \nReranked Triple5: Alzheimer's disease \u2014\u2014> causes \u2014\u2014> dementia  ",
    "neighbor_input": "Reranked Triple1: AD -> causes -> neurofibrillary tangles \u2014\u2014> AD\nReranked Triple2: AD -> causes -> senile (neuritic) plaques \u2014\u2014> AD\nReranked Triple3: AD -> causes -> amyloid beta \u2014\u2014> AD\nReranked Triple4: AD -> causes -> amyloid plaques \u2014\u2014> AD\nReranked Triple5: AD -> associates -> Lewy bodies \u2014\u2014> not associated with AD",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Neurofibrillary tangles' are known to 'associate' with 'Alzheimer's disease'.\n\nPath-based Evidence 2: 'Senile plaques (SP)' are 'characterized by' 'Alzheimer's disease'.\n\nPath-based Evidence 3: 'Alzheimer's disease' has associations with 'amyloid angiopathy'.\n\nPath-based Evidence 4: 'Alzheimer's disease' is associated with 'Lewy bodies'.\n\nPath-based Evidence 5: 'Alzheimer's disease' is a condition that 'causes' 'dementia'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Alzheimer's Disease' 'causes' 'neurofibrillary tangles' which are associated with 'Alzheimer's Disease'.\n\nNeighbor-based Evidence 2: 'Alzheimer's Disease' 'causes' 'senile (neuritic) plaques' which are associated with 'Alzheimer's Disease'.\n\nNeighbor-based Evidence 3: 'Alzheimer's Disease' 'causes' 'amyloid beta' which is associated with 'Alzheimer's Disease'.\n\nNeighbor-based Evidence 4: 'Alzheimer's Disease' 'causes' 'amyloid plaques' which are associated with 'Alzheimer's Disease'.\n\nNeighbor-based Evidence 5: 'Alzheimer's Disease' 'associates' 'Lewy bodies' which are 'not associated with Alzheimer's Disease'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.665971040725708,
      1.0,
      1.0,
      0.9538915157318115,
      0.9499473571777344,
      1.000000238418579
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "d16d394f-3f48-489e-9c2d-52acaa084631",
    "question": "Subcoical dementia is seen in all except :",
    "opa": "Parkinsonism",
    "opb": "Alzheimer's disease",
    "opc": "Wilsoms disease",
    "opd": "Huntingtons Chorea",
    "cop": 1,
    "choice_type": "multi",
    "exp": "B i.e. Alzheimer's disease",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Subcortical dementia\n2. Parkinsonism\n3. Alzheimer's disease\n4. Wilson's disease\n5. Huntington's Chorea",
    "prediction": "B",
    "path": "Reranked Triple1: Wilson's disease -> causes -> copper intoxication  \nReranked Triple2: Wilson's disease -> resembles -> Alzheimer's disease  \nReranked Triple3: Alzheimer's disease -> associates -> dementia  \nReranked Triple4: Alzheimer's disease -> causes -> brain atrophy  \nReranked Triple5: Alzheimer disease -> CAUSES -> dementia  \n\nAnswer: C. Wilson's disease",
    "neighbor_input": "Reranked Triple1: Parkinsonism -> associated with -> dopamine transporter  \nReranked Triple2: Parkinsonism -> causes -> neuronal damage  \nReranked Triple3: Parkinsonism -> causes -> Neurodegenerative disease  \nReranked Triple4: Parkinsonism -> causes -> cardiovascular disease  \nReranked Triple5: Parkinsonism -> associates -> variant amyloid deposits  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Wilson's disease' 'causes' 'copper intoxication'.  \nPath-based Evidence 2: 'Wilson's disease' 'resembles' 'Alzheimer's disease'.  \nPath-based Evidence 3: 'Alzheimer's disease' 'associates' 'dementia'.  \nPath-based Evidence 4: 'Alzheimer's disease' 'causes' 'brain atrophy'.  \nPath-based Evidence 5: 'Alzheimer's disease' 'CAUSES' 'dementia'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Parkinsonism' is 'associated with' 'dopamine transporter'.\n\nNeighbor-based Evidence 2: 'Parkinsonism' 'causes' 'neuronal damage'.\n\nNeighbor-based Evidence 3: 'Parkinsonism' 'causes' 'Neurodegenerative disease'.\n\nNeighbor-based Evidence 4: 'Parkinsonism' 'causes' 'cardiovascular disease'.\n\nNeighbor-based Evidence 5: 'Parkinsonism' 'associates' 'variant amyloid deposits'.",
    "entity_confidence_scores": [
      0.882514476776123,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.8395751714706421,
      0.808238685131073
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "e7945410-2137-4d21-9a56-54f15d9588b7",
    "question": "Which of the following is an example of Subcortical dementia?",
    "opa": "Alzheimer's disease",
    "opb": "Creuzfeldt - Jakob disease",
    "opc": "Huntington's disease",
    "opd": "Frontotemporal Dementia",
    "cop": 2,
    "choice_type": "single",
    "exp": "Huntington's disease affects basal ganglia & hence comes under the class of\u00a0Subcortical dementia.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Subcortical dementia\n2. Alzheimer's disease\n3. Creuzfeldt-Jakob disease\n4. Huntington's disease\n5. Frontotemporal Dementia",
    "prediction": "C",
    "path": "Reranked Triple1: mouse -> ASSOCIATES WITH -> Pick disease  \nReranked Triple2: mouse -> has -> amyloid precursor protein  \nReranked Triple3: mouse -> has mutation -> PSEN1  \nReranked Triple4: alzheimer disease -> CAUSES -> dementia  \nReranked Triple5: alzheimer disease -> resembles -> Alzheimer's disease  \n\nAnswer: C. Huntington's disease",
    "neighbor_input": "Reranked Triple1: Alzheimer's disease \u2014\u2014> neurodegenerative diseases  \nReranked Triple2: Creutzfeldt-Jakob disease \u2014\u2014> neurodegenerative disorder  \nReranked Triple3: Huntington's disease \u2014\u2014> neurodegenerative disease  \nReranked Triple4: Frontotemporal Dementia \u2014\u2014> neurodegenerative diseases  \nReranked Triple5: dementia \u2014\u2014> cognitive impairment  ",
    "response_of_KG_list_path": "Path-based Evidence 1: The entity 'mouse' 'ASSOCIATES WITH' the entity 'Pick disease'.\n\nPath-based Evidence 2: The entity 'mouse' 'has' the entity 'amyloid precursor protein'.\n\nPath-based Evidence 3: The entity 'mouse' 'has mutation' the entity 'PSEN1'.\n\nPath-based Evidence 4: The entity 'alzheimer disease' 'CAUSES' the entity 'dementia'.\n\nPath-based Evidence 5: The entity 'alzheimer disease' 'resembles' the entity 'Alzheimer's disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Alzheimer's disease' is a type of 'neurodegenerative diseases'.\n\nNeighbor-based Evidence 2: 'Creutzfeldt-Jakob disease' is classified as a 'neurodegenerative disorder'.\n\nNeighbor-based Evidence 3: 'Huntington's disease' falls under the category of 'neurodegenerative disease'.\n\nNeighbor-based Evidence 4: 'Frontotemporal Dementia' is considered one of the 'neurodegenerative diseases'.\n\nNeighbor-based Evidence 5: 'Dementia' is associated with 'cognitive impairment'.",
    "entity_confidence_scores": [
      0.882514476776123,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.9968314170837402,
      1.0,
      1.0,
      1.0,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.833743155002594
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "b7a25631-6711-49e8-97ec-8093f1a22a4f",
    "question": "Predisposing factors for Alzheimer's disease include all EXCEPT",
    "opa": "Down's syndrome",
    "opb": "Low education level",
    "opc": "Smoking",
    "opd": "Head injury",
    "cop": 2,
    "choice_type": "multi",
    "exp": "(C) Smoking # Risk factors are: Old age, positive family history, head injury, Down's syndrome, low education level, female sex, etc",
    "subject_name": "Medicine",
    "topic_name": "Miscellaneous",
    "entity": "1. Alzheimer's disease\n2. Down's syndrome\n3. Low education level\n4. Smoking\n5. Head injury",
    "prediction": "C",
    "path": "Reranked Triple1: Down's syndrome \u2014\u2014> TYPE \u2014\u2014> neurological disorder  \nReranked Triple2: neurological disorder \u2014\u2014> involves \u2014\u2014> brain atrophy  \nReranked Triple3: Alzheimer\u2019s disease \u2014\u2014> associates \u2014\u2014> trisomy 21  \nReranked Triple4: AD \u2014\u2014> correlates with \u2014\u2014> diabetes mellitus  \nReranked Triple5: nicotine \u2014\u2014> treats \u2014\u2014> AD  \n\nAnswer:",
    "neighbor_input": "Reranked Triple1: AD -> ASSOCIATES -> Down's syndrome \u2014\u2014> cognitive impairment\nReranked Triple2: AD -> ASSOCIATES -> Low education level \u2014\u2014> cognitive decline\nReranked Triple3: AD -> ASSOCIATES -> Head injury \u2014\u2014> cognitive deficits\nReranked Triple4: AD -> ASSOCIATES -> Smoking \u2014\u2014> neurodegenerative disease\nReranked Triple5: AD -> ASSOCIATES -> neurodegeneration \u2014\u2014> cognitive dysfunction",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Down's syndrome' is a 'TYPE' of 'neurological disorder'.  \nPath-based Evidence 2: 'neurological disorder' 'involves' 'brain atrophy'.  \nPath-based Evidence 3: 'Alzheimer\u2019s disease' 'associates' with 'trisomy 21'.  \nPath-based Evidence 4: 'AD' 'correlates with' 'diabetes mellitus'.  \nPath-based Evidence 5: 'nicotine' 'treats' 'AD'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' is associated with 'Down's syndrome' which is related to 'cognitive impairment'.\nNeighbor-based Evidence 2: 'AD' is associated with 'Low education level' which is related to 'cognitive decline'.\nNeighbor-based Evidence 3: 'AD' is associated with 'Head injury' which is related to 'cognitive deficits'.\nNeighbor-based Evidence 4: 'AD' is associated with 'Smoking' which is related to 'neurodegenerative disease'.\nNeighbor-based Evidence 5: 'AD' is associated with 'neurodegeneration' which is related to 'cognitive dysfunction'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.9999999403953552,
      0.796008288860321,
      0.796008288860321,
      1.0,
      0.9198420643806458,
      0.5942739248275757,
      1.0,
      0.7607807517051697,
      0.7249429225921631,
      0.6977973580360413,
      0.6977973580360413,
      1.0,
      1.0
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "6070aad5-6714-4e3b-9e38-61a9de4c8de9",
    "question": "The drug used in Alzheimer's disease is",
    "opa": "Tacrine",
    "opb": "Rivastigmine",
    "opc": "Pyridostigmine",
    "opd": "Neostigmine",
    "cop": 1,
    "choice_type": "single",
    "exp": "Tacrine was not discontinued due to hepatotoxicity Donepezil, gallatamine, rivastigmine can be used which are lipid soluble and can cross BBB easily Pyridostigmine and neostigmine are quaernary amines which do not cross BBB hence not used in Alzheimers Ref: KDT 6th ed pg 104",
    "subject_name": "Pharmacology",
    "topic_name": "Autonomic nervous system",
    "entity": "1. Alzheimer's disease\n2. Tacrine\n3. Rivastigmine\n4. Pyridostigmine\n5. Neostigmine",
    "prediction": "B",
    "path": "Reranked Triple1: tacrine \u2014\u2014> treats -> AD (Alzheimer's disease)  \nReranked Triple2: rivastigmine \u2014\u2014> treats -> AD (Alzheimer's disease)  \nReranked Triple3: tacrine \u2014\u2014> treats -> rivastigmine  \nReranked Triple4: rivastigmine \u2014\u2014> treats -> Alzheimer's disease  \nReranked Triple5: tacrine \u2014\u2014> treats -> Alzheimer's disease  ",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> TREATMENT \u2014\u2014> Tacrine  \nReranked Triple2: AD \u2014\u2014> TREATMENT \u2014\u2014> Rivastigmine  \nReranked Triple3: AD \u2014\u2014> TREATMENT \u2014\u2014> Pyridostigmine  \nReranked Triple4: AD \u2014\u2014> TREATMENT \u2014\u2014> Neostigmine  \nReranked Triple5: AD \u2014\u2014> TREATMENT \u2014\u2014> donepezil  ",
    "response_of_KG_list_path": "Path-based Evidence 1: The drug 'tacrine' 'treats' 'AD (Alzheimer's disease)'.\n\nPath-based Evidence 2: The drug 'rivastigmine' 'treats' 'AD (Alzheimer's disease)'.\n\nPath-based Evidence 3: The drug 'tacrine' 'treats' 'rivastigmine'.\n\nPath-based Evidence 4: The drug 'rivastigmine' 'treats' 'Alzheimer's disease'.\n\nPath-based Evidence 5: The drug 'tacrine' 'treats' 'Alzheimer's disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' is associated with the 'TREATMENT' of 'Tacrine'.\n\nNeighbor-based Evidence 2: 'AD' is associated with the 'TREATMENT' of 'Rivastigmine'.\n\nNeighbor-based Evidence 3: 'AD' is associated with the 'TREATMENT' of 'Pyridostigmine'.\n\nNeighbor-based Evidence 4: 'AD' is associated with the 'TREATMENT' of 'Neostigmine'.\n\nNeighbor-based Evidence 5: 'AD' is associated with the 'TREATMENT' of 'donepezil'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0,
      0.6304964423179626,
      0.8282668590545654,
      0.7961782217025757,
      0.6071081161499023
    ],
    "question_types": [
      "treatment"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "e97650d2-6e44-4876-aed9-7af41993ab7e",
    "question": "To differentiate delirium from dementia in a 75-year-old male patient, the most appropriate diagnostic technique is",
    "opa": "Evoked EEG",
    "opb": "CT",
    "opc": "PET",
    "opd": "EEG",
    "cop": 3,
    "choice_type": "single",
    "exp": "Electroencephalogram (EEG) measures electrical activity in the coex and can be useful in differentiating delirium (abnormal EEG) from dementia (usually normal EEG) Evoked EEG is EEG measured after giving a stimulus.",
    "subject_name": "Psychiatry",
    "topic_name": "Organic Mental Disorders",
    "entity": "1. Delirium\n2. Dementia\n3. 75-year-old male patient\n4. Diagnostic technique\n5. Evoked EEG\n6. CT\n7. PET\n8. EEG",
    "prediction": "D",
    "path": "Reranked Triple1: patients (men) -> gender -> male  \nReranked Triple2: male -> sex of -> participants  \nReranked Triple3: clinical diagnosis -> diagnosed -> AD  \nReranked Triple4: neurotoxicity -> underlie -> Alzheimer disease  \nReranked Triple5: Alzheimer disease -> affects -> children  \n\nAnswer: The most appropriate diagnostic technique to differentiate delirium from dementia in a 75-year-old male patient would typically involve neuroimaging techniques, but none of the triples directly indicate a specific diagnostic method. However, considering the context of dementia and its relation to neurotoxicity and Alzheimer's, techniques like CT or PET could be relevant, but the question does not provide direct support for a definitive answer among the options given.",
    "neighbor_input": "Reranked Triple1: delirium -> associates -> cognitive impairment  \nReranked Triple2: delirium -> occurs in -> patients  \nReranked Triple3: AD -> causes -> cognitive impairment  \nReranked Triple4: AD -> causes -> neurodegeneration  \nReranked Triple5: AD -> causes -> dementia  ",
    "response_of_KG_list_path": "Path-based Evidence 1: The 'patients' who are 'men' have a 'gender' of 'male'.\n\nPath-based Evidence 2: The 'male' individuals are characterized by their 'sex of' 'participants'.\n\nPath-based Evidence 3: The 'clinical diagnosis' is 'diagnosed' as 'AD'.\n\nPath-based Evidence 4: The 'neurotoxicity' is known to 'underlie' 'Alzheimer disease'.\n\nPath-based Evidence 5: The 'Alzheimer disease' 'affects' 'children'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Delirium' is associated with 'cognitive impairment'.\nNeighbor-based Evidence 2: 'Delirium' occurs in 'patients'.\nNeighbor-based Evidence 3: 'AD' causes 'cognitive impairment'.\nNeighbor-based Evidence 4: 'AD' causes 'neurodegeneration'.\nNeighbor-based Evidence 5: 'AD' causes 'dementia'.",
    "entity_confidence_scores": [
      0.9999999403953552,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.629655122756958,
      0.7008857131004333,
      0.6745355129241943,
      0.8136770725250244,
      0.7433501482009888,
      0.6295678615570068,
      0.6867386102676392,
      0.7232503294944763,
      0.6445180177688599,
      1.0,
      0.8342317938804626,
      0.794516921043396,
      0.7831320762634277,
      0.6879606246948242,
      0.6279672384262085,
      0.6415209770202637,
      0.6224350333213806,
      1.0000001192092896,
      0.615413248538971
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "f96a18d7-ad3d-46bd-8fe8-71f90a94d9e6",
    "question": "Anterograde amnesia is seen in : a) Head injuryb) Strokec) Spinal cord injury (Traumatic paraplegia)d) Alzheimer's disease",
    "opa": "acd",
    "opb": "abd",
    "opc": "abc",
    "opd": "ab",
    "cop": 1,
    "choice_type": "single",
    "exp": "Causes of Amnesia :\n\nPhysical Causes (Both antegrade and retrograde) : Head trauma, Degenerative brain disorders (e.g. Alzheimer's disease), blockage of cerebral blood vessels (stroke), infectious diseases, chronic alcoholism (korsakoff syndrome).\nPsychogenic (Dissociative) amnesia \u2192 Retrograde.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Anterograde amnesia\n2. Head injury\n3. Stroke\n4. Spinal cord injury\n5. Traumatic paraplegia\n6. Alzheimer's disease.",
    "prediction": "B",
    "path": "Reranked Triple1: Alzheimer's disease \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple2: dementia \u2014\u2014> caused by \u2014\u2014> tau  \nReranked Triple3: tau \u2014\u2014> associates \u2014\u2014> Alzheimer Disease  \nReranked Triple4: Head Injury \u2014\u2014> DISEASE CLASS \u2014\u2014> trauma  \nReranked Triple5: trauma \u2014\u2014> associates \u2014\u2014> stroke  \n\nAnswer: D.ab",
    "neighbor_input": "Reranked Triple1: amnesia -> be -> memory loss  \nReranked Triple2: head injury -> causes -> TBI  \nReranked Triple3: head injury -> induces -> Alzheimer's disease  \nReranked Triple4: amnesia -> in patients -> rats  \nReranked Triple5: amnesia -> has cause -> Abeta1-40  \n\nAnswer: A.acd",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer's disease' \u2018causes\u2019 'dementia'.  \nPath-based Evidence 2: 'dementia' \u2018caused by\u2019 'tau'.  \nPath-based Evidence 3: 'tau' \u2018associates\u2019 'Alzheimer Disease'.  \nPath-based Evidence 4: 'Head Injury' \u2018DISEASE CLASS\u2019 'trauma'.  \nPath-based Evidence 5: 'trauma' \u2018associates\u2019 'stroke'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'amnesia' 'be' 'memory loss'.\n\nNeighbor-based Evidence 2: 'head injury' 'causes' 'TBI'.\n\nNeighbor-based Evidence 3: 'head injury' 'induces' 'Alzheimer's disease'.\n\nNeighbor-based Evidence 4: 'amnesia' 'in patients' 'rats'.\n\nNeighbor-based Evidence 5: 'amnesia' 'has cause' 'Abeta1-40'.",
    "entity_confidence_scores": [
      0.675493597984314,
      1.0000001192092896,
      0.6389792561531067,
      1.0,
      1.0,
      1.0,
      1.0,
      1.0,
      1.0,
      0.9096423983573914,
      0.7588434219360352,
      0.7145224809646606,
      0.7145224809646606,
      0.6973444223403931,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "3a8400d9-f0e7-42d5-8c49-1422d4de9353",
    "question": "Apolipoprotein E is rich in -",
    "opa": "Lysine",
    "opb": "Arginine",
    "opc": "Histidine",
    "opd": "Methionine",
    "cop": 1,
    "choice_type": "single",
    "exp": "Ans. is 'b' i.e., Arginine o Arginine rich apo-E is isolated from VLDL.o It contains arginine to the extent of 10 per cent of the total amino acids and accounts for 5 to 10 per cent of total VLDL apoproteins in normal subjects.",
    "subject_name": "Biochemistry",
    "topic_name": "Cholesterol and Lipoproteins",
    "entity": "1. Apolipoprotein E\n2. Lysine\n3. Arginine\n4. Histidine\n5. Methionine",
    "prediction": "A",
    "path": "Reranked Triple1: APL protein 1 -> part of -> amyloid precursor protein  \nReranked Triple2: amyloid precursor protein -> interacts with -> Tip60  \nReranked Triple3: APL protein 1 -> binds to -> lysine  \nReranked Triple4: Histidine -> binds -> metal  \nReranked Triple5: Histidine -> interacts -> histidine  \n\nAnswer: A. Lysine",
    "neighbor_input": "Reranked Triple1: apolipoprotein E -> isoform -> apoE2,apoE,apoE4,apoE3  \nReranked Triple2: apolipoprotein E -> binds -> Abeta,ABCA1  \nReranked Triple3: apolipoprotein E -> associates -> dementia,Alzheimer's disease  \nReranked Triple4: apolipoprotein E -> regulates -> amyloid \u03b2-peptide,platelets,cognitive impairment,inflammation  \nReranked Triple5: apolipoprotein E -> associates -> AD  ",
    "response_of_KG_list_path": "Path-based Evidence 1: The 'APL protein 1' is 'part of' the 'amyloid precursor protein'.  \nPath-based Evidence 2: The 'amyloid precursor protein' 'interacts with' 'Tip60'.  \nPath-based Evidence 3: The 'APL protein 1' 'binds to' 'lysine'.  \nPath-based Evidence 4: 'Histidine' 'binds' to 'metal'.  \nPath-based Evidence 5: 'Histidine' 'interacts' with 'histidine'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: The entity 'apolipoprotein E' has isoforms including 'apoE2', 'apoE', 'apoE4', and 'apoE3'.\n\nNeighbor-based Evidence 2: The entity 'apolipoprotein E' binds to 'Abeta' and 'ABCA1'.\n\nNeighbor-based Evidence 3: The entity 'apolipoprotein E' is associated with 'dementia' and 'Alzheimer's disease'.\n\nNeighbor-based Evidence 4: The entity 'apolipoprotein E' regulates 'amyloid \u03b2-peptide', 'platelets', 'cognitive impairment', and 'inflammation'.\n\nNeighbor-based Evidence 5: The entity 'apolipoprotein E' is associated with 'AD'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      0.647192120552063,
      1.0,
      0.6397554874420166,
      0.6288114190101624,
      0.6203294992446899,
      0.6098872423171997,
      1.0,
      1.0,
      1.0,
      1.0,
      1.0
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "5f60f00d-0825-43c8-9f34-6842dfb02d3c",
    "question": "Sub coical dementia is seen in all except",
    "opa": "Multiple sclerosis",
    "opb": "Alzheimer's disease",
    "opc": "Parkinson's disease",
    "opd": "HIV related dementia",
    "cop": 1,
    "choice_type": "multi",
    "exp": "People with these types of dementia usually have severe memory loss and can't remember words or understand language.Alzheimer's and Creutzfeldt-Jakob disease are two forms of coical dementia.Subcoical dementias happen because of problems in the pas of the brain beneath the coex. Ref ganong's review of medical physiology 25e p751",
    "subject_name": "Physiology",
    "topic_name": "All India exam",
    "entity": "1. Sub cortical dementia\n2. Multiple sclerosis\n3. Alzheimer's disease\n4. Parkinson's disease\n5. HIV related dementia",
    "prediction": "B",
    "path": "Reranked Triple1: subcortical vascular dementia -> causes -> cognitive decline  \nReranked Triple2: cognitive decline -> causes -> dementia  \nReranked Triple3: dementia -> ASSOCIATES -> multiple sclerosis  \nReranked Triple4: alzheimer disease -> CAUSES -> dementia  \nReranked Triple5: dementia -> ASSOCIATES -> HIV related dementia  \n\nAnswer: A. Multiple sclerosis",
    "neighbor_input": "Reranked Triple1: subcortical vascular dementia -> resembles -> vascular dementia  \nReranked Triple2: multiple sclerosis -> causes -> cognitive deficit  \nReranked Triple3: multiple sclerosis -> has symptom -> sclerosis  \nReranked Triple4: subcortical vascular dementia -> causes -> cognitive decline  \nReranked Triple5: multiple sclerosis -> treats -> patients  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'subcortical vascular dementia' is known to 'cause' 'cognitive decline'.  \nPath-based Evidence 2: 'cognitive decline' is a 'cause' of 'dementia'.  \nPath-based Evidence 3: 'dementia' 'associates' with 'multiple sclerosis'.  \nPath-based Evidence 4: 'alzheimer disease' 'causes' 'dementia'.  \nPath-based Evidence 5: 'dementia' 'associates' with 'HIV related dementia'.  ",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Subcortical vascular dementia' 'resembles' 'vascular dementia'.\n\nNeighbor-based Evidence 2: 'Multiple sclerosis' 'causes' 'cognitive deficit'.\n\nNeighbor-based Evidence 3: 'Multiple sclerosis' 'has symptom' 'sclerosis'.\n\nNeighbor-based Evidence 4: 'Subcortical vascular dementia' 'causes' 'cognitive decline'.\n\nNeighbor-based Evidence 5: 'Multiple sclerosis' 'treats' 'patients'.",
    "entity_confidence_scores": [
      0.8161798715591431,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.000000238418579,
      0.9776468873023987,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "4ccf4a1d-c1f4-45c3-8970-709bfda21d2d",
    "question": "Which drug is not used in Alzheimer Disease ?",
    "opa": "Memantine",
    "opb": "Galantamine",
    "opc": "Ropinirole",
    "opd": "Donepezil",
    "cop": 2,
    "choice_type": "single",
    "exp": "Ropinirole is an antiparkinsonian drug, while the rest of them are drugs for Alzheimer disease.The management of AD is challenging and gratifying despite the absence of a cure or a robust pharmacologic treatment. Donepezil (target dose, 10 mg daily), rivastigmine (target dose, 6 mg twice daily or 9.5-mg patch daily), galantamine (target dose 24 mg daily, extended-release), and memantine (target dose, 10 mg twice daily) are approved by the Food and Drug Administration (FDA) for the treatment of AD. Due to hepatotoxicity, tacrine is no longer used. Reference: Harrison's Principles of Internal Medicine; 19th edition; Chapter 448 Alzheimer's Disease and Other Dementias",
    "subject_name": "Pharmacology",
    "topic_name": "Central Nervous system",
    "entity": "1. Alzheimer Disease\n2. Memantine\n3. Galantamine\n4. Ropinirole\n5. Donepezil",
    "prediction": "C",
    "path": "Reranked Triple1: alzheimer disease -> CAUSES -> dementia  \nReranked Triple2: dementia -> caused by -> AD  \nReranked Triple3: AD -> resembles -> Alzheimers disease  \nReranked Triple4: alzheimer disease -> CAUSES -> dementia -> causes -> AD  \nReranked Triple5: roscovitine -> downregulates -> Cdk5  \n\nAnswer: C. Ropinirole",
    "neighbor_input": "Reranked Triple1: AD->TREATMENT->TUDCA \u2014\u2014> metal  \nReranked Triple2: AD->causes->oxidative stress \u2014\u2014> cognitive decline  \nReranked Triple3: AD->causes->oxidative stress \u2014\u2014> cognitive deficit  \nReranked Triple4: AD->CAUSES->neurodegeneration \u2014\u2014> cognitive disorders  \nReranked Triple5: AD->CAUSES->neurodegeneration \u2014\u2014> cognitive impairment  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'alzheimer disease' 'CAUS' 'dementia'.\n\nPath-based Evidence 2: 'dementia' 'caused by' 'AD'.\n\nPath-based Evidence 3: 'AD' 'resembles' 'Alzheimers disease'.\n\nPath-based Evidence 4: 'alzheimer disease' 'CAUS' 'dementia' 'causes' 'AD'.\n\nPath-based Evidence 5: 'roscovitine' 'downregulates' 'Cdk5'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Alzheimer's Disease' is associated with the 'TREATMENT' of 'TUDCA', which is a metal.\n\nNeighbor-based Evidence 2: 'Alzheimer's Disease' 'causes' 'oxidative stress', which leads to 'cognitive decline'.\n\nNeighbor-based Evidence 3: 'Alzheimer's Disease' 'causes' 'oxidative stress', which results in 'cognitive deficit'.\n\nNeighbor-based Evidence 4: 'Alzheimer's Disease' 'causes' 'neurodegeneration', which is linked to 'cognitive disorders'.\n\nNeighbor-based Evidence 5: 'Alzheimer's Disease' 'causes' 'neurodegeneration', leading to 'cognitive impairment'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0,
      0.6840345859527588,
      0.6204968094825745,
      1.0,
      0.6575609445571899
    ],
    "question_types": [
      "treatment",
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "e1deab6e-e333-4927-944f-1e3e33f573f0",
    "question": "Apolipoprotein E is rich in",
    "opa": "Lysine",
    "opb": "Arginine",
    "opc": "Histidine",
    "opd": "Methionine",
    "cop": 1,
    "choice_type": "single",
    "exp": "TYPES OF APOPROTEINS PRESENT IN VARIOUS LIPOPROTEIN FRACTIONS (CHEMISTRY OF APOPROTEINS)HDL: Two major apoproteins of HDL are designated as apo-A-I and apo-A-II. In addition to the above, HDL also contains apo-C-I, C-II, and C-III. HDL-3 is characterised by having apo-D and HDL may also acquire arginine-rich apo-E.LDL: The main apoprotein of LDL is apo-B100, which is also present in VLDL.Chylomicrons: Principal apoprotein of chylomicrons is apo-B48 (Mol.wt = 200 Kd). In addition, chylomicrons also contain apo-A (AI and AII) and apo-C (C-II and C-III), also arginine-rich apo-E (34 Kd). Apo- C seems to be freely transferable between chylomicrons and VLDL on one hand and HDL on the other.VLDL and LDL: Principal apoproteins of VLDL, IDL, and LDL is apo-B100 (350 Kd). They also contain apo-C (C-I, C-II, and C-III), and apo-E. IDL carries some apo-E apoprotein. Apo-E: Arginine-rich apo-E, isolated from VLDL. It contains arginine to the extent of 10 percent of the total amino acids and accounts for 5 to 10 percent of total VLDL apo-proteins in normal subjects but is present in excess in the \"broad\" b-VLDL of patients of type III hyperlipoproteinemia. Carbohydrate content: Carbohydrates account for approx. 5 percent Apo-B and include mannose, galactose, fucose, glucose, glucosamine and sialic acid. So, some of the lipoproteins are glycoproteins.Ref: Textbook of Medical Biochemistry 8th Edition Dr (Brig) MN Chatterjea, Rana Shinde page no: 445",
    "subject_name": "Biochemistry",
    "topic_name": "Metabolism of lipid",
    "entity": "1. Apolipoprotein E\n2. Lysine\n3. Arginine\n4. Histidine\n5. Methionine",
    "prediction": "B",
    "path": "Reranked Triple1: Apolipoprotein E -> associates -> APL protein 1\nReranked Triple2: APL protein 1 -> part of -> amyloid precursor protein\nReranked Triple3: amyloid precursor protein -> interacts with -> Tip60\nReranked Triple4: Tip60 -> binds to -> lysine\nReranked Triple5: Histidine -> regulates -> copper toxicity",
    "neighbor_input": "Reranked Triple1: apolipoprotein E \u2014\u2014> binds \u2014\u2014> Abeta\nReranked Triple2: apolipoprotein E \u2014\u2014> regulates \u2014\u2014> cognitive impairment\nReranked Triple3: apolipoprotein E \u2014\u2014> isoform \u2014\u2014> apoE4\nReranked Triple4: apolipoprotein E \u2014\u2014> regulates \u2014\u2014> inflammation\nReranked Triple5: apolipoprotein E \u2014\u2014> associates \u2014\u2014> Alzheimer's disease",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Apolipoprotein E' 'associates' with 'APL protein 1'.\nPath-based Evidence 2: 'APL protein 1' is 'part of' 'amyloid precursor protein'.\nPath-based Evidence 3: 'Amyloid precursor protein' 'interacts with' 'Tip60'.\nPath-based Evidence 4: 'Tip60' 'binds to' 'lysine'.\nPath-based Evidence 5: 'Histidine' 'regulates' 'copper toxicity'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Apolipoprotein E' binds 'Abeta'.\nNeighbor-based Evidence 2: 'Apolipoprotein E' regulates 'cognitive impairment'.\nNeighbor-based Evidence 3: 'Apolipoprotein E' has isoform 'apoE4'.\nNeighbor-based Evidence 4: 'Apolipoprotein E' regulates 'inflammation'.\nNeighbor-based Evidence 5: 'Apolipoprotein E' associates with 'Alzheimer's disease'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      0.647192120552063,
      1.0,
      0.6397554874420166,
      0.6288114190101624,
      0.6203294992446899,
      0.6098872423171997,
      1.0,
      1.0,
      1.0,
      1.0,
      1.0
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "ce28178d-1eca-44a0-8a98-6d57002aaeb7",
    "question": "All of the following are true of early onsets Alzheimer's disease except -",
    "opa": "Associated with chromosomal anomalies",
    "opb": "Profound retardation seen",
    "opc": "Necrosis of brain neurons seen",
    "opd": "None",
    "cop": 3,
    "choice_type": "multi",
    "exp": null,
    "subject_name": "Medicine",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. Chromosomal anomalies\n3. Retardation\n4. Necrosis\n5. Brain neurons",
    "prediction": "B",
    "path": "Reranked Triple1: AD \u2014\u2014> resembles \u2014\u2014> Alzheimers disease\nReranked Triple2: AD \u2014\u2014> correlates with \u2014\u2014> diabetes mellitus\nReranked Triple3: Alzheimer Disease \u2014\u2014> causes \u2014\u2014> brain atrophy\nReranked Triple4: tau \u2014\u2014> associates \u2014\u2014> Alzheimer Disease\nReranked Triple5: Alzheimer Disease \u2014\u2014> associates \u2014\u2014> participants",
    "neighbor_input": "Reranked Triple1: AD->CAUSES->neurodegeneration,cognitive lesion,impairment of spatial learning and memory,dementia,lamin A (lamin) toxicity,proteinopathy,behavioral deficits,brain damage,Abeta aggregation,hypoxia,Alzheimer's disease,cognitive impairment,neurofibrillary tangle pathology,cognitive disorders,Abeta,astrogliosis,dysfunctional microglia,neuronal loss,brain disorder,neurodegenerative disorder,brain deficits,learning and memory impairments,tau,BACE1,Oxidative stress,neurodegenerative diseases \u2014\u2014> This triple does not mention any association with chromosomal anomalies.\nReranked Triple2: AD->TREATMENT->TUDCA,metal,insulin-like growth factor (IGF) signaling,tropisetron,deep learning,N-acetylcysteine,MB,3H3,NEP,flavonoids,reserpine,protoporphyrin IX,retardation,neuron-specific IGF-1R knockout,neuronal IGF resistance,Abeta,participant,bexarotene,fasudil,alpha-lipoic acid,curcumin,IGF-1R ablation,Rg1,thiethylperazine,MDR-1339,patients,secondary prevention,HBMVECs-Ex,redox-proteomic approach,nobiletin,vaccine,insulin-like growth factor I (IGF-I),alpha-tocopherol,PBS,EPR imaging \u2014\u2014> This triple does not mention any association with chromosomal anomalies.\nReranked Triple3: AD->treats->phloroglucinol,cognitive deficits,cognitive loss,Water,neurodegenerative diseases,Abeta toxicity,reactive oxygen species,neurodegeneration,Neurotoxicity,neurotoxicity,attenuated the behavior impairment,behavioral dysfunction,VK3,Alzheimer-like cognitive deficits,dementia,PPARgamma agonists,ankG,VK3-9,neurotoxic,hyperforin,Kanamycin,mitochondrial dysfunction,impairment of spatial learning and memory,ginsenoside Rd,Abeta aggregation,RS 67333,Abeta fibrillogenesis,off-pathway oligomers,mice,neuronal dysfunction,Mice,beta-secretase inhibitor,insulin,Alzheimer's disease,diosmin,cholinesterase inhibitor,brain deficits,tacrine,BACE1 inhibitors,7d,Abeta,n-3 PUFAs,Diosmetin,Transgenic Mice,chalcones,THH,amyloid-beta aggregation inhibitor,mice (mouse),Neuronal Injury,aid,SSP-002392,Neuropep-4,AD \u2014\u2014> This triple does not mention any association with chromosomal anomalies.\nReranked Triple4: AD->ASSOCIATES->glycogen synthase kinase 3beta,memory deficit,tauopathies,MAPT,altered neuronal ion transport,oxidative stress,Co-infection,cerebral ischaemic injury,memory loss and impaired cognitive function,brain volume loss and memory decline,weight loss,cyclin-dependent kinase reduction,toxicity,copper,amyloid-beta,mitochondrial morphology,PATIENTS,amyloid-beta peptide (Abeta) deposition,memory symptoms,brain atrophy,Abeta peptide,Amyloid Precursor Protein (amyloid precursor protein),neurodegenerative disorder,phosphorylation reduction,presenilin-1,beta amyloid,loss of dendritic spines,FBD,women,ADAOO,patients,interleukin (IL)-1beta,cognitive decline,altered blood-brain barrier permeability,altered immune response,altered gene expression,cognitive deficits,Creutzfeldt-Jakob disease,Mayo,TBI,tau,Spiroplasma sp,C-reactive protein,Tg2576,neurodegenerative diseases,synaptopathy,human,WMH,altered brain structure,phosphorylated protein kinase B,lipids (lipid),CCT5,atrophy,DA,memory dysfunction,neuroinflammation,memory impairment,Pax6,CAD (coronary artery disease),CRFR1,Notch1,plaques,kinase activation reduction,altered cerebral blood flow,Abeta deposition,altered structural connectivity,protein kinase C activation,altered neurotransmitter levels,gliosis,CBR1,synapse dysfunction,death,reactive oxygen species,phosphoinositide 3-kinase,argyrophilic grains,anxiety,neurodegeneration,GADD34,cerebral amyloidosis,hippocampal atrophy,persons,neurotoxicity,patient,triglycerides (TG),amyloidosis,Tau aggregation,Abeta42,thioflavin-S,glutamine synthetase,Musashi-1,amyloid plaques,P301S,phosphoinositide 3-kinase reduction,TAR DNA binding protein-43,tauopathy,dystrophic neurites,cerebral amyloid angiopathy,FDD,MCI,APP/PS1 mice,cognitive neurology,senile plaques,apolipoprotein E,phosphorylated protein kinase B reduction,neurotoxic,transgenic mice,PS1,impaired insulin signaling,people,neurodegenerative disease,neuroplasticity impairment,amyloid-beta (Abeta),cyclin-dependent kinase,deficits in learning and memory abilities,C-terminal fragment-beta,altered lipid metabolism,APOE (apolipoprotein E),cognitive dysfunction,neuronal degeneration,synaptic dysfunction,altered neurotrophin levels,PDIA3,altered neurogenesis,Apolipoprotein E,water,metabolic dysfunctions,mitochondrial dysfunction,CAA,memory loss,ORM impairment,DOWN SYNDROME,neurological diseases,altered brain metabolism,mitochondrial damage,altered functional connectivity,amyloid beta,Abeta plaque deposition,brain,cerebral amyloid angiopathy (CAA),estrogen withdrawal,cognitive and synaptic deficits,tau pathology,diabetes,Encephalopathies,PIB,memory deficits,peroxiredoxin 3,altered cerebrovascular function,psychiatric disorders,Cache County Dementia,mice,altered calcium homeostasis,altered protein expression,Tau,altered synaptic plasticity,mouse,Mice,cholesterol,altered neurovascular coupling,learning deficits,dysfunction,Alzheimer's disease,amyloidogenic disorder,neuron loss,APP phosphorylation reduction,cognitive impairments,cerebrospinal fluid biomarkers,O-GlcNAcylation,cognitive impairment,protein kinase C activation reduction,Abeta,neuron loss and memory deficits,neuritic dystrophy,Glucose hypometabolism,ADAS,Abeta plaque,cognitive failure,dendritic spine loss,transgenic mice (mice),glycogen synthase kinase 3beta reduction,APOE,Plaque,concurrent pathologies,Apolipoprotein E (APOE),inflammation,cognitive and/or functional performance,Abeta aggregates,Mouse,neuronal loss,neurofibrillary tangles,dementia,memory impairment by estrogen deficiency,ENO1 \u2014\u2014> This triple does not mention any association with chromosomal anomalies.\nReranked Triple5: AD->causes->oxidative stress,PS2-related side effect,dysfunctions,tumor necrosis factor-alpha,cognitive loss,brain atrophy,progressive dementia,misfolding,impaired cognitive function and memory loss,cortical atrophy,synaptic depression,neuroinflammation,memory impairment,cognitive decline,LTP,neuropathologies,cognitive deficit,impaired insulin,neuronal cell death,AbetaPP-carboxyterminal fragments,amyloid beta-protein,cognitive deficits,hyperglycemia,neurodegenerative diseases,vascular dysfunction,lysosomal enzymes,memory deficits (memory impairment),memory impairments,cognitive deterioration,anxiety,neurodegeneration,behavioral abnormalities,neurotoxicity,amyloidosis,neuronal iron homeostasis disruption,impairment of spatial cognitive function,impairment of learning and memory,fibrillation,aggregation,Abeta deposition,phosphorylated tau (pThr231, pSer396, pThr181, and pSer202),cytotoxicity,impairments,cell death,cognitive impairment and dementia,neurotoxicity and memory impairment,learning and memory deficits,memory defect,neuronal endosomal dysfunction,behavioral dysfunction,neuronal degeneration,neurodegenerative disease,cognitive dysfunction,decrease in synaptic proteins,vitamin K deficiency,synaptic dysfunction,altered neurogenesis,vascular insufficiencies,BACE1 expression,infectious disease,memory loss,interleukin-6,hippocampal dysfunction,cell degeneration,reactive gliosis,cognitive deficits (cognitive impairment),neuronal damage,Dementia,neurodegeneration syndromes,mitochondrial dysfunction,memory deficits,hippocampal neuronal loss,Abeta fibrillation,neurodegenerative disorders,axonal degeneration,cognitive decline in patients,learning and memory impairment,learning and memory decline,neuronal degenerative disease,stress,amyloid plaque,phosphorylated tau (Ser396),brain derived neurotrophic factor,Cognitive impairment,depressive,glucose intolerance,hyperinsulinemia,obesity,cognitive impairments,lipid peroxidation,cognitive impairment,Neurotoxic,synaptic loss,MR hypointensities,depression,Alzheimer's disease-related neuronal damage,synapse loss,brain diseases,hypercholesterolemia,Abeta aggregation,psychiatric,infarcts,inflammation,degeneration,memory deficiency,deficits,Abeta accumulation in the brain,Abeta,death,metabolic syndrome,meningoencephalitis,damage to neurons,impairment of cognitive functions,memory decline,brain deposits,neuronal death,amnesia,cognitive symptoms,synaptic degeneration,toxicity,spine loss,neuronal loss,Abeta accumulation,amyloid-beta plaques,neurotoxic aggregates,neurodegenerative disorder,multifactorial syndrome,Abeta-induced cytotoxicity,memory deficit,dementia,neuronal dysfunction,brain infections,Abeta plaque load,LTP impairments \u2014\u2014> This triple does not mention any association with chromosomal anomalies.",
    "response_of_KG_list_path": "Path-based Evidence 1: 'AD' resembles 'Alzheimer's disease'\n\nPath-based Evidence 2: 'AD' correlates with 'diabetes mellitus'\n\nPath-based Evidence 3: 'Alzheimer Disease' causes 'brain atrophy'\n\nPath-based Evidence 4: 'tau' associates with 'Alzheimer Disease'\n\nPath-based Evidence 5: 'Alzheimer Disease' associates with 'participants'",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Alzheimer's disease' 'causes' a range of issues including 'neurodegeneration', 'cognitive lesion', 'impairment of spatial learning and memory', 'dementia', and various forms of 'brain damage', which encompass 'Abeta aggregation', 'hypoxia', and 'cognitive disorders' among others.\n\nNeighbor-based Evidence 2: 'Alzheimer's disease' 'treatment' options include substances such as 'TUDCA', 'N-acetylcysteine', and 'curcumin', along with approaches like 'insulin-like growth factor (IGF) signaling' and 'deep learning', indicating a multifaceted strategy for managing the disease.\n\nNeighbor-based Evidence 3: 'Alzheimer's disease' 'treats' conditions related to 'cognitive deficits' and 'neurodegenerative diseases', utilizing compounds like 'phloroglucinol' and 'ginsenoside Rd' to address various aspects of 'neurotoxicity' and 'behavioral dysfunction'.\n\nNeighbor-based Evidence 4: 'Alzheimer's disease' 'associates' with factors such as 'glycogen synthase kinase 3beta', 'oxidative stress', and 'tauopathies', which contribute to 'memory deficits', 'brain atrophy', and 'cognitive decline', indicating a complex interaction with multiple neurobiological pathways.\n\nNeighbor-based Evidence 5: 'Alzheimer's disease' 'causes' various neurological issues including 'oxidative stress', 'cognitive decline', and 'memory impairment', highlighting its role in 'neurodegenerative diseases' and the resulting 'neuronal dysfunction' and 'brain damage'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.742550253868103,
      0.6801071166992188,
      0.6357147693634033,
      0.6314394474029541,
      1.0,
      0.8837226629257202,
      1.0,
      0.8944271206855774,
      1.0000001192092896
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "bb7e7af3-3f7e-4569-a59c-a424f33ece05",
    "question": "Which of the following drug can prevent or delay the onset of Alzheimer disease?",
    "opa": "Tacrine",
    "opb": "NSAID",
    "opc": "Donepezil",
    "opd": "None of the above",
    "cop": 1,
    "choice_type": "multi",
    "exp": "Following drugs have been shown to prevent or delay Alzheimer's disease. a. Estrogen replacement therapy b. NSAID c. Selegiline Tacrine and donepezil are used in the treatment of Alzheimer's disease.",
    "subject_name": "Anatomy",
    "topic_name": "All India exam",
    "entity": "1. drug\n2. Alzheimer disease\n3. Tacrine\n4. NSAID\n5. Donepezil",
    "prediction": "D",
    "path": "Reranked Triple1: AD -> correlates with -> diabetes mellitus  \nReranked Triple2: diabetes mellitus -> associates -> alzheimer disease  \nReranked Triple3: alzheimer disease -> CAUSES -> dementia  \nReranked Triple4: dementia -> caused by -> AD  \nReranked Triple5: AD -> resembles -> Alzheimers disease  \n\nAnswer: D. None of the above",
    "neighbor_input": "Reranked Triple1: AD -> TREATMENT -> tacrine  \nReranked Triple2: AD -> TREATMENT -> donepezil  \nReranked Triple3: AD -> TREATMENT -> TUDCA  \nReranked Triple4: AD -> TREATMENT -> N-acetylcysteine  \nReranked Triple5: AD -> TREATMENT -> curcumin  \n\nAnswer: A. Tacrine and C. Donepezil are drugs that can prevent or delay the onset of Alzheimer disease.",
    "response_of_KG_list_path": "Path-based Evidence 1: 'AD' 'correlates with' 'diabetes mellitus'.\n\nPath-based Evidence 2: 'diabetes mellitus' 'associates' 'alzheimer disease'.\n\nPath-based Evidence 3: 'alzheimer disease' 'CAUSES' 'dementia'.\n\nPath-based Evidence 4: 'dementia' 'caused by' 'AD'.\n\nPath-based Evidence 5: 'AD' 'resembles' 'Alzheimers disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: The relationship 'TREATMENT' connects the entity 'AD' with the entity 'tacrine'. \n\nNeighbor-based Evidence 2: The relationship 'TREATMENT' connects the entity 'AD' with the entity 'donepezil'.\n\nNeighbor-based Evidence 3: The relationship 'TREATMENT' connects the entity 'AD' with the entity 'TUDCA'.\n\nNeighbor-based Evidence 4: The relationship 'TREATMENT' connects the entity 'AD' with the entity 'N-acetylcysteine'.\n\nNeighbor-based Evidence 5: The relationship 'TREATMENT' connects the entity 'AD' with the entity 'curcumin'.",
    "entity_confidence_scores": [
      0.9999999403953552,
      1.0,
      0.6544378995895386,
      0.7847082018852234,
      0.7727140188217163,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.911976158618927,
      1.000000238418579,
      1.0,
      0.6575609445571899
    ],
    "question_types": [
      "treatment",
      "prevention"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "c7ea6de8-33f7-411a-92fb-d6876f8929b3",
    "question": "Which of the following gene is associated with Alzheimer's disease ?",
    "opa": "APOE1",
    "opb": "APOE",
    "opc": "APOE3",
    "opd": "APOE4",
    "cop": 3,
    "choice_type": "single",
    "exp": "Alzheimer's disease is caused by mutation in :\n\nAPOE4 gene\nPresenilin 1 : Chromosome 14\nPresenilin 2\u00a0: Chromosome 1\nAPP4 ( Amyloid precursor protein - 4 ) :\u00a0Chromosome 21",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. gene\n3. APOE1\n4. APOE\n5. APOE3\n6. APOE4",
    "prediction": "D",
    "path": "Reranked Triple1: apoE3 \u2014\u2014> is neutral with respect to -> Alzheimer's disease  \nReranked Triple2: apoE3 \u2014\u2014> regulates -> Alzheimer's disease  \nReranked Triple3: apoE3 \u2014\u2014> associates -> APOE4  \nReranked Triple4: Alzheimer's disease \u2014\u2014> associated with -> APOE4  \nReranked Triple5: APOE4 \u2014\u2014> associated with -> Alzheimer's disease  ",
    "neighbor_input": "Reranked Triple1: AD -> ASSOCIATES -> Apolipoprotein E  \nReranked Triple2: Apolipoprotein E -> causes -> Alzheimer's disease  \nReranked Triple3: Apolipoprotein E -> causes -> neurodegenerative disorder  \nReranked Triple4: Apolipoprotein E -> causes -> cognitive impairment  \nReranked Triple5: AD -> causes -> cognitive dysfunction  ",
    "response_of_KG_list_path": "Path-based Evidence 1: The entity 'apoE3' 'is neutral with respect to' the entity 'Alzheimer's disease'.\n\nPath-based Evidence 2: The entity 'apoE3' 'regulates' the entity 'Alzheimer's disease'.\n\nPath-based Evidence 3: The entity 'apoE3' 'associates' with the entity 'APOE4'.\n\nPath-based Evidence 4: The entity 'Alzheimer's disease' 'associated with' the entity 'APOE4'.\n\nPath-based Evidence 5: The entity 'APOE4' 'associated with' the entity 'Alzheimer's disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' is associated with 'Apolipoprotein E'.\n\nNeighbor-based Evidence 2: 'Apolipoprotein E' causes 'Alzheimer's disease'.\n\nNeighbor-based Evidence 3: 'Apolipoprotein E' causes 'neurodegenerative disorder'.\n\nNeighbor-based Evidence 4: 'Apolipoprotein E' causes 'cognitive impairment'.\n\nNeighbor-based Evidence 5: 'AD' causes 'cognitive dysfunction'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.9999999403953552,
      0.9050863981246948,
      1.0000001192092896,
      1.0000001192092896,
      0.8890658020973206,
      1.000000238418579,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "3e6f85b5-80c2-4998-a1ab-4699686221b5",
    "question": "Dementia of Alzheimer's type is not associated with one of the following",
    "opa": "Depressive symptoms",
    "opb": "Delusions",
    "opc": "Apraxia and aphasia",
    "opd": "Cerebral infarcts",
    "cop": 3,
    "choice_type": "single",
    "exp": "An estimated 20 to 30 percent of patients with dementia (primarily patients with dementia of the Alzheimer's type) have hallucinations, and 30 to 40 percent have delusions, primarily of a paranoid or persecutory. In addition to psychosis and personality changes, depression and anxiety are major symptoms in an estimated 40 to 50 percent of patients with dementia. In addition to the aphasias in patients with dementia, apraxias and agnosias are common. Other neurological signs that can be associated with dementia are seizures, seen in approximately 10 percent of patients with dementia of the Alzheimer's type. Reference: Kaplan & Sadock's Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry, 11th Edition, page no.713.",
    "subject_name": "Psychiatry",
    "topic_name": "Organic mental disorders",
    "entity": "1. Dementia of Alzheimer's type\n2. Depressive symptoms\n3. Delusions\n4. Apraxia\n5. Aphasia\n6. Cerebral infarcts",
    "prediction": "D",
    "path": "Reranked Triple1: dementia of the Alzheimer type -> patients -> Abeta -> causes -> AD  \nReranked Triple2: delusions -> affects -> patients -> with -> Alzheimer's disease -> has symptom -> apraxia  \nReranked Triple3: delusions -> affects -> patients -> diagnosed with -> Alzheimer's disease -> has symptom -> apraxia  \nReranked Triple4: delusions -> affects -> patients -> treats -> Alzheimer's disease -> has symptom -> apraxia  \nReranked Triple5: delusions -> affects -> patients -> treats -> Alzheimer's disease  \n\nAnswer: D.Cerebral infarcts",
    "neighbor_input": "Reranked Triple1: AD -> has symptom -> depressive symptoms\nReranked Triple2: AD -> has symptom -> aphasia\nReranked Triple3: AD -> has symptom -> cognitive impairment\nReranked Triple4: AD -> has symptom -> memory loss\nReranked Triple5: AD -> has symptom -> behavioral symptoms",
    "response_of_KG_list_path": "Path-based Evidence 1: 'dementia of the Alzheimer type' 'patients' 'Abeta' 'causes' 'AD'.\n\nPath-based Evidence 2: 'delusions' 'affects' 'patients' 'with' 'Alzheimer's disease' 'has symptom' 'apraxia'.\n\nPath-based Evidence 3: 'delusions' 'affects' 'patients' 'diagnosed with' 'Alzheimer's disease' 'has symptom' 'apraxia'.\n\nPath-based Evidence 4: 'delusions' 'affects' 'patients' 'treats' 'Alzheimer's disease' 'has symptom' 'apraxia'.\n\nPath-based Evidence 5: 'delusions' 'affects' 'patients' 'treats' 'Alzheimer's disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'has symptom' 'depressive symptoms'.  \nNeighbor-based Evidence 2: 'AD' 'has symptom' 'aphasia'.  \nNeighbor-based Evidence 3: 'AD' 'has symptom' 'cognitive impairment'.  \nNeighbor-based Evidence 4: 'AD' 'has symptom' 'memory loss'.  \nNeighbor-based Evidence 5: 'AD' 'has symptom' 'behavioral symptoms'.  ",
    "entity_confidence_scores": [
      0.9736135005950928,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.9381810426712036,
      1.0,
      1.000000238418579,
      1.0,
      0.6450759768486023,
      1.0,
      1.0000001192092896,
      0.7298930883407593,
      0.7964770793914795,
      0.633560061454773,
      0.6898353099822998,
      0.5880182981491089,
      0.5017680525779724,
      1.0,
      1.0000001192092896
    ],
    "question_types": [
      "symptom",
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "58c5c8b8-e314-4023-a069-50028cfafe94",
    "question": "In Alzheimer&;s disease (AD) which of the following is not seen:",
    "opa": "Aphasia",
    "opb": "Acalculia",
    "opc": "Agnosia",
    "opd": "Apraxia",
    "cop": 2,
    "choice_type": "single",
    "exp": "Aphasia, Apraxia, Acalculia and Agnosia may all be seen in Alzheimer&;s Dementia. Agnosia in Alzheimer&;s disease usually presents late in the disease and is not included in the ICD-10 Diagnostic criteria for dementia in Alzheimer&;s disease with early onset and hence may be selected as the single best answer by exclusion REF: Harrison book of internal medicine 21ST EDITION",
    "subject_name": "Medicine",
    "topic_name": "All India exam",
    "entity": "1. Alzheimer's disease\n2. Aphasia\n3. Acalculia\n4. Agnosia\n5. Apraxia",
    "prediction": "B",
    "path": "Reranked Triple1: Aphasia -> type of -> neurodegenerative diseases  \nReranked Triple2: Aphasia -> associated with -> Alzheimer  \nReranked Triple3: Alzheimer disease -> CAUSES -> dementia  \nReranked Triple4: dementia -> caused by -> tau  \nReranked Triple5: Alzheimer Disease -> associates -> AD  \n\nAnswer: Based on the reranked triples, Aphasia is associated with Alzheimer's disease, indicating that it is seen in AD. The other options (Acalculia, Agnosia, Apraxia) are not explicitly mentioned, but based on general knowledge of Alzheimer's disease, Acalculia is often not associated with AD, making it likely the correct answer for what is NOT seen in AD.",
    "neighbor_input": "Reranked Triple1: AD -> causes -> cognitive decline  \nReranked Triple2: AD -> causes -> cognitive impairment  \nReranked Triple3: AD -> causes -> memory impairment  \nReranked Triple4: AD -> causes -> aphasia  \nReranked Triple5: AD -> causes -> agnosia  \n\nAnswer: Based on the reranked triples, aphasia and agnosia are associated with Alzheimer's disease. Therefore, the option that is not typically associated with Alzheimer's disease is likely to be acalculia or apraxia, as they are less frequently mentioned in the context of cognitive deficits in AD.",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Aphasia' is a 'type of' 'neurodegenerative diseases'.\n\nPath-based Evidence 2: 'Aphasia' is 'associated with' 'Alzheimer'.\n\nPath-based Evidence 3: 'Alzheimer disease' 'CAUSES' 'dementia'.\n\nPath-based Evidence 4: 'dementia' is 'caused by' 'tau'.\n\nPath-based Evidence 5: 'Alzheimer Disease' 'associates' with 'AD'.",
    "response_of_KG_neighbor": "Based on the provided knowledge graph information, here are the natural language conversions:\n\nNeighbor-based Evidence 1: 'Alzheimer's disease' 'causes' 'cognitive decline'.  \nNeighbor-based Evidence 2: 'Alzheimer's disease' 'causes' 'cognitive impairment'.  \nNeighbor-based Evidence 3: 'Alzheimer's disease' 'causes' 'memory impairment'.  \nNeighbor-based Evidence 4: 'Alzheimer's disease' 'causes' 'aphasia'.  \nNeighbor-based Evidence 5: 'Alzheimer's disease' 'causes' 'agnosia'.  ",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.6475889682769775,
      1.0000001192092896,
      1.0000001192092896,
      0.7298930883407593,
      0.7964770793914795,
      0.633560061454773,
      0.6898353099822998,
      0.5880182981491089,
      0.5017680525779724
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "283375a4-f258-4370-b284-7e432b416c16",
    "question": "Features of Alzheimer include all Except:",
    "opa": "More common in females",
    "opb": "Recent memory loss",
    "opc": "MMSE useful for diagnosis",
    "opd": "Medication offer near 100% cure",
    "cop": 3,
    "choice_type": "multi",
    "exp": "Pharmacological treatments available for dementia are limited to symptomatic relief. To date, with the exception of interventions to reduce the risk of recurrent stroke in vascular dementia, there are no treatments available that can alter the disease course or produce substantial or long-lived improvements in symptomatology. Risk factors for Dementia Old age Alcohol obesity DM/HT/CAD Female Uneducated Saturated fat Screening tools MMSE, Mental test score Severity assessment clinical dementia rating scale, Functional Assessment Staging, Hachinski 's ischemic score (Vascular Dementia) Imaging SPECT, FDG-PET treatment Reference: P.1175 10.3 Dementia (Kaplan & Sadock's Comprehensive Textbook of Psychiatry, 9th Edition)",
    "subject_name": "Psychiatry",
    "topic_name": "All India exam",
    "entity": "1. Alzheimer\n2. females\n3. memory loss\n4. MMSE\n5. diagnosis\n6. Medication\n7. cure",
    "prediction": "D",
    "path": "Reranked Triple1: Alzheimer -> ASSOCIATES -> AD  \nReranked Triple2: AD -> resembles -> Alzheimers disease  \nReranked Triple3: memory loss -> causes -> Abeta  \nReranked Triple4: Abeta -> causes -> memory deficit  \nReranked Triple5: MMSE -> useful for -> diagnosis  \n\nAnswer: D.Medication offer near 100% cure",
    "neighbor_input": "Reranked Triple1: Alzheimer -> treats -> HSA,gamma-secretase inhibition,anthranilic acid,N-cyclopropylmethyl derivatives R-12c and R-13c,imidazopyridines \u2014\u2014> Medication offer near 100% cure\nReranked Triple2: Alzheimer -> TREATMENT TARGET -> SFN,water \u2014\u2014> Medication offer near 100% cure\nReranked Triple3: Alzheimer -> causes -> neurodegeneration,death,dementia,beta-amyloid plaques \u2014\u2014> Recent memory loss\nReranked Triple4: Alzheimer -> disease associated with -> anxiety,prion,amnestic behavior \u2014\u2014> Recent memory loss\nReranked Triple5: Alzheimer -> CAUSES -> Abeta,dementia,Abeta42,inflammation \u2014\u2014> More common in females",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer' 'ASSOCIATES' with 'AD'.\n\nPath-based Evidence 2: 'AD' 'resembles' 'Alzheimers disease'.\n\nPath-based Evidence 3: 'memory loss' 'causes' 'Abeta'.\n\nPath-based Evidence 4: 'Abeta' 'causes' 'memory deficit'.\n\nPath-based Evidence 5: 'MMSE' 'useful for' 'diagnosis'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: The condition 'Alzheimer' is treated by various medications such as 'HSA', 'gamma-secretase inhibition', 'anthranilic acid', 'N-cyclopropylmethyl derivatives R-12c and R-13c', and 'imidazopyridines', which together offer a near 100% cure.\n\nNeighbor-based Evidence 2: The treatment target for 'Alzheimer' includes 'SFN' and 'water', which are associated with a medication that offers near 100% cure.\n\nNeighbor-based Evidence 3: 'Alzheimer' causes 'neurodegeneration', 'death', 'dementia', and the formation of 'beta-amyloid plaques', which lead to recent memory loss.\n\nNeighbor-based Evidence 4: The disease 'Alzheimer' is associated with 'anxiety', 'prion', and 'amnestic behavior', all contributing to recent memory loss.\n\nNeighbor-based Evidence 5: The causes of 'Alzheimer' include 'Abeta', 'dementia', 'Abeta42', and 'inflammation', and it is noted to be more common in females.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.9707714319229126,
      1.0000001192092896,
      1.0,
      0.9099191427230835,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.9999999403953552,
      1.0,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.9252252578735352,
      0.8978093862533569,
      1.0000001192092896,
      1.0000001192092896,
      0.7327340245246887,
      0.5146227478981018,
      1.0,
      0.671769380569458,
      0.7847082018852234,
      0.7243226170539856,
      0.7727140188217163,
      0.750420331954956,
      0.750420331954956
    ],
    "question_types": [
      "treatment",
      "diagnosis",
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "fe2a9033-bf70-428b-a1bd-9393344552e0",
    "question": "Reversible dementia is seen in?",
    "opa": "Alzheimer's disease",
    "opb": "Hypothyroidism",
    "opc": "Subacute demyelination of spinal cord",
    "opd": "Pick's disease",
    "cop": 1,
    "choice_type": "single",
    "exp": "Causes of Reversible dementia: Hypothyroidism (Myxoedema) Thiamine deficiency Vitamin B12 deficiency Normal pressure hydrocephalus (NPH) Subdural hematoma Chronic infection Brain abscess",
    "subject_name": "Anatomy",
    "topic_name": "FMGE 2019",
    "entity": "1. Reversible dementia\n2. Alzheimer's disease\n3. Hypothyroidism\n4. Subacute demyelination of spinal cord\n5. Pick's disease",
    "prediction": "B",
    "path": "Reranked Triple1: dementia -> caused by -> tau  \nReranked Triple2: alzheimer disease -> CAUSES -> dementia  \nReranked Triple3: dementia -> associates -> Alzheimer Disease  \nReranked Triple4: Alzheimer Disease -> causes -> brain atrophy  \nReranked Triple5: AD -> resembles -> Alzheimers disease  \n\nAnswer: B. Hypothyroidism",
    "neighbor_input": "Reranked Triple1: AD -> causes -> cognitive impairment  \nReranked Triple2: AD -> causes -> dementia  \nReranked Triple3: AD -> treats -> cognitive deficits  \nReranked Triple4: AD -> associates -> memory loss  \nReranked Triple5: AD -> associates -> neurodegenerative disorder  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'dementia' is 'caused by' 'tau'.  \nPath-based Evidence 2: 'alzheimer disease' 'CAUSES' 'dementia'.  \nPath-based Evidence 3: 'dementia' 'associates' 'Alzheimer Disease'.  \nPath-based Evidence 4: 'Alzheimer Disease' 'causes' 'brain atrophy'.  \nPath-based Evidence 5: 'AD' 'resembles' 'Alzheimers disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'cognitive impairment'.  \nNeighbor-based Evidence 2: 'AD' 'causes' 'dementia'.  \nNeighbor-based Evidence 3: 'AD' 'treats' 'cognitive deficits'.  \nNeighbor-based Evidence 4: 'AD' 'associates' 'memory loss'.  \nNeighbor-based Evidence 5: 'AD' 'associates' 'neurodegenerative disorder'.  ",
    "entity_confidence_scores": [
      0.7703178524971008,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.903645396232605,
      1.0000001192092896,
      0.6205008029937744
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "a10d4360-a538-42a2-b3d3-f1c61fa10fa4",
    "question": "Delirium is distinguished from dementia by the presence of:",
    "opa": "Impaired judgment",
    "opb": "Impaired memory",
    "opc": "Clouding of consciousness",
    "opd": "Thought disorder",
    "cop": 2,
    "choice_type": "single",
    "exp": "The hallmark of delirium is fluctuation in level of consciousness. Periods of lucency may be interspersed with periods of marked unresponsiveness. Another distinguishing feature is that the onset of delirium usually occurs within hours or days, whereas the onset of dementia may be insidious throughout a period of weeks to months. Ref: Johnston B., Yaffe K. (2008). Chapter 27. Dementia & Delirium. In M.D. Feldman, J.F. Christensen (Eds), Behavioral Medicine: A Guide for Clinical Practice, 3e.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Delirium\n2. Dementia\n3. Impaired judgment\n4. Impaired memory\n5. Clouding of consciousness\n6. Thought disorder",
    "prediction": "C",
    "path": "Reranked Triple1: Delirium \u2014\u2014> Presence of clouding of consciousness  \nReranked Triple2: Dementia \u2014\u2014> Absence of clouding of consciousness  \nReranked Triple3: Delirium \u2014\u2014> Impaired judgment  \nReranked Triple4: Dementia \u2014\u2014> Impaired memory  \nReranked Triple5: Delirium \u2014\u2014> Disorientation  ",
    "neighbor_input": "Reranked Triple1: delirium -> associates -> cognitive impairment  \nReranked Triple2: delirium -> occurs in -> patients  \nReranked Triple3: delirium -> cause -> neuronal damage  \nReranked Triple4: AD -> causes -> cognitive impairment  \nReranked Triple5: AD -> causes -> dementia  \n\nAnswer: C. Clouding of consciousness",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Delirium' is associated with the 'Presence of clouding of consciousness'.\n\nPath-based Evidence 2: 'Dementia' is associated with the 'Absence of clouding of consciousness'.\n\nPath-based Evidence 3: 'Delirium' is linked to 'Impaired judgment'.\n\nPath-based Evidence 4: 'Dementia' is linked to 'Impaired memory'.\n\nPath-based Evidence 5: 'Delirium' is characterized by 'Disorientation'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'delirium' 'associates' 'cognitive impairment'.\n\nNeighbor-based Evidence 2: 'delirium' 'occurs in' 'patients'.\n\nNeighbor-based Evidence 3: 'delirium' 'cause' 'neuronal damage'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'cognitive impairment'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'dementia'.",
    "entity_confidence_scores": [
      0.9999999403953552,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.8025338649749756,
      0.9999999403953552,
      0.9434635639190674,
      0.6790475845336914,
      0.6790474653244019,
      0.7678353786468506
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "4c927b6d-2ea2-4c4c-9632-b3ac7e706802",
    "question": "An elderly patient dies with chronic dementia. At autopsy, the brain showed diffuse coical atrophy with relative sparing of primary motor and sensory areas. Which of the following would most likely be a prominent feature on microscopic examination of her brain tissue?",
    "opa": "Central chromatolysis",
    "opb": "Lewy bodies",
    "opc": "Gliosis of the caudate nucleus",
    "opd": "Neurofibrillary tangles",
    "cop": 3,
    "choice_type": "single",
    "exp": "The clinical history and gross pathology suggest Alzheimer's disease. Neurofibrillary tangles and senile plaques are found primarily in higher order association coex. Other microscopic features of Alzheimer's disease include granulovacuolar degeneration and, sometimes, Hirano bodies. Central chromatolysis is a loss of histological staining seen in lower motor neurons whose axons have been damaged, for example by injury to the ventral roots. Gliosis of the caudate nucleus is a feature of Huntington's disease, and ceain other degenerative diseases of the basal ganglia. Lewy bodies (eosinophilic intracytoplasmic spherules) and loss of pigmented neurons in the substantia nigra are features of Parkinson's disease. Ref: Kwentus J.A., Kirshner H.S. (2008). Chapter 14. Delirium, Dementia, and Amnestic Syndromes. In M.H. Ebe, P.T. Loosen, B. Nurcombe, J.F. Leckman (Eds), CURRENT Diagnosis & Treatment: Psychiatry, 2e.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. elderly patient \n2. chronic dementia\n3. autopsy\n4. brain \n5. diffuse cortical atrophy \n6. primary motor and sensory areas \n7. microscopic examination \n8. brain tissue \n9. central chromatolysis \n10. Lewy bodies \n11. gliosis of the caudate nucleus \n12. neurofibrillary tangles",
    "prediction": "D",
    "path": "Reranked Triple1: brain tissue -> interacts -> Abeta (amyloid beta)  \nReranked Triple2: Abeta (amyloid beta) -> ASSOCIATES -> tau  \nReranked Triple3: tau -> ASSOCIATES -> Alzheimer disease  \nReranked Triple4: localized gliosis -> are part of -> gliosis  \nReranked Triple5: neurofibrillary tangles -> FORM BY -> microtubule-associated protein tau  ",
    "neighbor_input": "Reranked Triple1: Dementias \u2014\u2014> causes \u2014\u2014> Cognitive impairment  \nReranked Triple2: cortical atrophy \u2014\u2014> found in \u2014\u2014> transgenic mice  \nReranked Triple3: brain tissue \u2014\u2014> fix \u2014\u2014> formalin  \nReranked Triple4: brain tissue \u2014\u2014> embed \u2014\u2014> paraffin  \nReranked Triple5: subarachnoid hemorrhage \u2014\u2014> interacts \u2014\u2014> cerebral amyloid angiopathy (CAA)  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'brain tissue' 'interacts' with 'Abeta (amyloid beta)'.\n\nPath-based Evidence 2: 'Abeta (amyloid beta)' 'ASSOCIATES' with 'tau'.\n\nPath-based Evidence 3: 'tau' 'ASSOCIATES' with 'Alzheimer disease'.\n\nPath-based Evidence 4: 'localized gliosis' 'are part of' 'gliosis'.\n\nPath-based Evidence 5: 'neurofibrillary tangles' 'FORM BY' 'microtubule-associated protein tau'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Dementias' are known to have 'causes' that lead to 'Cognitive impairment'.\n\nNeighbor-based Evidence 2: 'Cortical atrophy' is 'found in' 'transgenic mice'.\n\nNeighbor-based Evidence 3: 'Brain tissue' is 'fixed' in 'formalin'.\n\nNeighbor-based Evidence 4: 'Brain tissue' is 'embedded' in 'paraffin'.\n\nNeighbor-based Evidence 5: 'Subarachnoid hemorrhage' 'interacts' with 'cerebral amyloid angiopathy (CAA)'.",
    "entity_confidence_scores": [
      0.7421262264251709,
      0.86156165599823,
      0.6836393475532532,
      1.0,
      1.0,
      0.7348365783691406,
      1.0,
      0.9029036164283752,
      0.6628539562225342,
      0.8169856071472168,
      0.6409632563591003,
      1.0,
      0.9462835192680359,
      1.000000238418579,
      0.7746833562850952,
      1.0,
      1.0
    ],
    "question_types": [
      "diagnosis"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "4dc090b7-0dfa-40fe-87e5-72645fca1e01",
    "question": "In Alzheimer's disease, plaque is made up of -",
    "opa": "Tau protein",
    "opb": "Beta amyloid",
    "opc": "Huntington",
    "opd": "Alpha synnuclein",
    "cop": 1,
    "choice_type": "single",
    "exp": ". Beta amyloid",
    "subject_name": "Pathology",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. plaque\n3. Tau protein\n4. Beta amyloid\n5. Huntington\n6. Alpha synnuclein",
    "prediction": "B",
    "path": "Reranked Triple1: Alzheimer's disease \u2014\u2014> CAUSES \u2014\u2014> dementia  \nReranked Triple2: dementia \u2014\u2014> caused by \u2014\u2014> tau  \nReranked Triple3: dementia \u2014\u2014> caused by \u2014\u2014> tau  \nReranked Triple4: Alzheimer's disease \u2014\u2014> associates \u2014\u2014> tau  \nReranked Triple5: Alzheimer's disease \u2014\u2014> resembles \u2014\u2014> Alzheimer's disease  ",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> causes \u2014\u2014> amyloid beta-protein  \nReranked Triple2: AD \u2014\u2014> causes \u2014\u2014> Abeta aggregation  \nReranked Triple3: AD \u2014\u2014> causes \u2014\u2014> amyloid-beta plaques  \nReranked Triple4: AD \u2014\u2014> causes \u2014\u2014> Abeta plaque load  \nReranked Triple5: AD \u2014\u2014> causes \u2014\u2014> Abeta deposition  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer's disease' is known to 'CAUSE' 'dementia'.\n\nPath-based Evidence 2: 'Dementia' is 'caused by' 'tau'.\n\nPath-based Evidence 3: 'Dementia' is 'caused by' 'tau'.\n\nPath-based Evidence 4: 'Alzheimer's disease' 'associates' with 'tau'.\n\nPath-based Evidence 5: 'Alzheimer's disease' 'resembles' 'Alzheimer's disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'amyloid beta-protein'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'Abeta aggregation'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'amyloid-beta plaques'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'Abeta plaque load'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'Abeta deposition'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.8603709936141968,
      0.8603709936141968,
      1.0,
      0.8382810950279236,
      1.0,
      0.9567092657089233,
      1.0,
      0.8395751714706421,
      0.9474924802780151,
      1.0,
      0.7870264649391174,
      0.8690527677536011,
      0.7243181467056274
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "aaa393d4-f24f-4081-80d1-b08e5865ac75",
    "question": "All are true about dementia except",
    "opa": "Loss of sho term memory",
    "opb": "Loss of long term memory",
    "opc": "Deterioration of personality",
    "opd": "Impaired learning",
    "cop": 1,
    "choice_type": "multi",
    "exp": "Dementia is a chronic organic mental disorder, characterized by the following main clinical features: 1. Impairment of intellectual functions, 2. Impairment of memory (predominantly of recent memory, especially in early stages), 3. Deterioration of personality with lack of personal care. Reference: A sho textbook of Psychiatry by Niraj Ahuja, page no.22.",
    "subject_name": "Psychiatry",
    "topic_name": "Organic mental disorders",
    "entity": "1. Dementia\n2. short term memory\n3. long term memory\n4. personality\n5. impaired learning",
    "prediction": "B",
    "path": [],
    "neighbor_input": "Reranked Triple1: AD -> causes -> cognitive loss \u2014\u2014> cognitive impairment\nReranked Triple2: AD -> causes -> memory impairment \u2014\u2014> cognitive deficits\nReranked Triple3: AD -> causes -> cognitive decline \u2014\u2014> dementia\nReranked Triple4: AD -> causes -> impaired learning and memory \u2014\u2014> cognitive dysfunction\nReranked Triple5: AD -> causes -> deterioration of personality \u2014\u2014> behavioral dysfunction",
    "response_of_KG_list_path": [],
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' is known to 'cause' 'cognitive loss', which can lead to 'cognitive impairment'.\n\nNeighbor-based Evidence 2: 'AD' is known to 'cause' 'memory impairment', resulting in 'cognitive deficits'.\n\nNeighbor-based Evidence 3: 'AD' is known to 'cause' 'cognitive decline', which can progress to 'dementia'.\n\nNeighbor-based Evidence 4: 'AD' is known to 'cause' 'impaired learning and memory', leading to 'cognitive dysfunction'.\n\nNeighbor-based Evidence 5: 'AD' is known to 'cause' 'deterioration of personality', resulting in 'behavioral dysfunction'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.5980503559112549,
      0.5855745077133179,
      0.6152992248535156,
      0.6018508672714233,
      1.0
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "d59d09de-4b69-42ed-8932-d3a4f37130ec",
    "question": "All of the following are true about Alzheimer's disease except?",
    "opa": "Number of senile plaques correlate with age",
    "opb": "Underlying tau proteins suggest neurodegeneration",
    "opc": "Number of neurofibrillary tangles is associated with the severity of dementia",
    "opd": "Extracellular inclusions can be found in the absence of intracellular inclusions",
    "cop": 3,
    "choice_type": "multi",
    "exp": "Extracellular inclusions CANNOT be found in absence of intracellular inclusions. Neuritic plaques and neurofibrillary changes are found in all associated areas of the cerebral coex. Number of neuritic senile plaques correlate with age. Neuritic plaques can be seen in the normal aged brain also, so they are non-pathogenic in all cases. Neurofibrillary tangles and neuronal alterations correlate best with the severity of dementia, not neuritic plaques. Tau proteins are formed intracellularly causing neuronal degeneration leading to Alzheimer disease.",
    "subject_name": "Medicine",
    "topic_name": "Guillian Barre syndrome & Alzheimer's disease",
    "entity": "1. Alzheimer's disease\n2. senile plaques\n3. age\n4. tau proteins\n5. neurodegeneration\n6. neurofibrillary tangles\n7. severity of dementia\n8. extracellular inclusions\n9. intracellular inclusions",
    "prediction": "D",
    "path": "Reranked Triple1: Neurofibrillary tangles -> ASSOCIATE WITH -> Alzheimer's disease  \nReranked Triple2: Number of neurofibrillary tangles -> is associated with -> severity of dementia  \nReranked Triple3: tau -> COMPOSED OF -> Neurofibrillary tangles  \nReranked Triple4: tau -> suggests -> neurodegeneration  \nReranked Triple5: Number of senile plaques -> correlate with -> age  ",
    "neighbor_input": "Reranked Triple1: AD -> causes -> neurofibrillary tangles \u2014\u2014> severity of dementia  \nReranked Triple2: AD -> causes -> senile plaques \u2014\u2014> correlate with age  \nReranked Triple3: AD -> associates -> tau \u2014\u2014> neurodegeneration  \nReranked Triple4: AD -> causes -> extracellular inclusions \u2014\u2014> intracellular inclusions  \nReranked Triple5: AD -> associates -> neurodegeneration \u2014\u2014> cognitive decline  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Neurofibrillary tangles' are 'ASSOCIATE WITH' 'Alzheimer's disease'.\n\nPath-based Evidence 2: 'Number of neurofibrillary tangles' 'is associated with' 'severity of dementia'.\n\nPath-based Evidence 3: 'tau' 'COMPOSED OF' 'Neurofibrillary tangles'.\n\nPath-based Evidence 4: 'tau' 'suggests' 'neurodegeneration'.\n\nPath-based Evidence 5: 'Number of senile plaques' 'correlate with' 'age'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' is known to 'cause' 'neurofibrillary tangles', which are associated with the 'severity of dementia'.\n\nNeighbor-based Evidence 2: 'AD' is known to 'cause' 'senile plaques', which 'correlate with age'.\n\nNeighbor-based Evidence 3: 'AD' 'associates' with 'tau', which is linked to 'neurodegeneration'.\n\nNeighbor-based Evidence 4: 'AD' is known to 'cause' 'extracellular inclusions', which are related to 'intracellular inclusions'.\n\nNeighbor-based Evidence 5: 'AD' 'associates' with 'neurodegeneration', which leads to 'cognitive decline'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0,
      0.9743976593017578,
      0.8382810950279236,
      0.8309223055839539,
      1.0,
      1.0,
      1.0,
      1.0,
      0.7868137955665588,
      1.0000001192092896,
      0.9125262498855591,
      0.8683019876480103,
      0.712374746799469
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "c6877697-8135-4de5-9ca6-b24ce4138ede",
    "question": "All are reversible causes of dementia except -",
    "opa": "Hypothyroidism",
    "opb": "Hydrocephalus",
    "opc": "Meningoencephalitis",
    "opd": "Alzheimer's disease",
    "cop": 3,
    "choice_type": "multi",
    "exp": "Ans. is 'd' i.e., Alzhimer's disease Reversible causes of dementia1) Surgically treatable :- Normal pressure hydrocephalus, brain tumors (frontal lobe tumor), meningioma, subdural hematoma due to head injury, hydrocephalus.2) Medically treatable :- Depression, hypothyroidism, alcohol abuse, vitamin B Jfolate/Niacin deficiency, any metabolic or endocrine disturbance, neurosyphilis, Hashimoto's encephalopathy, Wilson's disease, celiac disease, whipple's disease, chronic meningoencephalitis, drugs and toxin (toxic dementia).Irreversible causes of dementia :- Alzheimer's disease, vascular (multi-infarct) dementia, Parkinsonism, Huntington 9s chorea, Lewy body dementia, Pick's disease.",
    "subject_name": "Psychiatry",
    "topic_name": "Degenerative Disorders",
    "entity": "1. dementia\n2. reversible causes\n3. Hypothyroidism\n4. Hydrocephalus\n5. Meningoencephalitis\n6. Alzheimer's disease",
    "prediction": "D",
    "path": [],
    "neighbor_input": "Reranked Triple1: AD -> causes -> dementia\nReranked Triple2: AD -> caused by -> neurodegenerative diseases\nReranked Triple3: AD -> cause -> neurodegenerative disease\nReranked Triple4: AD -> causes -> cognitive impairment\nReranked Triple5: AD -> caused by -> tauopathy",
    "response_of_KG_list_path": [],
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'dementia'.\n\nNeighbor-based Evidence 2: 'AD' 'caused by' 'neurodegenerative diseases'.\n\nNeighbor-based Evidence 3: 'AD' 'cause' 'neurodegenerative disease'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'cognitive impairment'.\n\nNeighbor-based Evidence 5: 'AD' 'caused by' 'tauopathy'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.6530424356460571,
      0.903645396232605,
      1.0,
      1.0,
      1.0000001192092896,
      1.0000001192092896
    ],
    "question_types": [
      "causation",
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "831072b8-6be9-4f96-855a-8e6c30f697a8",
    "question": "Which lobes are affected by Alzheimer's?",
    "opa": "Frontal and temporal lobe",
    "opb": "Temporal and parietal lobe",
    "opc": "Parietal and occipital lobe",
    "opd": "Parietal and frontal lobe",
    "cop": 1,
    "choice_type": "single",
    "exp": "AD presents with insidious onset of memory loss followed by a slowly progressive dementia over several years. Pathologically, atrophy is distributed throughout medial temporal lobe andl ateral and medial parietal lobes. 4 A's of Alzheimer's disease are: 1. Amnesia:(Temporal ) Sho term and Long term memory 2. Apraxia (Non dominant parietal lobe ) 3. Anosognosia 4. Aphasia (Dominant parietal lobe )",
    "subject_name": "Medicine",
    "topic_name": "Guillian Barre syndrome & Alzheimer's disease",
    "entity": "1. Alzheimer's\n2. lobes\n3. Frontal lobe\n4. Temporal lobe\n5. Parietal lobe\n6. Occipital lobe",
    "prediction": "A",
    "path": "Reranked Triple1: Alzheimer disease \u2014\u2014> causes \u2014\u2014> brain atrophy  \nReranked Triple2: Alzheimer disease \u2014\u2014> associates \u2014\u2014> AD  \nReranked Triple3: AD \u2014\u2014> correlates with \u2014\u2014> diabetes mellitus  \nReranked Triple4: Alzheimer disease \u2014\u2014> associates \u2014\u2014> participants  \nReranked Triple5: tau \u2014\u2014> caused by \u2014\u2014> dementia  ",
    "neighbor_input": "Reranked Triple1: Alzheimer's -> associated with -> dementia  \nReranked Triple2: Alzheimer's -> disease -> neurodegenerative  \nReranked Triple3: Alzheimer's -> causes -> Protein misfolded proteins  \nReranked Triple4: Alzheimer's -> causes -> protein fibrillization  \nReranked Triple5: Alzheimer's -> USES -> amyloid PET  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer disease' 'causes' 'brain atrophy'.\n\nPath-based Evidence 2: 'Alzheimer disease' 'associates' 'AD'.\n\nPath-based Evidence 3: 'AD' 'correlates with' 'diabetes mellitus'.\n\nPath-based Evidence 4: 'Alzheimer disease' 'associates' 'participants'.\n\nPath-based Evidence 5: 'tau' 'caused by' 'dementia'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Alzheimer's' is 'associated with' 'dementia'. \n\nNeighbor-based Evidence 2: 'Alzheimer's' is a 'disease' that is 'neurodegenerative'. \n\nNeighbor-based Evidence 3: 'Alzheimer's' 'causes' 'Protein misfolded proteins'. \n\nNeighbor-based Evidence 4: 'Alzheimer's' 'causes' 'protein fibrillization'. \n\nNeighbor-based Evidence 5: 'Alzheimer's' 'USES' 'amyloid PET'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.6757045388221741,
      0.6355853080749512,
      1.0,
      0.9287086725234985,
      0.8716716766357422,
      0.8949093818664551,
      0.8890469074249268,
      0.8683359622955322,
      0.8707143068313599,
      0.9178898334503174,
      0.8616503477096558,
      1.0,
      0.7078962326049805,
      1.0000001192092896,
      0.7904350757598877,
      0.9279533624649048,
      0.914618968963623,
      0.8224782347679138,
      0.8387764692306519
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "e27a0b10-5299-431b-9c21-51665da39388",
    "question": "True about aetiopathogenesis of Alzheimers disease-a) Absence of tau proteinb) Involvement of Apolipoprotein Ec) Preseneline-1and 2 involved  d) Mutation in chromosome 21e) Preseneline 2 is not involved",
    "opa": "abc",
    "opb": "bcd",
    "opc": "ac",
    "opd": "bd",
    "cop": 1,
    "choice_type": "multi",
    "exp": null,
    "subject_name": "Medicine",
    "topic_name": null,
    "entity": "1. Alzheimers disease\n2. tau protein\n3. Apolipoprotein E\n4. Preseneline-1\n5. Preseneline-2\n6. Mutation\n7. chromosome 21",
    "prediction": "B",
    "path": "Reranked Triple1: tau \u2014\u2014> associates -> Alzheimer Disease  \nReranked Triple2: AD -> correlates with -> diabetes mellitus  \nReranked Triple3: alzheimer disease -> CAUSES -> dementia  \nReranked Triple4: dementia -> causes -> cognitive decline  \nReranked Triple5: alzheimer disease -> associates -> tau  \n\nAnswer:",
    "neighbor_input": "Reranked Triple1: Alzheimers disease -> causes -> tau  \nReranked Triple2: Alzheimers disease -> associates -> dementia  \nReranked Triple3: Alzheimers disease -> hallmark -> amyloid plaques  \nReranked Triple4: AD -> causes -> neurofibrillary tangle pathology  \nReranked Triple5: AD -> causes -> preseneline-1 and 2 involved  ",
    "response_of_KG_list_path": "Path-based Evidence 1: The entity 'tau' is associated with the disease 'Alzheimer Disease'.\n\nPath-based Evidence 2: The condition 'AD' correlates with 'diabetes mellitus'.\n\nPath-based Evidence 3: The disease 'alzheimer disease' causes 'dementia'.\n\nPath-based Evidence 4: The condition 'dementia' causes 'cognitive decline'.\n\nPath-based Evidence 5: The disease 'alzheimer disease' is associated with 'tau'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Alzheimers disease' is known to have 'causes' related to 'tau'.\n\nNeighbor-based Evidence 2: 'Alzheimers disease' is often 'associated' with 'dementia'.\n\nNeighbor-based Evidence 3: A 'hallmark' of 'Alzheimers disease' is the presence of 'amyloid plaques'.\n\nNeighbor-based Evidence 4: 'AD' is linked to 'causes' involving 'neurofibrillary tangle pathology'.\n\nNeighbor-based Evidence 5: 'AD' has 'causes' that include the involvement of 'preseneline-1 and 2'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.8382810950279236,
      1.0000001192092896,
      0.647192120552063,
      1.0,
      0.6397554874420166,
      0.6288114190101624,
      0.6203294992446899,
      0.6098872423171997,
      0.8226277828216553,
      0.8316490650177002,
      1.0000001192092896,
      1.0,
      1.0
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "57491342-73db-49dc-b13c-cabcfd4e580f",
    "question": "The most common cause of dementia is",
    "opa": "Fronto-Temporal dementia",
    "opb": "Senile dementia",
    "opc": "Multi-infarct dementia",
    "opd": "Alzheimer\u2019s disease",
    "cop": 3,
    "choice_type": "single",
    "exp": "Causes of Dementia:\u00a0\n\nAlzheimer\u2019s\u00a0 (most common in >65 years old)\nVascular dementia/Multi-infarct dementia\nLewy body dementia\nFronto-Temporal dementia (50-70 years)\nHuntington\u2019s\nTraumatic/Dementia pugilistica\nCreutzfeldt-Jakob disease\n\n\u00a0\nReversible causes of Dementia\n\nStructural brain lesions:- Normal Pressure Hydrocephalus, SubDural Hematoma, Brain Tumors\nAlcohol dementia/ Wernicke\u2019s encephalopathy\nVitamin B12 deficiency\nEndocrine:- Hypo/Hyper-thyroidism, Hypo-Parathyroidism\nMetabolic disorders:- Dyselectrolytemia (Na, Ca, K), hepatic or renal failure\nAutoimmune:- Hashimoto\u2019s paraneoplastic encephalopathy (anti- Yo, Hu, Ri)\nInfections:- Whipple\u2019s, Lyme disease, Syphilis, HIV dementia.",
    "subject_name": "Medicine",
    "topic_name": null,
    "entity": "1. dementia\n2. Fronto-Temporal dementia\n3. Senile dementia\n4. Multi-infarct dementia\n5. Alzheimer\u2019s disease",
    "prediction": "D",
    "path": "Reranked Triple1: Alzheimer\u2019s disease \u2014\u2014> most common cause of dementia  \nReranked Triple2: Frontotemporal dementia \u2014\u2014> type of dementia  \nReranked Triple3: Senile dementia \u2014\u2014> type of dementia  \nReranked Triple4: Multi-infarct dementia \u2014\u2014> type of dementia  \nReranked Triple5: Dementia \u2014\u2014> includes Alzheimer\u2019s disease, Frontotemporal dementia, Senile dementia, Multi-infarct dementia  ",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple2: AD \u2014\u2014> cause \u2014\u2014> Alzheimer's disease  \nReranked Triple3: AD \u2014\u2014> caused by \u2014\u2014> neurodegenerative diseases  \nReranked Triple4: AD \u2014\u2014> causes \u2014\u2014> cognitive impairment  \nReranked Triple5: AD \u2014\u2014> causes \u2014\u2014> neurodegeneration  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer\u2019s disease' is the 'most common cause of dementia'.\n\nPath-based Evidence 2: 'Frontotemporal dementia' is a 'type of dementia'.\n\nPath-based Evidence 3: 'Senile dementia' is a 'type of dementia'.\n\nPath-based Evidence 4: 'Multi-infarct dementia' is a 'type of dementia'.\n\nPath-based Evidence 5: 'Dementia' 'includes' 'Alzheimer\u2019s disease', 'Frontotemporal dementia', 'Senile dementia', and 'Multi-infarct dementia'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'dementia'.  \nNeighbor-based Evidence 2: 'AD' 'cause' 'Alzheimer's disease'.  \nNeighbor-based Evidence 3: 'AD' 'caused by' 'neurodegenerative diseases'.  \nNeighbor-based Evidence 4: 'AD' 'causes' 'cognitive impairment'.  \nNeighbor-based Evidence 5: 'AD' 'causes' 'neurodegeneration'.  ",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.9035530686378479,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.7850020527839661,
      1.0000001192092896,
      0.7687584161758423,
      0.7321019172668457,
      1.0000001192092896,
      0.7321019172668457,
      1.0000001192092896,
      0.7216620445251465,
      0.9831303954124451
    ],
    "question_types": [
      "causation"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "117bfe2c-0116-4045-9757-693c45765b2c",
    "question": "A chromosomal anomaly associated with alzheimer's dementia is -",
    "opa": "Trisomy 18",
    "opb": "Patau syndrome",
    "opc": "Trisomy 21",
    "opd": "Turners syndrome",
    "cop": 2,
    "choice_type": "single",
    "exp": null,
    "subject_name": "Medicine",
    "topic_name": null,
    "entity": "1. chromosomal anomaly\n2. Alzheimer's dementia\n3. Trisomy 18\n4. Patau syndrome\n5. Trisomy 21\n6. Turner's syndrome",
    "prediction": "C",
    "path": "Reranked Triple1: Alzheimer's dementia \u2014\u2014> associates \u2014\u2014> cognitive decline  \nReranked Triple2: cognitive decline \u2014\u2014> associated with \u2014\u2014> AD  \nReranked Triple3: AD \u2014\u2014> resembles \u2014\u2014> Alzheimer's disease  \nReranked Triple4: Alzheimer's disease \u2014\u2014> associated with \u2014\u2014> chromosomal anomalies  \nReranked Triple5: chromosomal anomalies \u2014\u2014> linked to \u2014\u2014> Trisomy 21  \n\nAnswer: C. Trisomy 21",
    "neighbor_input": "Reranked Triple1: Alzheimer's dementia \u2014\u2014> cause \u2014\u2014> neurodegeneration  \nReranked Triple2: Alzheimer's dementia \u2014\u2014> associates \u2014\u2014> cognitive decline  \nReranked Triple3: Alzheimer's dementia \u2014\u2014> ASSOCIATES \u2014\u2014> brain haemorrhages, dementia  \nReranked Triple4: congenital anomaly \u2014\u2014> related to \u2014\u2014> iatrogenic Creutzfeldt-Jakob disease  \nReranked Triple5: congenital anomaly \u2014\u2014> caused by \u2014\u2014> dural grafting  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer's dementia' 'associates' 'cognitive decline'.\n\nPath-based Evidence 2: 'cognitive decline' 'associated with' 'AD'.\n\nPath-based Evidence 3: 'AD' 'resembles' 'Alzheimer's disease'.\n\nPath-based Evidence 4: 'Alzheimer's disease' 'associated with' 'chromosomal anomalies'.\n\nPath-based Evidence 5: 'chromosomal anomalies' 'linked to' 'Trisomy 21'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Alzheimer's dementia' is known to 'cause' 'neurodegeneration'.\n\nNeighbor-based Evidence 2: 'Alzheimer's dementia' 'associates' with 'cognitive decline'.\n\nNeighbor-based Evidence 3: 'Alzheimer's dementia' 'ASSOCIATES' with 'brain haemorrhages' and 'dementia'.\n\nNeighbor-based Evidence 4: 'Congenital anomaly' is 'related to' 'iatrogenic Creutzfeldt-Jakob disease'.\n\nNeighbor-based Evidence 5: 'Congenital anomaly' is 'caused by' 'dural grafting'.",
    "entity_confidence_scores": [
      0.7584463357925415,
      0.6692334413528442,
      1.000000238418579,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      0.8488523960113525,
      0.7702889442443848,
      0.6812289357185364,
      0.8738721609115601,
      0.7554779052734375,
      0.6972866058349609,
      0.6903723478317261,
      0.7551724910736084,
      0.796008288860321
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "efb4dc93-49a7-47bd-9454-1113ddfc71d3",
    "question": "The area of the brain resistant to Neurofibrillary tangles of Alzheimer's disease is:",
    "opa": "Visual association areas",
    "opb": "Entorhinal coex",
    "opc": "Temporal lobe",
    "opd": "Lateral geniculate body",
    "cop": 3,
    "choice_type": "single",
    "exp": "Lateral geniculate body of the thalamus is resistant to the neurofibrillary tangles of Alzheimer's disease. So lateral geniculate body is the single best answer of choice. Ref: Harrisons Principles of Internal Medicine, 16th Edition, Pages 2398-2401.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Neurofibrillary tangles\n2. Alzheimer's disease\n3. Brain\n4. Visual association areas\n5. Entorhinal cortex\n6. Temporal lobe\n7. Lateral geniculate body",
    "prediction": "D",
    "path": "Reranked Triple1: entorhinal cortex -> associated with -> Alzheimer disease  \nReranked Triple2: Alzheimer disease -> causes -> dementia  \nReranked Triple3: entorhinal cortex -> has -> cortex  \nReranked Triple4: tau -> associates -> Alzheimer Disease  \nReranked Triple5: entorhinal cortex -> treats -> cognitive decline  ",
    "neighbor_input": "Reranked Triple1: Neurofibrillary tangles -> ASSOCIATES -> Alzheimer's disease  \nReranked Triple2: Neurofibrillary tangles -> FORM BY -> microtubule-associated protein tau  \nReranked Triple3: AD -> causes -> cognitive impairment and dementia  \nReranked Triple4: AD -> causes -> brain atrophy  \nReranked Triple5: AD -> causes -> synaptic loss  ",
    "response_of_KG_list_path": "Path-based Evidence 1: The 'entorhinal cortex' is 'associated with' 'Alzheimer disease'.\n\nPath-based Evidence 2: 'Alzheimer disease' 'causes' 'dementia'.\n\nPath-based Evidence 3: The 'entorhinal cortex' 'has' a 'cortex'.\n\nPath-based Evidence 4: 'Tau' 'associates' with 'Alzheimer Disease'.\n\nPath-based Evidence 5: The 'entorhinal cortex' 'treats' 'cognitive decline'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Neurofibrillary tangles' are known to 'ASSOCIATE' with 'Alzheimer's disease'.\n\nNeighbor-based Evidence 2: 'Neurofibrillary tangles' are 'FORMED BY' 'microtubule-associated protein tau'.\n\nNeighbor-based Evidence 3: 'Alzheimer's disease' 'causes' 'cognitive impairment and dementia'.\n\nNeighbor-based Evidence 4: 'Alzheimer's disease' 'causes' 'brain atrophy'.\n\nNeighbor-based Evidence 5: 'Alzheimer's disease' 'causes' 'synaptic loss'.",
    "entity_confidence_scores": [
      1.0,
      1.0,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.6233096718788147,
      1.0000001192092896,
      1.0,
      1.0,
      1.0000001192092896,
      0.695589005947113,
      0.6459761261940002,
      1.0000001192092896,
      1.0,
      0.8871150016784668,
      0.6459761261940002,
      0.9128051996231079,
      0.911994993686676,
      1.0000001192092896,
      0.8645899891853333,
      1.0000001192092896
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "2ad9041c-cbfb-4f65-a5c0-41958cdce222",
    "question": "Biochemical aetiology of Alzheimer's disease relates to",
    "opa": "Serotonin",
    "opb": "Dopamine",
    "opc": "Acetylcholine",
    "opd": "GABA",
    "cop": 2,
    "choice_type": "single",
    "exp": "Alzheimer's disease is the commonest cause of dementia and it is not treatable disorder. Neurochemically there is a marked decrease in the brain choline acetyltransferase (CAT) with a similar decrease in brain acetylcholinesterase(AchE) (Ref: a sho textbook of psychiatry, Niraj Ahuja, 7th edition, pg no.24). The main neurotransmitter implicated in Alzheimer's disease is Acetylcholine.",
    "subject_name": "Psychiatry",
    "topic_name": "Organic mental disorders",
    "entity": "1. Biochemical aetiology\n2. Alzheimer's disease\n3. Serotonin\n4. Dopamine\n5. Acetylcholine\n6. GABA",
    "prediction": "C",
    "path": "Reranked Triple1: d-GABA -> binds -> Abeta  \nReranked Triple2: d-GABA -> AFFECT -> COX-2  \nReranked Triple3: COX-2 -> interacts -> YY-1224  \nReranked Triple4: d-GABA -> regulates -> COX-2  \nReranked Triple5: YY-1224 -> binds -> G. biloba  ",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> causes \u2014\u2014> cognitive impairment  \nReranked Triple2: AD \u2014\u2014> causes \u2014\u2014> neurodegeneration  \nReranked Triple3: AD \u2014\u2014> causes \u2014\u2014> behavioral dysfunction  \nReranked Triple4: AD \u2014\u2014> causes \u2014\u2014> memory loss  \nReranked Triple5: AD \u2014\u2014> causes \u2014\u2014> synaptic dysfunction  \n\nAnswer: C.Acetylcholine",
    "response_of_KG_list_path": "Path-based Evidence 1: 'd-GABA' 'binds' to 'Abeta'.\n\nPath-based Evidence 2: 'd-GABA' 'AFFECTs' 'COX-2'.\n\nPath-based Evidence 3: 'COX-2' 'interacts' with 'YY-1224'.\n\nPath-based Evidence 4: 'd-GABA' 'regulates' 'COX-2'.\n\nPath-based Evidence 5: 'YY-1224' 'binds' to 'G. biloba'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'cognitive impairment'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'neurodegeneration'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'behavioral dysfunction'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'memory loss'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'synaptic dysfunction'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0,
      0.910812497138977,
      1.0,
      1.0,
      1.0,
      0.8863632082939148,
      0.7717458009719849,
      0.651431679725647,
      1.0
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "3044fe3d-7ce1-4dc9-8f38-1eb89a98b6d3",
    "question": "All are true statements about Alzheimer's disease except:",
    "opa": "Down's syndrome association is protective",
    "opb": "Neural plaques containing Ab amyloid are seen",
    "opc": "Hippocampus is severely affected",
    "opd": "10% patients develop Capgras syndrome",
    "cop": 0,
    "choice_type": "multi",
    "exp": "(A) Down's syndrome association is protective # Pathogenesis of Alzheimer's disease:> Earliest metabolic change occur in prenatal cortex but most severe lesion seen in hippocampus, temporal cortex and nucleus basalis of myernest (Lateral septur).> Important microscopic findings : \"Senile\" plaques an cytoplasmic neurofibrillary tangles (NFTs).> Neuritic plaque contain : AfJ amyloid, proteoglycans, ApoE, antichymotrypsin, and other proteins.> NFTs are silver-staining, twisted neurofilaments in neuronal cytoplasm that represent abnormally phosphorylated tau (t) protein and appear as paired helical filaments by electron microscopy. Tauis microtubule associated protein that may function to assemble and stabilize microtubules that convey cell organelles, glycoproteins and other important materials through neuron.> Phosphorylation of tau protein may disturb normal process.> Cerebral cortical level of Ach, CAT and nicotinic cholinergic receptors.> Genetic factors : Mutation on APP gene located on chromosome 21 Mutation in presenelins 1&2 (located on chromosome 1 & 14 respectively). ApoE gene is on chromosome no. 21. ApoE is involved in cholesterol transport. The e4 allele of ApoE genes shows strong association with AD. The ApoE e4 allele specially in homozygous state 4/4 is an important risk factor for AD.",
    "subject_name": "Medicine",
    "topic_name": "Miscellaneous",
    "entity": "1. Alzheimer's disease\n2. Down's syndrome\n3. Neural plaques\n4. Ab amyloid\n5. Hippocampus\n6. Capgras syndrome",
    "prediction": "A",
    "path": "Reranked Triple1: Down's syndrome \u2014\u2014> TYPE \u2014\u2014> neurological disorder  \nReranked Triple2: Down's syndrome \u2014\u2014> involves \u2014\u2014> brain atrophy  \nReranked Triple3: Alzheimer's disease \u2014\u2014> associates \u2014\u2014> trisomy 21  \nReranked Triple4: neuritic plaques \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple5: AD \u2014\u2014> correlates with \u2014\u2014> diabetes mellitus  ",
    "neighbor_input": "Reranked Triple1: AD -> ASSOCIATES -> Down's syndrome association is protective \u2014\u2014> false\nReranked Triple2: AD -> CAUSES -> neural plaques containing Ab amyloid are seen \u2014\u2014> true\nReranked Triple3: AD -> CAUSES -> Hippocampus is severely affected \u2014\u2014> true\nReranked Triple4: AD -> ASSOCIATES -> 10% patients develop Capgras syndrome \u2014\u2014> false\nReranked Triple5: AD -> CAUSES -> cognitive impairment \u2014\u2014> true",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Down's syndrome' is a 'TYPE' of 'neurological disorder'.\n\nPath-based Evidence 2: 'Down's syndrome' 'involves' 'brain atrophy'.\n\nPath-based Evidence 3: 'Alzheimer's disease' 'associates' with 'trisomy 21'.\n\nPath-based Evidence 4: 'Neuritic plaques' 'causes' 'dementia'.\n\nPath-based Evidence 5: 'AD' 'correlates with' 'diabetes mellitus'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' does not 'ASSOCIATE' with 'Down's syndrome association as protective'.\n\nNeighbor-based Evidence 2: 'AD' does 'CAUSE' 'neural plaques containing Ab amyloid to be seen'.\n\nNeighbor-based Evidence 3: 'AD' does 'CAUSE' the 'Hippocampus to be severely affected'.\n\nNeighbor-based Evidence 4: 'AD' does not 'ASSOCIATE' with '10% of patients developing Capgras syndrome'.\n\nNeighbor-based Evidence 5: 'AD' does 'CAUSE' 'cognitive impairment'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.9999999403953552,
      0.796008288860321,
      0.796008288860321,
      1.0,
      0.9198420643806458,
      0.8370298743247986,
      1.0000001192092896,
      0.9164281487464905,
      0.9999999403953552,
      0.9999999403953552,
      0.5457386374473572,
      1.0
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "8c1180b2-cf64-4caf-939f-b2216e73cec6",
    "question": "In Alzheimer's disease which area of brain is involved",
    "opa": "Cerebral coex",
    "opb": "Hippocampus",
    "opc": "Cerebellum",
    "opd": "A+ B",
    "cop": 3,
    "choice_type": "single",
    "exp": "*It is the accumulation of brain beta amyloid peptide in cerebral coex,hippocampus,basal ganglia, thalamus and even cerebellum. Alzheimer's disease typically destroys neurons and their connections in pas of the brain involved in memory, including the entorhinal coex and hippocampus. It later affects areas in the cerebral coex responsible for language, reasoning, and social behavior. Ultimately, the disease is fatal. Ref Harrison20th edition pg 2767",
    "subject_name": "Medicine",
    "topic_name": "C.N.S",
    "entity": "1. Alzheimer's disease\n2. brain\n3. cerebral cortex\n4. hippocampus\n5. cerebellum",
    "prediction": "D",
    "path": "Reranked Triple1: Alzheimer's disease \u2014\u2014> associates \u2014\u2014> dementia  \nReranked Triple2: dementia \u2014\u2014> caused by \u2014\u2014> tau  \nReranked Triple3: hippocampus \u2014\u2014> is part of \u2014\u2014> brain  \nReranked Triple4: hippocampus \u2014\u2014> part of \u2014\u2014> brain  \nReranked Triple5: hippocampus \u2014\u2014> REGION \u2014\u2014> cerebellum  \n\nAnswer: B. Hippocampus",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> causes \u2014\u2014> hippocampal dysfunction  \nReranked Triple2: AD \u2014\u2014> causes \u2014\u2014> hippocampal neuronal loss  \nReranked Triple3: AD \u2014\u2014> causes \u2014\u2014> cognitive decline  \nReranked Triple4: AD \u2014\u2014> causes \u2014\u2014> brain atrophy  \nReranked Triple5: AD \u2014\u2014> causes \u2014\u2014> neurodegeneration  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer's disease' 'associates' with 'dementia'.  \nPath-based Evidence 2: 'dementia' 'caused by' 'tau'.  \nPath-based Evidence 3: 'hippocampus' 'is part of' 'brain'.  \nPath-based Evidence 4: 'hippocampus' 'part of' 'brain'.  \nPath-based Evidence 5: 'hippocampus' 'REGION' 'cerebellum'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'hippocampal dysfunction'.  \nNeighbor-based Evidence 2: 'AD' 'causes' 'hippocampal neuronal loss'.  \nNeighbor-based Evidence 3: 'AD' 'causes' 'cognitive decline'.  \nNeighbor-based Evidence 4: 'AD' 'causes' 'brain atrophy'.  \nNeighbor-based Evidence 5: 'AD' 'causes' 'neurodegeneration'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.000000238418579,
      0.8071302771568298,
      0.9999999403953552,
      0.9999999403953552,
      1.0000001192092896
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "de15d16c-f5fe-447a-966f-3790018049c3",
    "question": "Which of the following regarding small vessel disease (SVD), cerebral amyloid angiopathy(CAand Alzheimer's disease (AD) is not true?",
    "opa": "SVD is related to CAA",
    "opb": "SVD is not correlated to AD",
    "opc": "SVD is related to AD",
    "opd": "CAA is associated with AD",
    "cop": 2,
    "choice_type": "multi",
    "exp": "Ans. c. SVD is related to AD (Ref: Harrison 19/e p2565, 2583, 2598, 2602, 18/e p3276, 3296, 3304-3309)Cerebral Amyloid Angiopathy (CAA) is associated with Alzheimer's disease (AD) but Small vessel disease (SVD) is not associated.\"In dementia, both small vessel disease (SVD) and large vessel disease are found. But Alzheimer disease is caused by involvement of large vessels, while subcortical dementia like progressive supranuclear palsy (PSP) involves small vessels.\"''The term \"small vessel\" is used for small penetrating branches that arise at acute angles from the large arteries of circle of Willis, stem of the middle cerebral artery and the basilar artery. These arteries penetrate at right angles to supply the deeper structures within the brain e.g. basal ganglia, internal capsule, thalamus, pons. These arteries are prone to thrombosis and are common causes of ischemic stroke.\"With normal aging, there is also an accumulation of amyloid in cerebral blood vessels, leading to a condition called cerebral amyloid angiopathy (without dementia), which predisposes older persons to lobarhemorrhage and brain micro- hemorrhages (Small vessel disease). AD patients appear to be at increased risk for amyloid angiopathy, and this may explain some of the observed association between AD and stroke.\"\"Cerebral amyloid angiopathy (CAA), although usually asymptomatic, is an important cause of primary lobar intracerebral hemorrhage in the elderly. It can occur as a sporadic disorder, sometimes in association with AD, or as a certain familial syndrome. CAA is characterized by deposition of cognophilic material in small to medium-sized blood vessels of the brain and leptomeninges. In its most severe stages, the amyloid deposits cause breakdown of the blood vessel wall with resultant hemorrhage.\"",
    "subject_name": "Medicine",
    "topic_name": "C.N.S.",
    "entity": "1. small vessel disease (SVD)\n2. cerebral amyloid angiopathy (CAA)\n3. Alzheimer's disease (AD)",
    "prediction": "B",
    "path": "Reranked Triple1: small vessel disease (SVD) \u2014\u2014> affects \u2014\u2014> cerebrovascular disease  \nReranked Triple2: small vessel disease (SVD) \u2014\u2014> affects \u2014\u2014> cerebrovascular disease \u2014\u2014> overlaps \u2014\u2014> Alzheimer's disease  \nReranked Triple3: small vessel disease (SVD) \u2014\u2014> affects \u2014\u2014> cerebrovascular disease \u2014\u2014> co-occurs with \u2014\u2014> Alzheimer disease  \nReranked Triple4: small vessel disease (SVD) \u2014\u2014> affects \u2014\u2014> cerebrovascular disease \u2014\u2014> associates \u2014\u2014> cerebral amyloid angiopathy (CAA)  \nReranked Triple5: small vessel disease (SVD) \u2014\u2014> affects \u2014\u2014> cerebrovascular disease \u2014\u2014> involves \u2014\u2014> Abeta  \n\nAnswer: B. SVD is not correlated to AD",
    "neighbor_input": "Reranked Triple1: small vessel disease (SVD) \u2014\u2014> affects \u2014\u2014> subcortical vascular cognitive impairment (vascular cognitive impairments), cerebrovascular disease  \nReranked Triple2: cerebral amyloid angiopathy (CAA) \u2014\u2014> causes \u2014\u2014> Alzheimer's disease (AD)  \nReranked Triple3: cerebral amyloid angiopathy (CAA) \u2014\u2014> caused by \u2014\u2014> Abeta  \nReranked Triple4: cerebral amyloid angiopathy (CAA) \u2014\u2014> cause \u2014\u2014> cerebrovascular and AD pathologies (Alzheimer's disease), intracerebral hemorrhages  \nReranked Triple5: cerebral amyloid angiopathy (CAA) \u2014\u2014> treat \u2014\u2014> PiB  \n\nAnswer:  \nB. SVD is not correlated to AD",
    "response_of_KG_list_path": "Path-based Evidence 1: 'small vessel disease (SVD)' 'affects' 'cerebrovascular disease'.\n\nPath-based Evidence 2: 'small vessel disease (SVD)' 'affects' 'cerebrovascular disease' 'overlaps' 'Alzheimer's disease'.\n\nPath-based Evidence 3: 'small vessel disease (SVD)' 'affects' 'cerebrovascular disease' 'co-occurs with' 'Alzheimer disease'.\n\nPath-based Evidence 4: 'small vessel disease (SVD)' 'affects' 'cerebrovascular disease' 'associates' 'cerebral amyloid angiopathy (CAA)'.\n\nPath-based Evidence 5: 'small vessel disease (SVD)' 'affects' 'cerebrovascular disease' 'involves' 'Abeta'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'small vessel disease (SVD)' 'affects' 'subcortical vascular cognitive impairment (vascular cognitive impairments), cerebrovascular disease'.\n\nNeighbor-based Evidence 2: 'cerebral amyloid angiopathy (CAA)' 'causes' 'Alzheimer's disease (AD)'.\n\nNeighbor-based Evidence 3: 'cerebral amyloid angiopathy (CAA)' 'caused by' 'Abeta'.\n\nNeighbor-based Evidence 4: 'cerebral amyloid angiopathy (CAA)' 'cause' 'cerebrovascular and AD pathologies (Alzheimer's disease), intracerebral hemorrhages'.\n\nNeighbor-based Evidence 5: 'cerebral amyloid angiopathy (CAA)' 'treat' 'PiB'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.9999998807907104,
      1.0,
      1.000000238418579,
      0.9999998807907104,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "cefc1fc3-62a7-4323-a1d8-570e26ccb750",
    "question": "Treatable causes of dementia are :",
    "opa": "Alzheimer's ds.",
    "opb": "Hypothyroidism",
    "opc": "Multi-infarct dementia",
    "opd": "All",
    "cop": 1,
    "choice_type": "multi",
    "exp": "B i.e. Hypothyroidism",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. dementia\n2. Alzheimer's disease\n3. Hypothyroidism\n4. Multi-infarct dementia.",
    "prediction": "B",
    "path": [],
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> treats \u2014\u2014> phloroglucinol  \nReranked Triple2: AD \u2014\u2014> treats \u2014\u2014> cognitive deficits  \nReranked Triple3: AD \u2014\u2014> treats \u2014\u2014> cholinesterase inhibitor  \nReranked Triple4: AD \u2014\u2014> treats \u2014\u2014> beta-secretase inhibitor  \nReranked Triple5: AD \u2014\u2014> treats \u2014\u2014> PPARgamma agonists  ",
    "response_of_KG_list_path": [],
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'treats' 'phloroglucinol'.  \nNeighbor-based Evidence 2: 'AD' 'treats' 'cognitive deficits'.  \nNeighbor-based Evidence 3: 'AD' 'treats' 'cholinesterase inhibitor'.  \nNeighbor-based Evidence 4: 'AD' 'treats' 'beta-secretase inhibitor'.  \nNeighbor-based Evidence 5: 'AD' 'treats' 'PPARgamma agonists'.  ",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.903645396232605,
      0.7850020527839661,
      1.0000001192092896,
      0.7687584161758423,
      0.7321019172668457,
      1.0000001192092896,
      0.7321019172668457,
      1.0000001192092896,
      0.7216620445251465
    ],
    "question_types": [
      "causation",
      "treatment"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "0858faf5-99ed-436b-b4ba-a3b2cc11540d",
    "question": "All are examples of coical dementia except",
    "opa": "Alzheimer's disease",
    "opb": "Multiple sclerosis",
    "opc": "Creutzfeldt Jacob disease",
    "opd": "Pick's disease",
    "cop": 1,
    "choice_type": "multi",
    "exp": "B i.e Multiple sclerosis",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. Multiple sclerosis\n3. Creutzfeldt Jacob disease\n4. Pick's disease",
    "prediction": "B",
    "path": "Reranked Triple1: Alzheimer's disease \u2014\u2014> associates -> dementia  \nReranked Triple2: Creutzfeldt-Jakob disease \u2014\u2014> causes -> dementia  \nReranked Triple3: Pick's disease \u2014\u2014> causes -> dementia  \nReranked Triple4: Multiple sclerosis \u2014\u2014> NOT mentioned in the context of dementia  \nReranked Triple5: AD \u2014\u2014> resembles -> Alzheimer's disease  ",
    "neighbor_input": "Reranked Triple1: AD -> causes -> Alzheimer's disease \u2014> dementia  \nReranked Triple2: AD -> causes -> Creutzfeldt-Jakob disease \u2014> dementia  \nReranked Triple3: AD -> associates -> multiple sclerosis \u2014> cognitive impairment  \nReranked Triple4: AD -> associates -> Pick's disease \u2014> dementia  \nReranked Triple5: AD -> causes -> neurodegenerative diseases \u2014> dementia  \n\nAnswer: B. Multiple sclerosis",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer's disease' is associated with 'dementia'.\n\nPath-based Evidence 2: 'Creutzfeldt-Jakob disease' causes 'dementia'.\n\nPath-based Evidence 3: 'Pick's disease' causes 'dementia'.\n\nPath-based Evidence 4: 'Multiple sclerosis' is not mentioned in the context of 'dementia'.\n\nPath-based Evidence 5: 'AD' resembles 'Alzheimer's disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'Alzheimer's disease' which leads to 'dementia'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'Creutzfeldt-Jakob disease' which leads to 'dementia'.\n\nNeighbor-based Evidence 3: 'AD' 'associates' with 'multiple sclerosis' which can result in 'cognitive impairment'.\n\nNeighbor-based Evidence 4: 'AD' 'associates' with 'Pick's disease' which leads to 'dementia'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'neurodegenerative diseases' which can lead to 'dementia'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.9487361907958984,
      0.6887068748474121,
      1.000000238418579,
      1.0000001192092896,
      0.6205008029937744,
      0.5583708882331848
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "57a52a90-6fe6-41f3-b03a-87314cfe66a4",
    "question": "Dementia is seen in all except -",
    "opa": "Schizophrenia",
    "opb": "Alzheimer's disease",
    "opc": "Huntington's chorea",
    "opd": "Pick's ds.",
    "cop": 0,
    "choice_type": "multi",
    "exp": null,
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Dementia\n2. Schizophrenia\n3. Alzheimer's disease\n4. Huntington's chorea\n5. Pick's ds.",
    "prediction": "A",
    "path": [],
    "neighbor_input": "Reranked Triple1: AD -> causes -> dementia  \nReranked Triple2: AD -> associates -> dementia  \nReranked Triple3: AD -> treats -> dementia  \nReranked Triple4: AD -> causes -> cognitive impairment  \nReranked Triple5: AD -> causes -> cognitive deficits  ",
    "response_of_KG_list_path": [],
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'dementia'.\n\nNeighbor-based Evidence 2: 'AD' 'associates' 'dementia'.\n\nNeighbor-based Evidence 3: 'AD' 'treats' 'dementia'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'cognitive impairment'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'cognitive deficits'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.8395751714706421,
      0.808238685131073,
      0.6911654472351074
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "77a4490c-b55b-4e64-9e00-429865f9a236",
    "question": "All the following are featuring Alzheimer's disease except-",
    "opa": "Cerebellar atrophy",
    "opb": "Common in 5th and 6th decade",
    "opc": "Atrophied gyri and widened sulci",
    "opd": "Progressive dementia",
    "cop": 0,
    "choice_type": "multi",
    "exp": "Cerebellar atrophy is seen in subcortical dementia, therefore, it is not a feature of Alzheimer's disease as it is a cortical type of dementia.\n\nPathology in Alzheimer's disease\n\nGross:- Atrophy of gyri, widening of sulci, enlarged ventricles.\nMicroscopy :- Senile plaque, neurofibrillary tangles, neuronal loss, synaptic loss, granulovascular degeneration.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. Cerebellar atrophy\n3. 5th and 6th decade\n4. Atrophied gyri\n5. Widened sulci\n6. Progressive dementia",
    "prediction": "A",
    "path": "Reranked Triple1: Alzheimer Disease -> causes -> brain atrophy  \nReranked Triple2: Alzheimer Disease -> associates -> AD  \nReranked Triple3: AD -> correlates with -> diabetes mellitus  \nReranked Triple4: Alzheimer Disease -> causes -> dementia  \nReranked Triple5: dementia -> caused by -> tau  \n\nAnswer:  \nCerebellar atrophy is not commonly associated with Alzheimer's disease, while the other options are related to its features.",
    "neighbor_input": "Reranked Triple1: AD -> causes -> brain atrophy \u2014\u2014> Alzheimer's disease\nReranked Triple2: AD -> causes -> progressive dementia \u2014\u2014> Alzheimer's disease\nReranked Triple3: AD -> causes -> cognitive decline \u2014\u2014> Alzheimer's disease\nReranked Triple4: AD -> causes -> atrophied gyri and widened sulci \u2014\u2014> Alzheimer's disease\nReranked Triple5: AD -> causes -> cognitive impairment \u2014\u2014> Alzheimer's disease\n\nAnswer: A. Cerebellar atrophy",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer Disease' is known to 'cause' 'brain atrophy'. \n\nPath-based Evidence 2: 'Alzheimer Disease' is 'associated' with 'AD'. \n\nPath-based Evidence 3: 'AD' 'correlates with' 'diabetes mellitus'. \n\nPath-based Evidence 4: 'Alzheimer Disease' 'causes' 'dementia'.\n\nPath-based Evidence 5: 'dementia' is 'caused by' 'tau'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'brain atrophy' which is linked to 'Alzheimer's disease'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'progressive dementia' which is associated with 'Alzheimer's disease'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'cognitive decline' related to 'Alzheimer's disease'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'atrophied gyri and widened sulci' connected to 'Alzheimer's disease'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'cognitive impairment' tied to 'Alzheimer's disease'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.8508630990982056,
      0.5570242404937744,
      0.5975096225738525,
      0.5254132747650146,
      1.0,
      0.9130909442901611
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "ac94bea3-14b0-440d-8490-d84bf6ac7b76",
    "question": "EEG changes are useful in diagnosis of which of the following dementias",
    "opa": "Alzheimer's",
    "opb": "Pick's Dementia",
    "opc": "Prion associated dementia",
    "opd": "Vascular dementia",
    "cop": 2,
    "choice_type": "single",
    "exp": "CJD's are have characteristic spike patterns on EEG",
    "subject_name": "Anatomy",
    "topic_name": "All India exam",
    "entity": "1. EEG\n2. diagnosis\n3. dementia\n4. Alzheimer's\n5. Pick's Dementia\n6. Prion associated dementia\n7. Vascular dementia.",
    "prediction": "A",
    "path": "Reranked Triple1: Alzheimer's \u2014\u2014> EEG changes are useful in diagnosis\nReranked Triple2: Pick's Dementia \u2014\u2014> EEG changes are useful in diagnosis\nReranked Triple3: Prion associated dementia \u2014\u2014> EEG changes are useful in diagnosis\nReranked Triple4: Vascular dementia \u2014\u2014> EEG changes are useful in diagnosis\nReranked Triple5: EEG changes \u2014\u2014> are relevant for dementia diagnosis",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> causes \u2014\u2014> Alzheimer's disease  \nReranked Triple2: AD \u2014\u2014> treats \u2014\u2014> cognitive deficits  \nReranked Triple3: AD \u2014\u2014> associates \u2014\u2014> neurodegenerative disorder  \nReranked Triple4: AD \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple5: AD \u2014\u2014> associates \u2014\u2014> cognitive impairment  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer's' 'EEG changes are useful in diagnosis'.\n\nPath-based Evidence 2: 'Pick's Dementia' 'EEG changes are useful in diagnosis'.\n\nPath-based Evidence 3: 'Prion associated dementia' 'EEG changes are useful in diagnosis'.\n\nPath-based Evidence 4: 'Vascular dementia' 'EEG changes are useful in diagnosis'.\n\nPath-based Evidence 5: 'EEG changes' 'are relevant for dementia diagnosis'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'Alzheimer's disease'.\n\nNeighbor-based Evidence 2: 'AD' 'treats' 'cognitive deficits'.\n\nNeighbor-based Evidence 3: 'AD' 'associates' 'neurodegenerative disorder'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'dementia'.\n\nNeighbor-based Evidence 5: 'AD' 'associates' 'cognitive impairment'.",
    "entity_confidence_scores": [
      0.6879606246948242,
      0.7433501482009888,
      0.6415209770202637,
      0.6648846864700317,
      1.0000001192092896,
      0.6279672384262085,
      1.0000001192092896,
      0.7327340245246887,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.7594513893127441,
      0.833743155002594,
      0.6907686591148376,
      0.8191841840744019,
      1.0,
      0.8961988091468811
    ],
    "question_types": [
      "diagnosis"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "d9db17d9-06be-4106-a412-9b91dacdc510",
    "question": "Alzheimer's disease is associated with -a) Deleriumb) Delusionc) Dementiad) Depression",
    "opa": "ab",
    "opb": "bc",
    "opc": "bd",
    "opd": "cd",
    "cop": 3,
    "choice_type": "single",
    "exp": null,
    "subject_name": "Medicine",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. Delerium\n3. Delusion\n4. Dementia\n5. Depression",
    "prediction": "D",
    "path": "Reranked Triple1: Alzheimer's disease \u2014\u2014> associates \u2014\u2014> dementia  \nReranked Triple2: Alzheimer's disease \u2014\u2014> has symptom \u2014\u2014> delusions  \nReranked Triple3: Depression \u2014\u2014> associates \u2014\u2014> Alzheimer's disease  \nReranked Triple4: Depression \u2014\u2014> is associated with \u2014\u2014> cognitive decline  \nReranked Triple5: Depression \u2014\u2014> associates \u2014\u2014> Parkinson's disease  \n\nAnswer: C.bd",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple2: AD \u2014\u2014> causes \u2014\u2014> depression  \nReranked Triple3: AD \u2014\u2014> associated with \u2014\u2014> cognitive impairment  \nReranked Triple4: AD \u2014\u2014> causes \u2014\u2014> behavioral deficits  \nReranked Triple5: AD \u2014\u2014> causes \u2014\u2014> cognitive disorders  \n\nAnswer: C.bd",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer's disease' 'associates' 'dementia'.\n\nPath-based Evidence 2: 'Alzheimer's disease' 'has symptom' 'delusions'.\n\nPath-based Evidence 3: 'Depression' 'associates' 'Alzheimer's disease'.\n\nPath-based Evidence 4: 'Depression' 'is associated with' 'cognitive decline'.\n\nPath-based Evidence 5: 'Depression' 'associates' 'Parkinson's disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'dementia'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'depression'.\n\nNeighbor-based Evidence 3: 'AD' 'associated with' 'cognitive impairment'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'behavioral deficits'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'cognitive disorders'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0,
      0.6239832639694214,
      1.000000238418579,
      1.0000001192092896,
      1.0,
      0.8745613098144531,
      1.0
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "42c24ecb-7f91-4856-802d-70c579b1277e",
    "question": "In Alzheimer's disease which area of brain in involved-",
    "opa": "Cerebral cortex",
    "opb": "Hippocampus",
    "opc": "Cerebellum",
    "opd": "A + B",
    "cop": 3,
    "choice_type": "single",
    "exp": null,
    "subject_name": "Medicine",
    "topic_name": null,
    "entity": "1. Alzheimer's disease \n2. brain \n3. Cerebral cortex \n4. Hippocampus \n5. Cerebellum",
    "prediction": "D",
    "path": "Reranked Triple1: Alzheimer's disease \u2014\u2014> associates \u2014\u2014> hippocampus  \nReranked Triple2: hippocampus \u2014\u2014> is part of \u2014\u2014> brain  \nReranked Triple3: hippocampus \u2014\u2014> part of \u2014\u2014> brain  \nReranked Triple4: Alzheimer's disease \u2014\u2014> causes \u2014\u2014> brain atrophy  \nReranked Triple5: brain atrophy \u2014\u2014> associates \u2014\u2014> Alzheimer's disease  ",
    "neighbor_input": "Reranked Triple1: AD -> causes -> hippocampal dysfunction  \nReranked Triple2: AD -> causes -> brain atrophy  \nReranked Triple3: AD -> causes -> cognitive impairment  \nReranked Triple4: AD -> causes -> cerebral cortex  \nReranked Triple5: AD -> causes -> memory loss  \n\nAnswer: D (A + B)",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer's disease' 'associates' with 'hippocampus'.\n\nPath-based Evidence 2: 'hippocampus' 'is part of' 'brain'.\n\nPath-based Evidence 3: 'hippocampus' 'part of' 'brain'.\n\nPath-based Evidence 4: 'Alzheimer's disease' 'causes' 'brain atrophy'.\n\nPath-based Evidence 5: 'brain atrophy' 'associates' with 'Alzheimer's disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' causes 'hippocampal dysfunction'.  \nNeighbor-based Evidence 2: 'AD' causes 'brain atrophy'.  \nNeighbor-based Evidence 3: 'AD' causes 'cognitive impairment'.  \nNeighbor-based Evidence 4: 'AD' causes 'cerebral cortex'.  \nNeighbor-based Evidence 5: 'AD' causes 'memory loss'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.000000238418579,
      0.8071302771568298,
      0.9999999403953552,
      0.9999999403953552,
      1.0000001192092896
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "c9750a6f-ca37-4c49-98f3-9eeb038c1f46",
    "question": "Which of the following is not a pathological finding seen in alzheimer's disease ?",
    "opa": "Coical atrophy",
    "opb": "Neurofibrillary tangles",
    "opc": "Neuritic plaques",
    "opd": "Lewy body",
    "cop": 3,
    "choice_type": "single",
    "exp": "Ans. is 'd' i.e., Lewy bodyImpoant pathological findings in Alzheimer's disease :?Coical atrophy with sidening of the cerebral sulciCompensatory ventricular enlargement Hydrocephalus exvacuo.Neuritic (senile) plaques --> Made up of A f390 & Al342.Diffuse plaques Contain Ab42.Neurofibrillary tangles --> Contain tau proteinCerebral amyloid angiopathy.Granulovascular degeneration",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. Coical atrophy\n3. Neurofibrillary tangles\n4. Neuritic plaques\n5. Lewy body",
    "prediction": "D",
    "path": "Reranked Triple1: Alzheimer's disease -> associated with -> Neurofibrillary tangles  \nReranked Triple2: Alzheimer's disease -> associated with -> neuritic plaques  \nReranked Triple3: Lewy bodies -> found in -> brain  \nReranked Triple4: Lewy body disease -> involves -> Lewy bodies  \nReranked Triple5: Lewy body -> NOT found in -> Alzheimer's disease  \n\nAnswer: D. Lewy body",
    "neighbor_input": "Reranked Triple1: AD -> causes -> neurofibrillary tangles \u2014\u2014> Alzheimer's disease\nReranked Triple2: AD -> causes -> neuritic plaques \u2014\u2014> Alzheimer's disease\nReranked Triple3: AD -> causes -> cortical atrophy \u2014\u2014> Alzheimer's disease\nReranked Triple4: AD -> associates -> amyloid-beta peptide (Abeta) deposition \u2014\u2014> Alzheimer's disease\nReranked Triple5: AD -> causes -> dementia \u2014\u2014> Alzheimer's disease \n\nAnswer:\nBased on the reranked triples, options A (Cortical atrophy), B (Neurofibrillary tangles), and C (Neuritic plaques) are all associated with Alzheimer's disease, while D (Lewy body) is not mentioned in the context of Alzheimer's disease and thus is the correct answer.",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer's disease' is 'associated with' 'Neurofibrillary tangles'.\n\nPath-based Evidence 2: 'Alzheimer's disease' is 'associated with' 'neuritic plaques'.\n\nPath-based Evidence 3: 'Lewy bodies' are 'found in' the 'brain'.\n\nPath-based Evidence 4: 'Lewy body disease' 'involves' 'Lewy bodies'.\n\nPath-based Evidence 5: 'Lewy body' is 'NOT found in' 'Alzheimer's disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'neurofibrillary tangles' which are associated with 'Alzheimer's disease'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'neuritic plaques' which are associated with 'Alzheimer's disease'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'cortical atrophy' which is associated with 'Alzheimer's disease'.\n\nNeighbor-based Evidence 4: 'AD' 'associates' 'amyloid-beta peptide (Abeta) deposition' which is related to 'Alzheimer's disease'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'dementia' which is associated with 'Alzheimer's disease'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.7898662686347961,
      1.0,
      1.0,
      1.0,
      0.9429672360420227,
      0.7109739780426025,
      0.702234148979187,
      1.0,
      0.6846673488616943,
      1.0
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "0653b7d3-75ae-4762-9020-c536a752db82",
    "question": "Dementia of Alzheimer's type is not associated with one of the following:",
    "opa": "Depressive symptoms",
    "opb": "Delusions",
    "opc": "Apraxia and aphasia",
    "opd": "Cerebral infarcts",
    "cop": 3,
    "choice_type": "single",
    "exp": "Alzheimer's disease is a type of Coical dementia -Cognitive impairment Amnesia Disturbance of memory Apraxia Aphasia -Behavioral and psychological symptoms of depression Personality changes Delusion / Hallucinations Catastrophic reaction Cerebral infarcts are associated with vascular dementia",
    "subject_name": "Psychiatry",
    "topic_name": "Neurotic, Stress Related and Somatoform Disorders",
    "entity": "1. Dementia of Alzheimer's type\n2. Depressive symptoms\n3. Delusions\n4. Apraxia and aphasia \n5. Cerebral infarcts",
    "prediction": "D",
    "path": "Reranked Triple1: dementia of the Alzheimer type \u2014\u2014> patients\nReranked Triple2: delusions \u2014\u2014> affects \u2014\u2014> patients\nReranked Triple3: patients \u2014\u2014> have \u2014\u2014> aphasia syndromes\nReranked Triple4: Abeta \u2014\u2014> causes \u2014\u2014> AD\nReranked Triple5: Abeta \u2014\u2014> treats \u2014\u2014> AD",
    "neighbor_input": "Reranked Triple1: AD -> has symptom -> depressive symptoms  \nReranked Triple2: AD -> has symptom -> aphasia  \nReranked Triple3: AD -> has symptom -> memory loss  \nReranked Triple4: AD -> has symptom -> cognitive impairment  \nReranked Triple5: AD -> has symptom -> behavioral symptoms  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'dementia of the Alzheimer type' is associated with 'patients'.\n\nPath-based Evidence 2: 'delusions' affects 'patients'.\n\nPath-based Evidence 3: 'patients' have 'aphasia syndromes'.\n\nPath-based Evidence 4: 'Abeta' causes 'AD'.\n\nPath-based Evidence 5: 'Abeta' treats 'AD'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'has symptom' 'depressive symptoms'.\n\nNeighbor-based Evidence 2: 'AD' 'has symptom' 'aphasia'.\n\nNeighbor-based Evidence 3: 'AD' 'has symptom' 'memory loss'.\n\nNeighbor-based Evidence 4: 'AD' 'has symptom' 'cognitive impairment'.\n\nNeighbor-based Evidence 5: 'AD' 'has symptom' 'behavioral symptoms'.",
    "entity_confidence_scores": [
      0.9736135005950928,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.9381810426712036,
      1.0,
      1.000000238418579,
      1.0,
      0.6450759768486023,
      1.0,
      0.8186885714530945,
      1.0000001192092896
    ],
    "question_types": [
      "symptom",
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "0d35bf59-54e0-4458-a34c-9f7938ad1934",
    "question": "A patient presents with ataxia, urinary incontinence and dementia. The likely diagnosis is:",
    "opa": "Alzheimer's Disease",
    "opb": "Parkinson's disease",
    "opc": "Steel Richardson syndrome",
    "opd": "Normal Pressure Hydrocephalus",
    "cop": 3,
    "choice_type": "single",
    "exp": "Answer is D (Normal Pressure Hydrocephalus): Normal Pressure Hydrocephalus This is a communicating hydrocephalus with a aqueduct of sylvius caused by obstruction to normal flow of CSF over the cerebral convexities and delayed absorption into the venous system. The CSF opening pressure is in the high normal range (Hence called Normal Pressure Hydrocephalus). Characteristic Clinical Triad Abnormal Gait (Ataxic or Apractic) Dementia (Usually mild or moderate) Urinary I ncontinance",
    "subject_name": "Medicine",
    "topic_name": null,
    "entity": "1. Ataxia\n2. Urinary incontinence\n3. Dementia\n4. Alzheimer's Disease\n5. Parkinson's disease\n6. Steel Richardson syndrome\n7. Normal Pressure Hydrocephalus",
    "prediction": "D",
    "path": "Reranked Triple1: ataxia \u2014\u2014> associated with \u2014\u2014> cognitive decline  \nReranked Triple2: cognitive decline \u2014\u2014> in \u2014\u2014> Alzheimer's disease  \nReranked Triple3: Alzheimer's disease \u2014\u2014> has symptom \u2014\u2014> urinary incontinence  \nReranked Triple4: ataxia \u2014\u2014> associated with \u2014\u2014> urinary incontinence  \nReranked Triple5: Alzheimer's disease \u2014\u2014> has symptom \u2014\u2014> dementia  \n\nAnswer: A. Alzheimer's Disease",
    "neighbor_input": "Reranked Triple1: ataxia \u2014\u2014> ataxic cerebral palsy  \nReranked Triple2: ataxia \u2014\u2014> associated with \u2014\u2014> cognitive decline  \nReranked Triple3: AD \u2014\u2014> causes \u2014\u2014> cognitive decline  \nReranked Triple4: AD \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple5: AD \u2014\u2014> causes \u2014\u2014> cognitive impairment  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'ataxia' 'associated with' 'cognitive decline'.\n\nPath-based Evidence 2: 'cognitive decline' 'in' 'Alzheimer's disease'.\n\nPath-based Evidence 3: 'Alzheimer's disease' 'has symptom' 'urinary incontinence'.\n\nPath-based Evidence 4: 'ataxia' 'associated with' 'urinary incontinence'.\n\nPath-based Evidence 5: 'Alzheimer's disease' 'has symptom' 'dementia'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'ataxia' is related to 'ataxic cerebral palsy'.  \nNeighbor-based Evidence 2: 'ataxia' is 'associated with' 'cognitive decline'.  \nNeighbor-based Evidence 3: 'AD' 'causes' 'cognitive decline'.  \nNeighbor-based Evidence 4: 'AD' 'causes' 'dementia'.  \nNeighbor-based Evidence 5: 'AD' 'causes' 'cognitive impairment'.",
    "entity_confidence_scores": [
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.000000238418579,
      0.9169323444366455,
      0.7333592176437378,
      0.7333592176437378
    ],
    "question_types": [
      "symptom",
      "diagnosis"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "aa12622c-91bc-4ce9-a33d-dece9bdb5362",
    "question": "In Alzheimer disease, seen are:",
    "opa": "Neurofibrillary tangles",
    "opb": "Neuritic plaques",
    "opc": "Pick's protein",
    "opd": "Amyloid angiopathy",
    "cop": 1,
    "choice_type": "single",
    "exp": "Microscopically, the main features are as under: i) Senile neuritic plaque is the most conspicuous lesion and consists of focal area which has a central core containing Ab amyloid. ii) Neurofibrillary tangle is a filamentous collection of neurofilaments and neurotubules within the cytoplasm of neurons. iii) Amyloid angiopathy is deposition of the same amyloid in the vessel wall which is deposited in the amyloid core of the plaque. iv) Granulovacuolar degeneration is presence of multiple, small intraneuronal cytoplasmic vacuoles, some of which contain one or more dark granules called Hirano bodies. Ref: TEXTBOOK OF PATHOLOGY 6th EDITION -HARSH MOHAN PAGE NO:884",
    "subject_name": "Pathology",
    "topic_name": "Nervous system",
    "entity": "1. Alzheimer disease\n2. Neurofibrillary tangles\n3. Neuritic plaques\n4. Pick's protein\n5. Amyloid angiopathy",
    "prediction": "A",
    "path": "Reranked Triple1: Neurofibrillary tangles \u2014\u2014> Alzheimer's disease  \nReranked Triple2: Neurofibrillary tangles \u2014\u2014> associated with neuritic plaques  \nReranked Triple3: neuritic plaques \u2014\u2014> associated with Alzheimer's disease  \nReranked Triple4: Neurofibrillary tangles \u2014\u2014> composed of Tau  \nReranked Triple5: Alzheimer disease \u2014\u2014> causes -> dementia  ",
    "neighbor_input": "Reranked Triple1: AD -> causes -> neurofibrillary tangle pathology \u2014\u2014> Alzheimer's disease  \nReranked Triple2: AD -> causes -> amyloid-beta peptide (Abeta) deposition \u2014\u2014> neurodegenerative disorder  \nReranked Triple3: AD -> associates -> amyloid angiopathy \u2014\u2014> cognitive impairment   \nReranked Triple4: AD -> causes -> amyloidosis \u2014\u2014> dementia  \nReranked Triple5: AD -> associates -> neurodegenerative diseases \u2014\u2014> cognitive dysfunction  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Neurofibrillary tangles' are associated with 'Alzheimer's disease'.\n\nPath-based Evidence 2: 'Neurofibrillary tangles' are 'associated with' 'neuritic plaques'.\n\nPath-based Evidence 3: 'Neuritic plaques' are 'associated with' 'Alzheimer's disease'.\n\nPath-based Evidence 4: 'Neurofibrillary tangles' are 'composed of' 'Tau'.\n\nPath-based Evidence 5: 'Alzheimer's disease' 'causes' 'dementia'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Alzheimer's disease' is known to 'cause' 'neurofibrillary tangle pathology'.\n\nNeighbor-based Evidence 2: 'Alzheimer's disease' is known to 'cause' 'amyloid-beta peptide (Abeta) deposition', which is associated with 'neurodegenerative disorder'.\n\nNeighbor-based Evidence 3: 'Alzheimer's disease' is known to 'associate' with 'amyloid angiopathy', which can lead to 'cognitive impairment'.\n\nNeighbor-based Evidence 4: 'Alzheimer's disease' is known to 'cause' 'amyloidosis', which is linked to 'dementia'.\n\nNeighbor-based Evidence 5: 'Alzheimer's disease' is known to 'associate' with 'neurodegenerative diseases', which can result in 'cognitive dysfunction'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0,
      1.0,
      0.6884418725967407,
      1.0000001192092896,
      1.0000001192092896,
      0.9499473571777344
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "0864976a-ae1f-4524-b0f9-29f3b5081cab",
    "question": "Alzheimer's disease is treated by:",
    "opa": "Neostigmine",
    "opb": "Rivastigmine",
    "opc": "Trihexyphenidyl",
    "opd": "Benztropine",
    "cop": 1,
    "choice_type": "single",
    "exp": "Ans. B. Rivastigminea. The mainstay of therapy for patients with Alzheimer disease (AD) is the use of centrally acting cholinesterase inhibitors to attempt to compensate for the depletion of acetylcholine (ACh) in the cerebral cortex and hippocampusb. Rivastigmine, Galantamine, Donepezil are centrally acting ChE inhibitors used for Alzheimer's disease. Donepezil is long acting and can be used once daily. Rivastigmine is also available as a transdermal patchc. Memantine, an NMDA receptor antagonist is also used for Alzheimer's.",
    "subject_name": "Pharmacology",
    "topic_name": "A.N.S.",
    "entity": "1. Alzheimer's disease \n2. Neostigmine\n3. Rivastigmine\n4. Trihexyphenidyl\n5. Benztropine",
    "prediction": "B",
    "path": "Reranked Triple1: rivastigmine \u2014\u2014> treats \u2014\u2014> AD (Alzheimer's disease)  \nReranked Triple2: rivastigmine \u2014\u2014> treat \u2014\u2014> Alzheimer's disease  \nReranked Triple3: rivastigmine \u2014\u2014> treat \u2014\u2014> Alzheimer's disease  \nReranked Triple4: rivastigmine \u2014\u2014> CAUSES \u2014\u2014> death  \nReranked Triple5: rivastigmine \u2014\u2014> induced by \u2014\u2014> staurosporine  ",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> TREATMENT \u2014\u2014> TUDCA  \nReranked Triple2: AD \u2014\u2014> TREATMENT \u2014\u2014> N-acetylcysteine  \nReranked Triple3: AD \u2014\u2014> TREATMENT \u2014\u2014> tropisetron  \nReranked Triple4: AD \u2014\u2014> TREATMENT \u2014\u2014> reserpine  \nReranked Triple5: AD \u2014\u2014> TREATMENT \u2014\u2014> alpha-lipoic acid  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Rivastigmine' 'treats' 'AD (Alzheimer's disease)'.\n\nPath-based Evidence 2: 'Rivastigmine' 'treats' 'Alzheimer's disease'.\n\nPath-based Evidence 3: 'Rivastigmine' 'treats' 'Alzheimer's disease'.\n\nPath-based Evidence 4: 'Rivastigmine' 'CAUS' 'death'.\n\nPath-based Evidence 5: 'Rivastigmine' 'induced by' 'staurosporine'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: The treatment for 'AD' includes 'TUDCA'.  \nNeighbor-based Evidence 2: The treatment for 'AD' includes 'N-acetylcysteine'.  \nNeighbor-based Evidence 3: The treatment for 'AD' includes 'tropisetron'.  \nNeighbor-based Evidence 4: The treatment for 'AD' includes 'reserpine'.  \nNeighbor-based Evidence 5: The treatment for 'AD' includes 'alpha-lipoic acid'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.6694677472114563,
      0.628110408782959,
      0.6071081161499023,
      0.622585117816925,
      0.6208632588386536,
      0.6894457340240479,
      0.6884069442749023,
      0.8880565166473389
    ],
    "question_types": [
      "treatment"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "e9d46596-2431-44a9-8a4b-8c039f75398d",
    "question": "Dementia of Alzheimer&;s type is not associated with one of the following",
    "opa": "Depressive symptoms",
    "opb": "Delusions",
    "opc": "Apraxia and Aphasia",
    "opd": "Cerebral infarcts",
    "cop": 3,
    "choice_type": "single",
    "exp": "Dementia is a chronic organic mental disorder, characterized by the following main clinical features: 1. Impairment of intellectual functions, 2. Impairment of memory (predominantly of recent memory, especially in early stages), 3. Deterioration of personality with lack of personal care. Reference: A sho textbook of Psychiatry by Niraj Ahuja, page no.22.",
    "subject_name": "Psychiatry",
    "topic_name": "Organic mental disorders",
    "entity": "1. Dementia \n2. Alzheimer's type \n3. Depressive symptoms \n4. Delusions \n5. Apraxia \n6. Aphasia \n7. Cerebral infarcts",
    "prediction": "D",
    "path": "Reranked Triple1: dementia of the Alzheimer type -> patients -> Abeta -> causes -> cognitive decline -> associates -> depressive symptoms\nReranked Triple2: delusions -> affects -> patients -> with -> Alzheimer's disease -> has symptom -> apraxia\nReranked Triple3: delusions -> affects -> patients -> diagnosed with -> Alzheimer's disease -> has symptom -> apraxia\nReranked Triple4: delusions -> affects -> patients -> treats -> Alzheimer's disease -> has symptom -> apraxia\nReranked Triple5: dementia of the Alzheimer type -> patients -> Abeta -> associates -> people -> has symptom -> depressive symptoms\n\nAnswer: D. Cerebral infarcts",
    "neighbor_input": "Reranked Triple1: AD -> has symptom -> depressive symptoms \u2014\u2014> AD\nReranked Triple2: AD -> has symptom -> delusions \u2014\u2014> AD\nReranked Triple3: AD -> has symptom -> aphasia \u2014\u2014> AD\nReranked Triple4: AD -> has symptom -> memory loss \u2014\u2014> AD\nReranked Triple5: AD -> has symptom -> cognitive impairment \u2014\u2014> AD\n\nAnswer: D.Cerebral infarcts",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Dementia of the Alzheimer type' 'affects' 'patients' 'through' 'Abeta' 'which' 'causes' 'cognitive decline' 'and' 'associates' 'with' 'depressive symptoms'.\n\nPath-based Evidence 2: 'Delusions' 'affect' 'patients' 'who' 'have' 'Alzheimer's disease' 'and' 'exhibit' 'the symptom' 'apraxia'.\n\nPath-based Evidence 3: 'Delusions' 'affect' 'patients' 'diagnosed with' 'Alzheimer's disease' 'and' 'exhibit' 'the symptom' 'apraxia'.\n\nPath-based Evidence 4: 'Delusions' 'affect' 'patients' 'who' 'are' 'treated for' 'Alzheimer's disease' 'and' 'exhibit' 'the symptom' 'apraxia'.\n\nPath-based Evidence 5: 'Dementia of the Alzheimer type' 'affects' 'patients' 'through' 'Abeta' 'which' 'associates' 'with' 'people' 'having' 'the symptom' 'depressive symptoms'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Alzheimer's Disease' 'has symptom' 'depressive symptoms'.\n\nNeighbor-based Evidence 2: 'Alzheimer's Disease' 'has symptom' 'delusions'.\n\nNeighbor-based Evidence 3: 'Alzheimer's Disease' 'has symptom' 'aphasia'.\n\nNeighbor-based Evidence 4: 'Alzheimer's Disease' 'has symptom' 'memory loss'.\n\nNeighbor-based Evidence 5: 'Alzheimer's Disease' 'has symptom' 'cognitive impairment'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.9129931926727295,
      0.9031563401222229,
      0.8855912685394287,
      0.878637433052063,
      1.0,
      1.000000238418579,
      1.0,
      0.6450759768486023,
      1.0,
      1.0000001192092896,
      0.7298930883407593,
      0.7964770793914795,
      0.633560061454773,
      0.6898353099822998,
      0.5880182981491089,
      0.5017680525779724,
      1.0,
      1.0000001192092896
    ],
    "question_types": [
      "symptom",
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "960eff06-dd28-47c5-8ecc-6cf3658c854d",
    "question": "Protein deposited in Alzheimer's disease is?",
    "opa": "Tau protein",
    "opb": "Alpha synuclein protein",
    "opc": "Huntington protein",
    "opd": "Protein 14.3.3.",
    "cop": 0,
    "choice_type": "single",
    "exp": "Ans. (a) Tau proteinRef: Harrison 19th ed. / 172t, 175* Tau proteins are proteins that stabilize microtubules. They are abundant in neurons of the central nervous system and are less common elsewhere, but are also expressed at very low levels in CNS astrocytes and oligodendrocytes.* Pathologies and dementias of the nervous system such as Alzheimer's disease can result when tau proteins become defective and no longer stabilize microtubules properly. Alpha synuclein protein is seen in parkinsonism.* Huntington protein is related to Huntington disease related to chromosome 4. Protein 14.3.3 is related to prion disease like variant Creutzfeldt Jakob disease.",
    "subject_name": "Medicine",
    "topic_name": "Dementia",
    "entity": "1. Alzheimer's disease\n2. Tau protein\n3. Alpha synuclein protein\n4. Huntington protein\n5. Protein 14.3.3",
    "prediction": "A",
    "path": "Reranked Triple1: Alzheimer's disease \u2014\u2014> CAUSES \u2014\u2014> dementia  \nReranked Triple2: dementia \u2014\u2014> caused by \u2014\u2014> tau  \nReranked Triple3: tau \u2014\u2014> associates with \u2014\u2014> Alzheimer's disease  \nReranked Triple4: Alzheimer's disease \u2014\u2014> resembles \u2014\u2014> AD  \nReranked Triple5: AD \u2014\u2014> correlates with \u2014\u2014> diabetes mellitus  ",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> causes \u2014\u2014> neurofibrillary tangle pathology  \nReranked Triple2: AD \u2014\u2014> causes \u2014\u2014> Tau  \nReranked Triple3: AD \u2014\u2014> causes \u2014\u2014> amyloid-beta  \nReranked Triple4: AD \u2014\u2014> associates \u2014\u2014> tauopathies  \nReranked Triple5: AD \u2014\u2014> causes \u2014\u2014> cognitive impairment  \n\nAnswer: A. Tau protein",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer's disease' 'CAUSES' 'dementia'.  \nPath-based Evidence 2: 'dementia' 'caused by' 'tau'.  \nPath-based Evidence 3: 'tau' 'associates with' 'Alzheimer's disease'.  \nPath-based Evidence 4: 'Alzheimer's disease' 'resembles' 'AD'.  \nPath-based Evidence 5: 'AD' 'correlates with' 'diabetes mellitus'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'neurofibrillary tangle pathology'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'Tau'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'amyloid-beta'.\n\nNeighbor-based Evidence 4: 'AD' 'associates' 'tauopathies'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'cognitive impairment'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.8382810950279236,
      0.9080621004104614,
      0.9080621004104614,
      0.7607138156890869,
      0.6696229577064514
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "422aa9b0-fb93-4a53-8980-ddee6344a8bd",
    "question": "Which of the following is not seen in early onset Alzheimer's Disease:",
    "opa": "Aphasia",
    "opb": "Apraxia",
    "opc": "Acalculia",
    "opd": "None",
    "cop": 3,
    "choice_type": "multi",
    "exp": "Answer is None (All are seen) > AgnosiaAphasia, Apraxia, Acalculia and Agnosias may all be seen in Alzheimer's Dementia.`Agnosia' in Alzheimer's disease usually presents late in the disease and is not included in the ICD-10 Diagnostic criteria for dementia in Alzheimer's disease with early onset and hence may be selected as the single best answer by exclusion.Dementia in Alzheimer's Disease with Early Onset (ICD-10 criterion)The criteria for dementia in Alzheimer's Disease must be met, and the age at onset must be less than 65 years.In addition atleast one of the following requirements must be met:a) evidence of relatively rapid onset and progressionb) in addition to memory impairment there must be:- Aphasia (Amnesia or sensory)- Agraphia- Alexia (indicating the presence of temporal, parietal or frontal lobe involvement)- Acalculia or- Apraxia",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Alzheimer's Disease\n2. Aphasia\n3. Apraxia\n4. Acalculia",
    "prediction": "C",
    "path": "Reranked Triple1: Aphasia \u2014\u2014> type of \u2014\u2014> neurodegenerative diseases  \nReranked Triple2: Aphasia \u2014\u2014> has symptom \u2014\u2014> apraxia  \nReranked Triple3: Apraxia \u2014\u2014> type of \u2014\u2014> neurodegenerative diseases  \nReranked Triple4: Apraxia \u2014\u2014> associates with \u2014\u2014> Alzheimer's disease  \nReranked Triple5: Alzheimer's disease \u2014\u2014> has symptom \u2014\u2014> apraxia  \n\nAnswer: C. Acalculia",
    "neighbor_input": "Reranked Triple1: AD -> causes -> cognitive impairment \u2014\u2014> dementia  \nReranked Triple2: AD -> causes -> cognitive decline \u2014\u2014> cognitive deficits  \nReranked Triple3: AD -> causes -> behavioral abnormalities \u2014\u2014> cognitive dysfunction  \nReranked Triple4: AD -> causes -> memory impairment \u2014\u2014> cognitive decline  \nReranked Triple5: AD -> causes -> aphasia \u2014\u2014> cognitive deficits  \n\nAnswer: C. Acalculia",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Aphasia' is a 'type of' 'neurodegenerative diseases'.\n\nPath-based Evidence 2: 'Aphasia' 'has symptom' 'apraxia'.\n\nPath-based Evidence 3: 'Apraxia' is a 'type of' 'neurodegenerative diseases'.\n\nPath-based Evidence 4: 'Apraxia' 'associates with' 'Alzheimer's disease'.\n\nPath-based Evidence 5: 'Alzheimer's disease' 'has symptom' 'apraxia'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'cognitive impairment', which can lead to 'dementia'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'cognitive decline', which may result in 'cognitive deficits'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'behavioral abnormalities', leading to 'cognitive dysfunction'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'memory impairment', contributing to 'cognitive decline'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'aphasia', which can result in 'cognitive deficits'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      0.7298930883407593,
      0.7964770793914795,
      0.633560061454773,
      0.6898353099822998,
      0.5880182981491089,
      0.5017680525779724,
      0.6475889682769775
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "64eb5c57-a171-4128-83ff-690d0912eabe",
    "question": "Area of brain resistant to neurofibrillary tangles in Alzheimer's disease:",
    "opa": "Visual association area",
    "opb": "Entorhinal coex",
    "opc": "Lateral geniculate body",
    "opd": "Cuneal gyrus area VI/temporal lobe",
    "cop": 2,
    "choice_type": "single",
    "exp": "Histopathological studies have shown that neurofibrillary tangles are rarely present in lateral geniculate bodies Neurofibrillary tangles : These are intracellular deposits made up of Tau proteins Amount & distribution of NFTs correlates with severity , distribution of Alzheimer NFTs are found commonly in following areas: Coical neurons (esp entorhinal coex) Hippocampus Amygdala Basal forebrain Raphe nuclei",
    "subject_name": "Psychiatry",
    "topic_name": "Organic Mental Disorders",
    "entity": "1. Alzheimer's disease\n2. Visual association area\n3. Entorhinal coex\n4. Lateral geniculate body\n5. Cuneal gyrus\n6. area VI\n7. temporal lobe",
    "prediction": "C",
    "path": "Reranked Triple1: alzheimer disease \u2014\u2014> CAUSES \u2014\u2014> dementia  \nReranked Triple2: dementia \u2014\u2014> caused by \u2014\u2014> tau  \nReranked Triple3: alzheimer disease \u2014\u2014> associates \u2014\u2014> AD  \nReranked Triple4: AD \u2014\u2014> correlates with \u2014\u2014> diabetes mellitus  \nReranked Triple5: alzheimer disease \u2014\u2014> causes \u2014\u2014> brain atrophy  ",
    "neighbor_input": "Reranked Triple1: AD -> causes -> neurofibrillary tangle pathology\nReranked Triple2: AD -> associates -> brain disorder\nReranked Triple3: AD -> associates -> cognitive impairment\nReranked Triple4: AD -> causes -> dementia\nReranked Triple5: AD -> causes -> cognitive deficits",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer disease' 'CAUSES' 'dementia'.\n\nPath-based Evidence 2: 'dementia' 'caused by' 'tau'.\n\nPath-based Evidence 3: 'Alzheimer disease' 'associates' 'AD'.\n\nPath-based Evidence 4: 'AD' 'correlates with' 'diabetes mellitus'.\n\nPath-based Evidence 5: 'Alzheimer disease' 'causes' 'brain atrophy'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'neurofibrillary tangle pathology'.\n\nNeighbor-based Evidence 2: 'AD' 'associates' 'brain disorder'.\n\nNeighbor-based Evidence 3: 'AD' 'associates' 'cognitive impairment'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'dementia'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'cognitive deficits'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.6131659746170044,
      1.0000001192092896,
      0.7429633140563965,
      0.6036741733551025,
      1.0000001192092896,
      1.0,
      0.9178898334503174,
      0.8846515417098999,
      1.0,
      0.9128051996231079,
      0.7078962326049805,
      1.0000001192092896,
      0.8645899891853333
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "639d477f-ed3a-4cd6-be8d-20e61d000fc8",
    "question": "Difference between Delirium and Dementia:",
    "opa": "Fluctuating course",
    "opb": "Hypoactive psychomotor activity",
    "opc": "Difficulty in finding words",
    "opd": "Poor Memory",
    "cop": 2,
    "choice_type": "single",
    "exp": "Ref. Oxford textbook of Psychiatry. Page. 358",
    "subject_name": "Unknown",
    "topic_name": null,
    "entity": "1. Delirium\n2. Dementia \n3. Fluctuating course \n4. Hypoactive psychomotor activity \n5. Difficulty in finding words \n6. Poor Memory",
    "prediction": "A",
    "path": [],
    "neighbor_input": "Reranked Triple1: delirium -> associates -> cognitive impairment  \nReranked Triple2: delirium -> occurs in -> patients  \nReranked Triple3: AD -> causes -> cognitive impairment  \nReranked Triple4: AD -> causes -> dementia  \nReranked Triple5: AD -> causes -> neurodegenerative diseases  ",
    "response_of_KG_list_path": [],
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'delirium' is associated with 'cognitive impairment'.\n\nNeighbor-based Evidence 2: 'delirium' occurs in 'patients'.\n\nNeighbor-based Evidence 3: 'AD' causes 'cognitive impairment'.\n\nNeighbor-based Evidence 4: 'AD' causes 'dementia'.\n\nNeighbor-based Evidence 5: 'AD' causes 'neurodegenerative diseases'.",
    "entity_confidence_scores": [
      0.9999999403953552,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.7229970693588257,
      0.7695422768592834,
      0.7695422172546387
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "5c1c4f90-afb7-4eee-9c0d-c0bb460fbc81",
    "question": "Which apolipoprotein is responsible for Alzeihmers disease",
    "opa": "APOE1",
    "opb": "APOE2",
    "opc": "APOE3",
    "opd": "APOE4",
    "cop": 3,
    "choice_type": "single",
    "exp": "* Familial AD and Apo-E4 gene: There is an association between patients possessing the apo E4 allele and the incidence of Alzheimer disease. Apparently, apo E4 binds more avidly to beta-amyloid found in neuritic plaques. * Genes identified with AD are that coding for APP, presenilin-1 (chromosome 14), presenilin-2 (chromosome 1) or AD3 (chromosome 14) or AD4 (chromosome 1), and Apo-E4 gene (chromosome 19). * The presence of Apo-E4 gene is the major risk factor for AD. Apo-E2 gene reduces the risk of AD. Ref:- Harper 30/e; pg num:- 275",
    "subject_name": "Biochemistry",
    "topic_name": "Metabolism of lipid",
    "entity": "1. apolipoprotein\n2. Alzeihmers disease\n3. APOE1\n4. APOE2\n5. APOE3\n6. APOE4",
    "prediction": "D",
    "path": "Reranked Triple1: APOE4 \u2014\u2014> associated with \u2014\u2014> Alzheimer's disease  \nReranked Triple2: APOE3 \u2014\u2014> is neutral with respect to \u2014\u2014> Alzheimer's disease  \nReranked Triple3: Alzheimer's disease \u2014\u2014> associated with \u2014\u2014> APOE4  \nReranked Triple4: APOE4 \u2014\u2014> is a variant of \u2014\u2014> APOE  \nReranked Triple5: APOE3 \u2014\u2014> is a variant of \u2014\u2014> APOE  ",
    "neighbor_input": "Reranked Triple1: apolipoprotein (APOE) \u2014\u2014> associated with \u2014\u2014> AD (Alzheimer's disease)  \nReranked Triple2: apoE2 \u2014\u2014> resembles \u2014\u2014> apoE4  \nReranked Triple3: apoE2 \u2014\u2014> regulates \u2014\u2014> Abeta clearance  \nReranked Triple4: apoE2 \u2014\u2014> interacts \u2014\u2014> ApoE 4  \nReranked Triple5: apoE4 \u2014\u2014> associated with \u2014\u2014> AD (Alzheimer's disease)  \n\nAnswer: D.APOE4",
    "response_of_KG_list_path": "Path-based Evidence 1: 'APOE4' is 'associated with' 'Alzheimer's disease'.  \nPath-based Evidence 2: 'APOE3' 'is neutral with respect to' 'Alzheimer's disease'.  \nPath-based Evidence 3: 'Alzheimer's disease' is 'associated with' 'APOE4'.  \nPath-based Evidence 4: 'APOE4' 'is a variant of' 'APOE'.  \nPath-based Evidence 5: 'APOE3' 'is a variant of' 'APOE'.  ",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: The entity 'apolipoprotein (APOE)' is 'associated with' the entity 'AD (Alzheimer's disease)'.\n\nNeighbor-based Evidence 2: The entity 'apoE2' 'resembles' the entity 'apoE4'.\n\nNeighbor-based Evidence 3: The entity 'apoE2' 'regulates' the entity 'Abeta clearance'.\n\nNeighbor-based Evidence 4: The entity 'apoE2' 'interacts' with the entity 'ApoE 4'.\n\nNeighbor-based Evidence 5: The entity 'apoE4' is 'associated with' the entity 'AD (Alzheimer's disease)'.",
    "entity_confidence_scores": [
      0.9572594165802002,
      0.8959727883338928,
      0.8721412420272827,
      0.8691518306732178,
      0.9050863981246948,
      1.0,
      1.0,
      1.000000238418579,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "47886619-1086-42dc-b81b-a4581bdb8fb1",
    "question": "Amongst the following cause of dementia, neurofibrillary tangles, senile plaques and amyloid angiopathy are associated with: September 2003",
    "opa": "Creutzfeldt-Jacob disease",
    "opb": "Vascular dementia",
    "opc": "Niemann Pick disease",
    "opd": "Alzheimer's disease",
    "cop": 3,
    "choice_type": "single",
    "exp": "Ans. D i.e. Alzheimer's disease",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. dementia\n2. neurofibrillary tangles\n3. senile plaques\n4. amyloid angiopathy\n5. Creutzfeldt-Jacob disease\n6. Vascular dementia\n7. Niemann Pick disease\n8. Alzheimer's disease",
    "prediction": "D",
    "path": "Reranked Triple1: neurofibrillary tangles \u2014\u2014> ASSOCIATES \u2014\u2014> Alzheimer's disease  \nReranked Triple2: senile plaques \u2014\u2014> found in \u2014\u2014> Abeta  \nReranked Triple3: neurofibrillary tangles \u2014\u2014> treats \u2014\u2014> Abeta  \nReranked Triple4: neuritic plaques \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple5: neuritic plaques \u2014\u2014> DISEASE OF \u2014\u2014> human  ",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> causes \u2014\u2014> neurofibrillary tangle pathology  \nReranked Triple2: AD \u2014\u2014> causes \u2014\u2014> senile plaques  \nReranked Triple3: AD \u2014\u2014> causes \u2014\u2014> amyloid angiopathy  \nReranked Triple4: AD \u2014\u2014> caused by \u2014\u2014> deposition of Abeta in the brain  \nReranked Triple5: AD \u2014\u2014> cause \u2014\u2014> Alzheimer's disease  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Neurofibrillary tangles' ASSOCIATES 'Alzheimer's disease'.  \nPath-based Evidence 2: 'Senile plaques' found in 'Abeta'.  \nPath-based Evidence 3: 'Neurofibrillary tangles' treats 'Abeta'.  \nPath-based Evidence 4: 'Neuritic plaques' causes 'dementia'.  \nPath-based Evidence 5: 'Neuritic plaques' DISEASE OF 'human'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'neurofibrillary tangle pathology'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'senile plaques'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'amyloid angiopathy'.\n\nNeighbor-based Evidence 4: 'AD' 'caused by' 'deposition of Abeta in the brain'.\n\nNeighbor-based Evidence 5: 'AD' 'cause' 'Alzheimer's disease'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.9499473571777344,
      0.9375072717666626,
      1.000000238418579,
      1.0,
      0.8961988091468811,
      0.8652123212814331,
      0.8520457744598389,
      1.0000001192092896,
      1.0000001192092896
    ],
    "question_types": [
      "causation"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "6bbd2c35-9dfc-4234-905f-334b5f7e593b",
    "question": "Most common cause dementia in adult:",
    "opa": "Alzheimer's",
    "opb": "Multiinfarct",
    "opc": "Pick' disease",
    "opd": "Metabolic cause",
    "cop": 0,
    "choice_type": "single",
    "exp": "A i.e. Alzheimer's",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. dementia\n2. Alzheimer's\n3. Multiinfarct\n4. Pick's disease\n5. Metabolic cause",
    "prediction": "A",
    "path": "Reranked Triple1: Alzheimer's disease \u2014\u2014> most common cause of dementia in adults  \nReranked Triple2: Multiinfarct dementia \u2014\u2014> type of vascular dementia  \nReranked Triple3: Pick's disease \u2014\u2014> frontotemporal dementia  \nReranked Triple4: Metabolic causes \u2014\u2014> potential contributors to dementia  \nReranked Triple5: Dementia \u2014\u2014> various causes including Alzheimer's and vascular conditions  ",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple2: AD \u2014\u2014> caused by \u2014\u2014> neurodegenerative diseases  \nReranked Triple3: AD \u2014\u2014> cause \u2014\u2014> Alzheimer's disease  \nReranked Triple4: AD \u2014\u2014> causes \u2014\u2014> cognitive impairment  \nReranked Triple5: AD \u2014\u2014> treats \u2014\u2014> dementia  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer's disease' is the 'most common cause of dementia in adults'.\n\nPath-based Evidence 2: 'Multiinfarct dementia' is a 'type of vascular dementia'.\n\nPath-based Evidence 3: 'Pick's disease' is a 'form of frontotemporal dementia'.\n\nPath-based Evidence 4: 'Metabolic causes' are 'potential contributors to dementia'.\n\nPath-based Evidence 5: 'Dementia' has 'various causes including Alzheimer's and vascular conditions'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' causes 'dementia'.  \nNeighbor-based Evidence 2: 'AD' is caused by 'neurodegenerative diseases'.  \nNeighbor-based Evidence 3: 'AD' can cause 'Alzheimer's disease'.  \nNeighbor-based Evidence 4: 'AD' causes 'cognitive impairment'.  \nNeighbor-based Evidence 5: 'AD' treats 'dementia'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.7281678915023804,
      1.0000001192092896,
      0.6205008029937744,
      0.8001323342323303
    ],
    "question_types": [
      "causation"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "cbc90419-55c4-4972-8083-a39a19f4e6a3",
    "question": "A 72-year-old man is brought to the clinic by his daughter because she is concerned about his memory. A careful history, mini mental status, and physical examination confirm your suspicions of the patient having Alzheimer's disease. Which of the following investigations is included in the initial work up for reversible causes of dementia?",
    "opa": "electroencephalogram (EEG)",
    "opb": "urine tests for heavy metals",
    "opc": "thyroid function tests",
    "opd": "red blood cell (RBC) folate",
    "cop": 2,
    "choice_type": "single",
    "exp": "Other tests to rule out reversible disease might include serum electrolytes, B12 levels, CBC, Venereal Disease Research Laboratory (VDRL), and CT or MRI. Diagnosis of Alzheimer's disease remains a diagnosis of exclusion. However, the insidious and subtle onset, with few focal signs (except for higher mental functioning) and a slowly progressive course are characteristic. Careful attention to the pattern of cognitive defects also improves diagnostic accuracy. The intensity of investigation will depend on numerous factors, including age, presence of atypical findings, and the timing of presentation. There is as yet no definite consensus on the most appropriate plan of investigation.",
    "subject_name": "Medicine",
    "topic_name": "Miscellaneous",
    "entity": "1. 72-year-old man\n2. clinic\n3. daughter\n4. memory\n5. careful history\n6. mini mental status exam\n7. physical examination\n8. Alzheimer's disease\n9. investigations\n10. initial work up\n11. reversible causes\n12. dementia\n13. electroencephalogram (EEG)\n14. urine tests\n15. heavy metals\n16. thyroid function tests\n17. red blood cell (RBC) folate.",
    "prediction": "C",
    "path": "Reranked Triple1: patients \u2014\u2014> has symptom \u2014\u2014> tau\nReranked Triple2: tau \u2014\u2014> correlates \u2014\u2014> Amyloid-beta\nReranked Triple3: Amyloid-beta \u2014\u2014> interacts \u2014\u2014> Neuroglobin\nReranked Triple4: Neuroglobin \u2014\u2014> regulates \u2014\u2014> Memory\nReranked Triple5: alzheimer disease \u2014\u2014> CAUSES \u2014\u2014> dementia",
    "neighbor_input": "Reranked Triple1: patients -> has disease -> Alzheimer's disease  \nReranked Triple2: patients -> associated with -> cognitive impairment (cognitive decline)  \nReranked Triple3: patients -> associated with -> neurodegenerative disorders  \nReranked Triple4: patients -> with -> Alzheimer's disease  \nReranked Triple5: patients -> has disease -> dementia  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'patients' 'has symptom' 'tau'.\n\nPath-based Evidence 2: 'tau' 'correlates' 'Amyloid-beta'.\n\nPath-based Evidence 3: 'Amyloid-beta' 'interacts' 'Neuroglobin'.\n\nPath-based Evidence 4: 'Neuroglobin' 'regulates' 'Memory'.\n\nPath-based Evidence 5: 'alzheimer disease' 'CAUSES' 'dementia'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'patients' 'has disease' 'Alzheimer's disease'.\n\nNeighbor-based Evidence 2: 'patients' 'associated with' 'cognitive impairment (cognitive decline)'.\n\nNeighbor-based Evidence 3: 'patients' 'associated with' 'neurodegenerative disorders'.\n\nNeighbor-based Evidence 4: 'patients' 'with' 'Alzheimer's disease'.\n\nNeighbor-based Evidence 5: 'patients' 'has disease' 'dementia'.",
    "entity_confidence_scores": [
      0.6046806573867798,
      0.6903693675994873,
      0.6305551528930664,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.8125131726264954,
      0.7301366329193115,
      0.7348365783691406,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.6530424356460571,
      0.7013178467750549,
      0.6648846864700317,
      0.6879606246948242,
      0.6371057033538818,
      0.6731107234954834,
      0.6286761164665222,
      0.6198825240135193,
      0.6773883104324341,
      0.6481890082359314,
      0.6199196577072144,
      0.7755240201950073,
      0.8129289746284485
    ],
    "question_types": [
      "causation",
      "diagnosis"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "a22492b1-1b05-4292-904f-0bcc4fba264f",
    "question": "Fronto temporal dementias include A/E",
    "opa": "Pick's disease",
    "opb": "Nonfluent aphasia",
    "opc": "Semantic dementia",
    "opd": "Alzheimer's disease",
    "cop": 3,
    "choice_type": "single",
    "exp": "D i.e. Alzheimer's disease Alzheimer's disease, the most common cause of dementiaQ initially presents with minor forgetfulness & gradually progressive sho term memory lossQ (making learning of new information difficult). Language is usually affected early with difficulty in finding words or naming objects, & impairments in the ability to construct fluent & informative sentences. The memory is lost for recent events first with a delayed loss of long term memory mainly affecting episodic memoryQ. It is a parieto temporal disease. Multi infarct (or vascular) dementia (or atherosclerotic psychosis), the 2,0 most common cause of dementia (not Alzheimer's disease) is caused by cerebro- vascular disease (ischemia or infarct)Q. It is characterized by an abrupt onset, acute exacerbations ((lit repeated infarcts), stepwise wise (step-ladder pattern) progressionQ (i.e. impairment of memory & intellect), fluctuating course (periods of deterioration f/b paial recovery for few months) and presence of hypeension (m.c.), cardiovascular disease & h/o previous stroke or transient ischemic attack. Lewy Body dementia, the 2,,d most common cause of degenerative dementia characteristically presents with progressive & fluctuating dementia (affecting cognition, attention & visuosptial ability), recurrent delirium like phase, systematized delusions, visual hallucinations (usually well formed & detailed), motor features of Parkinsonism (bradykinesia > tremor, rigidity), extra pyramidal symptoms, neuroleptic sensitivity syndrome (to antipsychotics)Q, together with repeated fallsQ, syncope, transient loss of consciousness, autonomic dysfunctions (eg. ohostatic hypotension) & urinary incontinence. It is (like Parkinson's disease) a ' synucleinpathy' reflecting abnormal aggregation of eosinophilic inclusion Lewy bodies (i.e. a synuclein & ubiquitin) in cytoplasm of neurons of neocoex & substantia nigra. Pick's disease (in contrast to parietal - temporal- Alzheimers ds,)Q is a prototype fronto- temporal dementia. It classically presents with insidious onset gradually progressive behavioural & personality changes (frontal lobe function) and language disorder (such as aphasia - left temporal lobe function) usually preceding or overshadowing patient's cognitive problems. Patients may show apathy (medial frontal damage), disinhibition (basal - frontal dysfunction), symptoms of kluver Bucy syndrome (i.e. hypersexuality, hyperorality, placidity, and a compulsion to attend to any visual stimulus) and loss of drive, motivation, insight and spontaneity of speech (frontal language). The striking pathological findings is Knife blade atrophy of frontal & temporal poles with Pick's cells (ballooned neurons) and Pick's inclusion body (irregular, silver staining, intracytoplasmic bodies composed of tau, ubiquitin etc that displace nucleus towards periphery). Fronto- temporal dementias include - Pick's disease, lobar atrophyQ, frontal lobe degeneration (non- Alzheimer's type), fronto temporal dementia with parkinsonism, motor neuron diseaseQ (MND) with dementia, semantic dementiaQ with aphasia & agnosia, progressive nonfluent aphasic syndromeQ. Sometimes (not always) coicobasal degeneration, progressive supranuclear palsy & parkinsonism dementia complex of Guam are also included.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Fronto temporal dementias\n2. Pick's disease\n3. Nonfluent aphasia\n4. Semantic dementia\n5. Alzheimer's disease",
    "prediction": "A",
    "path": "Reranked Triple1: Pick->GENE ASSOCIATION->PRESENILIN1 (PSEN1)  \nReranked Triple2: alzheimer disease->CAUSES->dementia  \nReranked Triple3: alzheimer disease->associated with->aphasia  \nReranked Triple4: Alzheimer's disease->ASSOCIATES->AD  \nReranked Triple5: Alzheimer's disease->causes->brain atrophy  ",
    "neighbor_input": "Reranked Triple1: frontotemporal dementia \u2014\u2014> TYPE \u2014\u2014> neurodegenerative disease  \nReranked Triple2: Pick's disease \u2014\u2014> involves \u2014\u2014> tau  \nReranked Triple3: Pick's disease \u2014\u2014> PATHOLOGY \u2014\u2014> tauopathy  \nReranked Triple4: Pick's disease \u2014\u2014> DISEASE TYPE \u2014\u2014> neurological  \nReranked Triple5: Pick's disease \u2014\u2014> GENE ASSOCIATION \u2014\u2014> PRESENILIN1 (PSEN1)  ",
    "response_of_KG_list_path": "Path-based Evidence 1: The action of 'Pick' is related to the 'GENE ASSOCIATION' with the entity 'PRESENILIN1 (PSEN1)'.\n\nPath-based Evidence 2: The condition 'alzheimer disease' 'CAUSES' the condition 'dementia'.\n\nPath-based Evidence 3: The condition 'alzheimer disease' is 'associated with' the symptom 'aphasia'.\n\nPath-based Evidence 4: The condition 'Alzheimer's disease' 'ASSOCIATES' with the abbreviation 'AD'.\n\nPath-based Evidence 5: The condition 'Alzheimer's disease' 'causes' 'brain atrophy'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'frontotemporal dementia' is a 'neurodegenerative disease'.\nNeighbor-based Evidence 2: 'Pick's disease' involves 'tau'.\nNeighbor-based Evidence 3: 'Pick's disease' is a 'tauopathy'.\nNeighbor-based Evidence 4: 'Pick's disease' is a 'neurological' disease.\nNeighbor-based Evidence 5: 'Pick's disease' has a 'GENE ASSOCIATION' with 'PRESENILIN1 (PSEN1)'.",
    "entity_confidence_scores": [
      0.8989477753639221,
      1.0000001192092896,
      0.6205008029937744,
      0.8075450658798218,
      0.8075450658798218,
      0.8067836761474609,
      0.8071926236152649,
      0.7706060409545898,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "4daf8a71-4bcc-4776-8d3d-655a287fedc3",
    "question": "Characteristic imaging findings in Alzheimer's disease?",
    "opa": "Temporal lobe and parietal lobe atrophy",
    "opb": "Temporal and occipital lobe atrophy",
    "opc": "Frontal and parietal lobe atrophy",
    "opd": "Parietal and occipital lobe atrophy",
    "cop": 0,
    "choice_type": "single",
    "exp": "Ans AThe 2 most specific findings of Alzeimer's disease on neuroimaging are mesial temporal lobe atrophy (especially hippocampus and Enterohinal cortex) and temporoparietal cortical atrophy.",
    "subject_name": "Radiology",
    "topic_name": "Nervous System",
    "entity": "1. Alzheimer's disease\n2. Temporal lobe\n3. Parietal lobe\n4. Occipital lobe\n5. Frontal lobe",
    "prediction": "A",
    "path": "Reranked Triple1: Alzheimer Disease \u2014\u2014> causes \u2014\u2014> brain atrophy  \nReranked Triple2: Alzheimer Disease \u2014\u2014> associates \u2014\u2014> AD  \nReranked Triple3: AD \u2014\u2014> correlates with \u2014\u2014> diabetes mellitus  \nReranked Triple4: Alzheimer Disease \u2014\u2014> associates \u2014\u2014> dementia  \nReranked Triple5: tau \u2014\u2014> caused by \u2014\u2014> dementia  ",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> causes \u2014\u2014> brain atrophy  \nReranked Triple2: AD \u2014\u2014> causes \u2014\u2014> cortical atrophy  \nReranked Triple3: AD \u2014\u2014> causes \u2014\u2014> hippocampal dysfunction  \nReranked Triple4: AD \u2014\u2014> causes \u2014\u2014> temporal lobe atrophy  \nReranked Triple5: AD \u2014\u2014> causes \u2014\u2014> parietal lobe atrophy  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer Disease' 'causes' 'brain atrophy'.\n\nPath-based Evidence 2: 'Alzheimer Disease' 'associates' 'AD'.\n\nPath-based Evidence 3: 'AD' 'correlates with' 'diabetes mellitus'.\n\nPath-based Evidence 4: 'Alzheimer Disease' 'associates' 'dementia'.\n\nPath-based Evidence 5: 'tau' 'caused by' 'dementia'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'brain atrophy'.  \nNeighbor-based Evidence 2: 'AD' 'causes' 'cortical atrophy'.  \nNeighbor-based Evidence 3: 'AD' 'causes' 'hippocampal dysfunction'.  \nNeighbor-based Evidence 4: 'AD' 'causes' 'temporal lobe atrophy'.  \nNeighbor-based Evidence 5: 'AD' 'causes' 'parietal lobe atrophy'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.8871150016784668,
      1.0,
      0.9128051996231079,
      0.7078962326049805,
      0.911994993686676,
      1.0000001192092896,
      0.8645899891853333,
      1.0000001192092896,
      0.9279533624649048,
      0.8494541049003601,
      0.8224782347679138,
      0.8658101558685303,
      0.8387764692306519,
      0.9287086725234985,
      0.8570481538772583,
      0.8716716766357422,
      0.8890469074249268
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "f3048a12-6150-4ea3-8b4b-5b4313297cfa",
    "question": "In Alzheimer's disease (AD) which of the following are seen:",
    "opa": "Aphasia",
    "opb": "Apraxia",
    "opc": "Agnosia",
    "opd": "All the above",
    "cop": 3,
    "choice_type": "multi",
    "exp": "Ans. All the aboveAll 4 A's are seen early in Alzheimer's disease.4 A's are:Amnesia-Memory disturbancesAphasia-Disturbances in language functionApraxia-Difficulty in performing learned motor movementsAgnosia-Difficulty to interpret a sensory stimulus",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. Aphasia\n3. Apraxia\n4. Agnosia",
    "prediction": "D",
    "path": "Reranked Triple1: Aphasia \u2014\u2014> type of \u2014\u2014> neurodegenerative diseases  \nReranked Triple2: Aphasia \u2014\u2014> associates \u2014\u2014> Alzheimer's disease  \nReranked Triple3: Aphasia \u2014\u2014> has symptom \u2014\u2014> apraxia  \nReranked Triple4: Alzheimer's disease \u2014\u2014> has symptom \u2014\u2014> apraxia  \nReranked Triple5: Alzheimer's disease \u2014\u2014> has symptom \u2014\u2014> aphasia  \n\nAnswer: D. All the above",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> causes \u2014\u2014> cognitive impairment  \nReranked Triple2: AD \u2014\u2014> causes \u2014\u2014> cognitive dysfunction  \nReranked Triple3: AD \u2014\u2014> causes \u2014\u2014> cognitive decline  \nReranked Triple4: AD \u2014\u2014> causes \u2014\u2014> behavioral deficits  \nReranked Triple5: AD \u2014\u2014> causes \u2014\u2014> dementia  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Aphasia' is a 'type of' 'neurodegenerative diseases'.  \nPath-based Evidence 2: 'Aphasia' 'associates' with 'Alzheimer's disease'.  \nPath-based Evidence 3: 'Aphasia' 'has symptom' 'apraxia'.  \nPath-based Evidence 4: 'Alzheimer's disease' 'has symptom' 'apraxia'.  \nPath-based Evidence 5: 'Alzheimer's disease' 'has symptom' 'aphasia'.  ",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'cognitive impairment'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'cognitive dysfunction'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'cognitive decline'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'behavioral deficits'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'dementia'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      0.7298930883407593,
      0.7964770793914795,
      0.633560061454773,
      0.6898353099822998,
      1.0000001192092896
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "8b5c6a64-4f2a-4180-aa53-a147cdd45916",
    "question": "Most common cause of dementia is :",
    "opa": "Vitamin B12",
    "opb": "Parkinsonism",
    "opc": "Alzheimer's disease",
    "opd": "Road traffic accidents",
    "cop": 2,
    "choice_type": "single",
    "exp": "Alzheimer's disease is the most common cause of dementia.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. dementia\n2. Vitamin B12\n3. Parkinsonism\n4. Alzheimer's disease\n5. Road traffic accidents",
    "prediction": "C",
    "path": "Reranked Triple1: Alzheimer's disease \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple2: parkinsonism \u2014\u2014> type \u2014\u2014> dementia  \nReranked Triple3: neuronal damage \u2014\u2014> causes \u2014\u2014> Alzheimer's disease  \nReranked Triple4: cognitive decline \u2014\u2014> ameliorates \u2014\u2014> Alzheimer's disease  \nReranked Triple5: parkinsonism \u2014\u2014> co-occurs with \u2014\u2014> Alzheimer's disease  ",
    "neighbor_input": "Reranked Triple1: AD \u2014> causes \u2014> dementia  \nReranked Triple2: AD \u2014> caused by \u2014> neurodegenerative diseases  \nReranked Triple3: AD \u2014> cause \u2014> Alzheimer's disease  \nReranked Triple4: AD \u2014> causes \u2014> cognitive impairment  \nReranked Triple5: AD \u2014> causes \u2014> neurodegeneration  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer's disease' is known to 'cause' 'dementia'.\n\nPath-based Evidence 2: 'Parkinsonism' is a 'type' of 'dementia'.\n\nPath-based Evidence 3: 'Neuronal damage' 'causes' 'Alzheimer's disease'.\n\nPath-based Evidence 4: 'Cognitive decline' 'ameliorates' 'Alzheimer's disease'.\n\nPath-based Evidence 5: 'Parkinsonism' 'co-occurs with' 'Alzheimer's disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'dementia'.  \nNeighbor-based Evidence 2: 'AD' 'caused by' 'neurodegenerative diseases'.  \nNeighbor-based Evidence 3: 'AD' 'cause' 'Alzheimer's disease'.  \nNeighbor-based Evidence 4: 'AD' 'causes' 'cognitive impairment'.  \nNeighbor-based Evidence 5: 'AD' 'causes' 'neurodegeneration'.  ",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.7011339068412781
    ],
    "question_types": [
      "causation"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "3a282879-8038-4bc0-9960-bd3155bd2650",
    "question": "A 72-year-old man complains of memory difficulties. He is worried that he has Alzheimer disease. He has trouble recalling the names of friends, and last month forgot his son's birthday, which had never happened before. On two occasions he became lost driving to a familiar department store. He is now afraid to make trips away from home. His children tell him that he has forgotten things they have discussed even 1 day previously. He lives independently and has not had any difficulty preparing meals, paying bills, using the telephone, or taking his medications. He takes lisinopril and hydrochlorothiazide for hypertension. He does not use alcohol. Folstein MMSE score is 27/30 and Montreal Cognitive Assessment (MoCA) score is 26/30. Neurologic examination is normal. Which of the following is most appropriate?",
    "opa": "Inform the patient that his symptoms are a normal consequence of aging and that his risk of Alzheimer disease is no higher than average",
    "opb": "Tell the patient that he has dementia and must stop driving",
    "opc": "Perform screening tests for vitamin deficiency and psychiatric disease",
    "opd": "Begin donepezil",
    "cop": 2,
    "choice_type": "multi",
    "exp": "Difficulty recalling names and temporarily misplacing objects are commonly seen with advancing age but becoming lost and having trouble recalling recent conversations are more worrisome symptoms of significant cognitive impairment. This patient does not have dementia, which requires impairment in memory and one other cognitive domain (language, spatial orientation, or executive function). The Folstein mini-mental state examination (MMSE) and the Montreal Cognitive Assessment (MoCA) are screening tests for Alzheimer disease. Most authorities use MMSE and MoCA scores of less than 26 as a positive screen. This patient is on the borderline of a positive screen. Patients with isolated but significant cognitive impairment, but who do not meet the diagnostic criteria for dementia, are often classified as having mild cognitive impairment (MCI). MCI is often accompanied by depression and can be due to vitamin B12 deficiency, for which the patient should be screened. Patients with mild cognitive impairment are at higher risk for progression to frank dementia (12% per year in some series), but some of these patients will never develop progressive memory loss. Randomized trials of the acetylcholinesterase inhibitors donepezil and galantamine have failed to establish efficacy of either of these drugs in patients with MCI. Holter monitoring is used to detect cardiac arrhythmias, which can be associated with syncope but not selective memory impairment.",
    "subject_name": "Medicine",
    "topic_name": "C.N.S.",
    "entity": "1. 72-year-old man\n2. Alzheimer disease\n3. memory difficulties\n4. trouble recalling names\n5. forgotten son's birthday\n6. lost driving\n7. trips away from home\n8. forgotten recent discussions\n9. lisinopril and hydrochlorothiazide\n10. hypertension\n11. alcohol use\n12. Folstein MMSE score\n13. Montreal Cognitive Assessment score\n14. Neurologic examination\n15. aging\n16. dementia\n17. driving\n18. screening tests\n19. vitamin deficiency\n20. psychiatric disease\n21. donepezil",
    "prediction": "C",
    "path": "Reranked Triple1: hypertension -> risk factor for -> Alzheimer's disease  \nReranked Triple2: word recall -> regulates -> AD  \nReranked Triple3: lisinopril -> regulates -> angiotensin converting enzyme (ACE)  \nReranked Triple4: dementia -> caused by -> AD  \nReranked Triple5: Alzheimer-related disease -> interacts -> mice  ",
    "neighbor_input": "Reranked Triple1: AD -> causes -> brain atrophy \u2014\u2014> cognitive loss  \nReranked Triple2: AD -> causes -> cognitive impairment and dementia \u2014\u2014> memory loss  \nReranked Triple3: AD -> caused by -> mutations in presenilins (PS1, PS2) \u2014\u2014> Alzheimer's disease  \nReranked Triple4: AD -> causes -> cognitive decline \u2014\u2014> dementia  \nReranked Triple5: AD -> treatment -> screening tests for vitamin deficiency and psychiatric disease \u2014\u2014> cognitive dysfunction",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Hypertension' is a 'risk factor for' 'Alzheimer's disease'. \n\nPath-based Evidence 2: 'Word recall' 'regulates' 'AD'. \n\nPath-based Evidence 3: 'Lisinopril' 'regulates' 'angiotensin converting enzyme (ACE)'. \n\nPath-based Evidence 4: 'Dementia' is 'caused by' 'AD'. \n\nPath-based Evidence 5: 'Alzheimer-related disease' 'interacts' with 'mice'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Alzheimer's disease' 'causes' 'brain atrophy', which leads to 'cognitive loss'.\n\nNeighbor-based Evidence 2: 'Alzheimer's disease' 'causes' 'cognitive impairment and dementia', resulting in 'memory loss'.\n\nNeighbor-based Evidence 3: 'Alzheimer's disease' 'caused by' 'mutations in presenilins (PS1, PS2)', which are linked to 'Alzheimer's disease'.\n\nNeighbor-based Evidence 4: 'Alzheimer's disease' 'causes' 'cognitive decline', culminating in 'dementia'.\n\nNeighbor-based Evidence 5: 'Alzheimer's disease' 'treatment' involves 'screening tests for vitamin deficiency and psychiatric disease', which address 'cognitive dysfunction'.",
    "entity_confidence_scores": [
      0.6046806573867798,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.8572791218757629,
      0.6250050663948059,
      0.7606849670410156,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.8563955426216125,
      0.9050577878952026,
      0.8971245288848877,
      0.48070040345191956,
      0.7501602172851562,
      0.7503789663314819,
      0.7547256946563721,
      0.7511031627655029,
      1.0,
      1.0,
      0.5481347441673279,
      0.5109264254570007,
      1.0000001192092896,
      0.7998999357223511,
      0.7998950481414795,
      0.7289376258850098,
      0.9527064561843872,
      0.9258928298950195,
      1.0,
      0.6575609445571899
    ],
    "question_types": [
      "treatment",
      "symptom",
      "diagnosis",
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "04e382f8-4f1a-4818-bba9-3a3a686678f7",
    "question": "Alzheimer's disease, which is involved ?",
    "opa": "Frontal cortex",
    "opb": "Cortical atrophy of temporoparietal cortex",
    "opc": "Frontal and parietal cortex",
    "opd": "Occipital cortex",
    "cop": 1,
    "choice_type": "single",
    "exp": null,
    "subject_name": "Medicine",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. Frontal cortex\n3. Temporoparietal cortex\n4. Cortical atrophy\n5. Parietal cortex\n6. Occipital cortex",
    "prediction": "B",
    "path": "Reranked Triple1: Alzheimer's disease \u2014\u2014> correlates with \u2014\u2014> dementia  \nReranked Triple2: Alzheimer's disease \u2014\u2014> associates with \u2014\u2014> tau  \nReranked Triple3: Alzheimer's disease \u2014\u2014> causes \u2014\u2014> brain atrophy  \nReranked Triple4: brain atrophy \u2014\u2014> associates with \u2014\u2014> AD  \nReranked Triple5: Alzheimer's disease \u2014\u2014> causes \u2014\u2014> amyloid deposits in cerebral cortex  ",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> causes \u2014\u2014> cortical atrophy  \nReranked Triple2: AD \u2014\u2014> causes \u2014\u2014> brain atrophy  \nReranked Triple3: AD \u2014\u2014> causes \u2014\u2014> neurodegenerative diseases  \nReranked Triple4: AD \u2014\u2014> causes \u2014\u2014> cognitive impairment  \nReranked Triple5: AD \u2014\u2014> causes \u2014\u2014> cognitive decline  \n\nAnswer: B. Cortical atrophy of temporoparietal cortex",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer's disease' 'correlates with' 'dementia'.\n\nPath-based Evidence 2: 'Alzheimer's disease' 'associates with' 'tau'.\n\nPath-based Evidence 3: 'Alzheimer's disease' 'causes' 'brain atrophy'.\n\nPath-based Evidence 4: 'brain atrophy' 'associates with' 'AD'.\n\nPath-based Evidence 5: 'Alzheimer's disease' 'causes' 'amyloid deposits in cerebral cortex'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'cortical atrophy'.  \nNeighbor-based Evidence 2: 'AD' 'causes' 'brain atrophy'.  \nNeighbor-based Evidence 3: 'AD' 'causes' 'neurodegenerative diseases'.  \nNeighbor-based Evidence 4: 'AD' 'causes' 'cognitive impairment'.  \nNeighbor-based Evidence 5: 'AD' 'causes' 'cognitive decline'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.9999998807907104,
      0.9287086725234985,
      0.9038968086242676,
      1.0000001192092896,
      0.8865880966186523,
      1.000000238418579,
      0.8071302771568298,
      1.0,
      1.000000238418579,
      0.8506255149841309,
      0.8239187002182007,
      0.8235896825790405
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "aa0a4737-eed2-4bcd-ac64-ccae94781100",
    "question": "Dementia in ICD 10 is classified under",
    "opa": "F00",
    "opb": "F10",
    "opc": "F20",
    "opd": "F30",
    "cop": 0,
    "choice_type": "single",
    "exp": "ICD CHAPTERS ICD is a text book for classification of psychiatric disorders. The below table comprises chapter numbers dealing with various psychiatric disorders. Ref.Kaplon and Sadock, synopsis of Psychiatry, 10th edition",
    "subject_name": "Anatomy",
    "topic_name": "General anatomy",
    "entity": "1. Dementia\n2. ICD 10\n3. F00\n4. F10\n5. F20\n6. F30",
    "prediction": "A",
    "path": [],
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple2: AD \u2014\u2014> treats \u2014\u2014> dementia  \nReranked Triple3: AD \u2014\u2014> associates \u2014\u2014> dementia  \nReranked Triple4: AD \u2014\u2014> treatment \u2014\u2014> dementia  \nReranked Triple5: AD \u2014\u2014> causes \u2014\u2014> cognitive impairment",
    "response_of_KG_list_path": [],
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'dementia'.\n\nNeighbor-based Evidence 2: 'AD' 'treats' 'dementia'.\n\nNeighbor-based Evidence 3: 'AD' 'associates' 'dementia'.\n\nNeighbor-based Evidence 4: 'AD' 'treatment' 'dementia'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'cognitive impairment'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.6960260272026062,
      0.699533998966217,
      0.7627283930778503,
      0.9999999403953552,
      0.6227065920829773,
      0.9004683494567871,
      0.87357497215271,
      0.6714588403701782,
      0.6277211904525757
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "17890b22-a9a4-41fb-a62f-8f44c9ce51e6",
    "question": "Which drug is not used now in Alzheimer's disease",
    "opa": "Tacrine",
    "opb": "Galantamine",
    "opc": "Donepezil",
    "opd": "Rivastigmine",
    "cop": 0,
    "choice_type": "single",
    "exp": "Because of hepatotoxicity,and requirements of frequent dosing,tacrine is less often used than other agents Ref-KDT 6/e p104,472,473",
    "subject_name": "Pharmacology",
    "topic_name": "Autonomic nervous system",
    "entity": "1. Alzheimer's disease\n2. Tacrine\n3. Galantamine\n4. Donepezil\n5. Rivastigmine",
    "prediction": "A",
    "path": "Reranked Triple1: tacrine \u2014\u2014> treats \u2014\u2014> AD (Alzheimer's disease)  \nReranked Triple2: tacrine \u2014\u2014> treats \u2014\u2014> galantamine  \nReranked Triple3: rivastigmine \u2014\u2014> treats \u2014\u2014> AD (Alzheimer's disease)  \nReranked Triple4: rivastigmine \u2014\u2014> treat \u2014\u2014> Alzheimer's disease  \nReranked Triple5: rivastigmine \u2014\u2014> CAUSES \u2014\u2014> death  \n\nAnswer: A. Tacrine",
    "neighbor_input": "Reranked Triple1: AD -> TREATMENT -> tacrine \u2014\u2014> tacrine is a drug associated with Alzheimer's disease treatment.\nReranked Triple2: AD -> TREATMENT -> donepezil \u2014\u2014> donepezil is a drug associated with Alzheimer's disease treatment.\nReranked Triple3: AD -> TREATMENT -> galantamine \u2014\u2014> galantamine is a drug associated with Alzheimer's disease treatment.\nReranked Triple4: AD -> TREATMENT -> rivastigmine \u2014\u2014> rivastigmine is a drug associated with Alzheimer's disease treatment.\nReranked Triple5: AD -> TREATMENT -> insulin-like growth factor (IGF) signaling \u2014\u2014> insulin-like growth factor (IGF) signaling is not a drug currently used for Alzheimer's disease. \n\nAnswer: A. Tacrine",
    "response_of_KG_list_path": "Path-based Evidence 1: 'tacrine' 'treats' 'AD (Alzheimer's disease)'.  \nPath-based Evidence 2: 'tacrine' 'treats' 'galantamine'.  \nPath-based Evidence 3: 'rivastigmine' 'treats' 'AD (Alzheimer's disease)'.  \nPath-based Evidence 4: 'rivastigmine' 'treats' 'Alzheimer's disease'.  \nPath-based Evidence 5: 'rivastigmine' 'CAUSES' 'death'.  ",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: The entity 'tacrine' is related to the entity 'AD' through the relationship 'TREATMENT', indicating that 'tacrine' is a drug associated with the treatment of 'Alzheimer's disease'. \n\nNeighbor-based Evidence 2: The entity 'donepezil' is connected to the entity 'AD' via the relationship 'TREATMENT', suggesting that 'donepezil' is a drug used in the treatment of 'Alzheimer's disease'.\n\nNeighbor-based Evidence 3: The entity 'galantamine' is linked to the entity 'AD' through the relationship 'TREATMENT', meaning that 'galantamine' is a drug that is utilized in treating 'Alzheimer's disease'.\n\nNeighbor-based Evidence 4: The entity 'rivastigmine' is associated with the entity 'AD' through the relationship 'TREATMENT', indicating that 'rivastigmine' serves as a drug for the treatment of 'Alzheimer's disease'.\n\nNeighbor-based Evidence 5: The entity 'insulin-like growth factor (IGF) signaling' is related to the entity 'AD' but is noted as not being a drug currently used for the treatment of 'Alzheimer's disease' through the relationship 'TREATMENT'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0,
      1.0,
      1.0,
      0.6575609445571899,
      1.0,
      0.6304964423179626
    ],
    "question_types": [
      "treatment",
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "ddd82448-9a8a-4406-9b54-4a8db0c90a97",
    "question": "A/E are true regarding Alzheimer's disease.",
    "opa": "Gradually progressive",
    "opb": "Abrupt onset acute exacerbation",
    "opc": "Episodic memory",
    "opd": "All",
    "cop": 1,
    "choice_type": "multi",
    "exp": "B i.e. Abrupt onset acute exacerbation",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. Gradually progressive\n3. Abrupt onset acute exacerbation\n4. Episodic memory",
    "prediction": "A",
    "path": "Reranked Triple1: Alzheimer disease \u2014\u2014> correlates with \u2014\u2014> AD  \nReranked Triple2: Alzheimer disease \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple3: dementia \u2014\u2014> caused by \u2014\u2014> tau  \nReranked Triple4: Alzheimer disease \u2014\u2014> associates \u2014\u2014> brain atrophy  \nReranked Triple5: AD \u2014\u2014> resembles \u2014\u2014> Alzheimers disease  \n\nAnswer: A. Gradually progressive",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> causes \u2014\u2014> cognitive impairment  \nReranked Triple2: AD \u2014\u2014> causes \u2014\u2014> cognitive decline  \nReranked Triple3: AD \u2014\u2014> causes \u2014\u2014> memory loss  \nReranked Triple4: AD \u2014\u2014> causes \u2014\u2014> episodic memory  \nReranked Triple5: AD \u2014\u2014> causes \u2014\u2014> dementia  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer disease' 'correlates with' 'AD'.\n\nPath-based Evidence 2: 'Alzheimer disease' 'causes' 'dementia'.\n\nPath-based Evidence 3: 'dementia' 'caused by' 'tau'.\n\nPath-based Evidence 4: 'Alzheimer disease' 'associates' 'brain atrophy'.\n\nPath-based Evidence 5: 'AD' 'resembles' 'Alzheimer's disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'cognitive impairment'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'cognitive decline'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'memory loss'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'episodic memory'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'dementia'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "b9b0fb89-1f7e-4c92-8bd2-06a102e276eb",
    "question": "Which of the following is predominantly involved in Alzheimer's dementia:",
    "opa": "Frontal coex",
    "opb": "Temporo-Parietal coex",
    "opc": "Fronto-Parietal coex",
    "opd": "Franto-Temporal coex",
    "cop": 1,
    "choice_type": "single",
    "exp": "Answer is B (Temporo-Parietal coex):Alzheimer's disease predominantly affects the temporoparietal coex although frontal lobe is also frequently involvedAlzheimer's disease predominantly affects the temporo-parietal coex' - Alzheimer's Disease by Terry Regional deficits are most prominent in the temporo-parietal coex' - Alzheimer's Disease by Terry",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Alzheimer's dementia\n2. Frontal cortex\n3. Temporo-Parietal cortex\n4. Fronto-Parietal cortex\n5. Franto-Temporal cortex",
    "prediction": "B",
    "path": "Reranked Triple1: Alzheimer's dementia \u2014\u2014> associates \u2014\u2014> cognitive decline  \nReranked Triple2: cognitive decline \u2014\u2014> associated with \u2014\u2014> AD  \nReranked Triple3: AD \u2014\u2014> resembles \u2014\u2014> Alzheimers disease  \nReranked Triple4: Alzheimer's disease \u2014\u2014> predominantly involves \u2014\u2014> Temporo-Parietal coex  \nReranked Triple5: Alzheimer's disease \u2014\u2014> predominantly involves \u2014\u2014> Fronto-Temporal coex  ",
    "neighbor_input": "Reranked Triple1: Alzheimer's dementia \u2014\u2014> cause \u2014\u2014> neurodegeneration  \nReranked Triple2: Alzheimer's dementia \u2014\u2014> ASSOCIATES \u2014\u2014> dementia  \nReranked Triple3: Alzheimer's dementia \u2014\u2014> associates \u2014\u2014> cognitive decline  \nReranked Triple4: Alzheimer's dementia \u2014\u2014> associated with \u2014\u2014> amnestic syndrome  \nReranked Triple5: Alzheimer's dementia \u2014\u2014> symptom \u2014\u2014> death  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer's dementia' is associated with 'cognitive decline'.\n\nPath-based Evidence 2: 'Cognitive decline' is associated with 'AD'.\n\nPath-based Evidence 3: 'AD' resembles 'Alzheimer's disease'.\n\nPath-based Evidence 4: 'Alzheimer's disease' predominantly involves 'Temporo-Parietal coex'.\n\nPath-based Evidence 5: 'Alzheimer's disease' predominantly involves 'Fronto-Temporal coex'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Alzheimer's dementia' is known to 'cause' 'neurodegeneration'.\n\nNeighbor-based Evidence 2: 'Alzheimer's dementia' 'ASSOCIATES' with 'dementia'.\n\nNeighbor-based Evidence 3: 'Alzheimer's dementia' 'associates' with 'cognitive decline'.\n\nNeighbor-based Evidence 4: 'Alzheimer's dementia' is 'associated with' 'amnestic syndrome'.\n\nNeighbor-based Evidence 5: 'Alzheimer's dementia' is a 'symptom' of 'death'.",
    "entity_confidence_scores": [
      1.000000238418579,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      0.9999998807907104,
      0.9287086725234985,
      1.0,
      0.8957004547119141,
      0.8238363265991211
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "116927cb-b3d1-4913-ac37-95a7cb60fa76",
    "question": "Subcoical dementia is seen in all Except:",
    "opa": "Parkinsonism",
    "opb": "Alzheimers disease",
    "opc": "Wilsons disease",
    "opd": "Huntingtons chorea",
    "cop": 1,
    "choice_type": "multi",
    "exp": "DEMENTIA SUBCOICAL COICAL 1 Characteristic Parkinson disease Huntington disease Wilson 's disease spinocerebellar degeneration coicobasal degeneration normal pressure hydrocephalus Alzheimer Vascular Frontotemporal Lewy Body Dementia 2 Pathology* Prominent changes in striatum , thalamus Prominent changes in coical association areas 3 Severity Mild to moderate More severe 4 Speed of cognition Slow Normal 5 Memory deficit * Initially failure of retrieval storage and recall deficit 6 Language Less affected initially Early aphasia 7 Gnostic -practice abilities Less affected initially Affected early 8 Personality * Apathetic , ine Indifferent 9 Mood * Depressed Euthymic 10 Abnormal movements Chorea , trembling , tics Rare 11 Motor abnormalities* Extrapyramidal Uncommon, gegenhalten 12 Posture Stooped Normal 13 Coordination Affected Normal 14 Reversibility Reversible Unlikely Reference: Page No.25 chap 2 clinical features of dementia",
    "subject_name": "Psychiatry",
    "topic_name": "All India exam",
    "entity": "1. Subcortical dementia\n2. Parkinsonism\n3. Alzheimer's disease\n4. Wilson's disease\n5. Huntington's chorea",
    "prediction": "B",
    "path": "Reranked Triple1: Wilson's disease -> causes -> copper intoxication  \nReranked Triple2: Wilson's disease -> resembles -> Alzheimer's disease  \nReranked Triple3: Alzheimer's disease -> causes -> dementia  \nReranked Triple4: Alzheimer's disease -> associates -> AD  \nReranked Triple5: Alzheimer's disease -> caused by -> amyloid-beta precursor protein  ",
    "neighbor_input": "Reranked Triple1: Parkinsonism -> associated with -> dopamine transporter  \nReranked Triple2: Parkinsonism -> causes -> neurodegenerative disease  \nReranked Triple3: Parkinsonism -> caused by -> 6-hydroxydopamine  \nReranked Triple4: Parkinsonism -> causes -> neuronal damage  \nReranked Triple5: Parkinsonism -> associates -> variant amyloid deposits  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Wilson's disease' is known to 'cause' 'copper intoxication'.\n\nPath-based Evidence 2: 'Wilson's disease' 'resembles' 'Alzheimer's disease'.\n\nPath-based Evidence 3: 'Alzheimer's disease' is known to 'cause' 'dementia'.\n\nPath-based Evidence 4: 'Alzheimer's disease' 'associates' with 'AD'.\n\nPath-based Evidence 5: 'Alzheimer's disease' is 'caused by' 'amyloid-beta precursor protein'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Parkinsonism' is 'associated with' 'dopamine transporter'.\n\nNeighbor-based Evidence 2: 'Parkinsonism' 'causes' 'neurodegenerative disease'.\n\nNeighbor-based Evidence 3: 'Parkinsonism' is 'caused by' '6-hydroxydopamine'.\n\nNeighbor-based Evidence 4: 'Parkinsonism' 'causes' 'neuronal damage'.\n\nNeighbor-based Evidence 5: 'Parkinsonism' 'associates' with 'variant amyloid deposits'.",
    "entity_confidence_scores": [
      0.882514476776123,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.8395751714706421,
      0.808238685131073
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "723ea8d6-028a-4ee5-a665-90d25305dc4a",
    "question": "The following is not a feature of Alzheimer's disease-",
    "opa": "Neurofibrillary tangles",
    "opb": "Senile (neuritic) plaques",
    "opc": "Amyloid Angiopathy",
    "opd": "lewy bodies",
    "cop": 3,
    "choice_type": "single",
    "exp": null,
    "subject_name": "Medicine",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. Neurofibrillary tangles\n3. Senile (neuritic) plaques\n4. Amyloid Angiopathy\n5. Lewy bodies",
    "prediction": "D",
    "path": "Reranked Triple1: neurofibrillary tangles \u2014\u2014> ASSOCIATES -> Alzheimer's disease  \nReranked Triple2: Neurofibrillary tangles \u2014\u2014> FORM BY -> microtubule-associated protein tau  \nReranked Triple3: senile plaques (SP) \u2014\u2014> characterized by -> Alzheimer's disease  \nReranked Triple4: neurofibrillary tangles \u2014\u2014> ASSOCIATES -> Alzheimer's disease  \nReranked Triple5: tau \u2014\u2014> ASSOCIATED WITH -> Neurofibrillary tangles  ",
    "neighbor_input": "Reranked Triple1: AD -> causes -> neurofibrillary tangle pathology \u2014\u2014> Alzheimer's disease\nReranked Triple2: AD -> causes -> amyloid-beta peptide (Abeta) deposition \u2014\u2014> Alzheimer's disease\nReranked Triple3: AD -> causes -> amyloid plaque \u2014\u2014> Alzheimer's disease\nReranked Triple4: AD -> causes -> senile plaques \u2014\u2014> Alzheimer's disease\nReranked Triple5: AD -> associates -> tauopathies \u2014\u2014> Alzheimer's disease\n\nAnswer:\n\nThe feature that is NOT associated with Alzheimer's disease from the options listed in the question is \"D. Lewy bodies.\"",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Neurofibrillary tangles' ASSOCIATES WITH 'Alzheimer's disease'\n\nPath-based Evidence 2: 'Neurofibrillary tangles' FORMED BY 'microtubule-associated protein tau'\n\nPath-based Evidence 3: 'Senile plaques (SP)' CHARACTERIZED BY 'Alzheimer's disease'\n\nPath-based Evidence 4: 'Neurofibrillary tangles' ASSOCIATES WITH 'Alzheimer's disease'\n\nPath-based Evidence 5: 'Tau' ASSOCIATED WITH 'Neurofibrillary tangles'",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'neurofibrillary tangle pathology' which is associated with 'Alzheimer's disease'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'amyloid-beta peptide (Abeta) deposition' which is associated with 'Alzheimer's disease'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'amyloid plaque' which is associated with 'Alzheimer's disease'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'senile plaques' which is associated with 'Alzheimer's disease'.\n\nNeighbor-based Evidence 5: 'AD' 'associates' 'tauopathies' which is associated with 'Alzheimer's disease'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0,
      0.9538915157318115,
      0.9499473571777344,
      1.000000238418579
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "7e47716b-5327-4fa1-8adc-5b1236ebb7c3",
    "question": "Which of the following areas of brain is most resistant to Neurofibrillary tangles in Alzheimer's disease",
    "opa": "Entorhinal coex",
    "opb": "Hippocampus /Temporal lobe",
    "opc": "Lateral Geniculate Body",
    "opd": "Visual Association area",
    "cop": 2,
    "choice_type": "single",
    "exp": "Answer is C (Lateral Geniculate Body):The topographical and neuroanatomical distribution of Neurofibrillary tangles and Neuritic Plaques in the Cerebral coex of patients with Alzheimer's Disease' - Cerebral Coex (1991): (1): 103-116`Lateral geniculate body' is the least commonly affected area amongst the options provided.Weurofibrillaiy tangles are region specific occuring predominantly in the Hippocampus, Entorhinal coex and association areas of the Neocoex 'The Neuropathology of Dementia' (Cambridge) 1997/7`Not even a single neuron with Neurofibrillary Tangles (NFT) was seen in the Lateral Geniculate Bodies' -- Distribution of Alzheimer's Neurofibrillary tangles (Taken from 'Alzheimer's Disease' by George Parry (2006)/55)Neuro fibrillary Tangles (NFT): Density distribution in Alzheimer's diseaseEntorhinal coex -- Hippocampus -- Amygdala interconnections (most vulnerable)Limbic and Temporal coical areas (next most severely involved)Association areas of the neocoex Topographical Distribution of NFTs in Alzheimer's disease`The spatiotemporal pattern of progression of NFTs in Alzheimer's disease is steriotypical and predictable. Briefly, the neurofibrillary degeneration stas in the aliocoex of medial temporal lobe (entorhinal coex and hippocampus) and spreads to the associative neocoex, relatively sparing the primary sensory and primary motor and visual coex.'Enterohinal coex, Hippocampus and Associative areas of neocoex are primarily involved.Taken from 'Neuropathological Alterations in Alzheimer's Disease': Perspectives in Medicine 2011 Braak and Braak distinguished six stages to explain topographical distribution and progression of NFT.Stage IThe first NFTs consistently appear in the Transentorhinal (perihilar) region along with Entorhinal coex properStage IINFTs appear in the CA I region of the HippocampusStage IIINFTs appear in the Limbic structures such as the subiculum of H ppocampal formationStage IVNFTs appear in the Amygdala, Thalamus & ClaustrumStage VNFTs appear in all isocoical areas with the affection of Associative areasStage VINFTs appear in primary sensory, motor and visual areas (Primary sensory, motor and visual area are considered most resistant)These six stages can be summarized into three for the purpose of understanding, namely: Entorhinal, Limbic and isocoical",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. brain\n2. Neurofibrillary tangles\n3. Alzheimer's disease\n4. Entorhinal coex\n5. Hippocampus\n6. Temporal lobe\n7. Lateral Geniculate Body\n8. Visual Association area",
    "prediction": "C",
    "path": "Reranked Triple1: hippocampus \u2014\u2014> causes \u2014\u2014> atrophy (hippocampal atrophy)  \nReranked Triple2: atrophy (hippocampal atrophy) \u2014\u2014> associates \u2014\u2014> neurodegeneration  \nReranked Triple3: neurodegeneration \u2014\u2014> causes \u2014\u2014> Alzheimer's disease  \nReranked Triple4: hippocampus \u2014\u2014> brain region \u2014\u2014> temporal lobe  \nReranked Triple5: Alzheimer's disease \u2014\u2014> associates \u2014\u2014> brain region  \n\nAnswer: B. Hippocampus / Temporal lobe",
    "neighbor_input": "Reranked Triple1: Neurofibrillary tangles -> ASSOCIATES -> Alzheimer's disease  \nReranked Triple2: Neurofibrillary tangles -> FORM BY -> microtubule-associated protein tau  \nReranked Triple3: Neurofibrillary tangles -> COMPOSED OF -> Tau  \nReranked Triple4: AD -> causes -> cognitive decline  \nReranked Triple5: AD -> causes -> neuronal cell death  ",
    "response_of_KG_list_path": "Path-based Evidence 1: The 'hippocampus' 'causes' 'atrophy (hippocampal atrophy)'.\n\nPath-based Evidence 2: 'atrophy (hippocampal atrophy)' 'associates' 'neurodegeneration'.\n\nPath-based Evidence 3: 'neurodegeneration' 'causes' 'Alzheimer's disease'.\n\nPath-based Evidence 4: The 'hippocampus' 'is a brain region' of the 'temporal lobe'.\n\nPath-based Evidence 5: 'Alzheimer's disease' 'associates' 'brain region'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Neurofibrillary tangles' 'ASSOCIATES' 'Alzheimer's disease'  \nNeighbor-based Evidence 2: 'Neurofibrillary tangles' 'FORM BY' 'microtubule-associated protein tau'  \nNeighbor-based Evidence 3: 'Neurofibrillary tangles' 'COMPOSED OF' 'Tau'  \nNeighbor-based Evidence 4: 'AD' 'causes' 'cognitive decline'  \nNeighbor-based Evidence 5: 'AD' 'causes' 'neuronal cell death'  ",
    "entity_confidence_scores": [
      1.0,
      1.0,
      1.0,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.6131659746170044,
      0.9999999403953552,
      0.9999999403953552,
      1.0000001192092896,
      1.0,
      0.8871150016784668,
      1.0,
      0.9128051996231079,
      0.7078962326049805,
      0.911994993686676,
      1.0000001192092896,
      0.8645899891853333,
      1.0000001192092896
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "6cd3acc5-94f3-4925-a542-f7e2c7349985",
    "question": "Protein involved in Alzheimer's disease :",
    "opa": "Apo E gene",
    "opb": "Presel in - II",
    "opc": "Amyloid poion",
    "opd": "All",
    "cop": 0,
    "choice_type": "multi",
    "exp": "A i.e. Apo E gene",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. Protein\n3. Apo E gene\n4. Preselin - II\n5. Amyloid protein",
    "prediction": "D",
    "path": "Reranked Triple1: Apo-E -> regulates -> lipids  \nReranked Triple2: Apo-E -> regulates -> cholesterol  \nReranked Triple3: presenilin-1 -> regulates -> Abeta  \nReranked Triple4: Abeta -> associated with -> presenilin-1  \nReranked Triple5: Abeta -> TYPE -> amyloid protein  ",
    "neighbor_input": "Reranked Triple1: AD->ASSOCIATES->Apo E gene\nReranked Triple2: AD->ASSOCIATES->Presenilin-II\nReranked Triple3: AD->ASSOCIATES->Amyloid beta\nReranked Triple4: Apo E gene->ASSOCIATES->Alzheimer's disease\nReranked Triple5: Presenilin-II->ASSOCIATES->Alzheimer's disease",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Apo-E' regulates 'lipids'.  \nPath-based Evidence 2: 'Apo-E' regulates 'cholesterol'.  \nPath-based Evidence 3: 'presenilin-1' regulates 'Abeta'.  \nPath-based Evidence 4: 'Abeta' is associated with 'presenilin-1'.  \nPath-based Evidence 5: 'Abeta' is a type of 'amyloid protein'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Alzheimer's disease' is associated with 'Apo E gene'.\n\nNeighbor-based Evidence 2: 'Alzheimer's disease' is associated with 'Presenilin-II'.\n\nNeighbor-based Evidence 3: 'Alzheimer's disease' is associated with 'Amyloid beta'.\n\nNeighbor-based Evidence 4: 'Apo E gene' is associated with 'Alzheimer's disease'.\n\nNeighbor-based Evidence 5: 'Presenilin-II' is associated with 'Alzheimer's disease'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.6919565200805664,
      0.7201132774353027,
      0.9999999403953552,
      0.9732257127761841
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "6765afd4-7ddc-46df-9d87-30241a54a9f6",
    "question": "Area of the brain most commonly undergoing atrophy in Alzheimer's disease:",
    "opa": "Temporoparietal",
    "opb": "Parieto-occipital",
    "opc": "Frontoparietal",
    "opd": "Temporo-occipital",
    "cop": 0,
    "choice_type": "single",
    "exp": "Ans. a. Temporoparietal (Ref: Harrison 19/e p2598, 18/e p3304-3308)Area of the brain most commonly undergoing atrophy in Alzheimer's disease is Temporoparietal.'Pathologically, atrophy is distributed throughout the medial temporal lobes, as well as lateral and medial parietal lobes and lateral frontal cortex.'- Harrison 18th/3305Alzheimer's DiseaseAD can occur in any decade of adulthood, but it is the MC cause of dementia in the elderly.AD most often presents with an insidious onset of memory loss followed by a slowly progressive dementia over several years.Dementia from Alzheimer's disease is the classical prototype of cortical dementias.Alzheimer's dementia is the MC cortical dementiaQ.Predominantly affects the temporoparietal cortex (although frontal lobe is also frequently involved)Pathology:Pathologically, atrophy is distributed throughout the medial temporal lobes, as well as lateral and medial parietal lobes and lateral frontal cortex.Microscopically, there are neuritic plaques and neurofibrillary tangles (INFTs) composed of hyperphosphorylated tau filaments, and accumulation of amyloid in blood vessel walls in cortex and leptomen ingesQ.At autopsy, the earliest and most severe degeneration is found in the medial temporal lobe (entorhinal/perirhinal cortex and hippocampus), lateral temporal cortex, and nucleus basalis of MeynertQ.Characteristic microscopic findings: Neuritic plaques and NFTsQ.Neurofibrillary tangles are intracellular accumulations that may appear extracellularly after degeneration of neuron (neuronal death)Q.A histopathological diagnosis of Alzheimer's disease is made in cases of progressive dementia when beta-amyloid plaques (Neuritic/Senile plaques) co-occur with Neurofibrillary TanglesQ.Decreased levels of ACH, its synthetic enzyme choline acetyltransferase and nicotinic cholinergic receptors are the primary biochemical abnormality observed in ADQ.Beta-Amyloid Plaques (Extracellular)Neurofibrillary Tangles (Intracellular)* Formed by extracellular accumulation of beta amyloid deposits.* Neuritic or senile beta- amyloid plaques are an early histopathological sign of AD* Amyloid beta-protein accumulated in single neuritic plaques is toxic to surrounding structures and adjacent neurons.* Clinicopathological studies have shown that amyloid burden does not directly correlate with severity or duration of dementia* Formed by intracellular accumulation of hyper phosphorylated microtubule binding protein 'tau'.* NFT's occur in many neurodegenerative diseases and/or a group of diseases called 'taupathies' (Frontotemporal dementia, Pick's disease).* The co-occurrence of beta-amyloid plaques with NFT's suggests a diagnosis of AD.* NFT's are toxic to the neurons and neurons with NFT's eventually die and degenerate leaving a residual 'ghost tangle', in the extracellular space reminding of the pyramidal cell body in which it was initially formed.* Ciinicopathoiogical studies have shown that dementia correlates more strongly with NFT's than with senile plaques (beta- amyloid)Epidemiology:Most important risk factors for AD: Old age and positive family history.Factors associated with increased risk of Alzheimer's disease* Increasing ageQ* Female sexQ* Lower educational attainmentQ* Family history of dementiaQ* Environmental factors (Al, Hg, Viruses and Prions)* Genetic factors: Amyloid Precursor Protein on chromosomes 21Q, adult with trisomy 21 (Down's)QClinical Manifestations:The cognitive changes of AD tend to follow a characteristic pattern, beginning with memory impairment and spreading to language and visuospatial deficits.Changes in environment (such as vacations or hospital stays) may be disorienting.Language becomes impaired-first naming, then comprehension, and finally fluency.In some patients, aphasia is an early and prominent feature.Apraxia emerges, and patients have trouble performing learned sequential motor tasks.Visuospatial deficits begin to interfere with dressing, eating, or even walking, and patients fail to solve simple puzzles or copy geometric figures.Approximately 10% of AD patients develop Capgras' syndrome, believing that a caregiver has been replaced by an impostor.Often death results from malnutrition, secondary infections, pulmonary emboli, heart disease, or, most commonly, aspiration.As AD progresses, more distributed but usually posterior-predominant cortical atrophy becomes apparent, along with atrophy of the medial temporal memory structures.Slowly progressive decline in memory and orientation, normal results on laboratory tests, and an MRI or CT scan showing only distributed or posteriorly predominant cortical and hippocampal atrophy is highly suggestive of AD.Treatment:DonepeziI (target dose, 10 mg daily),Rivastigmine (target dose, 6 mg twice daily or 9.5-mg patch daily)Galantamine (target dose 24 mg daily, extended-release)Memantine (target dose, 10 mg twice daily)TacrineDue to hepatotoxicity, tacrine is no longer used.Memantine appears to act by blocking overexcited A-methyl-d-aspartate (NMDA) glutamate receptors.",
    "subject_name": "Medicine",
    "topic_name": "Dementia",
    "entity": "1. Alzheimer's disease\n2. Temporoparietal\n3. Parieto-occipital\n4. Frontoparietal\n5. Temporo-occipital",
    "prediction": "A",
    "path": "Reranked Triple1: Alzheimer's disease \u2014\u2014> causes \u2014\u2014> brain atrophy  \nReranked Triple2: brain atrophy \u2014\u2014> associates \u2014\u2014> AD  \nReranked Triple3: Alzheimer's disease \u2014\u2014> REGION \u2014\u2014> parietal lobe  \nReranked Triple4: tempol \u2014\u2014> binds \u2014\u2014> Abeta  \nReranked Triple5: dementia \u2014\u2014> predisposes to \u2014\u2014> Alzheimer's disease  \n\nAnswer: A. Temporoparietal",
    "neighbor_input": "Reranked Triple1: AD -> causes -> brain atrophy  \nReranked Triple2: brain atrophy -> associated with -> Alzheimer's disease  \nReranked Triple3: AD -> associated with -> cognitive decline  \nReranked Triple4: cognitive decline -> linked to -> brain regions affected  \nReranked Triple5: AD -> causes -> neurodegenerative diseases  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer's disease' 'causes' 'brain atrophy'.\n\nPath-based Evidence 2: 'brain atrophy' 'associates' 'AD'.\n\nPath-based Evidence 3: 'Alzheimer's disease' 'REGION' 'parietal lobe'.\n\nPath-based Evidence 4: 'tempol' 'binds' 'Abeta'.\n\nPath-based Evidence 5: 'dementia' 'predisposes to' 'Alzheimer's disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Alzheimer's disease' is known to 'cause' 'brain atrophy'.\n\nNeighbor-based Evidence 2: 'Brain atrophy' is 'associated with' 'Alzheimer's disease'.\n\nNeighbor-based Evidence 3: 'Alzheimer's disease' is 'associated with' 'cognitive decline'.\n\nNeighbor-based Evidence 4: 'Cognitive decline' is 'linked to' 'brain regions affected'.\n\nNeighbor-based Evidence 5: 'Alzheimer's disease' is known to 'cause' 'neurodegenerative diseases'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.7134661674499512,
      0.8125871419906616,
      0.6719985604286194,
      0.6433367729187012,
      0.7248404026031494,
      0.6829724907875061
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "8aaca59e-9025-43b0-91f4-f9697fefb0fb",
    "question": "A chromosomal anomaly associated with Alzheimer's dementia is:",
    "opa": "Trisomy 18",
    "opb": "Patau syndrome",
    "opc": "Trisomy 21",
    "opd": "Turners syndrome",
    "cop": 2,
    "choice_type": "single",
    "exp": "Answer is C (Trisomy 21) : Several genetic factors are known to play impoant roles in pathogenesis of at least some cases of Alzheimers disease. Trisomy 21 is one of them. Adults with trisomy 21 (Down's) consistently develop the Neuropathologic hallmark's of Alzheimer's disease if they survive beyond age 40.",
    "subject_name": "Medicine",
    "topic_name": null,
    "entity": "1. chromosomal anomaly\n2. Alzheimer's dementia\n3. Trisomy 18\n4. Patau syndrome \n5. Trisomy 21\n6. Turners syndrome",
    "prediction": "C",
    "path": "Reranked Triple1: Alzheimer's dementia \u2014\u2014> associates \u2014\u2014> cognitive decline  \nReranked Triple2: cognitive decline \u2014\u2014> associated with \u2014\u2014> AD  \nReranked Triple3: AD \u2014\u2014> resembles \u2014\u2014> Alzheimers disease  \nReranked Triple4: Alzheimers disease \u2014\u2014> associated with \u2014\u2014> chromosomal anomalies  \nReranked Triple5: chromosomal anomalies \u2014\u2014> includes \u2014\u2014> Trisomy 21  \n\nAnswer: C. Trisomy 21",
    "neighbor_input": "Reranked Triple1: Alzheimer's dementia \u2014\u2014> associates \u2014\u2014> cognitive decline  \nReranked Triple2: Alzheimer's dementia \u2014\u2014> cause \u2014\u2014> neurodegeneration  \nReranked Triple3: congenital anomaly \u2014\u2014> caused by \u2014\u2014> dural grafting  \nReranked Triple4: congenital anomaly \u2014\u2014> related to \u2014\u2014> iatrogenic Creutzfeldt-Jakob disease  \nReranked Triple5: Alzheimer's dementia \u2014\u2014> ASSOCIATES \u2014\u2014> brain haemorrhages, dementia",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer's dementia' 'associates' 'cognitive decline'.  \nPath-based Evidence 2: 'cognitive decline' 'associated with' 'AD'.  \nPath-based Evidence 3: 'AD' 'resembles' 'Alzheimer's disease'.  \nPath-based Evidence 4: 'Alzheimer's disease' 'associated with' 'chromosomal anomalies'.  \nPath-based Evidence 5: 'chromosomal anomalies' 'includes' 'Trisomy 21'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Alzheimer's dementia' 'associates' 'cognitive decline'.\n\nNeighbor-based Evidence 2: 'Alzheimer's dementia' 'cause' 'neurodegeneration'.\n\nNeighbor-based Evidence 3: 'congenital anomaly' 'caused by' 'dural grafting'.\n\nNeighbor-based Evidence 4: 'congenital anomaly' 'related to' 'iatrogenic Creutzfeldt-Jakob disease'.\n\nNeighbor-based Evidence 5: 'Alzheimer's dementia' 'ASSOCIATES' 'brain haemorrhages, dementia'.",
    "entity_confidence_scores": [
      0.7584463357925415,
      0.6692334413528442,
      1.000000238418579,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      0.8488523960113525,
      0.7702889442443848,
      0.6812289357185364,
      0.8738721609115601,
      0.7554779052734375,
      0.6972866058349609,
      0.6903723478317261,
      0.7551724910736084,
      0.796008288860321
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "a0033c5a-cffd-4363-a5ae-6930d5017890",
    "question": "Which of the following is TRUE/FALSE about weight loss? a) Psychiatric disorders are a major cause of involuntary weight loss. b) Up to 20% of all cancer deaths are caused directly by cachexia. c) Connective tissue diseases decreases metabolic demand. d) Hypehyroidism in the elderly have more prominent sympathomimetic features. e) Involuntary weight loss may be one of the earliest manifestations of Alzheimer's dementia.",
    "opa": "a,b,c,d,e-True None-False",
    "opb": "a,b,c-True & d,e-False",
    "opc": "a,b,c,d-True & e-False",
    "opd": "a,b,e-True & c,d,-False",
    "cop": 3,
    "choice_type": "multi",
    "exp": "Connective tissue diseases may increase metabolic demand and disrupt nutritional balance. Hypehyroidism in the elderly may have less prominent sympathomimetic features and may present as \"apathetic hypehyroidism\" or T3 toxicosis Ref:Harrisons Principles of Internal Medicine, 18th Edition, Pages 642- 44",
    "subject_name": "Medicine",
    "topic_name": null,
    "entity": "1. weight loss \n2. psychiatric disorders \n3. involuntary weight loss \n4. cancer deaths \n5. cachexia \n6. connective tissue diseases \n7. metabolic demand \n8. Hypehyroidism \n9. elderly \n10. sympathomimetic features \n11. Alzheimer's dementia \n12. manifestations",
    "prediction": "C",
    "path": "Reranked Triple1: ataxia \u2014\u2014> associated with \u2014\u2014> cognitive decline\nReranked Triple2: cognitive decline \u2014\u2014> associated with \u2014\u2014> Alzheimer's disease\nReranked Triple3: Alzheimer's disease \u2014\u2014> regulates \u2014\u2014> metabolic impairment\nReranked Triple4: ataxia \u2014\u2014> associated with \u2014\u2014> Alzheimer's disease\nReranked Triple5: cognitive decline \u2014\u2014> in \u2014\u2014> Alzheimer's disease",
    "neighbor_input": "Reranked Triple1: cancer patients \u2014\u2014> has \u2014\u2014> chemobrain\nReranked Triple2: tumor \u2014\u2014> CAUSES \u2014\u2014> carcinogenesis\nReranked Triple3: tumor \u2014\u2014> results in \u2014\u2014> death\nReranked Triple4: tumor \u2014\u2014> ASSOCIATES \u2014\u2014> risk\nReranked Triple5: Weight gain \u2014\u2014> involves \u2014\u2014> mice",
    "response_of_KG_list_path": "Path-based Evidence 1: 'ataxia' is associated with 'cognitive decline'.\nPath-based Evidence 2: 'cognitive decline' is associated with 'Alzheimer's disease'.\nPath-based Evidence 3: 'Alzheimer's disease' regulates 'metabolic impairment'.\nPath-based Evidence 4: 'ataxia' is associated with 'Alzheimer's disease'.\nPath-based Evidence 5: 'cognitive decline' is in 'Alzheimer's disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'cancer patients' 'has' 'chemobrain'\nNeighbor-based Evidence 2: 'tumor' 'CAUSES' 'carcinogenesis'\nNeighbor-based Evidence 3: 'tumor' 'results in' 'death'\nNeighbor-based Evidence 4: 'tumor' 'ASSOCIATES' 'risk'\nNeighbor-based Evidence 5: 'Weight gain' 'involves' 'mice'",
    "entity_confidence_scores": [
      0.9999999403953552,
      1.0,
      0.8226057291030884,
      1.0,
      0.9607926607131958,
      0.6984996199607849,
      0.6440074443817139,
      0.7170511484146118,
      0.9999999403953552,
      0.9999999403953552,
      0.632957398891449,
      0.6032139658927917,
      0.6151267290115356,
      0.6662135124206543,
      0.6546497941017151,
      1.0000001192092896,
      0.8743891716003418,
      1.000000238418579,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896
    ],
    "question_types": [
      "causation",
      "symptom"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "7f33cc14-50f9-49c1-89f6-a0abaab30b13",
    "question": "A 42-year-old man is being followed up for worsening involuntary jerky movements. During the course of his disease, he develops depression and progressive dementia. Within several years he dies, and during an autopsy, bilateral atrophy of the caudate nuclei is found. What is the basic abnormality involved in this individual's disease process",
    "opa": "Acquired enzyme deficiency",
    "opb": "Slow virus infection",
    "opc": "Triple repeat mutation",
    "opd": "DNA repair defect",
    "cop": 2,
    "choice_type": "single",
    "exp": "Bilateral atrophy of the caudate nuclei is characteristic of Huntington disease, an inherited autosomal dominant disease that is characterized by the combination of choreiform movements, depression, and progressive dementia. This disorder results from increased numbers of trinucleotide repeats within the HD gene. Thus, this disorder is an example of a triple repeat mutation disorder, other examples of which include fragile X syndrome and myotonic dystrophy. Ref:- Harsha Mohan textbook of Pathology",
    "subject_name": "Pathology",
    "topic_name": "Nervous system",
    "entity": "1. age (42-year-old)\n2. involuntary jerky movements\n3. disease\n4. depression\n5. progressive dementia\n6. autopsy\n7. bilateral atrophy of the caudate nuclei\n8. abnormality\n9. acquired enzyme deficiency\n10. slow virus infection\n11. triple repeat mutation\n12. DNA repair defect",
    "prediction": "C",
    "path": "Reranked Triple1: disease \u2014\u2014> affects \u2014\u2014> Amyloid precursor protein\nReranked Triple2: disease \u2014\u2014> NAME \u2014\u2014> Alzheimer's disease\nReranked Triple3: Alzheimer's disease \u2014\u2014> CAUSE \u2014\u2014> Amyloid precursor protein\nReranked Triple4: disease \u2014\u2014> NAME \u2014\u2014> Alzheimer's disease\nReranked Triple5: Alzheimer's disease \u2014\u2014> CAUSE \u2014\u2014> Amyloid precursor protein",
    "neighbor_input": "Reranked Triple1: Depression \u2014\u2014> associates \u2014\u2014> Psychiatric  \nReranked Triple2: Depression \u2014\u2014> associated with \u2014\u2014> cognitive impairment  \nReranked Triple3: Depression \u2014\u2014> is associated with \u2014\u2014> cognitive decline  \nReranked Triple4: Depression \u2014\u2014> interacts \u2014\u2014> Abeta  \nReranked Triple5: Depression \u2014\u2014> biomarker \u2014\u2014> Abeta  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'disease' affects 'Amyloid precursor protein'.\n\nPath-based Evidence 2: 'disease' is named 'Alzheimer's disease'.\n\nPath-based Evidence 3: 'Alzheimer's disease' causes 'Amyloid precursor protein'.\n\nPath-based Evidence 4: 'disease' is named 'Alzheimer's disease'.\n\nPath-based Evidence 5: 'Alzheimer's disease' causes 'Amyloid precursor protein'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Depression' is associated with 'Psychiatric'.  \nNeighbor-based Evidence 2: 'Depression' is associated with 'cognitive impairment'.  \nNeighbor-based Evidence 3: 'Depression' is associated with 'cognitive decline'.  \nNeighbor-based Evidence 4: 'Depression' interacts with 'Abeta'.  \nNeighbor-based Evidence 5: 'Depression' is a biomarker for 'Abeta'.",
    "entity_confidence_scores": [
      0.6651722192764282,
      0.7225233316421509,
      1.0,
      1.0000001192092896,
      1.0,
      1.000000238418579,
      1.0000001192092896,
      1.0,
      0.8745613098144531,
      1.0,
      1.0,
      0.9130909442901611,
      1.0,
      1.0,
      0.7348365783691406,
      0.6956398487091064,
      1.0,
      0.6239837408065796,
      0.6791682243347168,
      0.6758190393447876,
      1.0,
      1.0,
      0.6730695962905884,
      0.6669217348098755,
      0.8237635493278503,
      0.7775499820709229
    ],
    "question_types": [
      "definition"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "45a77657-92ca-42bd-bc80-f6504045058b",
    "question": "Amyloid present in cerebral lesions of Alzheimer's disease -",
    "opa": "L",
    "opb": "AA",
    "opc": "Ab",
    "opd": "b-microglobulin",
    "cop": 2,
    "choice_type": "single",
    "exp": "Ans. c (Ab) (Ref. Harrison's medicine 17th ed., Table 324-1)Amyloid Fibril Proteins and their PrecursorsAmyloid ProteinPrecursorSystemic (S) or Localized (L)Syndrome or Involved TissuesALImmunoglobulin light chainS, LPrimaryMyeloma-associatedAHImmunoglobulin heavy chainS, LPrimaryMyeloma-associatedATTRTransthyretinSFamilialSenile systemic L?TenosynoviumA2M2-microglobulinSL?Hemodialysis, JointsAA(Apo)serum AASSecondary, reactiveAApoAIApolipoprotein AlSLFamilialAorticAApoAIIApolipoprotein AllSFamilialAGelGelsolinSFamilialAlysLysozymeSFamilialAFibFibrinogen -chainSFamilialACysCystatin CSFamilialABriABriPPL, S?Familial dementia, BritishADanADanPPLFamilial dementia, DanishAA protein precursor (APP)LAlzheimer's disease, agingAPrPPrion proteinLSpongiform encephalopathiesACal(Pro)calcitoninLC-cell thyroid tumorsAIAPPIslet amyloid polypeptideLIslets of LangerhansInsulinomasAANFAtrial natriuretic factorLCardiac atriaAProProlactinLAging pituitaryProlactinomasAlnsInsulinLIatrogenicAMedLactadherinLSenile aortic, mediaAkerKerato-epitheliumLCornea; familialA(tbn)tbnbLPindborg tumorsALacLactoferrinLCornea; familial",
    "subject_name": "Unknown",
    "topic_name": null,
    "entity": "1. Amyloid \n2. Cerebral lesions \n3. Alzheimer's disease \n4. A.L \n5. AA \n6. Ab \n7. b-microglobulin",
    "prediction": "C",
    "path": "Reranked Triple1: Amyloid->ASSOCIATES->Inflammation\nReranked Triple2: Inflammation->associates->Alzheimer's disease\nReranked Triple3: Alzheimer's disease->has symptom->tau\nReranked Triple4: tau->associates->Alzheimer's disease (AD)\nReranked Triple5: Alzheimer's disease (AD)->associates->brain lesions",
    "neighbor_input": "Reranked Triple1: amyloid->associated with->dementia\nReranked Triple2: amyloid->causes->neurodegenerative diseases\nReranked Triple3: amyloid->ASSOCIATES->toxicity\nReranked Triple4: amyloid->associates->neurodegeneration\nReranked Triple5: amyloid->associates->brain hypometabolism",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Amyloid' ASSOCIATES with 'Inflammation'.\n\nPath-based Evidence 2: 'Inflammation' associates with 'Alzheimer's disease'.\n\nPath-based Evidence 3: 'Alzheimer's disease' has symptom 'tau'.\n\nPath-based Evidence 4: 'tau' associates with 'Alzheimer's disease (AD)'.\n\nPath-based Evidence 5: 'Alzheimer's disease (AD)' associates with 'brain lesions'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'amyloid' is associated with 'dementia'.\nNeighbor-based Evidence 2: 'amyloid' causes 'neurodegenerative diseases'.\nNeighbor-based Evidence 3: 'amyloid' is associated with 'toxicity'.\nNeighbor-based Evidence 4: 'amyloid' associates with 'neurodegeneration'.\nNeighbor-based Evidence 5: 'amyloid' associates with 'brain hypometabolism'.",
    "entity_confidence_scores": [
      1.0,
      1.0,
      0.9999999403953552,
      0.936989426612854,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      0.7073312401771545,
      0.7766008377075195,
      0.861343264579773
    ],
    "question_types": [
      "symptom"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "fd8d9db7-1b47-442f-9ca2-f430903bd869",
    "question": "NMDA antagonist used in Alzheimer's disease is:",
    "opa": "Memantine",
    "opb": "Rivastigmine",
    "opc": "Donepezil",
    "opd": "Galantamine",
    "cop": 0,
    "choice_type": "single",
    "exp": "Ans: A (Memantine) Ref: Goodman and Gilman's \"Phannacologica! Basis of Therapeutics'' 12th eci p.622Explanation:Memantine* It is used either as an adjunct or an alternative to cholinesterase inhibitors in Alzheimer's disease, and is also commonly used to treat other neurodegenerative dementias,Memantine is a noncompetitive antagonist of the NMDA-type glutamate receptor.It interacts with the Mg2+ binding site of the channel to prevent excessive activation while sparing normal function.Adverse effects of memantine include headache or dizziness, hut are usually mild and reversible.The drug is excreted by the kidneys and dosage should be reduced in patients with severe renal impairment.",
    "subject_name": "Pharmacology",
    "topic_name": "C.N.S",
    "entity": "1. NMDA antagonist \n2. Alzheimer's disease \n3. Memantine \n4. Rivastigmine \n5. Donepezil \n6. Galantamine",
    "prediction": "A",
    "path": "Reranked Triple1: NMDA receptor antagonists \u2014\u2014> interacts \u2014\u2014> Abeta\nReranked Triple2: Abeta \u2014\u2014> downregulates \u2014\u2014> NMDA receptor\nReranked Triple3: NMDA receptor \u2014\u2014> interacts \u2014\u2014> AMPA receptor\nReranked Triple4: Abeta \u2014\u2014> associates \u2014\u2014> Alzheimer Disease\nReranked Triple5: staurosporine \u2014\u2014> TREATMENT \u2014\u2014> apoptosis",
    "neighbor_input": "Reranked Triple1: NMDA receptor antagonists \u2014\u2014> interacts \u2014\u2014> Abeta  \nReranked Triple2: NMDA receptor \u2014\u2014> binds \u2014\u2014> A+ oligomers, glutamate  \nReranked Triple3: NMDA receptor \u2014\u2014> accumulates \u2014\u2014> A+ oligomers  \nReranked Triple4: NMDA receptor \u2014\u2014> activates \u2014\u2014> GluN2B  \nReranked Triple5: NMDA receptor \u2014\u2014> interacts \u2014\u2014> AMPA receptor  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'NMDA receptor antagonists' interacts with 'Abeta'.\nPath-based Evidence 2: 'Abeta' downregulates 'NMDA receptor'.\nPath-based Evidence 3: 'NMDA receptor' interacts with 'AMPA receptor'.\nPath-based Evidence 4: 'Abeta' associates with 'Alzheimer Disease'.\nPath-based Evidence 5: 'staurosporine' TREATMENT 'apoptosis'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'NMDA receptor antagonists' 'interacts' with 'Abeta'.  \nNeighbor-based Evidence 2: 'NMDA receptor' 'binds' to 'A+ oligomers' and 'glutamate'.  \nNeighbor-based Evidence 3: 'NMDA receptor' 'accumulates' 'A+ oligomers'.  \nNeighbor-based Evidence 4: 'NMDA receptor' 'activates' 'GluN2B'.  \nNeighbor-based Evidence 5: 'NMDA receptor' 'interacts' with 'AMPA receptor'.",
    "entity_confidence_scores": [
      0.9047698378562927,
      1.0,
      0.8814483880996704,
      0.8536601662635803,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.6304964423179626,
      1.0,
      0.6575609445571899,
      1.0,
      1.0
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "cbb65396-bf33-4a01-9afa-a90dcec229d9",
    "question": "Which feature is MOST helpful in distinguishing dementia from severe depression?",
    "opa": "Weight loss",
    "opb": "Grasp reflex",
    "opc": "Persistent headache",
    "opd": "Poor attention spans",
    "cop": 1,
    "choice_type": "single",
    "exp": "Somatic complaints such as anorexia, weight loss and headache are features of both conditions, though more prominent in patients with depression. The behavioural and cognitive functions are affected in both conditions. Poor concentration, poor attention span, poor memory and social withdrawal are encountered in both. Grasp reflex and other primitive reflexes indicate neuronal loss in the frontal lobe, which does not occur in depression. A positive response to antidepressant treatment is a reliable sign in our of depression",
    "subject_name": "Pathology",
    "topic_name": "All India exam",
    "entity": "1. dementia\n2. severe depression\n3. weight loss\n4. grasp reflex\n5. persistent headache\n6. poor attention spans",
    "prediction": "D",
    "path": [],
    "neighbor_input": "Reranked Triple1: AD -> causes -> cognitive impairment  \nReranked Triple2: AD -> causes -> memory loss  \nReranked Triple3: AD -> causes -> cognitive decline  \nReranked Triple4: AD -> associates -> cognitive deficits  \nReranked Triple5: AD -> causes -> behavioral dysfunction  ",
    "response_of_KG_list_path": [],
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'cognitive impairment'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'memory loss'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'cognitive decline'.\n\nNeighbor-based Evidence 4: 'AD' 'associates' 'cognitive deficits'.\n\nNeighbor-based Evidence 5: 'AD' 'causes' 'behavioral dysfunction'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      0.8541277050971985,
      1.000000238418579,
      0.9999999403953552,
      1.0,
      0.8226057291030884,
      0.7335594892501831,
      0.752757728099823
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "bf82c509-b54f-40bb-83f3-bdb14fd3e630",
    "question": "Which of the following is the most impoant neurotransmitter deficient in the coex of patients with Alzheimer's Disease",
    "opa": "Acetylcholine",
    "opb": "Serotonin",
    "opc": "Dopamine",
    "opd": "Noradrenaline",
    "cop": 0,
    "choice_type": "single",
    "exp": "Answer is A (Acetylcholine):The most impoant biochemical abnormality in Alzheimer's disease is the decrease in coical levels of AcetylcholineBiochemically Alzheimer's disease is associated with a decrease in the coical levels of several proteins and neurotransmitters especially acetylcholine, its synthetic enzyme choline-acetyl-transferase, and nicotinic cholinergic receptors. Reduction of acetylcholine is related in pa to degeneration of cholinergic neurons in the nucleus basalis of Meyne (NBM) that projects through the coex. There is also noradrenergic and serotonergic depletion due to degeneration of brainstem nuclei such as the locus ceruleus and dorsal raphe' - Harrison's",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. neurotransmitter\n2. Alzheimer's Disease\n3. Acetylcholine\n4. Serotonin\n5. Dopamine\n6. Noradrenaline",
    "prediction": "A",
    "path": "Reranked Triple1: Alzheimer Disease \u2014\u2014> associates \u2014\u2014> cognitive dysfunction  \nReranked Triple2: cognitive dysfunction \u2014\u2014> associated with \u2014\u2014> noradrenaline  \nReranked Triple3: noradrenaline \u2014\u2014> regulates \u2014\u2014> inflammation  \nReranked Triple4: dopamine (Dopamine) \u2014\u2014> causes \u2014\u2014> neurodegeneration  \nReranked Triple5: dopamine (Dopamine) \u2014\u2014> associates \u2014\u2014> tau  ",
    "neighbor_input": "Reranked Triple1: AD -> causes -> cognitive impairment  \nReranked Triple2: AD -> causes -> cognitive decline  \nReranked Triple3: AD -> causes -> memory impairment  \nReranked Triple4: neurotransmitters -> activate -> GABAR-positive neurons  \nReranked Triple5: neurotransmitters -> activate -> alpha7nAChR-positive neurons  \n\nAnswer: A. Acetylcholine",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer Disease' 'associates' with 'cognitive dysfunction'.  \nPath-based Evidence 2: 'cognitive dysfunction' 'associated with' 'noradrenaline'.  \nPath-based Evidence 3: 'noradrenaline' 'regulates' 'inflammation'.  \nPath-based Evidence 4: 'dopamine (Dopamine)' 'causes' 'neurodegeneration'.  \nPath-based Evidence 5: 'dopamine (Dopamine)' 'associates' with 'tau'.  ",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'cognitive impairment'.  \nNeighbor-based Evidence 2: 'AD' 'causes' 'cognitive decline'.  \nNeighbor-based Evidence 3: 'AD' 'causes' 'memory impairment'.  \nNeighbor-based Evidence 4: 'neurotransmitters' 'activate' 'GABAR-positive neurons'.  \nNeighbor-based Evidence 5: 'neurotransmitters' 'activate' 'alpha7nAChR-positive neurons'.  ",
    "entity_confidence_scores": [
      1.0000001192092896,
      0.9202996492385864,
      0.8773843050003052,
      0.8702182769775391,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0,
      1.0,
      0.910812497138977,
      1.0,
      0.7705323100090027
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "b9093edf-d615-4ecf-bd39-af93a9544742",
    "question": "Which chromosomal anomaly associated with alzheimer's dementia?",
    "opa": "Trisomy 18",
    "opb": "Trisomy 21",
    "opc": "Patau syndrome.",
    "opd": "Turners syndrome",
    "cop": 1,
    "choice_type": "single",
    "exp": "Several genes play impoant pathogenic roles in at least some patients with Alzheimer's disease(AD). One is the APP gene on chromosome 21. Adults with trisomy 21 (Down syndrome) consistently develop the typical neuropathologic hallmarks of AD if they survive beyond age 40. Presenilin-1 (PS-1) is on chromosome 14 and encodes a protein called S182. Mutations in this gene cause an early-onset AD transmitted in an autosomal dominant, highly penetrant fashion. The Apo E gene on chromosome 19 is involved in the pathogenesis of late-onset familial and sporadic forms of AD. AD most often presents with an insidious onset of memory loss followed by a slowly progressive dementia over several years. Pathologically, atrophy is distributed throughout the medial temporal lobes, lateral and medial parietal lobes and lateral frontal coex. Microscopically, there are neuritic plaques containing A-beta, neurofibrillary tangles (NFTs) composed of hyperphosphorylated tau filaments, and accumulation of amyloid in blood vessel walls in coex and leptomeninges. Clinical Manifestation begins with memory impairment and spreading to language and visuospatial deficits.The management of AD is challenging and gratifying, despite the absence of a cure or a robust pharmacologic treatment. Donepezil (target dose, 10 mg daily), rivastigmine (target dose, 6 mg twice daily or 9.5-mg patch daily), galantamine (target dose 24 mg daily, extended-release), memantine (target dose, 10 mg twice daily), and tacrine are the drugs presently approved by the Food and Drug Administration (FDA) for treatment of AD.Ref:Harrison's Internal Medicine, 18th Edition, Pages 3307, 3309, 3049",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. chromosomal anomaly\n2. Alzheimer's dementia\n3. Trisomy 18\n4. Trisomy 21\n5. Patau syndrome\n6. Turner syndrome",
    "prediction": "B",
    "path": "Reranked Triple1: chromosome 3 \u2014\u2014> CONTAINS \u2014\u2014> BCHE  \nReranked Triple2: BCHE \u2014\u2014> regulates \u2014\u2014> Abeta (amyloid-beta)  \nReranked Triple3: Abeta (amyloid-beta) \u2014\u2014> ASSOCIATES \u2014\u2014> Alzheimer disease  \nReranked Triple4: Alzheimer disease \u2014\u2014> ASSOCIATES \u2014\u2014> genetic disorder  \nReranked Triple5: Alzheimer's dementia \u2014\u2014> associates \u2014\u2014> cognitive decline  ",
    "neighbor_input": "Reranked Triple1: Alzheimer's dementia \u2014\u2014> associates \u2014\u2014> cognitive decline  \nReranked Triple2: Alzheimer's dementia \u2014\u2014> ASSOCIATEs \u2014\u2014> brain haemorrhages, dementia  \nReranked Triple3: Alzheimer's dementia \u2014\u2014> cause \u2014\u2014> neurodegeneration  \nReranked Triple4: congenital anomaly \u2014\u2014> related to \u2014\u2014> iatrogenic Creutzfeldt-Jakob disease  \nReranked Triple5: congenital anomaly \u2014\u2014> caused by \u2014\u2014> dural grafting  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Chromosome 3' 'CONTAINS' 'BCHE'.\n\nPath-based Evidence 2: 'BCHE' 'regulates' 'Abeta (amyloid-beta)'.\n\nPath-based Evidence 3: 'Abeta (amyloid-beta)' 'ASSOCIATES' 'Alzheimer disease'.\n\nPath-based Evidence 4: 'Alzheimer disease' 'ASSOCIATES' 'genetic disorder'.\n\nPath-based Evidence 5: 'Alzheimer's dementia' 'associates' 'cognitive decline'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Alzheimer's dementia' is associated with 'cognitive decline'.\n\nNeighbor-based Evidence 2: 'Alzheimer's dementia' associates with 'brain haemorrhages' and 'dementia'.\n\nNeighbor-based Evidence 3: 'Alzheimer's dementia' causes 'neurodegeneration'.\n\nNeighbor-based Evidence 4: 'Congenital anomaly' is related to 'iatrogenic Creutzfeldt-Jakob disease'.\n\nNeighbor-based Evidence 5: 'Congenital anomaly' is caused by 'dural grafting'.",
    "entity_confidence_scores": [
      0.7584463357925415,
      0.6692334413528442,
      1.000000238418579,
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      0.8488523960113525,
      0.7702889442443848,
      0.6812289357185364,
      0.796008288860321,
      0.8738721609115601,
      0.7554779052734375,
      0.6972866058349609,
      0.6903723478317261,
      0.7551724910736084
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "fec1036c-b311-4547-898b-64ae1c073f15",
    "question": "Chromosomes involved in early onset Alzheimer's disease:",
    "opa": "1,14,21",
    "opb": "1,13,22",
    "opc": "3, 14, 20",
    "opd": "3, 14, X",
    "cop": 0,
    "choice_type": "single",
    "exp": "A i.e. 1,14,21Ref: Genetic Home ReferenceExplanation:Genes Involved in Alzheimers Disease:Early onset Alzehimer's disease involves three genes: APP-Ch 21.PSEN1 (Presenilin 1) - Ch 14.PSEN 2 (Presenilin 2) - Ch 1.Genes causing autosomal dominant AD* APP* PSEN1* PSEN 2All can cause early onset disease but PSEN2 is associated with a broad range of onset ages.Susceptibitity genes* Apolipoprotein E gene (APOE)- c2 allele: associated with decreased risk- s3 allele: neutral- e4 allele: high-risk* SORL1",
    "subject_name": "Pathology",
    "topic_name": "Central Nervous System",
    "entity": "1. Chromosomes\n2. Early onset Alzheimer's disease\n3. 1\n4. 14\n5. 21\n6. 13\n7. 22\n8. 3\n9. 20\n10. X",
    "prediction": "A",
    "path": "Reranked Triple1: early onset Alzheimer's disease \u2014\u2014> is associated with \u2014\u2014> chromosomes 1, 14, 21  \nReranked Triple2: Alzheimer's disease \u2014\u2014> involves \u2014\u2014> chromosome 21  \nReranked Triple3: Alzheimer's disease \u2014\u2014> involves \u2014\u2014> chromosome 14  \nReranked Triple4: Alzheimer's disease \u2014\u2014> involves \u2014\u2014> chromosome 1  \nReranked Triple5: chromosomes 1, 14, 21 \u2014\u2014> are related to \u2014\u2014> genetic factors in Alzheimer's disease  ",
    "neighbor_input": "Reranked Triple1: AD->CAUSES->neurodegeneration\nReranked Triple2: AD->CAUSES->cognitive lesion\nReranked Triple3: AD->CAUSES->dementia\nReranked Triple4: AD->CAUSES->Alzheimer's disease\nReranked Triple5: AD->ASSOCIATES->APOE",
    "response_of_KG_list_path": "Path-based Evidence 1: 'early onset Alzheimer's disease' 'is associated with' 'chromosomes 1, 14, 21'. \n\nPath-based Evidence 2: 'Alzheimer's disease' 'involves' 'chromosome 21'.\n\nPath-based Evidence 3: 'Alzheimer's disease' 'involves' 'chromosome 14'.\n\nPath-based Evidence 4: 'Alzheimer's disease' 'involves' 'chromosome 1'.\n\nPath-based Evidence 5: 'chromosomes 1, 14, 21' 'are related to' 'genetic factors in Alzheimer's disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'Alzheimer's disease' 'causes' 'neurodegeneration'.\n\nNeighbor-based Evidence 2: 'Alzheimer's disease' 'causes' 'cognitive lesion'.\n\nNeighbor-based Evidence 3: 'Alzheimer's disease' 'causes' 'dementia'.\n\nNeighbor-based Evidence 4: 'Alzheimer's disease' 'causes' 'Alzheimer's disease'.\n\nNeighbor-based Evidence 5: 'Alzheimer's disease' 'associates' 'APOE'.",
    "entity_confidence_scores": [
      0.7545731067657471,
      0.9707714319229126,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.9099191427230835,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.7758431434631348,
      0.7877929210662842,
      0.7789978981018066,
      1.0,
      0.9198420643806458,
      0.7554779052734375,
      0.7363262176513672,
      0.7708532810211182,
      0.7645511627197266,
      1.0,
      0.7953117489814758,
      0.6227065920829773
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "f2a1c6e5-211a-4372-8cae-c657208f5c56",
    "question": "Which of the following is a relatively cerebroselective anticholinesterase found to afford symptomatic improvement in Alzheimer&;s disease",
    "opa": "Donepezil",
    "opb": "Pyridostigmine",
    "opc": "Pyritinol",
    "opd": "Gemfibrozil",
    "cop": 0,
    "choice_type": "single",
    "exp": "Rivastigmine:- This lipophilic relatively cere-broselective ChE inhibitor has been introduced for Alzheimer's disease (AD). Donepezil:- Another centrally acting anti-AChE that has produced cognitive and behavioral improvement in AD. It is long-acting and suitable for once daily administration. Galantamine:- This natural alkaloid inhibitor of cerebral AChE has in addition weak agonistic action on nicotinic receptors. It is being used to afford symptomatic relief in AD. Ref:- kd tripathi; pg num:-108",
    "subject_name": "Pharmacology",
    "topic_name": "Autonomic nervous system",
    "entity": "1. cerebroselective anticholinesterase\n2. Alzheimer's disease\n3. Donepezil\n4. Pyridostigmine\n5. Pyritinol\n6. Gemfibrozil",
    "prediction": "A",
    "path": "Reranked Triple1: alzheimer disease \u2014\u2014> CAUSES \u2014\u2014> dementia  \nReranked Triple2: dementia \u2014\u2014> caused by \u2014\u2014> tau  \nReranked Triple3: tau \u2014\u2014> associates \u2014\u2014> Alzheimer Disease  \nReranked Triple4: Alzheimer Disease \u2014\u2014> causes \u2014\u2014> brain atrophy  \nReranked Triple5: Alzheimer Disease \u2014\u2014> ASSOCIATEs \u2014\u2014> participants  ",
    "neighbor_input": "Reranked Triple1: AD \u2014\u2014> has symptom \u2014\u2014> cognitive impairment  \nReranked Triple2: AD \u2014\u2014> has symptom \u2014\u2014> dementia  \nReranked Triple3: AD \u2014\u2014> has symptom \u2014\u2014> memory loss  \nReranked Triple4: AD \u2014\u2014> has symptom \u2014\u2014> cognitive decline  \nReranked Triple5: AD \u2014\u2014> has symptom \u2014\u2014> behavioral symptoms  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer disease' 'CAUSES' 'dementia'.\n\nPath-based Evidence 2: 'dementia' 'caused by' 'tau'.\n\nPath-based Evidence 3: 'tau' 'associates' 'Alzheimer Disease'.\n\nPath-based Evidence 4: 'Alzheimer Disease' 'causes' 'brain atrophy'.\n\nPath-based Evidence 5: 'Alzheimer Disease' 'ASSOCIATES' 'participants'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' has the symptom of 'cognitive impairment'.\n\nNeighbor-based Evidence 2: 'AD' has the symptom of 'dementia'.\n\nNeighbor-based Evidence 3: 'AD' has the symptom of 'memory loss'.\n\nNeighbor-based Evidence 4: 'AD' has the symptom of 'cognitive decline'.\n\nNeighbor-based Evidence 5: 'AD' has the symptom of 'behavioral symptoms'.",
    "entity_confidence_scores": [
      0.765696108341217,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.6575609445571899,
      0.8282668590545654,
      0.7961782217025757,
      0.7861275672912598,
      0.7675462365150452,
      0.7629760503768921,
      0.7613595724105835,
      1.0000001192092896
    ],
    "question_types": [
      "symptom"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "ad10cb42-e1a4-46c2-aae7-5117a6ed9c7d",
    "question": "Degenerated neurofilaments seen in patients with Alzheimer's disease are:",
    "opa": "Hirano bodies",
    "opb": "Lipofuscin granules",
    "opc": "Neurofibrillary tangles",
    "opd": "Amyloid plaques",
    "cop": 2,
    "choice_type": "single",
    "exp": "Neurofibrillary tanglesThe build-up manifests in two ways:Plaques- deposits of the protein beta-amyloid that accumulate in the spaces between nerve cells Tangles - deposits of the protein tau that accumulate inside of nerve cellsBoth amyloid plaques and neurofibrillary tangles are clearly visible by microscopy in brains of those afflicted by AD.Plaques are dense, mostly insoluble deposits of amyloid - beta peptides and cellular material outside and around neurons.Senile neural plaques correlates (increases) with ageTangles (neurofibrillary tangles) are aggregates of the microtubule-associated protein tau which has become hyperphosphorylated and accumulate inside the cells themselves & are associated with severe dementiaLateral geniculate body is resistant to neurofibrillary tangles.",
    "subject_name": "Psychiatry",
    "topic_name": null,
    "entity": "1. Degenerated neurofilaments\n2. Alzheimer's disease\n3. Hirano bodies\n4. Lipofuscin granules\n5. Neurofibrillary tangles\n6. Amyloid plaques",
    "prediction": "C",
    "path": "Reranked Triple1: Alzheimer Disease -> associates -> tau  \nReranked Triple2: tau -> causes -> neurofibrillary tangles  \nReranked Triple3: Alzheimer Disease -> causes -> dementia  \nReranked Triple4: dementia -> caused by -> tau  \nReranked Triple5: Alzheimer Disease -> resembles -> neurofibrillary tangles  ",
    "neighbor_input": "Reranked Triple1: neurofilaments \u2014\u2014> ASSOCIATES \u2014\u2014> neurodegenerative disorders  \nReranked Triple2: AD \u2014\u2014> CAUSES \u2014\u2014> neurodegenerative disorder  \nReranked Triple3: AD \u2014\u2014> CAUSES \u2014\u2014> neurofibrillary tangle pathology  \nReranked Triple4: AD \u2014\u2014> CAUSES \u2014\u2014> cognitive impairment  \nReranked Triple5: AD \u2014\u2014> CAUSES \u2014\u2014> dementia  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer Disease' is known to 'associate' with 'tau'.\n\nPath-based Evidence 2: 'Tau' is a factor that 'causes' 'neurofibrillary tangles'.\n\nPath-based Evidence 3: 'Alzheimer Disease' is a condition that 'causes' 'dementia'.\n\nPath-based Evidence 4: 'Dementia' is 'caused by' 'tau'.\n\nPath-based Evidence 5: 'Alzheimer Disease' 'resembles' 'neurofibrillary tangles'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'neurofilaments' ASSOCIATES 'neurodegenerative disorders'  \nNeighbor-based Evidence 2: 'AD' CAUSES 'neurodegenerative disorder'  \nNeighbor-based Evidence 3: 'AD' CAUSES 'neurofibrillary tangle pathology'  \nNeighbor-based Evidence 4: 'AD' CAUSES 'cognitive impairment'  \nNeighbor-based Evidence 5: 'AD' CAUSES 'dementia'",
    "entity_confidence_scores": [
      0.7705038785934448,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.630649745464325,
      1.0,
      1.0,
      1.0,
      1.0
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "ae34c60a-0334-4183-9d3d-e68fe9fe6bb0",
    "question": "Alzheimers disease, true is all except -",
    "opa": "Anterograde amnesia",
    "opb": "Dysdiadochokinesia",
    "opc": "Receptive aphasia",
    "opd": "Recognition of familiar faces is absent",
    "cop": 1,
    "choice_type": "multi",
    "exp": null,
    "subject_name": "Medicine",
    "topic_name": null,
    "entity": "1. Alzheimer's disease\n2. Anterograde amnesia\n3. Dysdiadochokinesia\n4. Receptive aphasia\n5. Recognition of familiar faces",
    "prediction": "B",
    "path": "Reranked Triple1: Alzheimer Disease -> associates -> dementia  \nReranked Triple2: dementia -> CAUSES -> tau  \nReranked Triple3: Alzheimer Disease -> causes -> brain atrophy  \nReranked Triple4: AD -> correlates with -> diabetes mellitus  \nReranked Triple5: AD -> resembles -> Alzheimers disease  ",
    "neighbor_input": "Reranked Triple1: AD->ASSOCIATES->memory impairment by estrogen deficiency \u2014\u2014> ENO1\nReranked Triple2: AD->CAUSES->depressive \u2014\u2014> glucose intolerance\nReranked Triple3: AD->CAUSES->neurofibrillary tangle pathology \u2014\u2014> cognitive disorders\nReranked Triple4: AD->TREATMENT->thiethylperazine \u2014\u2014> MDR-1339\nReranked Triple5: AD->TREATMENT->alpha-tocopherol \u2014\u2014> PBS",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer Disease' is known to 'associate' with 'dementia'.\n\nPath-based Evidence 2: 'Dementia' 'causes' 'tau'.\n\nPath-based Evidence 3: 'Alzheimer Disease' 'causes' 'brain atrophy'.\n\nPath-based Evidence 4: 'Alzheimer Disease' 'correlates with' 'diabetes mellitus'.\n\nPath-based Evidence 5: 'Alzheimer Disease' 'resembles' 'Alzheimer's disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' is associated with 'memory impairment by estrogen deficiency' through 'ASSOCIATES', leading to 'ENO1'.\n\nNeighbor-based Evidence 2: 'AD' causes 'depressive' through 'CAUSES', which leads to 'glucose intolerance'.\n\nNeighbor-based Evidence 3: 'AD' causes 'neurofibrillary tangle pathology' through 'CAUSES', resulting in 'cognitive disorders'.\n\nNeighbor-based Evidence 4: 'AD' has a treatment involving 'thiethylperazine' through 'TREATMENT', which corresponds to 'MDR-1339'.\n\nNeighbor-based Evidence 5: 'AD' has a treatment involving 'alpha-tocopherol' through 'TREATMENT', which corresponds to 'PBS'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.675493597984314,
      1.0000001192092896,
      0.6389792561531067,
      0.7284983396530151,
      0.7123255729675293,
      0.8301682472229004,
      1.0,
      0.8872448801994324,
      0.8571492433547974,
      1.0,
      0.8313072919845581,
      0.6454477310180664
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "1b061c59-19fe-4745-911f-fa4fcfde1237",
    "question": "Neurotransmitter playing major part in the pathogenesis of Alzheimer's disease -",
    "opa": "Serotonine",
    "opb": "Norepinephrine",
    "opc": "Acetylcholine",
    "opd": "Dopamine",
    "cop": 2,
    "choice_type": "single",
    "exp": "Ans. is 'c' i.e., Acetylcholine Neurotransmitters in Alzheimer's diseaseo Acetylcholine has a major role in memory functions and deficiency in cholinergic functioning is associated with memory disturbances particularly short term memory. In Alzheimer's disease there loss of cells in the nucleus basalis of meyernet results in marked reduction in choline acetyltransferase (CHAT), an enzyme involved in the synthesis of acetylcholine - Decreased Acetylcholine.o The other important neurotransmitter involved is norepinephrine - There is decrease in nor-epinephrine containing neurons in the locus ceruleus.o Two other neuroactive peptides have been implicated in AD - Somatostatin and corticotropin, both of which have decreased concentration.",
    "subject_name": "Psychiatry",
    "topic_name": "Degenerative Disorders",
    "entity": "1. Neurotransmitter\n2. Alzheimer's disease\n3. Serotonine\n4. Norepinephrine\n5. Acetylcholine\n6. Dopamine",
    "prediction": "C",
    "path": "Reranked Triple1: AD \u2014\u2014> correlates with \u2014\u2014> diabetes mellitus  \nReranked Triple2: diabetes mellitus \u2014\u2014> associates \u2014\u2014> alzheimer disease  \nReranked Triple3: alzheimer disease \u2014\u2014> CAUSES \u2014\u2014> dementia  \nReranked Triple4: dementia \u2014\u2014> caused by \u2014\u2014> tau  \nReranked Triple5: tau \u2014\u2014> associates \u2014\u2014> Alzheimer Disease  \n\nAnswer: C. Acetylcholine",
    "neighbor_input": "Reranked Triple1: neurotransmitters \u2014\u2014> activate \u2014\u2014> alpha7nAChR-positive neurons  \nReranked Triple2: neurotransmitters \u2014\u2014> activate \u2014\u2014> GABAR-positive neurons  \nReranked Triple3: AD \u2014\u2014> causes \u2014\u2014> cognitive decline  \nReranked Triple4: AD \u2014\u2014> causes \u2014\u2014> neurodegeneration  \nReranked Triple5: AD \u2014\u2014> treats \u2014\u2014> cholinesterase inhibitor  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'AD' 'correlates with' 'diabetes mellitus'.  \nPath-based Evidence 2: 'diabetes mellitus' 'associates' 'alzheimer disease'.  \nPath-based Evidence 3: 'alzheimer disease' 'CAUSES' 'dementia'.  \nPath-based Evidence 4: 'dementia' 'caused by' 'tau'.  \nPath-based Evidence 5: 'tau' 'associates' 'Alzheimer Disease'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'neurotransmitters' 'activate' 'alpha7nAChR-positive neurons'.\n\nNeighbor-based Evidence 2: 'neurotransmitters' 'activate' 'GABAR-positive neurons'.\n\nNeighbor-based Evidence 3: 'AD' 'causes' 'cognitive decline'.\n\nNeighbor-based Evidence 4: 'AD' 'causes' 'neurodegeneration'.\n\nNeighbor-based Evidence 5: 'AD' 'treats' 'cholinesterase inhibitor'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      0.9202996492385864,
      0.8773843050003052,
      0.8702182769775391,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.9430060386657715,
      1.0000001192092896,
      1.0,
      1.0,
      1.0,
      0.910812497138977
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "23b6a6ff-c056-4c39-8f9e-21763c2e6809",
    "question": "Lesion is Alzheimer's disease are commonest at",
    "opa": "Aniygdala",
    "opb": "Nucleus of Meynes",
    "opc": "Pineal gland",
    "opd": "Prefrontal sulcus",
    "cop": 1,
    "choice_type": "single",
    "exp": "Nucleus basalis of Meyne for Alzheimer's disease and Parkinson's disease dementia. The nucleus basalis of Meyne (NBM) is a large source of cholinergic innervation to widespread coical areas. There have been two repos of DBS of the NBM for either AD or PD. Ref Harrison20th edition pg 2456",
    "subject_name": "Medicine",
    "topic_name": "C.N.S",
    "entity": "1. Lesion\n2. Alzheimer's disease\n3. Amygdala\n4. Nucleus of Meynes\n5. Pineal gland\n6. Prefrontal sulcus",
    "prediction": "B",
    "path": "Reranked Triple1: amygdala -> part of -> brain  \nReranked Triple2: amygdala -> associates -> mouse  \nReranked Triple3: amygdala -> part of -> brain -> associates -> mouse -> model of -> AD  \nReranked Triple4: amygdala -> part of -> brain -> associates -> AD -> TREATMENT -> curcumin -> binds -> hypothalamus  \nReranked Triple5: alzheimer disease -> CAUSES -> dementia  \n\nAnswer: A. Amygdala",
    "neighbor_input": "Reranked Triple1: AD -> causes -> cognitive decline  \nReranked Triple2: AD -> causes -> brain atrophy  \nReranked Triple3: AD -> causes -> neurodegeneration  \nReranked Triple4: AD -> causes -> memory impairment  \nReranked Triple5: AD -> causes -> cerebral lesions  ",
    "response_of_KG_list_path": "Path-based Evidence 1: The 'amygdala' is a 'part of' the 'brain'.\n\nPath-based Evidence 2: The 'amygdala' 'associates' with 'mouse'.\n\nPath-based Evidence 3: The 'amygdala' is a 'part of' the 'brain', which 'associates' with 'mouse', leading to a 'model of' 'AD' (Alzheimer's Disease).\n\nPath-based Evidence 4: The 'amygdala' is a 'part of' the 'brain', which 'associates' with 'AD', leading to 'TREATMENT' with 'curcumin', which 'binds' to the 'hypothalamus'.\n\nPath-based Evidence 5: 'Alzheimer disease' 'CAUSES' 'dementia'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'cognitive decline'.  \nNeighbor-based Evidence 2: 'AD' 'causes' 'brain atrophy'.  \nNeighbor-based Evidence 3: 'AD' 'causes' 'neurodegeneration'.  \nNeighbor-based Evidence 4: 'AD' 'causes' 'memory impairment'.  \nNeighbor-based Evidence 5: 'AD' 'causes' 'cerebral lesions'.",
    "entity_confidence_scores": [
      1.0000001192092896,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0,
      0.7779178619384766,
      0.6668194532394409,
      1.0000001192092896,
      0.7149689197540283,
      0.7548696994781494
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "b523715d-b959-4929-9ae2-d0cd01aacde2",
    "question": "Which of the following are pathological hallmark of Alzheimer&;s disease",
    "opa": "Intercellular Lewy Bodies",
    "opb": "Intracellular Pick's Bodies",
    "opc": "Extracellular Beta Amyloid Plaques",
    "opd": "Extracellular Neurofibrillary Tangles",
    "cop": 2,
    "choice_type": "multi",
    "exp": "The two hallmark pathologies required for a diagnosis of Alzheimer&;s disease(AD) are the extracellular plaque deposits of the Beta-amyloid peptide (Ab) and the intracellular flame-shaped neurofibrillary tangles of the Hyper-Phophorylated microtubule binding protein &;tau&;. Histological Hallmarks of Alzheimer&;s disease: b-Amyloid Plaque (Extracellular) Neurofibrillary Tangles (Intracellular) b-Amyloid Neuritic plaques are formed by extracellular accumulation of beta amyloid deposits. &;Neuritic&; or &;Senile&; b-amyloid plaques are an early histopathological sign of Alzheimer&;s disease (that occur rarely in healthy subjects) The amyloid b-protein accumulated in single Neuritic plaques is toxic to surrounding structures and adjacent neurons. Clinico-pathological studies have shown that amyloid burden does not directly correlate with severity or duration of dementia. Neurofibrillary tangles are formed by intracellular accumulation of hyper-phophorylated microtubule binding protein &;tau&; NFT&;s occur in many neurodegenerative diseases and/or a group of diseases called &;taupathies&;. These include Frontotemporal dementia, Pick&;s disease etc., The co-occurence of b-amyloid plaques with NFT&;s suggests a diagnosis of Alzheimer&;s disease (AD) The NFT&;s are toxic to the neurons and neurons with NFT&;s eventually die and degnerate leaving a residual &;ghost tangle&; in the extramedullary space reminding of the pyramidal cell body in which it was initially formed. Clinico-pathological studies have shown that dementia correlates more strongly with NFT&;s than with senile plaques (b-Amyloid) Ref: Bailey and Love 27th edition",
    "subject_name": "Pathology",
    "topic_name": "Nervous system",
    "entity": "1. Alzheimer's disease\n2. Intercellular Lewy Bodies\n3. Intracellular Pick's Bodies\n4. Extracellular Beta Amyloid Plaques\n5. Extracellular Neurofibrillary Tangles",
    "prediction": "C",
    "path": "Reranked Triple1: Alzheimer Disease \u2014\u2014> associates \u2014\u2014> AD  \nReranked Triple2: Alzheimer Disease \u2014\u2014> causes \u2014\u2014> dementia  \nReranked Triple3: dementia \u2014\u2014> caused by \u2014\u2014> tau  \nReranked Triple4: Alzheimer Disease \u2014\u2014> associates \u2014\u2014> Abeta (amyloid-beta)  \nReranked Triple5: Abeta (amyloid-beta) \u2014\u2014> regulates \u2014\u2014> AD",
    "neighbor_input": "Reranked Triple1: AD\u2014\u2014>causes\u2014\u2014>Abeta aggregation  \nReranked Triple2: AD\u2014\u2014>causes\u2014\u2014>neurofibrillary tangle pathology  \nReranked Triple3: AD\u2014\u2014>ASSOCIATES\u2014\u2014>amyloid-beta plaques  \nReranked Triple4: AD\u2014\u2014>ASSOCIATES\u2014\u2014>tau  \nReranked Triple5: AD\u2014\u2014>CASES\u2014\u2014>extracellular Beta Amyloid Plaques  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer Disease' 'associates' with 'AD'.  \nPath-based Evidence 2: 'Alzheimer Disease' 'causes' 'dementia'.  \nPath-based Evidence 3: 'dementia' 'caused by' 'tau'.  \nPath-based Evidence 4: 'Alzheimer Disease' 'associates' with 'Abeta (amyloid-beta)'.  \nPath-based Evidence 5: 'Abeta (amyloid-beta)' 'regulates' 'AD'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'AD' 'causes' 'Abeta aggregation'.\n\nNeighbor-based Evidence 2: 'AD' 'causes' 'neurofibrillary tangle pathology'.\n\nNeighbor-based Evidence 3: 'AD' 'ASSOCIATES' 'amyloid-beta plaques'.\n\nNeighbor-based Evidence 4: 'AD' 'ASSOCIATES' 'tau'.\n\nNeighbor-based Evidence 5: 'AD' 'CASES' 'extracellular Beta Amyloid Plaques'.",
    "entity_confidence_scores": [
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.7450574040412903,
      0.6093674898147583,
      0.9581561088562012,
      0.913022518157959
    ],
    "question_types": [
      "general"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  },
  {
    "id": "d1e3de35-3e36-4bc5-b0a5-8f750dacadf6",
    "question": "A 90-year-old woman with mild diabetes and Alzheimer's disease die in her sleep. At autopsy, hepatocytes are noted to contain golden cytoplasmic granules that do not stain with Prussian blue. Which of the following best accounts for pigment accumulation in the liver of this patient?",
    "opa": "Advanced age",
    "opb": "Alzheimer disease",
    "opc": "Congestive hea failure",
    "opd": "Diabetic ketoacidosis",
    "cop": 0,
    "choice_type": "single",
    "exp": "The answer is A: Advanced age. Substances that cannot be metabolized accumulate in cells. Examples include:- (1) endogenous substrates that are not processed because a key enzyme is missing (lysosomal storage diseases) (2) insoluble endogenous pigments (lipofuscin and melanin) (3) exogenous paiculates (silica and carbon) Lipofuscin is a \"wear and tear\" pigment of aging that accumulates in organs such as the brain, hea, and liver. None of the other choices are associated with lipofuscin accumulation.Diagnosis: Aging, lipofuscin",
    "subject_name": "Pathology",
    "topic_name": "Pigmentation",
    "entity": "1. woman \n2. diabetes \n3. Alzheimer's disease \n4. hepatocytes \n5. cytoplasmic granules \n6. Prussian blue \n7. pigment accumulation \n8. liver \n9. advanced age \n10. congestive heart failure \n11. diabetic ketoacidosis",
    "prediction": "A",
    "path": "Reranked Triple1: Alzheimer disease -> affects -> Participants -> consists of -> Women  \nReranked Triple2: woman -> has disease -> Alzheimer's disease  \nReranked Triple3: Diabetic -> is a -> disease -> NAME -> Alzheimer's disease  \nReranked Triple4: Diabetic -> has disease -> Diabetes  \nReranked Triple5: woman -> has disease -> Diabetes  ",
    "neighbor_input": "Reranked Triple1: woman -> has disease -> Alzheimer's disease  \nReranked Triple2: diabetes mellitus -> associates -> Alzheimer's disease  \nReranked Triple3: diabetes mellitus -> associates -> obesity  \nReranked Triple4: diabetes mellitus -> cerebrovascular health indicator -> vascular health  \nReranked Triple5: Women -> associates -> 4+ drinks  ",
    "response_of_KG_list_path": "Path-based Evidence 1: 'Alzheimer disease' 'affects' 'Participants', who 'consist of' 'Women'.\n\nPath-based Evidence 2: A 'woman' 'has disease' 'Alzheimer's disease'.\n\nPath-based Evidence 3: 'Diabetic' 'is a' 'disease', specifically 'NAME', which is 'Alzheimer's disease'.\n\nPath-based Evidence 4: 'Diabetic' 'has disease' 'Diabetes'.\n\nPath-based Evidence 5: A 'woman' 'has disease' 'Diabetes'.",
    "response_of_KG_neighbor": "Neighbor-based Evidence 1: 'woman' 'has disease' 'Alzheimer's disease'.\n\nNeighbor-based Evidence 2: 'diabetes mellitus' 'associates' 'Alzheimer's disease'.\n\nNeighbor-based Evidence 3: 'diabetes mellitus' 'associates' 'obesity'.\n\nNeighbor-based Evidence 4: 'diabetes mellitus' 'cerebrovascular health indicator' 'vascular health'.\n\nNeighbor-based Evidence 5: 'Women' 'associates' '4+ drinks'.",
    "entity_confidence_scores": [
      1.0,
      1.0,
      0.9999999403953552,
      1.0,
      0.6596330404281616,
      0.8405250310897827,
      1.0,
      1.0000001192092896,
      1.000000238418579,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      1.0000001192092896,
      0.9257240295410156,
      0.6446938514709473,
      0.7185409069061279,
      1.0,
      0.7725170850753784,
      0.74434494972229,
      1.0000001192092896,
      1.0,
      0.7338776588439941,
      1.0,
      0.6089299917221069,
      0.8405250310897827
    ],
    "question_types": [
      "exception"
    ],
    "ablation_config": {
      "major_switches": {
        "umls_standardization_module": true,
        "multi_strategy_entity_linking": true,
        "medical_reasoning_rules": true,
        "multi_hop_reasoning_optimization": true,
        "hierarchical_kg_framework": true,
        "adaptive_knowledge_selection": true,
        "kg_guided_reasoning": true,
        "enhanced_evidence_generation": true
      },
      "fine_grained_switches": {
        "umls_normalization": true,
        "medical_abbreviation_expansion": true,
        "semantic_variants_expansion": true,
        "concept_hierarchy_integration": true,
        "semantic_similarity_matching": true,
        "context_aware_linking": true,
        "confidence_estimation_fusion": true,
        "enhanced_entity_matching": true,
        "transitivity_reasoning": true,
        "inverse_relations_reasoning": true,
        "semantic_implications": true,
        "hierarchical_reasoning": true,
        "intelligent_path_selection": true,
        "medical_relevance_weighting": true,
        "dynamic_pruning": true,
        "path_quality_ranking": true,
        "disease_hierarchy": true,
        "symptom_hierarchy": true,
        "treatment_hierarchy": true,
        "anatomy_hierarchy": true,
        "question_type_aware_selection": true,
        "treatment_focused_knowledge": true,
        "diagnosis_focused_knowledge": true,
        "causation_focused_knowledge": true,
        "schema_based_reasoning": true,
        "optimal_subgraph_generation": true,
        "llm_kg_integration": true,
        "enhanced_path_finding": true,
        "enhanced_neighbor_extraction": true,
        "knowledge_reranking": true,
        "evidence_quality_validation": true
      }
    }
  }
]